data_1yv8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1yv8 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.543 HG21 ' CE2' ' A' ' 13' ' ' PHE . 50.8 m . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.334 0.588 . . . . 0.0 110.409 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.439 ' N ' HG23 ' A' ' 2' ' ' THR . 32.7 m -134.5 124.95 26.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.316 -0.865 . . . . 0.0 109.897 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.11 146.82 49.98 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.08 -1.013 . . . . 0.0 110.519 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.57 ' HD3' ' CE1' ' A' ' 44' ' ' TYR . 50.3 Cg_endo -75.83 -94.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.091 1.574 . . . . 0.0 110.547 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.1 t -48.25 123.24 6.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.5 -0.75 . . . . 0.0 110.363 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.407 ' O ' ' C ' ' A' ' 8' ' ' VAL . 2.5 mp -47.71 -54.83 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 110.108 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.407 ' C ' ' O ' ' A' ' 7' ' ' ILE . 21.6 t -44.34 -45.93 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 109.847 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.449 ' O ' ' HB ' ' A' ' 30' ' ' THR . . . -50.74 -42.87 57.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.2 -0.938 . . . . 0.0 109.721 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.406 ' O ' ' C ' ' A' ' 11' ' ' SER . 0.1 OUTLIER -68.77 -48.32 63.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 0.0 109.994 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -43.71 -42.12 5.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.89 . . . . 0.0 109.824 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 -75.3 -36.08 61.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.898 . . . . 0.0 109.853 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.543 ' CE2' HG21 ' A' ' 2' ' ' THR . 27.1 t80 -62.32 -33.26 74.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.331 -0.856 . . . . 0.0 109.923 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.73 -26.74 37.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.298 -0.876 . . . . 0.0 109.021 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 16' ' ' CYS . 1.2 t -82.49 -42.66 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.661 -0.649 . . . . 0.0 109.249 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.471 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 30.7 t -66.74 -24.34 66.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.314 -0.867 . . . . 0.0 109.767 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 17' ' ' ARG . 0.7 OUTLIER -88.07 -12.48 44.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.322 -0.861 . . . . 0.0 109.785 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.578 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -54.97 -46.88 99.55 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.393 -0.817 . . . . 0.0 110.254 179.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 18' ' ' LEU . 49.7 Cg_endo -80.11 -157.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.927 1.488 . . . . 0.0 110.148 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.92 72.65 1.85 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.434 HG21 ' HD2' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -130.93 134.1 25.57 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.272 -1.134 . . . . 0.0 110.153 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.457 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 44.5 Cg_endo -72.98 139.16 29.56 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.95 1.5 . . . . 0.0 110.576 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -44.35 -31.64 1.1 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.406 -0.809 . . . . 0.0 110.412 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.89 -41.78 99.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.192 -0.943 . . . . 0.0 110.342 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.457 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -66.81 -37.16 83.98 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.313 -0.867 . . . . 0.0 110.259 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.418 ' O ' HG22 ' A' ' 30' ' ' THR . 47.3 m -85.8 -45.89 11.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.278 -0.889 . . . . 0.0 110.185 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -45.3 -36.05 3.85 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.203 -0.936 . . . . 0.0 109.888 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.0 m -79.09 -49.46 12.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.922 . . . . 0.0 109.912 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -64.54 -26.61 68.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.358 -0.839 . . . . 0.0 109.926 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.496 HG21 ' N ' ' A' ' 13' ' ' PHE . 26.5 p -96.53 -51.36 4.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.324 -0.86 . . . . 0.0 110.218 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.42 22.08 3.2 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 27.2 m -97.56 168.12 10.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.247 -1.149 . . . . 0.0 110.225 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.0 pt -121.04 155.71 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.212 -0.93 . . . . 0.0 110.273 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.9 mt -104.4 125.63 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.209 -0.932 . . . . 0.0 110.219 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.452 ' O ' HG13 ' A' ' 35' ' ' ILE . 3.9 pt -128.17 136.91 29.76 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.336 -0.853 . . . . 0.0 110.016 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 C--N 1.305 -1.751 0 O-C-N 124.029 1.541 . . . . 0.0 110.795 -179.762 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.474 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 86.8 m . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.517 ' HG2' ' CB ' ' A' ' 44' ' ' TYR . 43.1 Cg_endo -68.8 -161.4 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.917 1.482 . . . . 0.0 110.315 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.82 -3.83 34.23 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.73 -5.07 6.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.192 -1.181 . . . . 0.0 110.224 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.57 ' CE1' ' HD3' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -120.9 18.8 11.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.359 -0.838 . . . . 0.0 110.039 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.64 93.6 8.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.284 -0.885 . . . . 0.0 110.161 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.258 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.2 m . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.282 0.563 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.5 m -151.5 130.31 12.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.196 -0.94 . . . . 0.0 110.276 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.529 ' O ' ' CB ' ' A' ' 46' ' ' ASN . 0.5 OUTLIER -131.05 148.76 71.55 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.314 -0.866 . . . . 0.0 110.112 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.565 ' HG3' ' CE1' ' A' ' 44' ' ' TYR . 50.0 Cg_endo -84.3 -91.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.103 1.58 . . . . 0.0 110.894 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.471 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 3.8 t -39.05 127.66 1.65 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.505 0.669 . . . . 0.0 110.992 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.3 mt -49.92 -54.44 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.266 -0.897 . . . . 0.0 109.627 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.421 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 50.0 t -45.69 -48.88 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.324 -0.86 . . . . 0.0 109.701 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.479 ' O ' ' CB ' ' A' ' 13' ' ' PHE . . . -45.79 -39.57 8.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.261 -0.899 . . . . 0.0 109.646 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -67.57 -44.37 78.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.234 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.403 ' O ' ' C ' ' A' ' 12' ' ' ASN . 10.2 t -57.12 -77.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.214 -0.929 . . . . 0.0 110.182 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.492 ' OD1' ' N ' ' A' ' 13' ' ' PHE . 10.2 p30 -44.52 -35.8 2.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.177 -0.952 . . . . 0.0 110.053 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.519 ' N ' HG22 ' A' ' 30' ' ' THR . 19.5 t80 -64.99 -56.04 15.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.919 . . . . 0.0 110.096 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -62.62 -43.72 98.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.207 -0.933 . . . . 0.0 109.26 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.506 HG13 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -61.6 -45.58 98.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.539 -0.726 . . . . 0.0 109.246 179.156 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.506 ' N ' HG13 ' A' ' 15' ' ' VAL . 34.8 t -50.87 -29.99 13.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.572 -0.705 . . . . 0.0 110.304 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -85.23 -4.12 59.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.203 -0.935 . . . . 0.0 110.328 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.576 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 3.7 tt -69.88 -46.28 23.66 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.959 . . . . 0.0 110.633 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 47.8 Cg_endo -74.27 -155.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.382 0 O-C-N 123.289 1.152 . . . . 0.0 109.998 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.39 27.47 7.71 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.45 ' OG1' ' HG2' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -93.56 137.32 23.38 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.146 -1.208 . . . . 0.0 110.029 179.759 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.431 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 48.3 Cg_endo -75.42 166.78 28.01 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.988 1.52 . . . . 0.0 110.658 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 24' ' ' ALA . 4.1 tt0 -65.39 -50.34 65.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.329 -0.857 . . . . 0.0 110.228 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 23' ' ' GLU . . . -43.56 -51.66 6.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 0.0 110.382 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.431 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.9 OUTLIER -57.22 -37.71 72.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 110.35 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.465 ' O ' ' OG1' ' A' ' 30' ' ' THR . 39.5 m -74.96 -63.04 1.35 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.887 . . . . 0.0 110.527 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 26' ' ' CYS . . . -41.91 -26.87 0.1 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.908 . . . . 0.0 110.441 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.439 ' N ' ' O ' ' A' ' 26' ' ' CYS . 20.2 m -90.08 -49.0 6.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.144 -0.973 . . . . 0.0 110.43 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -68.42 -27.09 65.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.186 -0.946 . . . . 0.0 110.268 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.519 HG22 ' N ' ' A' ' 13' ' ' PHE . 26.4 p -87.03 -48.44 8.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.192 -0.942 . . . . 0.0 110.245 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.21 14.04 5.14 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.418 ' C ' HG22 ' A' ' 33' ' ' ILE . 56.8 m -86.7 -166.91 1.7 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.182 -1.187 . . . . 0.0 109.961 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.418 HG22 ' C ' ' A' ' 32' ' ' CYS . 11.4 pt -149.2 150.57 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.072 -1.017 . . . . 0.0 110.612 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.0 mt -100.53 138.38 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.347 -0.846 . . . . 0.0 109.981 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 27.1 pt -125.12 143.73 45.13 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.16 -0.962 . . . . 0.0 110.365 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo . . . . . 0 C--N 1.305 -1.734 0 O-C-N 124.015 1.534 . . . . 0.0 110.265 179.857 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 44' ' ' TYR . 5.4 t . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.08 -174.43 1.94 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.957 1.504 . . . . 0.0 110.706 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.6 -29.06 12.62 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -60.06 -26.0 65.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.281 -1.129 . . . . 0.0 110.184 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.565 ' CE1' ' HG3' ' A' ' 5' ' ' PRO . 0.8 OUTLIER -144.91 77.42 1.53 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.328 -0.857 . . . . 0.0 109.934 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -120.2 90.87 3.41 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.229 -0.919 . . . . 0.0 110.781 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.529 ' CB ' ' O ' ' A' ' 4' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 117.925 -1.036 . . . . 0.0 110.125 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.508 ' CG2' ' CE1' ' A' ' 13' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.192 0.52 . . . . 0.0 109.979 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.479 ' O ' ' CG1' ' A' ' 33' ' ' ILE . 5.1 m -132.44 108.48 9.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.192 -0.943 . . . . 0.0 109.905 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.2 m -109.32 162.99 18.08 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.413 -0.804 . . . . 0.0 110.021 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.22 -95.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.903 1.475 . . . . 0.0 110.534 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.6 t -68.78 139.44 55.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.39 -0.819 . . . . 0.0 110.266 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.491 HG23 HD11 ' A' ' 7' ' ' ILE . 24.4 mt -46.42 -41.72 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.174 -0.954 . . . . 0.0 109.769 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.509 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 44.1 t -49.14 -57.45 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.464 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 8' ' ' VAL . . . -44.76 -37.03 3.5 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.366 -0.834 . . . . 0.0 109.443 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.448 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -75.5 -41.06 56.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.386 -0.822 . . . . 0.0 109.864 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.2 t -48.73 -72.31 0.05 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.0 109.919 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 8' ' ' VAL . 2.2 p30 -48.74 -42.96 37.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.358 -0.839 . . . . 0.0 109.955 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.508 ' CE1' ' CG2' ' A' ' 2' ' ' THR . 53.4 t80 -51.79 -47.93 64.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.244 -0.91 . . . . 0.0 110.182 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 10' ' ' ARG . 11.2 m120 -60.81 -27.21 67.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.139 -0.976 . . . . 0.0 109.433 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.506 ' CG1' ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -78.93 -49.58 19.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 121.587 0.708 . . . . 0.0 109.453 179.704 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.506 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 14.2 t -55.33 -16.41 3.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.564 -0.71 . . . . 0.0 110.741 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.485 ' NH2' ' OE1' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -88.42 -3.13 58.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.191 -0.943 . . . . 0.0 110.721 -179.671 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.596 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 1.5 tt -76.4 -41.62 3.04 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.131 -0.981 . . . . 0.0 111.031 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 18' ' ' LEU . 47.1 Cg_endo -76.16 -156.19 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.35 1.184 . . . . 0.0 110.042 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.56 27.2 19.82 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.449 ' CG2' ' SG ' ' A' ' 26' ' ' CYS . 29.8 m -90.41 133.19 33.49 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.057 -1.261 . . . . 0.0 109.928 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.465 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 44.2 Cg_endo -72.22 141.8 36.52 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.948 1.499 . . . . 0.0 110.594 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.485 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 7.2 mt-10 -43.31 -52.13 5.94 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.317 -0.864 . . . . 0.0 110.548 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 23' ' ' GLU . . . -41.98 -62.03 1.01 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 0.0 110.541 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.465 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -53.73 -36.91 62.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.286 -0.884 . . . . 0.0 110.562 -179.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.449 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 91.2 m -76.68 -34.86 58.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.166 -0.959 . . . . 0.0 110.235 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.85 -16.6 63.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.173 -0.954 . . . . 0.0 110.326 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 45.6 m -91.01 -47.9 7.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.191 -0.943 . . . . 0.0 110.362 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -63.89 -23.22 67.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.198 -0.939 . . . . 0.0 110.226 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 37.0 p -101.19 -48.35 4.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 110.205 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.84 69.59 0.62 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 48.8 t -140.46 163.87 31.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.214 -1.168 . . . . 0.0 110.128 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.479 ' CG1' ' O ' ' A' ' 3' ' ' CYS . 5.8 pt -112.4 147.13 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.083 -1.011 . . . . 0.0 110.334 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.0 mt -119.12 145.73 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.328 -0.857 . . . . 0.0 109.968 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.5 pt -127.15 153.61 76.75 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 0.0 110.463 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo . . . . . 0 C--N 1.306 -1.706 0 O-C-N 124.02 1.537 . . . . 0.0 110.014 179.555 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 70.9 m . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.05 139.3 32.54 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.952 1.501 . . . . 0.0 110.28 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.17 -18.01 12.1 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -93.71 7.97 42.77 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.142 -1.21 . . . . 0.0 110.357 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -166.85 52.81 0.08 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.211 -0.931 . . . . 0.0 110.2 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -124.75 87.72 2.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.334 -0.854 . . . . 0.0 110.107 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.055 -179.98 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.7 m . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.164 0.507 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.471 ' O ' HG12 ' A' ' 33' ' ' ILE . 19.7 m -134.06 121.07 21.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.896 . . . . 0.0 110.252 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.466 ' HB2' ' OXT' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -116.75 165.43 15.28 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.327 -0.858 . . . . 0.0 110.083 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.443 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 49.3 Cg_endo -75.36 -94.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.116 1.588 . . . . 0.0 111.265 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.4 t -92.62 168.5 11.19 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.699 0.761 . . . . 0.0 111.28 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.536 HG13 ' ND2' ' A' ' 46' ' ' ASN . 3.0 mt -51.67 -51.17 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.487 -0.758 . . . . 0.0 110.302 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.422 ' C ' ' O ' ' A' ' 7' ' ' ILE . 51.6 t -40.88 -53.26 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.383 -0.823 . . . . 0.0 110.139 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.451 ' O ' ' OD1' ' A' ' 12' ' ' ASN . . . -50.3 -40.8 49.65 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.292 -0.88 . . . . 0.0 109.557 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 46' ' ' ASN . 6.0 ttm180 -66.17 -37.61 86.05 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.268 -0.895 . . . . 0.0 110.276 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.4 t -60.67 -78.13 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.243 -0.911 . . . . 0.0 110.343 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 13' ' ' PHE . 12.1 p30 -45.91 -33.71 3.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.296 -0.878 . . . . 0.0 110.379 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.527 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 24.7 t80 -64.54 -48.15 76.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.394 -0.816 . . . . 0.0 110.4 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -65.13 -55.07 20.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -0.953 . . . . 0.0 110.063 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.545 ' CG1' ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -49.77 -53.15 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.367 -0.833 . . . . 0.0 109.658 179.699 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.545 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 42.2 t -49.51 -31.47 10.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -0.848 . . . . 0.0 110.297 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.93 -17.59 50.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.148 -0.97 . . . . 0.0 110.058 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.577 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.6 tp -56.21 -49.91 90.56 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.287 -0.883 . . . . 0.0 110.983 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 45.1 Cg_endo -71.51 -155.36 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.551 1.29 . . . . 0.0 110.282 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.08 61.86 1.07 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.0 m -129.84 132.55 24.23 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.279 -1.13 . . . . 0.0 109.893 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.8 148.76 59.06 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.993 1.523 . . . . 0.0 110.739 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.478 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 15.9 pt-20 -53.53 -19.91 4.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.366 -0.834 . . . . 0.0 110.342 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.56 -48.55 76.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.226 -0.921 . . . . 0.0 110.22 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.09 -26.92 60.64 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.281 -0.887 . . . . 0.0 110.359 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 72.9 m -88.86 -29.26 19.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -0.918 . . . . 0.0 110.445 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.478 ' CB ' ' O ' ' A' ' 23' ' ' GLU . . . -74.42 -24.61 59.12 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.271 -0.893 . . . . 0.0 110.209 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.4 m -87.56 -50.34 6.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 110.258 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.06 -23.78 21.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.946 . . . . 0.0 110.124 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 67.5 p -98.27 -39.23 8.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 110.174 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.37 16.19 10.58 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -77.23 175.86 9.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -1.162 . . . . 0.0 110.01 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.471 HG12 ' O ' ' A' ' 3' ' ' CYS . 15.0 pt -136.43 163.51 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.174 -0.954 . . . . 0.0 110.294 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 58.0 mt -132.6 141.61 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.884 . . . . 0.0 110.253 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.475 ' O ' HG13 ' A' ' 35' ' ' ILE . 8.9 pt -145.41 127.18 7.79 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 110.265 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo . . . . . 0 C--N 1.306 -1.683 0 O-C-N 123.834 1.439 . . . . 0.0 110.089 179.873 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.455 ' SG ' ' HD2' ' A' ' 41' ' ' PRO . 7.7 t . . . . . 0 N--CA 1.493 1.715 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.455 ' HD2' ' SG ' ' A' ' 40' ' ' CYS . 44.7 Cg_endo -70.92 151.21 62.25 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.967 1.509 . . . . 0.0 110.467 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.05 -8.79 62.15 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.45 ' OD2' ' HB2' ' A' ' 41' ' ' PRO . 56.8 p30 -89.88 -1.51 58.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -1.173 . . . . 0.0 110.044 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.93 48.45 0.79 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.361 -0.837 . . . . 0.0 110.088 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.477 ' O ' ' OD1' ' A' ' 46' ' ' ASN . . . -114.57 87.78 2.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 0.0 110.099 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.536 ' ND2' HG13 ' A' ' 7' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.103 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.558 HG23 ' CE2' ' A' ' 13' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.245 0.545 . . . . 0.0 110.295 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.3 m -154.56 128.27 8.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.856 . . . . 0.0 109.937 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.421 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 61.1 m -115.29 163.28 20.69 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.23 -0.919 . . . . 0.0 110.328 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 49.4 Cg_endo -75.75 -94.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.021 1.537 . . . . 0.0 110.764 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.17 148.61 51.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.56 -0.713 . . . . 0.0 110.586 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.7 mt -60.0 -45.95 94.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.331 -0.856 . . . . 0.0 110.095 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.8 t -49.36 -43.73 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.185 -0.947 . . . . 0.0 109.786 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.02 -37.99 81.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 110.006 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.457 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 5.6 ttm180 -61.24 -55.66 29.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.23 -0.919 . . . . 0.0 110.106 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -45.52 -60.06 2.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.293 -0.88 . . . . 0.0 110.001 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -52.21 -22.93 4.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.334 -0.854 . . . . 0.0 110.114 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.558 ' CE2' HG23 ' A' ' 2' ' ' THR . 17.9 t80 -75.83 -29.97 58.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 110.37 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -74.24 -31.17 62.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 109.363 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -69.3 -41.15 80.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.593 -0.692 . . . . 0.0 109.501 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.47 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 49.5 t -68.64 -32.14 71.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.555 -0.716 . . . . 0.0 110.998 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -84.77 -0.31 53.32 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.053 -1.029 . . . . 0.0 110.722 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.556 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -70.85 -48.9 14.57 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.086 -1.009 . . . . 0.0 110.208 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 48.2 Cg_endo -74.15 -155.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.584 1.308 . . . . 0.0 110.09 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.11 53.48 2.19 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.4 m -113.35 135.11 21.82 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.194 -1.18 . . . . 0.0 110.248 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.458 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 45.7 Cg_endo -73.64 158.56 47.15 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.876 1.461 . . . . 0.0 110.509 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.8 -35.86 77.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.303 -0.873 . . . . 0.0 110.327 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.34 -43.55 88.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.35 -0.844 . . . . 0.0 110.619 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.458 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -66.69 -34.42 77.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.109 -0.994 . . . . 0.0 110.285 -179.745 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 65.6 m -81.48 -47.93 12.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.193 -0.942 . . . . 0.0 110.066 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.93 -28.22 6.41 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.197 -0.939 . . . . 0.0 110.111 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.1 m -85.77 -37.8 18.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 110.251 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.84 -19.86 60.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.193 -0.942 . . . . 0.0 110.209 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.0 p -112.35 -58.94 2.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -0.914 . . . . 0.0 110.266 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.91 34.98 0.46 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 64.0 m -101.3 162.93 12.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.315 -1.109 . . . . 0.0 110.09 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.456 HD12 HG21 ' A' ' 35' ' ' ILE . 1.1 pp -122.99 149.55 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.218 -0.926 . . . . 0.0 110.176 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.9 mt -115.14 134.68 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.153 -0.967 . . . . 0.0 110.225 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.486 HD13 HG23 ' A' ' 35' ' ' ILE . 41.4 pt -119.39 151.68 51.67 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 110.175 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo . . . . . 0 C--N 1.305 -1.744 0 O-C-N 124.009 1.531 . . . . 0.0 110.487 -179.927 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.89 131.85 18.99 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.997 1.525 . . . . 0.0 110.61 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -48.31 -35.37 14.66 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.61 -47.12 58.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.206 -1.173 . . . . 0.0 110.049 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.92 62.48 0.68 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.333 -0.854 . . . . 0.0 110.054 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.432 ' O ' ' CG ' ' A' ' 46' ' ' ASN . . . -130.19 88.01 2.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 110.253 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.432 ' CG ' ' O ' ' A' ' 45' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.146 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.32 0.581 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.7 m -147.78 107.19 3.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.357 -0.84 . . . . 0.0 110.198 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.509 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 24.9 m -99.96 166.25 13.09 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.253 -0.904 . . . . 0.0 110.412 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.533 ' HG2' ' CB ' ' A' ' 9' ' ' ALA . 40.0 Cg_endo -71.41 -153.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 124.034 1.544 . . . . 0.0 110.353 179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.492 ' C ' ' O ' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -31.0 150.24 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.51 0.671 . . . . 0.0 111.548 -179.286 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.439 ' O ' ' C ' ' A' ' 8' ' ' VAL . 2.3 mt -48.44 -54.54 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.426 -0.796 . . . . 0.0 110.639 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.439 ' C ' ' O ' ' A' ' 7' ' ' ILE . 77.0 t -40.87 -55.29 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.437 -0.79 . . . . 0.0 110.322 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.533 ' CB ' ' HG2' ' A' ' 5' ' ' PRO . . . -53.22 -41.52 65.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.899 . . . . 0.0 109.961 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.477 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -67.39 -49.75 62.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.892 . . . . 0.0 109.951 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 p -47.66 -38.0 13.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -0.934 . . . . 0.0 109.969 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 13' ' ' PHE . 10.9 m-80 -70.72 -42.61 70.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.922 . . . . 0.0 110.007 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.477 ' HB3' ' O ' ' A' ' 10' ' ' ARG . 9.6 t80 -44.14 -46.43 8.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 0.0 109.764 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -69.55 -50.03 48.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.321 -0.862 . . . . 0.0 109.225 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -51.64 -45.35 36.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.512 -0.742 . . . . 0.0 109.094 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.467 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 40.0 t -66.4 -23.47 66.32 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.453 -0.779 . . . . 0.0 109.853 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.492 ' NH2' ' OE2' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -85.21 1.65 47.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 110.241 -179.819 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.548 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -60.87 -50.26 85.74 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.047 -1.033 . . . . 0.0 110.223 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 49.8 Cg_endo -73.65 -154.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.495 1.261 . . . . 0.0 109.621 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.9 64.01 0.88 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.431 HG21 ' HD2' ' A' ' 22' ' ' PRO . 18.6 m -115.12 140.28 25.45 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.242 -1.152 . . . . 0.0 110.453 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.433 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 47.8 Cg_endo -76.09 157.86 38.08 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.1 1.579 . . . . 0.0 110.279 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.492 ' OE2' ' NH2' ' A' ' 17' ' ' ARG . 1.2 mt-10 -58.3 -54.59 45.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.197 -0.94 . . . . 0.0 110.27 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 23' ' ' GLU . . . -42.06 -32.34 0.45 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.284 -0.885 . . . . 0.0 110.644 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.433 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -76.94 -52.14 9.93 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.195 -0.941 . . . . 0.0 110.735 -179.502 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 73.0 m -76.82 -28.5 55.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.112 -0.992 . . . . 0.0 110.156 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 23' ' ' GLU . . . -62.73 -48.2 80.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -0.891 . . . . 0.0 109.879 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 93.8 m -66.55 -43.09 86.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.312 -0.867 . . . . 0.0 109.657 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -54.92 -26.64 37.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.361 -0.837 . . . . 0.0 109.909 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 9' ' ' ALA . 7.3 p -105.27 -11.98 16.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.33 -0.856 . . . . 0.0 110.082 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.88 14.47 60.89 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 7.5 t -78.57 167.94 20.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.155 -1.203 . . . . 0.0 110.167 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.2 pt -136.24 159.16 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.234 -0.916 . . . . 0.0 110.234 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.2 mt -124.51 122.95 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.857 . . . . 0.0 110.498 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 23.1 pt -126.08 142.99 44.13 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.297 -0.877 . . . . 0.0 109.948 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo . . . . . 0 C--N 1.305 -1.755 0 O-C-N 123.98 1.516 . . . . 0.0 110.309 -179.945 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.94 -174.2 1.47 Allowed 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.018 1.536 . . . . 0.0 110.413 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.88 10.87 41.19 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 43' ' ' ASP . 32.4 p-10 -104.86 -18.61 14.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.183 -1.187 . . . . 0.0 110.148 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.403 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 0.1 OUTLIER -131.71 13.02 4.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -0.924 . . . . 0.0 110.117 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.83 88.65 5.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.246 -0.909 . . . . 0.0 110.17 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.181 179.958 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.603 ' CG2' ' CZ ' ' A' ' 13' ' ' PHE . 17.4 m . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.313 0.578 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.3 m -146.81 158.48 43.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.294 -0.879 . . . . 0.0 110.237 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.484 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -150.66 162.45 27.21 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.3 -0.875 . . . . 0.0 110.023 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.484 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 49.7 Cg_endo -81.34 -92.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.892 1.47 . . . . 0.0 110.645 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -50.99 133.08 27.51 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.566 -0.708 . . . . 0.0 110.805 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.459 ' O ' ' HB3' ' A' ' 10' ' ' ARG . 11.7 mm -52.45 -38.46 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.393 -0.817 . . . . 0.0 110.046 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.1 t -58.21 -53.12 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.911 . . . . 0.0 110.103 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -46.6 -37.1 7.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.167 -0.958 . . . . 0.0 110.019 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.459 ' HB3' ' O ' ' A' ' 7' ' ' ILE . 2.1 tpp180 -65.02 -48.39 74.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.356 -0.84 . . . . 0.0 110.323 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 12' ' ' ASN . 0.5 OUTLIER -52.76 -64.6 0.76 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.152 -0.967 . . . . 0.0 110.176 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.419 ' C ' ' O ' ' A' ' 11' ' ' SER . 71.8 m-20 -43.18 -41.7 3.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.908 . . . . 0.0 110.22 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.603 ' CZ ' ' CG2' ' A' ' 2' ' ' THR . 33.0 t80 -62.03 -38.13 87.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.178 -0.951 . . . . 0.0 110.063 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -67.22 -32.6 73.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.933 . . . . 0.0 109.717 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.532 ' CG1' ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -71.8 -52.33 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.518 -0.739 . . . . 0.0 109.688 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.532 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 41.0 t -54.54 -28.59 46.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.408 -0.808 . . . . 0.0 110.432 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.3 ttp85 -83.96 -12.42 55.35 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.203 -0.936 . . . . 0.0 110.132 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.563 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -59.34 -48.97 94.93 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.374 -0.829 . . . . 0.0 110.485 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 47.6 Cg_endo -74.94 -155.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.731 1.385 . . . . 0.0 110.117 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.86 69.14 0.72 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.469 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 0.7 OUTLIER -130.38 145.28 56.76 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.207 -1.172 . . . . 0.0 110.134 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.469 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 46.0 Cg_endo -73.4 135.13 21.85 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.917 1.483 . . . . 0.0 110.561 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 22' ' ' PRO . 39.4 mt-10 -43.15 -46.57 5.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.348 -0.845 . . . . 0.0 110.053 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' GLU . . . -42.8 -64.86 0.55 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.236 -0.915 . . . . 0.0 110.401 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.31 -33.12 19.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 110.461 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.461 ' O ' ' OG1' ' A' ' 30' ' ' THR . 85.7 m -80.49 -53.68 6.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.179 -0.951 . . . . 0.0 110.197 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.442 ' HA ' ' OG1' ' A' ' 30' ' ' THR . . . -57.85 -16.24 11.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 109.725 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 51.6 m -79.19 -60.31 2.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.391 -0.818 . . . . 0.0 110.215 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -66.83 -16.24 64.15 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.296 -0.877 . . . . 0.0 110.51 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 26' ' ' CYS . 24.1 p -92.67 -38.98 11.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.892 . . . . 0.0 110.097 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.37 18.56 10.93 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 83.9 m -89.74 167.57 12.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.137 -1.213 . . . . 0.0 110.109 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 pt -115.37 152.08 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.888 . . . . 0.0 110.174 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 85.7 mt -118.74 121.99 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.283 -0.886 . . . . 0.0 110.291 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.3 pt -117.84 157.02 49.27 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.188 -0.945 . . . . 0.0 110.416 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo . . . . . 0 C--N 1.306 -1.673 0 O-C-N 124.091 1.574 . . . . 0.0 110.546 -179.828 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.409 ' SG ' ' HA ' ' A' ' 45' ' ' ALA . 15.3 t . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 120.763 0.316 . . . . 0.0 110.343 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.04 133.34 19.57 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.971 1.511 . . . . 0.0 110.417 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -51.34 -43.01 51.16 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -49.86 -22.89 1.63 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -1.145 . . . . 0.0 110.155 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.458 ' CE2' ' HD3' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -145.68 59.29 1.26 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -0.884 . . . . 0.0 109.932 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.409 ' HA ' ' SG ' ' A' ' 40' ' ' CYS . . . -122.12 87.65 2.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.238 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.334 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.27 0.557 . . . . 0.0 110.298 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 44' ' ' TYR . 1.8 m -148.75 99.95 3.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 110.397 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.448 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 0.6 OUTLIER -105.8 142.33 24.57 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.271 -0.893 . . . . 0.0 110.139 179.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.448 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 45.8 Cg_endo -73.47 -93.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.004 1.528 . . . . 0.0 110.561 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.457 ' O ' ' HB1' ' A' ' 9' ' ' ALA . 0.9 OUTLIER -42.92 121.22 2.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.484 -0.76 . . . . 0.0 110.432 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.455 HD13 ' HB3' ' A' ' 46' ' ' ASN . 38.8 mm -55.13 -44.98 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.92 . . . . 0.0 110.108 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.9 t -53.54 -42.42 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 109.839 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' A' ' 6' ' ' SER . . . -53.48 -50.7 64.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.195 -0.941 . . . . 0.0 109.942 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -47.86 -46.25 31.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.247 -0.908 . . . . 0.0 109.857 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.79 -36.45 83.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.882 . . . . 0.0 109.912 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -71.1 -19.04 62.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.935 . . . . 0.0 109.878 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 23' ' ' GLU . 12.3 t80 -75.11 -44.41 47.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.325 -0.859 . . . . 0.0 109.848 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.424 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 76.7 m-20 -68.14 -43.85 77.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -0.907 . . . . 0.0 109.421 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.436 ' CG1' ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -53.02 -48.19 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.447 -0.783 . . . . 0.0 109.344 179.35 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.473 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 13.7 t -68.38 -15.27 63.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.494 -0.754 . . . . 0.0 110.049 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -87.07 -12.26 47.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.242 -0.911 . . . . 0.0 109.969 179.606 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.589 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 3.2 tm? -67.37 -41.67 34.02 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.291 -0.88 . . . . 0.0 111.507 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 48.0 Cg_endo -74.66 -155.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.264 1.139 . . . . 0.0 110.325 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.94 52.86 2.92 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.4 m -129.69 137.49 31.03 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.146 -1.208 . . . . 0.0 110.145 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.449 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 43.6 Cg_endo -71.43 167.78 25.37 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.053 1.554 . . . . 0.0 110.549 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.437 ' O ' ' C ' ' A' ' 24' ' ' ALA . 32.5 mp0 -68.42 -52.79 28.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.285 -0.884 . . . . 0.0 110.336 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 23' ' ' GLU . . . -41.04 -41.48 1.7 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.378 -0.826 . . . . 0.0 110.474 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.449 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -68.81 -45.41 71.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.351 -0.843 . . . . 0.0 110.177 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 59.9 m -74.85 -51.69 13.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.344 -0.847 . . . . 0.0 110.27 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.425 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -49.77 -48.31 50.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.0 110.423 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.7 m -63.26 -35.03 79.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.227 -0.921 . . . . 0.0 110.334 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -78.56 -0.98 31.83 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.304 -0.873 . . . . 0.0 110.486 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.3 p -120.88 -25.61 5.37 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.196 -0.94 . . . . 0.0 110.226 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.92 6.4 22.81 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 27' ' ' ALA . 22.5 m -84.35 139.71 32.08 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.149 -1.207 . . . . 0.0 110.266 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.53 HG12 ' CE1' ' A' ' 44' ' ' TYR . 1.1 pp -111.8 149.56 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 110.037 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.4 mt -120.74 117.39 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 110.349 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.7 pt -122.19 140.38 32.31 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.387 -0.82 . . . . 0.0 110.081 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo . . . . . 0 C--N 1.305 -1.742 0 O-C-N 124.086 1.572 . . . . 0.0 110.619 -179.834 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.504 ' O ' ' N ' ' A' ' 43' ' ' ASP . 47.7 Cg_endo -82.53 26.41 0.64 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.89 1.468 . . . . 0.0 111.378 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.45 -66.26 0.1 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 41' ' ' PRO . 22.5 p-10 -48.33 -32.22 7.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.186 -1.185 . . . . 0.0 110.496 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.53 ' CE1' HG12 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -81.38 -31.3 33.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.27 -0.894 . . . . 0.0 110.283 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.44 88.03 0.89 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.322 -0.861 . . . . 0.0 110.047 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.455 ' HB3' HD13 ' A' ' 7' ' ' ILE . 5.8 m120 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.296 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.406 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.313 0.577 . . . . 0.0 110.176 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 17.1 m -135.49 141.83 45.37 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.339 -0.851 . . . . 0.0 109.832 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -126.82 154.89 76.02 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.131 -0.981 . . . . 0.0 110.557 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -75.76 -94.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.195 1.629 . . . . 0.0 110.435 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.76 136.07 34.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.481 -0.762 . . . . 0.0 110.695 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.426 ' O ' ' HB3' ' A' ' 10' ' ' ARG . 13.8 mm -55.36 -53.27 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.342 -0.849 . . . . 0.0 110.077 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.414 ' C ' ' O ' ' A' ' 7' ' ' ILE . 53.0 t -44.15 -51.43 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 110.023 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -45.65 -52.15 11.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.102 -0.999 . . . . 0.0 109.786 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.469 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -50.48 -47.07 57.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.405 -0.809 . . . . 0.0 109.867 179.63 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.477 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 4.6 t -59.85 -40.99 90.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.303 -0.873 . . . . 0.0 110.073 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -76.19 -8.32 56.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.33 -0.856 . . . . 0.0 110.254 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.469 ' HB3' ' O ' ' A' ' 10' ' ' ARG . 53.9 t80 -77.05 -62.24 1.72 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.242 -0.912 . . . . 0.0 110.154 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -60.83 -34.35 74.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.149 -0.969 . . . . 0.0 108.899 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.494 HG13 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -60.98 -46.77 95.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.945 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.494 ' N ' HG13 ' A' ' 15' ' ' VAL . 7.0 t -55.92 -25.23 42.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.424 -0.798 . . . . 0.0 109.92 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -85.62 -13.19 49.46 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.304 -0.872 . . . . 0.0 110.554 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.597 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 4.0 tp -57.66 -43.58 98.9 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.198 -0.939 . . . . 0.0 111.416 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 45.0 Cg_endo -72.98 -30.42 10.95 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.309 1.163 . . . . 0.0 110.5 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.44 6.28 4.31 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.464 HG21 ' HD2' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -67.07 143.28 97.74 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.094 -1.239 . . . . 0.0 110.093 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.464 ' HD2' HG21 ' A' ' 21' ' ' THR . 43.9 Cg_endo -71.96 158.46 52.58 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.889 1.468 . . . . 0.0 110.814 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.45 -47.16 76.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.434 -0.791 . . . . 0.0 110.524 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.54 -45.25 26.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.232 -0.918 . . . . 0.0 110.627 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.412 ' HB3' HG21 ' A' ' 21' ' ' THR . 0.3 OUTLIER -67.14 -42.65 84.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.156 -0.965 . . . . 0.0 110.365 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 39.7 m -70.75 -52.85 18.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.208 -0.933 . . . . 0.0 110.179 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.414 ' HA ' ' HB2' ' A' ' 32' ' ' CYS . . . -53.12 -22.37 6.19 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 110.37 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.9 m -86.99 -34.44 19.26 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.211 -0.931 . . . . 0.0 110.324 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -79.08 -20.34 49.01 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.197 -0.939 . . . . 0.0 110.197 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.0 p -110.28 -24.49 10.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.156 -0.965 . . . . 0.0 110.202 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.34 61.0 1.34 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -117.32 174.94 5.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -1.131 . . . . 0.0 110.418 -179.85 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 2' ' ' THR . 1.0 OUTLIER -135.92 147.43 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.369 -0.832 . . . . 0.0 110.29 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.1 mt -116.17 108.88 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 110.156 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.447 ' O ' HG13 ' A' ' 35' ' ' ILE . 18.1 pt -88.78 145.05 34.09 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.268 -0.895 . . . . 0.0 110.342 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo . . . . . 0 C--N 1.306 -1.705 0 O-C-N 123.997 1.525 . . . . 0.0 110.345 179.957 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.464 ' SG ' ' HD2' ' A' ' 41' ' ' PRO . 4.4 t . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 120.634 0.254 . . . . 0.0 110.38 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.464 ' HD2' ' SG ' ' A' ' 40' ' ' CYS . 43.6 Cg_endo -71.08 -160.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.927 1.488 . . . . 0.0 110.311 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -113.52 4.75 24.77 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -96.78 -29.95 13.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.101 -1.235 . . . . 0.0 110.241 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.46 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 5.9 t80 -119.26 7.98 11.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.268 -0.895 . . . . 0.0 110.435 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 41' ' ' PRO . . . -94.81 87.47 5.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -0.99 . . . . 0.0 110.138 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.227 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.575 HG22 ' CE1' ' A' ' 13' ' ' PHE . 2.1 m . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.202 0.525 . . . . 0.0 110.143 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.449 ' HB3' ' HA ' ' A' ' 45' ' ' ALA . 57.7 m -146.19 156.34 43.34 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.139 -0.976 . . . . 0.0 110.716 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.434 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -134.34 174.26 4.85 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.386 -0.821 . . . . 0.0 109.95 179.672 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.434 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 46.2 Cg_endo -72.99 -93.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.993 1.523 . . . . 0.0 109.913 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 7' ' ' ILE . 5.8 t -75.33 143.65 42.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.528 -0.732 . . . . 0.0 109.789 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.417 ' C ' ' O ' ' A' ' 6' ' ' SER . 71.2 mt -42.79 -47.9 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.223 -0.923 . . . . 0.0 110.125 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.4 t -50.36 -51.19 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -0.924 . . . . 0.0 110.047 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.85 -34.95 13.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.169 -0.957 . . . . 0.0 110.214 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 11' ' ' SER . 0.1 OUTLIER -65.64 -58.74 5.0 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 110.2 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 10' ' ' ARG . 4.9 p -42.38 -45.07 4.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.231 -0.918 . . . . 0.0 110.323 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -57.49 -51.47 69.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.199 -0.938 . . . . 0.0 110.322 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.575 ' CE1' HG22 ' A' ' 2' ' ' THR . 6.1 t80 -54.44 -39.04 67.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.21 -0.931 . . . . 0.0 110.19 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -67.93 -23.01 65.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -0.895 . . . . 0.0 109.129 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -85.34 -46.9 17.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.302 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.5 ' N ' HG12 ' A' ' 15' ' ' VAL . 9.6 t -60.2 -14.33 16.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.594 -0.691 . . . . 0.0 110.312 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.498 ' NH2' ' HB3' ' A' ' 17' ' ' ARG . 7.5 mmm180 -86.98 -7.74 57.86 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.156 -0.965 . . . . 0.0 109.957 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.589 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 2.4 tp -81.18 -43.68 1.17 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.367 -0.833 . . . . 0.0 111.248 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 46.3 Cg_endo -73.34 -155.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.228 1.12 . . . . 0.0 110.214 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.99 6.36 62.03 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.37 129.85 88.4 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.186 -1.185 . . . . 0.0 110.047 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.0 157.76 53.88 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.921 1.485 . . . . 0.0 110.513 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -52.91 -33.84 52.27 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.363 -0.836 . . . . 0.0 110.433 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.56 -65.08 0.69 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.954 . . . . 0.0 110.328 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.97 -27.33 18.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.322 -0.861 . . . . 0.0 110.436 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 82.0 m -81.1 -56.52 4.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.963 . . . . 0.0 110.392 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -47.99 -22.92 0.67 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.332 -0.855 . . . . 0.0 110.509 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.9 m -82.09 -58.57 2.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.133 -0.979 . . . . 0.0 110.535 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.7 -21.4 40.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.291 -0.881 . . . . 0.0 110.315 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.6 p -109.42 -29.13 8.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -0.897 . . . . 0.0 110.209 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 85.98 20.53 55.33 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.99 173.19 8.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.214 -1.168 . . . . 0.0 110.393 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.409 ' C ' HG13 ' A' ' 34' ' ' ILE . 4.5 pt -130.64 152.86 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.359 -0.838 . . . . 0.0 109.774 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.409 HG13 ' C ' ' A' ' 33' ' ' ILE . 34.3 mt -131.96 118.19 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.034 -1.041 . . . . 0.0 110.749 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.2 pt -105.14 159.91 27.78 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.313 -0.867 . . . . 0.0 109.952 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo . . . . . 0 C--N 1.306 -1.675 0 O-C-N 123.925 1.487 . . . . 0.0 110.817 -179.902 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 120.744 0.307 . . . . 0.0 110.468 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.443 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 47.7 Cg_endo -73.92 149.48 42.22 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.029 1.541 . . . . 0.0 110.286 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.78 -19.01 66.95 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -59.47 -34.9 73.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -1.188 . . . . 0.0 110.293 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -147.35 55.57 1.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.933 . . . . 0.0 110.239 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.449 ' HA ' ' HB3' ' A' ' 3' ' ' CYS . . . -129.32 87.61 2.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.874 . . . . 0.0 110.181 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.251 179.988 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.55 HG21 ' CE2' ' A' ' 13' ' ' PHE . 2.0 m . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.407 0.623 . . . . 0.0 110.43 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 83.8 m -133.55 116.21 15.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 110.172 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 0.7 OUTLIER -108.86 149.86 40.11 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.308 -0.87 . . . . 0.0 110.646 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.499 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 48.9 Cg_endo -79.07 -91.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.299 1.684 . . . . 0.0 110.479 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.2 t -50.18 133.24 23.72 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 110.303 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.5 mt -52.81 -54.3 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.174 -0.954 . . . . 0.0 109.898 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 9' ' ' ALA . 2.5 t -46.86 -47.49 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -0.935 . . . . 0.0 109.36 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 8' ' ' VAL . . . -43.96 -48.5 8.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.276 -0.89 . . . . 0.0 109.445 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -58.34 -41.55 84.88 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.285 -0.884 . . . . 0.0 109.666 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 8' ' ' VAL . 0.3 OUTLIER -60.14 -59.38 5.51 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.345 -0.847 . . . . 0.0 109.621 179.553 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -59.23 -25.6 64.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.558 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.55 ' CE2' HG21 ' A' ' 2' ' ' THR . 24.1 t80 -71.4 -25.35 62.31 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.43 -0.794 . . . . 0.0 109.809 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.17 -46.41 34.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.314 -0.866 . . . . 0.0 109.053 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.525 ' O ' ' CD ' ' A' ' 19' ' ' PRO . 1.1 t -56.61 -38.77 58.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.1 t -69.13 -27.65 65.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.485 -0.759 . . . . 0.0 110.455 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.521 ' HB3' ' CZ ' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -86.0 -11.84 51.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.102 -0.999 . . . . 0.0 110.616 -179.719 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.566 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -69.41 -50.03 20.92 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.206 -0.934 . . . . 0.0 110.824 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 45.4 Cg_endo -73.04 -155.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.553 1.291 . . . . 0.0 110.351 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.21 75.36 0.29 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 m -135.93 138.71 28.45 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.247 -1.149 . . . . 0.0 109.887 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.463 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 43.8 Cg_endo -72.19 150.76 54.07 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.982 1.517 . . . . 0.0 110.372 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.1 -49.23 66.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.325 -0.859 . . . . 0.0 110.462 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -44.19 -54.26 5.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.378 -0.826 . . . . 0.0 110.695 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.463 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.6 OUTLIER -56.7 -37.87 71.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.182 -0.949 . . . . 0.0 110.646 -179.626 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 83.7 m -78.88 -44.28 23.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.167 -0.958 . . . . 0.0 110.261 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.94 -24.98 7.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 110.408 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.1 m -89.5 -48.54 7.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.214 -0.929 . . . . 0.0 110.064 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -63.66 -22.2 66.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.352 -0.842 . . . . 0.0 110.38 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.6 p -110.79 -47.02 3.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.201 -0.937 . . . . 0.0 110.378 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.75 56.89 0.34 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.487 ' CB ' ' CE1' ' A' ' 13' ' ' PHE . 0.1 OUTLIER -120.36 176.37 5.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.259 -1.142 . . . . 0.0 110.063 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.85 148.51 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.181 -0.949 . . . . 0.0 110.316 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 23.9 mt -104.68 132.67 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 110.132 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.5 pt -103.83 155.39 37.08 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.132 -0.98 . . . . 0.0 110.392 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 C--N 1.305 -1.729 0 O-C-N 124.061 1.558 . . . . 0.0 110.809 179.988 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 44' ' ' TYR . 4.2 t . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 120.86 0.362 . . . . 0.0 110.581 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.463 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 47.2 Cg_endo -72.27 -163.51 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.941 1.495 . . . . 0.0 110.322 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.44 -14.62 29.68 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.01 -32.63 67.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.312 -1.111 . . . . 0.0 110.33 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.461 ' O ' ' SG ' ' A' ' 40' ' ' CYS . 0.2 OUTLIER -135.5 68.32 1.46 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.313 -0.867 . . . . 0.0 110.096 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 41' ' ' PRO . . . -130.45 88.93 2.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.111 -0.993 . . . . 0.0 110.793 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.499 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 1.2 m120 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.039 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.549 HG22 ' CZ ' ' A' ' 13' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.328 0.585 . . . . 0.0 110.447 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 26.7 m -129.48 97.08 4.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 0.0 109.922 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.422 ' N ' ' SG ' ' A' ' 32' ' ' CYS . 22.0 m -99.2 158.02 33.01 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.295 -0.878 . . . . 0.0 110.391 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -77.08 -95.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 124.075 1.566 . . . . 0.0 110.469 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.7 t -54.68 134.34 47.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.462 -0.773 . . . . 0.0 110.255 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.4 mt -57.93 -44.25 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -0.918 . . . . 0.0 109.852 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.3 t -50.45 -49.17 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.364 -0.835 . . . . 0.0 109.835 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.93 -43.52 63.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 109.749 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.451 ' HG3' ' OXT' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -53.81 -58.27 7.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.202 -0.936 . . . . 0.0 109.842 179.652 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -45.97 -51.11 13.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.193 -0.942 . . . . 0.0 109.477 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -55.17 -36.73 66.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.329 -0.857 . . . . 0.0 109.137 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.549 ' CZ ' HG22 ' A' ' 2' ' ' THR . 38.4 t80 -74.6 -28.58 60.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.444 -0.785 . . . . 0.0 109.435 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -68.14 -27.39 66.4 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.454 -0.779 . . . . 0.0 109.147 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -82.46 -49.3 17.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.184 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.504 ' N ' HG12 ' A' ' 15' ' ' VAL . 42.7 t -58.92 -20.84 55.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.383 -0.823 . . . . 0.0 109.973 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.511 ' CD ' ' HG3' ' A' ' 23' ' ' GLU . 2.7 tpt85 -89.61 -20.11 24.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.217 -0.927 . . . . 0.0 110.179 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.585 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 15.4 tp -56.75 -41.71 92.66 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.882 . . . . 0.0 110.841 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 18' ' ' LEU . 47.9 Cg_endo -76.11 -156.17 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.324 1.171 . . . . 0.0 110.293 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.84 14.35 65.33 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 m -75.5 137.65 71.01 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.11 -1.229 . . . . 0.0 110.008 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.427 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 47.9 Cg_endo -73.44 158.56 47.88 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.968 1.509 . . . . 0.0 110.587 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.511 ' HG3' ' CD ' ' A' ' 17' ' ' ARG . 1.0 OUTLIER -60.45 -49.06 79.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.34 -0.85 . . . . 0.0 110.354 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' GLU . . . -43.37 -49.02 7.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 110.306 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.427 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -59.84 -47.28 86.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.278 -0.889 . . . . 0.0 110.398 -179.798 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.407 ' HB2' ' CE1' ' A' ' 13' ' ' PHE . 25.9 m -72.38 -43.86 63.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.175 -0.953 . . . . 0.0 110.21 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.6 -38.94 70.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.158 -0.963 . . . . 0.0 110.103 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.4 m -80.32 -21.83 42.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 0.0 110.157 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -85.32 -11.07 55.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.202 -0.936 . . . . 0.0 110.131 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 55.4 p -123.87 -31.77 3.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.321 -0.862 . . . . 0.0 110.126 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.58 60.05 0.52 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.422 ' SG ' ' N ' ' A' ' 4' ' ' CYS . 8.4 t -131.76 173.42 11.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.285 -1.127 . . . . 0.0 110.185 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.0 pt -135.02 157.81 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.289 -0.882 . . . . 0.0 110.33 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.403 HD13 ' CB ' ' A' ' 23' ' ' GLU . 26.2 mt -114.29 144.72 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.349 -0.845 . . . . 0.0 110.059 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.432 ' O ' HG13 ' A' ' 35' ' ' ILE . 3.8 pt -120.11 150.42 51.18 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.913 . . . . 0.0 110.259 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo . . . . . 0 C--N 1.305 -1.742 0 O-C-N 124.103 1.581 . . . . 0.0 110.434 179.98 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 120.721 0.296 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 42' ' ' GLY . 46.8 Cg_endo -74.7 127.1 10.63 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.967 1.509 . . . . 0.0 110.402 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -44.68 -28.49 1.64 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -51.82 -35.88 46.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.304 -1.116 . . . . 0.0 110.367 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.443 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 1.1 t80 -134.0 31.76 3.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 0.0 110.332 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -110.07 98.03 7.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.189 -0.944 . . . . 0.0 110.276 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.451 ' OXT' ' HG3' ' A' ' 10' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.261 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.467 ' CG2' ' HB3' ' A' ' 32' ' ' CYS . 99.5 m . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.435 0.636 . . . . 0.0 110.451 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.501 ' SG ' ' CD1' ' A' ' 35' ' ' ILE . 61.5 m -120.28 112.25 18.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.375 -0.828 . . . . 0.0 109.93 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.457 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -122.34 146.56 47.43 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.167 -0.958 . . . . 0.0 110.193 -179.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.562 ' HG3' ' CE2' ' A' ' 44' ' ' TYR . 48.0 Cg_endo -72.95 -93.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.983 1.517 . . . . 0.0 110.42 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 5' ' ' PRO . 1.6 t -42.21 109.51 0.13 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.527 -0.733 . . . . 0.0 110.334 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.2 mt -44.23 -50.83 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.167 -0.958 . . . . 0.0 110.178 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 69.7 t -47.13 -41.79 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -0.953 . . . . 0.0 109.885 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.09 -47.71 77.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.92 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.46 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 0.9 OUTLIER -60.93 -42.01 97.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.317 -0.864 . . . . 0.0 110.295 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.73 -48.43 72.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.179 -0.951 . . . . 0.0 110.223 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -65.71 -22.44 66.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.153 -0.967 . . . . 0.0 110.016 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.46 ' HB3' ' O ' ' A' ' 10' ' ' ARG . 49.6 t80 -74.83 -35.07 62.42 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.318 -0.864 . . . . 0.0 109.945 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -64.18 -51.3 64.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 0.0 109.477 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.508 ' CG1' ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -55.57 -51.06 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.408 -0.807 . . . . 0.0 109.33 179.422 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.508 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 53.4 t -48.39 -28.55 3.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.371 -0.831 . . . . 0.0 109.944 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.444 ' C ' ' HD2' ' A' ' 19' ' ' PRO . 11.1 tpt180 -83.99 -20.99 31.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.344 -0.847 . . . . 0.0 110.07 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.574 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 3.4 tm? -49.61 -45.37 78.53 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 110.934 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 47.3 Cg_endo -73.02 -155.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.254 1.134 . . . . 0.0 110.033 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.46 50.74 1.26 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.449 HG23 ' HD2' ' A' ' 22' ' ' PRO . 93.2 m -115.5 140.06 25.45 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.21 -1.17 . . . . 0.0 110.099 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.474 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 43.8 Cg_endo -71.63 165.92 31.02 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.846 1.445 . . . . 0.0 110.315 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -69.4 -46.36 67.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -0.906 . . . . 0.0 110.424 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.76 -45.34 19.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 0.0 110.372 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.474 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -62.6 -48.29 80.07 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.157 -0.964 . . . . 0.0 110.281 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.453 ' O ' ' OG1' ' A' ' 30' ' ' THR . 73.0 m -68.44 -44.81 74.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.136 -0.978 . . . . 0.0 110.047 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.58 -37.13 26.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.181 -0.949 . . . . 0.0 109.867 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.1 m -72.73 -40.63 65.93 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.322 -0.861 . . . . 0.0 109.967 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -78.37 -9.75 59.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.855 . . . . 0.0 110.045 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 26' ' ' CYS . 17.3 p -110.54 -19.57 12.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.297 -0.877 . . . . 0.0 110.169 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.23 23.42 48.35 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.467 ' HB3' ' CG2' ' A' ' 2' ' ' THR . 33.4 m -101.02 171.1 7.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -1.181 . . . . 0.0 110.231 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 3' ' ' CYS . 23.8 pt -123.47 156.04 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.917 . . . . 0.0 109.985 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.438 HD11 ' OG1' ' A' ' 2' ' ' THR . 20.9 mm -106.09 152.37 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 110.404 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.501 ' CD1' ' SG ' ' A' ' 3' ' ' CYS . 4.6 pt -156.18 150.73 20.23 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.336 -0.852 . . . . 0.0 110.331 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo . . . . . 0 C--N 1.305 -1.712 0 O-C-N 124.15 1.605 . . . . 0.0 110.957 -179.665 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.412 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 8.2 m . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.525 ' O ' ' N ' ' A' ' 43' ' ' ASP . 52.8 Cg_endo -79.78 32.77 0.49 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.843 1.444 . . . . 0.0 111.593 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.422 ' CA ' ' HB3' ' A' ' 45' ' ' ALA . . . 65.06 -68.21 0.08 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 41' ' ' PRO . 0.3 OUTLIER -48.67 -41.44 31.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.111 -1.229 . . . . 0.0 109.774 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.562 ' CE2' ' HG3' ' A' ' 5' ' ' PRO . 0.5 OUTLIER -106.34 32.78 4.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -0.837 . . . . 0.0 109.887 179.629 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.51 ' O ' ' CB ' ' A' ' 46' ' ' ASN . . . -105.31 96.33 6.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.324 -0.86 . . . . 0.0 110.243 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 45' ' ' ALA . 1.3 m-20 . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.111 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.45 ' O ' ' SG ' ' A' ' 3' ' ' CYS . 91.9 m . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.168 0.508 . . . . 0.0 110.363 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.451 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 49.1 m -153.63 154.7 34.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.344 -0.847 . . . . 0.0 110.321 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.13 171.31 9.15 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 109.983 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.1 -95.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.99 1.521 . . . . 0.0 110.707 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.4 t -76.11 157.77 32.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.496 -0.753 . . . . 0.0 110.423 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.409 ' O ' ' C ' ' A' ' 8' ' ' VAL . 2.4 mp -58.33 -50.07 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.882 . . . . 0.0 109.874 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.409 ' C ' ' O ' ' A' ' 7' ' ' ILE . 91.1 t -44.69 -47.97 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.312 -0.868 . . . . 0.0 109.901 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.91 -45.17 71.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 109.915 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.419 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 9.5 ttm-85 -63.45 -48.6 77.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.388 -0.82 . . . . 0.0 110.271 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -50.11 -59.26 4.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.141 -0.975 . . . . 0.0 110.132 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -55.2 -40.45 70.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.912 . . . . 0.0 110.016 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.46 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 51.0 t80 -56.88 -43.8 81.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 0.0 110.097 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -58.4 -42.08 86.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.241 -0.912 . . . . 0.0 109.263 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.515 ' CG1' ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -61.89 -50.65 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.599 -0.688 . . . . 0.0 109.282 179.25 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.515 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 13.9 t -48.25 -25.61 1.61 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.443 -0.786 . . . . 0.0 110.099 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.549 ' NH2' ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -91.16 10.53 26.6 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.428 -0.795 . . . . 0.0 109.585 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.618 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 2.3 tt -84.04 -36.87 0.64 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.517 -0.739 . . . . 0.0 112.349 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 43.8 Cg_endo -72.54 -37.61 4.01 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 O-C-N 122.994 0.997 . . . . 0.0 111.356 -178.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 135.38 1.22 3.19 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.526 -1.321 . . . . 0.0 110.429 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.549 ' O ' ' NH2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -66.4 157.04 83.81 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 120.97 -1.312 . . . . 0.0 109.486 179.733 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.536 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 47.7 Cg_endo -74.98 149.5 36.86 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.795 1.418 . . . . 0.0 110.71 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.54 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 1.6 pt-20 -54.84 -25.4 28.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.349 -0.844 . . . . 0.0 110.14 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.17 -44.22 84.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.311 -0.868 . . . . 0.0 110.44 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.461 HD22 ' O ' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -68.55 -33.69 74.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 110.444 -179.782 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.45 ' O ' ' OG1' ' A' ' 30' ' ' THR . 69.6 m -87.45 -32.83 19.29 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.052 -1.03 . . . . 0.0 110.581 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.58 -30.35 70.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.098 -1.001 . . . . 0.0 110.035 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.86 -28.1 17.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 0.0 110.15 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.452 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -68.84 -28.9 67.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.216 -0.928 . . . . 0.0 110.324 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -101.68 -30.52 11.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.214 -0.929 . . . . 0.0 110.092 179.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.52 19.05 9.04 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -76.43 -177.55 4.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -1.135 . . . . 0.0 110.003 179.936 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.443 HG23 ' O ' ' A' ' 32' ' ' CYS . 1.6 pp -145.81 159.53 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.154 -0.966 . . . . 0.0 110.485 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 53.4 mt -125.58 121.37 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.354 -0.842 . . . . 0.0 110.061 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.443 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 12.1 pt -93.46 163.79 23.38 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.935 . . . . 0.0 110.361 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.443 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 48.7 Cg_endo . . . . . 0 C--N 1.306 -1.701 0 O-C-N 124.008 1.531 . . . . 0.0 110.584 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 120.937 0.398 . . . . 0.0 110.314 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.448 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 46.4 Cg_endo -72.98 -166.56 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.152 1.606 . . . . 0.0 110.866 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.47 -5.62 39.48 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.517 ' OD2' ' N ' ' A' ' 44' ' ' TYR . 4.3 p30 -82.35 -24.42 34.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -1.14 . . . . 0.0 110.038 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.517 ' N ' ' OD2' ' A' ' 43' ' ' ASP . 0.2 OUTLIER -144.64 47.15 1.37 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 110.311 -179.817 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -118.61 89.42 3.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 110.065 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.1 m120 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.258 -179.94 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.448 ' CG2' ' O ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.273 0.559 . . . . 0.0 110.256 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 44' ' ' TYR . 1.8 t -142.49 121.68 13.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.323 -0.861 . . . . 0.0 110.107 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.443 ' O ' ' OXT' ' A' ' 46' ' ' ASN . 57.8 m -120.71 150.11 51.9 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.246 -0.909 . . . . 0.0 110.214 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.525 ' HD3' ' CE2' ' A' ' 44' ' ' TYR . 52.6 Cg_endo -77.79 -94.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.125 1.592 . . . . 0.0 110.614 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 t -50.29 129.54 21.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.476 -0.765 . . . . 0.0 110.593 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.3 mm -50.71 -41.05 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.212 -0.93 . . . . 0.0 109.369 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 56.1 t -53.32 -47.3 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.436 -0.79 . . . . 0.0 109.715 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.47 -52.72 27.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.344 -0.847 . . . . 0.0 109.91 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.9 ttm-85 -55.64 -43.85 76.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.266 -0.896 . . . . 0.0 109.941 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.55 -56.97 6.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.0 109.933 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -60.08 -33.1 71.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.332 -0.855 . . . . 0.0 109.903 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.444 ' CZ ' ' HD3' ' A' ' 17' ' ' ARG . 16.1 t80 -70.96 -35.91 72.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.0 109.804 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -73.51 -44.57 57.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.346 -0.846 . . . . 0.0 109.447 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -54.91 -47.3 76.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.459 -0.775 . . . . 0.0 109.197 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.453 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 29.7 t -68.78 -25.53 64.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.464 -0.772 . . . . 0.0 109.93 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.444 ' HD3' ' CZ ' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -88.74 -8.44 54.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.384 -0.822 . . . . 0.0 109.879 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.577 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -61.94 -45.62 91.95 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.462 -0.774 . . . . 0.0 110.654 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 18' ' ' LEU . 47.4 Cg_endo -78.29 -157.41 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.759 1.4 . . . . 0.0 110.075 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.6 61.77 2.75 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.448 HG22 ' SG ' ' A' ' 16' ' ' CYS . 99.1 m -119.47 140.67 29.55 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.237 -1.155 . . . . 0.0 110.306 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.31 170.37 19.36 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.006 1.53 . . . . 0.0 110.841 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.463 ' O ' ' N ' ' A' ' 25' ' ' LEU . 1.4 mt-10 -72.44 -55.27 7.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.358 -0.839 . . . . 0.0 110.477 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 23' ' ' GLU . . . -39.8 -28.48 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.355 -0.84 . . . . 0.0 110.603 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.463 ' N ' ' O ' ' A' ' 23' ' ' GLU . 0.7 OUTLIER -81.3 -50.13 9.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.169 -0.957 . . . . 0.0 110.599 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.446 ' O ' HG21 ' A' ' 30' ' ' THR . 13.2 m -83.5 -27.6 29.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.141 -0.975 . . . . 0.0 110.666 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -74.14 -49.31 24.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.168 -0.957 . . . . 0.0 110.561 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.2 m -76.17 -23.41 54.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.224 -0.922 . . . . 0.0 110.503 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.428 ' CB ' ' O ' ' A' ' 25' ' ' LEU . 48.1 t80 -81.44 -6.41 58.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.931 . . . . 0.0 110.413 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.446 HG21 ' O ' ' A' ' 26' ' ' CYS . 31.3 p -119.19 -21.71 7.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 0.0 110.189 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.85 38.93 3.26 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 57.0 m -108.86 -179.34 3.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.18 -1.188 . . . . 0.0 110.23 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.448 ' O ' ' CG2' ' A' ' 2' ' ' THR . 9.1 pt -126.17 149.26 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.271 -0.893 . . . . 0.0 110.398 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.7 mt -109.0 124.65 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.265 -0.897 . . . . 0.0 109.957 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 23.5 pt -123.44 135.34 25.96 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.161 -0.962 . . . . 0.0 110.51 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 C--N 1.305 -1.738 0 O-C-N 123.958 1.504 . . . . 0.0 110.489 -179.941 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.427 ' HG2' ' OD1' ' A' ' 43' ' ' ASP . 50.0 Cg_endo -79.27 15.51 1.54 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.937 1.493 . . . . 0.0 111.189 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.32 -64.16 3.53 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.433 ' CG ' ' N ' ' A' ' 44' ' ' TYR . 4.6 p-10 -52.77 -44.14 66.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.272 -1.134 . . . . 0.0 110.971 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.525 ' CE2' ' HD3' ' A' ' 5' ' ' PRO . 1.8 m-85 -89.87 -2.13 58.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.066 -1.021 . . . . 0.0 110.5 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.501 ' O ' ' ND2' ' A' ' 46' ' ' ASN . . . -75.31 87.93 2.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.214 -0.929 . . . . 0.0 110.407 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 45' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.136 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.17 0.51 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 29.9 m -139.21 128.58 24.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.201 -0.937 . . . . 0.0 110.345 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -123.25 165.24 23.34 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.294 -0.879 . . . . 0.0 110.214 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.456 ' O ' ' CB ' ' A' ' 46' ' ' ASN . 47.8 Cg_endo -73.87 -93.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.924 1.486 . . . . 0.0 110.524 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.9 t -62.38 154.99 26.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.583 -0.698 . . . . 0.0 110.339 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.43 HD13 ' HB3' ' A' ' 46' ' ' ASN . 48.7 mm -66.28 -30.01 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.333 -0.854 . . . . 0.0 109.776 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.7 t -69.44 -44.1 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.329 -0.857 . . . . 0.0 109.794 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.76 -42.1 67.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.394 -0.816 . . . . 0.0 110.067 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.452 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 5.2 ttp180 -67.22 -50.96 58.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 0.0 110.154 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.1 t -50.84 -46.26 60.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.256 -0.902 . . . . 0.0 110.334 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -61.71 -30.49 70.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.296 -0.877 . . . . 0.0 110.329 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.452 ' HB3' ' O ' ' A' ' 10' ' ' ARG . 48.5 t80 -67.9 -40.47 83.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.918 . . . . 0.0 110.232 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -58.05 -47.46 83.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -0.941 . . . . 0.0 109.381 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.529 ' CG1' ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -54.31 -51.57 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.494 -0.754 . . . . 0.0 109.278 179.319 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.529 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 35.4 t -48.66 -28.23 3.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.573 -0.704 . . . . 0.0 110.217 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.492 ' NE ' ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -88.6 -14.06 38.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.243 -0.911 . . . . 0.0 110.35 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.569 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.8 tm? -54.89 -43.56 98.88 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.241 -0.912 . . . . 0.0 111.182 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 47.7 Cg_endo -75.86 -90.11 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.382 1.201 . . . . 0.0 110.495 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -175.12 55.7 0.12 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.492 ' O ' ' NE ' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -106.76 146.18 32.57 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.293 -1.122 . . . . 0.0 110.059 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.47 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 44.0 Cg_endo -72.04 136.0 26.35 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.903 1.475 . . . . 0.0 110.404 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 22' ' ' PRO . 3.9 mt-10 -39.7 -46.13 1.81 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.461 -0.774 . . . . 0.0 110.779 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.11 -38.51 52.27 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.324 -0.86 . . . . 0.0 111.038 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.47 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -72.51 -42.71 64.53 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.112 -0.993 . . . . 0.0 110.81 -179.248 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.42 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 73.8 m -74.49 -39.95 62.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.156 -0.965 . . . . 0.0 110.319 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.428 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -59.8 -41.81 92.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.139 -0.975 . . . . 0.0 110.238 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 38.7 m -75.09 -21.02 59.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.24 -0.913 . . . . 0.0 110.281 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -85.04 -20.9 29.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.283 -0.885 . . . . 0.0 110.24 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.7 p -120.01 -16.16 8.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.888 . . . . 0.0 110.342 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 80.96 53.58 3.9 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.53 -175.17 2.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.207 -1.172 . . . . 0.0 110.168 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 pt -142.04 147.42 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 110.41 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.407 ' O ' ' CG2' ' A' ' 35' ' ' ILE . 2.2 mp -115.11 139.69 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.445 -0.785 . . . . 0.0 110.129 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.407 ' CG2' ' O ' ' A' ' 34' ' ' ILE . 0.9 OUTLIER -154.68 121.15 2.74 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.199 -0.938 . . . . 0.0 110.367 -179.848 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo . . . . . 0 C--N 1.308 -1.605 0 O-C-N 123.896 1.472 . . . . 0.0 110.686 -179.957 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 120.684 0.278 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.403 ' O ' ' N ' ' A' ' 45' ' ' ALA . 44.9 Cg_endo -72.27 135.04 23.99 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.94 1.495 . . . . 0.0 110.424 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.468 ' HA2' ' HB3' ' A' ' 45' ' ' ALA . . . -46.25 -38.73 9.02 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -48.15 -27.1 2.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.164 -1.198 . . . . 0.0 110.314 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.58 6.41 2.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.27 -0.894 . . . . 0.0 110.392 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.468 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . . . -90.94 89.45 7.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.111 -0.993 . . . . 0.0 110.147 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.456 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 43.0 m-20 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.131 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 99.3 m . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.264 0.554 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.487 ' SG ' ' CD1' ' A' ' 35' ' ' ILE . 19.0 m -128.94 131.23 47.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.269 -0.894 . . . . 0.0 110.174 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.472 ' CB ' ' OXT' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -122.02 153.48 60.93 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.225 -0.922 . . . . 0.0 110.324 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.559 ' HD3' ' CE1' ' A' ' 44' ' ' TYR . 50.9 Cg_endo -78.1 -93.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.08 1.568 . . . . 0.0 110.719 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.81 138.05 58.31 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.547 -0.721 . . . . 0.0 110.914 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.401 ' O ' ' HB3' ' A' ' 10' ' ' ARG . 89.0 mt -47.92 -38.9 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.265 -0.897 . . . . 0.0 109.808 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.463 ' O ' ' OG ' ' A' ' 11' ' ' SER . 94.4 t -51.71 -61.49 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.381 -0.824 . . . . 0.0 110.285 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.442 ' O ' ' OD1' ' A' ' 12' ' ' ASN . . . -45.91 -32.3 2.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.159 -0.963 . . . . 0.0 110.251 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 46' ' ' ASN . 0.3 OUTLIER -74.87 -46.96 32.72 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.306 -0.871 . . . . 0.0 110.748 -179.734 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 8' ' ' VAL . 10.6 p -54.88 -69.05 0.14 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.091 -1.006 . . . . 0.0 110.534 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 13' ' ' PHE . 9.4 p30 -51.15 -37.6 47.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.167 -0.958 . . . . 0.0 110.656 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.516 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 37.0 t80 -50.82 -50.04 57.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.146 -0.971 . . . . 0.0 110.538 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.509 ' OD1' ' NH2' ' A' ' 17' ' ' ARG . 18.9 m-80 -63.91 -41.84 97.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.191 -0.943 . . . . 0.0 109.604 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.484 HG11 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -59.61 -48.84 85.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.52 -0.737 . . . . 0.0 109.424 179.369 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.484 ' N ' HG11 ' A' ' 15' ' ' VAL . 44.8 t -57.16 -22.8 42.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.588 -0.695 . . . . 0.0 110.342 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.509 ' NH2' ' OD1' ' A' ' 14' ' ' ASN . 9.7 mtm180 -83.78 -3.98 58.28 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.1 -1.0 . . . . 0.0 110.244 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.592 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 16.6 tp -71.68 -47.75 12.2 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 110.749 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 46.1 Cg_endo -71.33 -155.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.352 1.185 . . . . 0.0 110.39 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.98 2.55 87.12 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.83 125.49 91.13 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.092 -1.24 . . . . 0.0 109.982 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.29 146.95 46.52 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.883 1.465 . . . . 0.0 110.521 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.506 ' HG3' ' N ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -50.21 -22.56 1.78 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.274 -0.891 . . . . 0.0 110.176 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.506 ' N ' ' HG3' ' A' ' 23' ' ' GLU . . . -67.27 -48.78 66.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.932 . . . . 0.0 110.013 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.416 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 1.0 OUTLIER -69.25 -30.52 68.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.873 . . . . 0.0 109.843 179.707 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 78.7 m -75.97 -49.67 17.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -0.885 . . . . 0.0 109.967 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.39 -25.62 50.37 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.155 -0.965 . . . . 0.0 109.819 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.6 m -89.91 -18.85 25.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.307 -0.871 . . . . 0.0 110.025 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.416 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 1.6 t80 -89.01 -20.36 24.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.395 -0.816 . . . . 0.0 110.402 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.6 p -108.42 -39.86 5.3 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.153 -0.967 . . . . 0.0 110.394 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.22 32.51 1.05 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.89 174.58 6.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -1.13 . . . . 0.0 110.14 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.439 HD12 ' HB2' ' A' ' 3' ' ' CYS . 2.6 pt -138.62 147.54 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 110.362 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.9 mp -109.17 138.36 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.329 -0.857 . . . . 0.0 110.259 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.487 ' CD1' ' SG ' ' A' ' 3' ' ' CYS . 21.8 pt -134.24 143.94 49.17 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.317 -0.864 . . . . 0.0 110.203 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo . . . . . 0 C--N 1.306 -1.675 0 O-C-N 124.014 1.534 . . . . 0.0 110.435 -179.915 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.485 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 87.6 m . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 40' ' ' CYS . 43.1 Cg_endo -70.98 -166.23 0.22 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.88 1.463 . . . . 0.0 110.272 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.72 -1.94 43.03 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -108.64 -6.5 15.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -1.159 . . . . 0.0 110.218 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.559 ' CE1' ' HD3' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -143.59 36.46 1.32 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.217 -0.927 . . . . 0.0 110.155 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.51 88.23 3.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.288 -0.882 . . . . 0.0 110.297 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.472 ' OXT' ' CB ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.25 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.48 HG22 ' CE1' ' A' ' 13' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.282 0.563 . . . . 0.0 110.378 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.412 ' C ' ' SG ' ' A' ' 32' ' ' CYS . 77.4 m -144.85 113.42 6.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.39 -0.819 . . . . 0.0 109.644 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.514 ' O ' ' CB ' ' A' ' 46' ' ' ASN . 65.6 m -99.41 151.21 37.35 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.929 . . . . 0.0 110.513 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 44' ' ' TYR . 50.8 Cg_endo -76.72 -93.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.998 1.525 . . . . 0.0 110.503 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.67 137.5 58.28 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.595 -0.69 . . . . 0.0 110.598 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.453 ' O ' ' HB3' ' A' ' 10' ' ' ARG . 10.0 mt -54.39 -33.64 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.18 -0.95 . . . . 0.0 109.789 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.6 t -48.98 -53.08 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.13 -0.981 . . . . 0.0 109.581 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.11 -40.43 73.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.268 -0.895 . . . . 0.0 109.48 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.491 ' CZ ' ' OXT' ' A' ' 46' ' ' ASN . 0.6 OUTLIER -52.9 -57.02 11.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.41 -0.806 . . . . 0.0 109.932 179.581 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 14' ' ' ASN . 9.6 m -51.42 -40.86 60.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.255 -0.903 . . . . 0.0 109.921 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -64.25 -43.98 93.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.331 -0.856 . . . . 0.0 109.867 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.48 ' CE1' HG22 ' A' ' 2' ' ' THR . 10.9 t80 -53.72 -26.79 24.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -0.855 . . . . 0.0 109.828 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 11' ' ' SER . 48.5 m-80 -74.83 -43.7 53.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.377 -0.827 . . . . 0.0 109.598 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 18' ' ' LEU . 0.8 OUTLIER -63.9 -49.17 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.406 -0.809 . . . . 0.0 109.41 179.594 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.457 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 42.3 t -52.4 -41.81 63.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.362 -0.836 . . . . 0.0 110.222 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -80.93 -2.0 45.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.284 -0.885 . . . . 0.0 110.531 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.558 ' HB3' ' HD3' ' A' ' 19' ' ' PRO . 3.9 tp -51.75 -54.17 42.9 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.085 -1.009 . . . . 0.0 110.259 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' A' ' 18' ' ' LEU . 43.9 Cg_endo -69.6 -52.72 0.32 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.38 1.2 . . . . 0.0 110.396 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.19 39.43 0.05 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.485 HG23 ' HD2' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -87.37 152.0 51.79 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.19 -1.182 . . . . 0.0 109.768 179.769 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.485 ' HD2' HG23 ' A' ' 21' ' ' THR . 43.5 Cg_endo -70.93 155.21 62.5 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.823 1.433 . . . . 0.0 110.57 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 24' ' ' ALA . 1.5 mp0 -53.64 -49.67 67.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.316 -0.865 . . . . 0.0 110.511 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.456 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -42.33 -49.74 5.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.225 -0.922 . . . . 0.0 110.341 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.82 -42.6 93.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 110.506 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.5 m -77.93 -50.12 12.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.163 -0.961 . . . . 0.0 110.472 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.51 -20.23 64.41 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.239 -0.913 . . . . 0.0 110.366 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 46.3 m -88.04 -26.27 22.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.894 . . . . 0.0 110.378 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -101.77 -10.49 19.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.152 -0.968 . . . . 0.0 110.399 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 76.4 p -103.66 -27.16 12.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 110.274 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.48 28.97 5.82 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.412 ' SG ' ' C ' ' A' ' 3' ' ' CYS . 1.6 t -99.73 -178.17 3.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.349 -1.089 . . . . 0.0 110.306 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.7 pt -139.43 148.79 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.879 . . . . 0.0 110.23 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.4 mt -112.25 133.97 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 109.976 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.3 pt -119.38 154.14 53.96 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 110.119 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 C--N 1.304 -1.796 0 O-C-N 124.145 1.603 . . . . 0.0 110.645 -179.736 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.467 ' HB3' ' HA ' ' A' ' 45' ' ' ALA . 23.4 m . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.492 ' O ' ' CB ' ' A' ' 45' ' ' ALA . 43.1 Cg_endo -70.35 -178.25 2.47 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.984 1.518 . . . . 0.0 110.552 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.21 -8.56 57.64 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -114.97 -29.17 6.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -1.156 . . . . 0.0 110.04 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.569 ' CZ ' ' HB3' ' A' ' 5' ' ' PRO . 0.5 OUTLIER -107.47 9.36 29.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 110.151 179.889 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.492 ' CB ' ' O ' ' A' ' 41' ' ' PRO . . . -72.75 90.9 1.44 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.352 -0.842 . . . . 0.0 110.271 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.514 ' CB ' ' O ' ' A' ' 4' ' ' CYS . 1.6 m-20 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.156 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.507 HG23 ' CE2' ' A' ' 13' ' ' PHE . 1.1 m . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.14 0.495 . . . . 0.0 109.986 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.412 ' C ' ' SG ' ' A' ' 32' ' ' CYS . 0.5 OUTLIER -139.69 91.99 2.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.21 -0.931 . . . . 0.0 110.297 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.478 ' N ' ' SG ' ' A' ' 32' ' ' CYS . 25.7 m -96.5 165.64 15.72 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.28 -0.887 . . . . 0.0 110.09 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 46' ' ' ASN . 49.3 Cg_endo -78.59 -92.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.31 1.689 . . . . 0.0 110.442 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 7' ' ' ILE . 1.4 t -75.55 143.29 42.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.499 -0.75 . . . . 0.0 109.932 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.401 ' C ' ' O ' ' A' ' 6' ' ' SER . 11.8 mt -42.76 -52.91 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.188 -0.945 . . . . 0.0 110.198 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.7 t -43.09 -54.03 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 109.985 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.64 -40.4 19.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.306 -0.871 . . . . 0.0 109.962 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -63.78 -49.87 71.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.327 -0.858 . . . . 0.0 110.077 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.61 -50.53 65.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.875 . . . . 0.0 110.021 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.474 ' O ' HG11 ' A' ' 15' ' ' VAL . 38.5 m-80 -51.3 -40.02 58.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.883 . . . . 0.0 110.07 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.568 ' CZ ' ' HB2' ' A' ' 23' ' ' GLU . 71.7 t80 -60.15 -54.04 50.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.921 . . . . 0.0 110.043 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -62.91 -24.89 68.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.295 -0.878 . . . . 0.0 109.19 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.5 ' CG1' ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -78.59 -50.72 18.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.404 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.5 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 46.3 t -51.64 -20.97 2.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.412 -0.805 . . . . 0.0 110.118 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.45 10.12 23.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.211 -0.931 . . . . 0.0 110.167 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.594 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 2.3 tp -83.44 -42.0 0.81 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.199 -0.938 . . . . 0.0 111.575 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 46.1 Cg_endo -73.9 -94.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.331 1.174 . . . . 0.0 111.0 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -160.82 33.46 0.4 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -107.13 141.58 23.22 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.229 -1.159 . . . . 0.0 110.087 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 23' ' ' GLU . 44.9 Cg_endo -70.96 136.25 29.38 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.984 1.518 . . . . 0.0 110.313 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.568 ' HB2' ' CZ ' ' A' ' 13' ' ' PHE . 5.7 pt-20 -42.35 -32.23 0.49 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.24 -0.913 . . . . 0.0 110.205 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.43 -59.54 3.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.171 -0.956 . . . . 0.0 109.945 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.96 -28.52 69.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.183 -0.948 . . . . 0.0 109.938 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.408 ' O ' ' OG1' ' A' ' 30' ' ' THR . 58.6 m -73.62 -50.88 18.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 110.381 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.63 -43.12 79.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 0.0 110.348 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.8 m -64.69 -28.67 69.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.221 -0.924 . . . . 0.0 110.511 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -97.91 -34.0 11.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.105 -0.997 . . . . 0.0 110.565 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 26' ' ' CYS . 63.9 p -77.62 -8.13 57.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.198 -0.939 . . . . 0.0 110.161 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.443 ' O ' ' HD3' ' A' ' 5' ' ' PRO . . . 70.95 42.71 59.36 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.478 ' SG ' ' N ' ' A' ' 4' ' ' CYS . 14.3 t -127.26 170.15 12.75 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.103 -1.233 . . . . 0.0 110.081 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.445 HG21 ' O ' ' A' ' 32' ' ' CYS . 1.1 pt -140.32 156.98 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.099 -1.0 . . . . 0.0 110.439 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.3 mt -110.84 127.31 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.342 -0.849 . . . . 0.0 110.092 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.0 pt -119.25 140.9 29.63 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.155 -0.966 . . . . 0.0 110.586 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 C--N 1.307 -1.642 0 O-C-N 124.109 1.584 . . . . 0.0 110.516 179.929 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.456 ' SG ' ' HD2' ' A' ' 41' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 120.711 0.291 . . . . 0.0 110.279 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.456 ' HD2' ' SG ' ' A' ' 40' ' ' CYS . 47.7 Cg_endo -74.08 166.68 29.01 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.979 1.515 . . . . 0.0 110.276 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.98 -22.75 75.98 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -61.67 -34.18 75.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.235 -1.156 . . . . 0.0 110.208 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -136.38 66.13 1.5 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 110.173 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.477 ' O ' ' CB ' ' A' ' 46' ' ' ASN . . . -121.87 86.71 2.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.097 -1.002 . . . . 0.0 110.648 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.553 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 1.5 m-20 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.084 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.243 0.544 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 59.4 m -128.31 113.78 16.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.885 . . . . 0.0 110.182 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -105.88 169.01 7.44 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 0.0 110.28 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 48.4 Cg_endo -72.77 -94.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.973 1.512 . . . . 0.0 110.986 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.6 t -78.89 156.7 28.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.463 -0.773 . . . . 0.0 110.699 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.9 mt -49.29 -54.48 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -0.874 . . . . 0.0 109.836 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.5 t -46.7 -42.87 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.893 . . . . 0.0 109.492 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.413 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . . . -50.44 -40.62 51.01 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.312 -0.868 . . . . 0.0 109.413 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.47 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 0.8 OUTLIER -70.69 -43.99 67.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.436 -0.79 . . . . 0.0 109.67 179.518 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.9 t -48.99 -63.15 1.18 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 109.735 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -47.1 -47.01 23.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.783 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.47 ' HB3' ' O ' ' A' ' 10' ' ' ARG . 11.2 t80 -54.41 -38.29 66.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.387 -0.821 . . . . 0.0 109.769 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.66 -30.09 66.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 108.999 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.484 HG13 ' N ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -65.22 -44.3 95.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.523 0.678 . . . . 0.0 109.24 179.242 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.484 ' N ' HG13 ' A' ' 15' ' ' VAL . 37.9 t -65.45 -26.16 67.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.465 -0.772 . . . . 0.0 110.435 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -75.61 -33.17 60.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.468 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.532 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -50.51 -52.51 54.81 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.16 -0.963 . . . . 0.0 110.541 -179.775 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 47.6 Cg_endo -71.65 -156.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.413 1.217 . . . . 0.0 110.299 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.93 59.22 0.42 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.49 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 6.7 m -113.24 144.26 30.85 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.354 -1.086 . . . . 0.0 110.08 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.49 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 45.6 Cg_endo -71.98 151.4 56.19 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 124.038 1.547 . . . . 0.0 110.382 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -53.69 -32.88 53.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.301 -0.874 . . . . 0.0 110.154 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.45 ' O ' ' HB ' ' A' ' 28' ' ' THR . . . -57.93 -50.65 72.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.323 -0.861 . . . . 0.0 110.542 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.455 ' HB3' ' CG2' ' A' ' 21' ' ' THR . 0.1 OUTLIER -65.69 -26.88 67.97 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.074 -1.016 . . . . 0.0 110.358 -179.65 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.433 ' O ' ' OG1' ' A' ' 30' ' ' THR . 19.0 m -81.64 -49.13 10.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.235 -0.916 . . . . 0.0 110.412 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -72.2 -50.14 29.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.148 -0.97 . . . . 0.0 110.622 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 80.4 m -59.62 -44.97 93.25 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.23 -0.919 . . . . 0.0 110.85 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -67.37 -15.62 63.79 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.104 -0.997 . . . . 0.0 110.637 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 26' ' ' CYS . 30.3 p -110.98 -22.16 11.64 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.114 -0.991 . . . . 0.0 110.512 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 98.89 23.21 11.96 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.44 175.01 9.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.329 -1.101 . . . . 0.0 109.922 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.449 ' CD1' HG22 ' A' ' 35' ' ' ILE . 2.3 pp -138.93 152.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.134 -0.979 . . . . 0.0 110.484 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.3 mt -115.19 124.46 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.39 -0.819 . . . . 0.0 110.363 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.463 ' O ' HG13 ' A' ' 35' ' ' ILE . 11.8 pt -110.89 148.01 37.71 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.18 -0.95 . . . . 0.0 110.207 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 C--N 1.305 -1.719 0 O-C-N 123.951 1.501 . . . . 0.0 110.627 -179.876 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.452 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 45.2 Cg_endo -72.42 162.99 39.94 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.918 1.483 . . . . 0.0 110.462 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.29 11.61 57.61 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -99.79 -21.69 15.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -1.148 . . . . 0.0 110.185 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.458 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 1.7 t80 -150.08 48.08 0.92 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.24 -0.912 . . . . 0.0 110.092 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 41' ' ' PRO . . . -121.83 101.45 7.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.324 -0.86 . . . . 0.0 110.275 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.068 179.891 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.842 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.216 -0.693 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.543 HG21 ' CE2' ' A' ' 13' ' ' PHE . 50.8 m -136.69 149.77 48.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 110.409 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.439 ' N ' HG23 ' A' ' 2' ' ' THR . 32.7 m -134.5 124.95 26.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.316 -0.865 . . . . 0.0 109.897 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.11 146.82 49.98 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.08 -1.013 . . . . 0.0 110.519 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.57 ' HD3' ' CE1' ' A' ' 44' ' ' TYR . 50.3 Cg_endo -75.83 -94.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.091 1.574 . . . . 0.0 110.547 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.1 t -48.25 123.24 6.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.5 -0.75 . . . . 0.0 110.363 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.407 ' O ' ' C ' ' A' ' 8' ' ' VAL . 2.5 mp -47.71 -54.83 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 110.108 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.407 ' C ' ' O ' ' A' ' 7' ' ' ILE . 21.6 t -44.34 -45.93 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 109.847 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.449 ' O ' ' HB ' ' A' ' 30' ' ' THR . . . -50.74 -42.87 57.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.2 -0.938 . . . . 0.0 109.721 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.406 ' O ' ' C ' ' A' ' 11' ' ' SER . 0.1 OUTLIER -68.77 -48.32 63.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 0.0 109.994 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -43.71 -42.12 5.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.89 . . . . 0.0 109.824 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 -75.3 -36.08 61.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.898 . . . . 0.0 109.853 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.543 ' CE2' HG21 ' A' ' 2' ' ' THR . 27.1 t80 -62.32 -33.26 74.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.331 -0.856 . . . . 0.0 109.923 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.73 -26.74 37.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.298 -0.876 . . . . 0.0 109.021 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 16' ' ' CYS . 1.2 t -82.49 -42.66 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.661 -0.649 . . . . 0.0 109.249 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.471 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 30.7 t -66.74 -24.34 66.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.314 -0.867 . . . . 0.0 109.767 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' A' ' 17' ' ' ARG . 0.7 OUTLIER -88.07 -12.48 44.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.322 -0.861 . . . . 0.0 109.785 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.578 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -54.97 -46.88 99.55 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.393 -0.817 . . . . 0.0 110.254 179.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 18' ' ' LEU . 49.7 Cg_endo -80.11 -157.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.927 1.488 . . . . 0.0 110.148 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.92 72.65 1.85 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.434 HG21 ' HD2' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -130.93 134.1 25.57 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.272 -1.134 . . . . 0.0 110.153 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.457 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 44.5 Cg_endo -72.98 139.16 29.56 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.95 1.5 . . . . 0.0 110.576 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -44.35 -31.64 1.1 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.406 -0.809 . . . . 0.0 110.412 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.89 -41.78 99.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.192 -0.943 . . . . 0.0 110.342 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.457 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -66.81 -37.16 83.98 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.313 -0.867 . . . . 0.0 110.259 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.418 ' O ' HG22 ' A' ' 30' ' ' THR . 47.3 m -85.8 -45.89 11.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.278 -0.889 . . . . 0.0 110.185 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -45.3 -36.05 3.85 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.203 -0.936 . . . . 0.0 109.888 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.0 m -79.09 -49.46 12.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.922 . . . . 0.0 109.912 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -64.54 -26.61 68.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.358 -0.839 . . . . 0.0 109.926 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.496 HG21 ' N ' ' A' ' 13' ' ' PHE . 26.5 p -96.53 -51.36 4.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.324 -0.86 . . . . 0.0 110.218 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.42 22.08 3.2 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 27.2 m -97.56 168.12 10.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.247 -1.149 . . . . 0.0 110.225 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.0 pt -121.04 155.71 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.212 -0.93 . . . . 0.0 110.273 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.9 mt -104.4 125.63 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.209 -0.932 . . . . 0.0 110.219 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.452 ' O ' HG13 ' A' ' 35' ' ' ILE . 3.9 pt -128.17 136.91 29.76 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.336 -0.853 . . . . 0.0 110.016 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.8 -12.77 24.28 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.029 1.541 . . . . 0.0 110.795 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.404 ' O ' ' CB ' ' A' ' 38' ' ' ALA . . . 173.34 -154.38 20.14 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.524 ' O ' ' CG2' ' A' ' 39' ' ' THR . . . 62.99 28.18 16.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.3 -1.118 . . . . 0.0 110.184 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' A' ' 38' ' ' ALA . 9.0 t 38.91 -159.62 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.554 -0.716 . . . . 0.0 110.636 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.474 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 86.8 m -96.53 165.36 16.26 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.31 -0.868 . . . . 0.0 109.96 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.517 ' HG2' ' CB ' ' A' ' 44' ' ' TYR . 43.1 Cg_endo -68.8 -161.4 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.917 1.482 . . . . 0.0 110.315 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.82 -3.83 34.23 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.73 -5.07 6.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.192 -1.181 . . . . 0.0 110.224 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.57 ' CE1' ' HD3' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -120.9 18.8 11.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.359 -0.838 . . . . 0.0 110.039 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.64 93.6 8.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.284 -0.885 . . . . 0.0 110.161 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.258 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.851 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.728 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 2.2 m -130.21 154.82 47.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.0 110.018 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.5 m -151.5 130.31 12.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.196 -0.94 . . . . 0.0 110.276 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.529 ' O ' ' CB ' ' A' ' 46' ' ' ASN . 0.5 OUTLIER -131.05 148.76 71.55 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.314 -0.866 . . . . 0.0 110.112 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.565 ' HG3' ' CE1' ' A' ' 44' ' ' TYR . 50.0 Cg_endo -84.3 -91.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.103 1.58 . . . . 0.0 110.894 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.471 ' HB3' ' HB2' ' A' ' 9' ' ' ALA . 3.8 t -39.05 127.66 1.65 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.505 0.669 . . . . 0.0 110.992 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.3 mt -49.92 -54.44 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.266 -0.897 . . . . 0.0 109.627 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.421 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 50.0 t -45.69 -48.88 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.324 -0.86 . . . . 0.0 109.701 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.479 ' O ' ' CB ' ' A' ' 13' ' ' PHE . . . -45.79 -39.57 8.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.261 -0.899 . . . . 0.0 109.646 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -67.57 -44.37 78.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.234 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.403 ' O ' ' C ' ' A' ' 12' ' ' ASN . 10.2 t -57.12 -77.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.214 -0.929 . . . . 0.0 110.182 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.492 ' OD1' ' N ' ' A' ' 13' ' ' PHE . 10.2 p30 -44.52 -35.8 2.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.177 -0.952 . . . . 0.0 110.053 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.519 ' N ' HG22 ' A' ' 30' ' ' THR . 19.5 t80 -64.99 -56.04 15.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.919 . . . . 0.0 110.096 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -62.62 -43.72 98.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.207 -0.933 . . . . 0.0 109.26 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.506 HG13 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -61.6 -45.58 98.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.539 -0.726 . . . . 0.0 109.246 179.156 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.506 ' N ' HG13 ' A' ' 15' ' ' VAL . 34.8 t -50.87 -29.99 13.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.572 -0.705 . . . . 0.0 110.304 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -85.23 -4.12 59.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.203 -0.935 . . . . 0.0 110.328 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.576 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 3.7 tt -69.88 -46.28 23.66 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.959 . . . . 0.0 110.633 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 47.8 Cg_endo -74.27 -155.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.382 0 O-C-N 123.289 1.152 . . . . 0.0 109.998 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.39 27.47 7.71 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.45 ' OG1' ' HG2' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -93.56 137.32 23.38 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.146 -1.208 . . . . 0.0 110.029 179.759 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.431 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 48.3 Cg_endo -75.42 166.78 28.01 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.988 1.52 . . . . 0.0 110.658 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 24' ' ' ALA . 4.1 tt0 -65.39 -50.34 65.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.329 -0.857 . . . . 0.0 110.228 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 23' ' ' GLU . . . -43.56 -51.66 6.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 0.0 110.382 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.431 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.9 OUTLIER -57.22 -37.71 72.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 110.35 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.465 ' O ' ' OG1' ' A' ' 30' ' ' THR . 39.5 m -74.96 -63.04 1.35 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.887 . . . . 0.0 110.527 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 26' ' ' CYS . . . -41.91 -26.87 0.1 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.908 . . . . 0.0 110.441 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.439 ' N ' ' O ' ' A' ' 26' ' ' CYS . 20.2 m -90.08 -49.0 6.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.144 -0.973 . . . . 0.0 110.43 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -68.42 -27.09 65.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.186 -0.946 . . . . 0.0 110.268 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.519 HG22 ' N ' ' A' ' 13' ' ' PHE . 26.4 p -87.03 -48.44 8.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.192 -0.942 . . . . 0.0 110.245 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.21 14.04 5.14 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.418 ' C ' HG22 ' A' ' 33' ' ' ILE . 56.8 m -86.7 -166.91 1.7 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.182 -1.187 . . . . 0.0 109.961 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.418 HG22 ' C ' ' A' ' 32' ' ' CYS . 11.4 pt -149.2 150.57 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.072 -1.017 . . . . 0.0 110.612 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.0 mt -100.53 138.38 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.347 -0.846 . . . . 0.0 109.981 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 27.1 pt -125.12 143.73 45.13 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.16 -0.962 . . . . 0.0 110.365 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.27 -16.5 24.9 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.015 1.534 . . . . 0.0 110.265 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -78.83 177.05 54.31 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -114.87 15.69 17.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.163 -1.198 . . . . 0.0 110.288 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.0 t -136.03 155.23 50.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 110.092 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 44' ' ' TYR . 5.4 t -107.72 135.31 19.8 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.271 -0.893 . . . . 0.0 110.086 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.08 -174.43 1.94 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.957 1.504 . . . . 0.0 110.706 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.6 -29.06 12.62 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -60.06 -26.0 65.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.281 -1.129 . . . . 0.0 110.184 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.565 ' CE1' ' HG3' ' A' ' 5' ' ' PRO . 0.8 OUTLIER -144.91 77.42 1.53 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.328 -0.857 . . . . 0.0 109.934 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -120.2 90.87 3.41 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.229 -0.919 . . . . 0.0 110.781 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.529 ' CB ' ' O ' ' A' ' 4' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 117.925 -1.036 . . . . 0.0 110.125 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.827 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.213 -0.832 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.508 ' CG2' ' CE1' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -89.88 140.37 29.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.03 -1.044 . . . . 0.0 109.979 . . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.479 ' O ' ' CG1' ' A' ' 33' ' ' ILE . 5.1 m -132.44 108.48 9.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.192 -0.943 . . . . 0.0 109.905 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.2 m -109.32 162.99 18.08 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.413 -0.804 . . . . 0.0 110.021 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.22 -95.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.903 1.475 . . . . 0.0 110.534 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.6 t -68.78 139.44 55.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.39 -0.819 . . . . 0.0 110.266 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.491 HG23 HD11 ' A' ' 7' ' ' ILE . 24.4 mt -46.42 -41.72 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.174 -0.954 . . . . 0.0 109.769 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.509 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 44.1 t -49.14 -57.45 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.464 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 8' ' ' VAL . . . -44.76 -37.03 3.5 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.366 -0.834 . . . . 0.0 109.443 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.448 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -75.5 -41.06 56.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.386 -0.822 . . . . 0.0 109.864 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.2 t -48.73 -72.31 0.05 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.0 109.919 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 8' ' ' VAL . 2.2 p30 -48.74 -42.96 37.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.358 -0.839 . . . . 0.0 109.955 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.508 ' CE1' ' CG2' ' A' ' 2' ' ' THR . 53.4 t80 -51.79 -47.93 64.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.244 -0.91 . . . . 0.0 110.182 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 10' ' ' ARG . 11.2 m120 -60.81 -27.21 67.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.139 -0.976 . . . . 0.0 109.433 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.506 ' CG1' ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -78.93 -49.58 19.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 121.587 0.708 . . . . 0.0 109.453 179.704 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.506 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 14.2 t -55.33 -16.41 3.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.564 -0.71 . . . . 0.0 110.741 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.485 ' NH2' ' OE1' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -88.42 -3.13 58.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.191 -0.943 . . . . 0.0 110.721 -179.671 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.596 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 1.5 tt -76.4 -41.62 3.04 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.131 -0.981 . . . . 0.0 111.031 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.596 ' CD ' ' N ' ' A' ' 18' ' ' LEU . 47.1 Cg_endo -76.16 -156.19 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.35 1.184 . . . . 0.0 110.042 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.56 27.2 19.82 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.449 ' CG2' ' SG ' ' A' ' 26' ' ' CYS . 29.8 m -90.41 133.19 33.49 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.057 -1.261 . . . . 0.0 109.928 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.465 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 44.2 Cg_endo -72.22 141.8 36.52 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.948 1.499 . . . . 0.0 110.594 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.485 ' OE1' ' NH2' ' A' ' 17' ' ' ARG . 7.2 mt-10 -43.31 -52.13 5.94 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.317 -0.864 . . . . 0.0 110.548 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 23' ' ' GLU . . . -41.98 -62.03 1.01 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 0.0 110.541 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.465 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -53.73 -36.91 62.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.286 -0.884 . . . . 0.0 110.562 -179.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.449 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 91.2 m -76.68 -34.86 58.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.166 -0.959 . . . . 0.0 110.235 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.85 -16.6 63.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.173 -0.954 . . . . 0.0 110.326 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 45.6 m -91.01 -47.9 7.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.191 -0.943 . . . . 0.0 110.362 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -63.89 -23.22 67.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.198 -0.939 . . . . 0.0 110.226 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 37.0 p -101.19 -48.35 4.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 110.205 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.84 69.59 0.62 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 48.8 t -140.46 163.87 31.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.214 -1.168 . . . . 0.0 110.128 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.479 ' CG1' ' O ' ' A' ' 3' ' ' CYS . 5.8 pt -112.4 147.13 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.083 -1.011 . . . . 0.0 110.334 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.0 mt -119.12 145.73 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.328 -0.857 . . . . 0.0 109.968 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 1' ' ' THR . 15.5 pt -127.15 153.61 76.75 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 0.0 110.463 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.91 -7.91 20.58 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.02 1.537 . . . . 0.0 110.014 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.64 -145.9 16.43 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.1 18.98 1.76 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -1.183 . . . . 0.0 110.478 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.422 ' O ' ' CD1' ' A' ' 35' ' ' ILE . 6.5 t -141.57 145.91 35.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.133 -0.98 . . . . 0.0 110.556 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 70.9 m -103.49 156.7 35.15 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.337 -0.852 . . . . 0.0 109.925 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.05 139.3 32.54 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.952 1.501 . . . . 0.0 110.28 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.17 -18.01 12.1 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -93.71 7.97 42.77 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.142 -1.21 . . . . 0.0 110.357 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -166.85 52.81 0.08 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.211 -0.931 . . . . 0.0 110.2 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -124.75 87.72 2.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.334 -0.854 . . . . 0.0 110.107 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.055 -179.98 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.838 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.734 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.491 ' N ' HG21 ' A' ' 1' ' ' THR . 22.7 m -121.65 142.89 49.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 110.329 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.471 ' O ' HG12 ' A' ' 33' ' ' ILE . 19.7 m -134.06 121.07 21.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.896 . . . . 0.0 110.252 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.466 ' HB2' ' OXT' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -116.75 165.43 15.28 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.327 -0.858 . . . . 0.0 110.083 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.443 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 49.3 Cg_endo -75.36 -94.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.116 1.588 . . . . 0.0 111.265 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.4 t -92.62 168.5 11.19 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.699 0.761 . . . . 0.0 111.28 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.536 HG13 ' ND2' ' A' ' 46' ' ' ASN . 3.0 mt -51.67 -51.17 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.487 -0.758 . . . . 0.0 110.302 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.422 ' C ' ' O ' ' A' ' 7' ' ' ILE . 51.6 t -40.88 -53.26 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.383 -0.823 . . . . 0.0 110.139 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.451 ' O ' ' OD1' ' A' ' 12' ' ' ASN . . . -50.3 -40.8 49.65 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.292 -0.88 . . . . 0.0 109.557 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 46' ' ' ASN . 6.0 ttm180 -66.17 -37.61 86.05 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.268 -0.895 . . . . 0.0 110.276 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.4 t -60.67 -78.13 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.243 -0.911 . . . . 0.0 110.343 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 13' ' ' PHE . 12.1 p30 -45.91 -33.71 3.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.296 -0.878 . . . . 0.0 110.379 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.527 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 24.7 t80 -64.54 -48.15 76.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.394 -0.816 . . . . 0.0 110.4 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -65.13 -55.07 20.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -0.953 . . . . 0.0 110.063 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.545 ' CG1' ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -49.77 -53.15 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.367 -0.833 . . . . 0.0 109.658 179.699 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.545 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 42.2 t -49.51 -31.47 10.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -0.848 . . . . 0.0 110.297 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.93 -17.59 50.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.148 -0.97 . . . . 0.0 110.058 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.577 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.6 tp -56.21 -49.91 90.56 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.287 -0.883 . . . . 0.0 110.983 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 45.1 Cg_endo -71.51 -155.36 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.551 1.29 . . . . 0.0 110.282 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.08 61.86 1.07 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.0 m -129.84 132.55 24.23 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.279 -1.13 . . . . 0.0 109.893 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.8 148.76 59.06 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.993 1.523 . . . . 0.0 110.739 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.478 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 15.9 pt-20 -53.53 -19.91 4.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.366 -0.834 . . . . 0.0 110.342 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.56 -48.55 76.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.226 -0.921 . . . . 0.0 110.22 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.09 -26.92 60.64 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.281 -0.887 . . . . 0.0 110.359 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 72.9 m -88.86 -29.26 19.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -0.918 . . . . 0.0 110.445 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.478 ' CB ' ' O ' ' A' ' 23' ' ' GLU . . . -74.42 -24.61 59.12 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.271 -0.893 . . . . 0.0 110.209 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.4 m -87.56 -50.34 6.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 110.258 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.06 -23.78 21.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.946 . . . . 0.0 110.124 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 67.5 p -98.27 -39.23 8.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 110.174 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.37 16.19 10.58 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -77.23 175.86 9.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -1.162 . . . . 0.0 110.01 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.471 HG12 ' O ' ' A' ' 3' ' ' CYS . 15.0 pt -136.43 163.51 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.174 -0.954 . . . . 0.0 110.294 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 58.0 mt -132.6 141.61 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.884 . . . . 0.0 110.253 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.475 ' O ' HG13 ' A' ' 35' ' ' ILE . 8.9 pt -145.41 127.18 7.79 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 110.265 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.13 57.47 3.33 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.834 1.439 . . . . 0.0 110.089 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.411 ' O ' ' HB3' ' A' ' 38' ' ' ALA . . . 119.27 -151.9 17.41 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 39' ' ' THR . . . 61.1 103.03 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.156 -1.203 . . . . 0.0 109.904 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.433 ' C ' ' O ' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -40.98 149.26 0.09 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.415 -0.803 . . . . 0.0 110.418 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.455 ' SG ' ' HD2' ' A' ' 41' ' ' PRO . 7.7 t -88.18 140.19 30.58 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.338 -0.851 . . . . 0.0 110.266 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.455 ' HD2' ' SG ' ' A' ' 40' ' ' CYS . 44.7 Cg_endo -70.92 151.21 62.25 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.967 1.509 . . . . 0.0 110.467 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.05 -8.79 62.15 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.45 ' OD2' ' HB2' ' A' ' 41' ' ' PRO . 56.8 p30 -89.88 -1.51 58.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -1.173 . . . . 0.0 110.044 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.93 48.45 0.79 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.361 -0.837 . . . . 0.0 110.088 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.477 ' O ' ' OD1' ' A' ' 46' ' ' ASN . . . -114.57 87.78 2.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 0.0 110.099 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.536 ' ND2' HG13 ' A' ' 7' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.103 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.851 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.777 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.558 HG23 ' CE2' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -111.7 163.38 14.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.181 -0.95 . . . . 0.0 110.295 . . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.3 m -154.56 128.27 8.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.856 . . . . 0.0 109.937 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.421 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 61.1 m -115.29 163.28 20.69 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.23 -0.919 . . . . 0.0 110.328 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 49.4 Cg_endo -75.75 -94.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.021 1.537 . . . . 0.0 110.764 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.17 148.61 51.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.56 -0.713 . . . . 0.0 110.586 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.7 mt -60.0 -45.95 94.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.331 -0.856 . . . . 0.0 110.095 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.8 t -49.36 -43.73 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.185 -0.947 . . . . 0.0 109.786 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.02 -37.99 81.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 110.006 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.457 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 5.6 ttm180 -61.24 -55.66 29.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.23 -0.919 . . . . 0.0 110.106 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -45.52 -60.06 2.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.293 -0.88 . . . . 0.0 110.001 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -52.21 -22.93 4.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.334 -0.854 . . . . 0.0 110.114 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.558 ' CE2' HG23 ' A' ' 2' ' ' THR . 17.9 t80 -75.83 -29.97 58.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 110.37 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -74.24 -31.17 62.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 109.363 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -69.3 -41.15 80.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.593 -0.692 . . . . 0.0 109.501 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.47 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 49.5 t -68.64 -32.14 71.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.555 -0.716 . . . . 0.0 110.998 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -84.77 -0.31 53.32 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.053 -1.029 . . . . 0.0 110.722 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.556 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -70.85 -48.9 14.57 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.086 -1.009 . . . . 0.0 110.208 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 48.2 Cg_endo -74.15 -155.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.584 1.308 . . . . 0.0 110.09 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.11 53.48 2.19 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.4 m -113.35 135.11 21.82 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.194 -1.18 . . . . 0.0 110.248 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.458 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 45.7 Cg_endo -73.64 158.56 47.15 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.876 1.461 . . . . 0.0 110.509 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.8 -35.86 77.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.303 -0.873 . . . . 0.0 110.327 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.34 -43.55 88.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.35 -0.844 . . . . 0.0 110.619 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.458 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -66.69 -34.42 77.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.109 -0.994 . . . . 0.0 110.285 -179.745 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 65.6 m -81.48 -47.93 12.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.193 -0.942 . . . . 0.0 110.066 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.93 -28.22 6.41 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.197 -0.939 . . . . 0.0 110.111 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.1 m -85.77 -37.8 18.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 110.251 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.84 -19.86 60.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.193 -0.942 . . . . 0.0 110.209 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.0 p -112.35 -58.94 2.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -0.914 . . . . 0.0 110.266 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.91 34.98 0.46 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 64.0 m -101.3 162.93 12.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.315 -1.109 . . . . 0.0 110.09 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.456 HD12 HG21 ' A' ' 35' ' ' ILE . 1.1 pp -122.99 149.55 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.218 -0.926 . . . . 0.0 110.176 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.9 mt -115.14 134.68 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.153 -0.967 . . . . 0.0 110.225 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.486 HG23 HD13 ' A' ' 35' ' ' ILE . 41.4 pt -119.39 151.68 51.67 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 110.175 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.07 -16.83 25.31 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.009 1.531 . . . . 0.0 110.487 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.436 ' O ' HG13 ' A' ' 35' ' ' ILE . . . -98.52 173.92 27.71 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.7 -22.07 15.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.233 -1.157 . . . . 0.0 110.405 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.6 t -79.62 151.88 30.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.173 -0.955 . . . . 0.0 110.44 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -138.45 145.85 48.55 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.334 -0.854 . . . . 0.0 110.016 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.89 131.85 18.99 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.997 1.525 . . . . 0.0 110.61 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -48.31 -35.37 14.66 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.61 -47.12 58.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.206 -1.173 . . . . 0.0 110.049 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.92 62.48 0.68 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.333 -0.854 . . . . 0.0 110.054 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.432 ' O ' ' CG ' ' A' ' 46' ' ' ASN . . . -130.19 88.01 2.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 110.253 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.432 ' CG ' ' O ' ' A' ' 45' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.146 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.852 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.729 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.64 150.75 45.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.151 -0.968 . . . . 0.0 110.253 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.7 m -147.78 107.19 3.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.357 -0.84 . . . . 0.0 110.198 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.509 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 24.9 m -99.96 166.25 13.09 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.253 -0.904 . . . . 0.0 110.412 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.533 ' HG2' ' CB ' ' A' ' 9' ' ' ALA . 40.0 Cg_endo -71.41 -153.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 124.034 1.544 . . . . 0.0 110.353 179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.492 ' C ' ' O ' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -31.0 150.24 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.51 0.671 . . . . 0.0 111.548 -179.286 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.439 ' O ' ' C ' ' A' ' 8' ' ' VAL . 2.3 mt -48.44 -54.54 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.426 -0.796 . . . . 0.0 110.639 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.439 ' C ' ' O ' ' A' ' 7' ' ' ILE . 77.0 t -40.87 -55.29 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.437 -0.79 . . . . 0.0 110.322 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.533 ' CB ' ' HG2' ' A' ' 5' ' ' PRO . . . -53.22 -41.52 65.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.899 . . . . 0.0 109.961 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.477 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -67.39 -49.75 62.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.892 . . . . 0.0 109.951 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 p -47.66 -38.0 13.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -0.934 . . . . 0.0 109.969 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 13' ' ' PHE . 10.9 m-80 -70.72 -42.61 70.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.922 . . . . 0.0 110.007 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.477 ' HB3' ' O ' ' A' ' 10' ' ' ARG . 9.6 t80 -44.14 -46.43 8.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 0.0 109.764 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -69.55 -50.03 48.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.321 -0.862 . . . . 0.0 109.225 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -51.64 -45.35 36.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.512 -0.742 . . . . 0.0 109.094 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.467 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 40.0 t -66.4 -23.47 66.32 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.453 -0.779 . . . . 0.0 109.853 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.492 ' NH2' ' OE2' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -85.21 1.65 47.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 110.241 -179.819 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.548 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -60.87 -50.26 85.74 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.047 -1.033 . . . . 0.0 110.223 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 49.8 Cg_endo -73.65 -154.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.495 1.261 . . . . 0.0 109.621 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.9 64.01 0.88 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.431 HG21 ' HD2' ' A' ' 22' ' ' PRO . 18.6 m -115.12 140.28 25.45 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.242 -1.152 . . . . 0.0 110.453 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.433 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 47.8 Cg_endo -76.09 157.86 38.08 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.1 1.579 . . . . 0.0 110.279 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.492 ' OE2' ' NH2' ' A' ' 17' ' ' ARG . 1.2 mt-10 -58.3 -54.59 45.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.197 -0.94 . . . . 0.0 110.27 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 23' ' ' GLU . . . -42.06 -32.34 0.45 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.284 -0.885 . . . . 0.0 110.644 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.433 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -76.94 -52.14 9.93 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.195 -0.941 . . . . 0.0 110.735 -179.502 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 73.0 m -76.82 -28.5 55.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.112 -0.992 . . . . 0.0 110.156 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 23' ' ' GLU . . . -62.73 -48.2 80.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -0.891 . . . . 0.0 109.879 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 93.8 m -66.55 -43.09 86.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.312 -0.867 . . . . 0.0 109.657 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -54.92 -26.64 37.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.361 -0.837 . . . . 0.0 109.909 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 9' ' ' ALA . 7.3 p -105.27 -11.98 16.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.33 -0.856 . . . . 0.0 110.082 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.88 14.47 60.89 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 7.5 t -78.57 167.94 20.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.155 -1.203 . . . . 0.0 110.167 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.2 pt -136.24 159.16 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.234 -0.916 . . . . 0.0 110.234 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.2 mt -124.51 122.95 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.857 . . . . 0.0 110.498 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 23.1 pt -126.08 142.99 44.13 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.297 -0.877 . . . . 0.0 109.948 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.14 -7.39 20.91 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.98 1.516 . . . . 0.0 110.309 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.421 ' O ' ' OG1' ' A' ' 1' ' ' THR . . . -81.87 170.96 52.05 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -116.18 13.93 15.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.284 -1.127 . . . . 0.0 109.986 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.492 ' O ' ' CG2' ' A' ' 39' ' ' THR . 10.8 t -120.92 123.22 41.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 110.303 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.77 151.91 52.87 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.17 -0.956 . . . . 0.0 110.177 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.94 -174.2 1.47 Allowed 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.018 1.536 . . . . 0.0 110.413 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.88 10.87 41.19 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 43' ' ' ASP . 32.4 p-10 -104.86 -18.61 14.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.183 -1.187 . . . . 0.0 110.148 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.403 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 0.1 OUTLIER -131.71 13.02 4.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -0.924 . . . . 0.0 110.117 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -93.83 88.65 5.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.246 -0.909 . . . . 0.0 110.17 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.181 179.958 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.83 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.808 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.603 ' CG2' ' CZ ' ' A' ' 13' ' ' PHE . 17.4 m -83.94 140.63 31.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.371 -0.831 . . . . 0.0 110.228 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.3 m -146.81 158.48 43.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.294 -0.879 . . . . 0.0 110.237 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.484 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -150.66 162.45 27.21 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.3 -0.875 . . . . 0.0 110.023 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.484 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 49.7 Cg_endo -81.34 -92.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.892 1.47 . . . . 0.0 110.645 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -50.99 133.08 27.51 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.566 -0.708 . . . . 0.0 110.805 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.459 ' O ' ' HB3' ' A' ' 10' ' ' ARG . 11.7 mm -52.45 -38.46 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.393 -0.817 . . . . 0.0 110.046 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.1 t -58.21 -53.12 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.911 . . . . 0.0 110.103 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -46.6 -37.1 7.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.167 -0.958 . . . . 0.0 110.019 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.459 ' HB3' ' O ' ' A' ' 7' ' ' ILE . 2.1 tpp180 -65.02 -48.39 74.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.356 -0.84 . . . . 0.0 110.323 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 12' ' ' ASN . 0.5 OUTLIER -52.76 -64.6 0.76 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.152 -0.967 . . . . 0.0 110.176 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.419 ' C ' ' O ' ' A' ' 11' ' ' SER . 71.8 m-20 -43.18 -41.7 3.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.908 . . . . 0.0 110.22 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.603 ' CZ ' ' CG2' ' A' ' 2' ' ' THR . 33.0 t80 -62.03 -38.13 87.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.178 -0.951 . . . . 0.0 110.063 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -67.22 -32.6 73.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.933 . . . . 0.0 109.717 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.532 ' CG1' ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -71.8 -52.33 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.518 -0.739 . . . . 0.0 109.688 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.532 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 41.0 t -54.54 -28.59 46.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.408 -0.808 . . . . 0.0 110.432 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.3 ttp85 -83.96 -12.42 55.35 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.203 -0.936 . . . . 0.0 110.132 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.563 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -59.34 -48.97 94.93 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.374 -0.829 . . . . 0.0 110.485 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 47.6 Cg_endo -74.94 -155.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.731 1.385 . . . . 0.0 110.117 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.86 69.14 0.72 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.469 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 0.7 OUTLIER -130.38 145.28 56.76 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.207 -1.172 . . . . 0.0 110.134 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.469 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 46.0 Cg_endo -73.4 135.13 21.85 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.917 1.483 . . . . 0.0 110.561 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 22' ' ' PRO . 39.4 mt-10 -43.15 -46.57 5.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.348 -0.845 . . . . 0.0 110.053 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' GLU . . . -42.8 -64.86 0.55 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.236 -0.915 . . . . 0.0 110.401 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.31 -33.12 19.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 110.461 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.461 ' O ' ' OG1' ' A' ' 30' ' ' THR . 85.7 m -80.49 -53.68 6.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.179 -0.951 . . . . 0.0 110.197 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.442 ' HA ' ' OG1' ' A' ' 30' ' ' THR . . . -57.85 -16.24 11.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 109.725 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 51.6 m -79.19 -60.31 2.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.391 -0.818 . . . . 0.0 110.215 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -66.83 -16.24 64.15 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.296 -0.877 . . . . 0.0 110.51 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 26' ' ' CYS . 24.1 p -92.67 -38.98 11.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.892 . . . . 0.0 110.097 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.37 18.56 10.93 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 83.9 m -89.74 167.57 12.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.137 -1.213 . . . . 0.0 110.109 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 pt -115.37 152.08 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.888 . . . . 0.0 110.174 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 85.7 mt -118.74 121.99 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.283 -0.886 . . . . 0.0 110.291 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 1' ' ' THR . 4.3 pt -117.84 157.02 49.27 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.188 -0.945 . . . . 0.0 110.416 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -77.2 -13.51 17.01 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 124.091 1.574 . . . . 0.0 110.546 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.446 ' O ' HD12 ' A' ' 35' ' ' ILE . . . 165.18 -146.11 10.88 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.534 ' O ' ' CG2' ' A' ' 39' ' ' THR . . . 63.14 42.95 6.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.329 -1.101 . . . . 0.0 110.293 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.534 ' CG2' ' O ' ' A' ' 38' ' ' ALA . 7.0 t 36.74 -153.14 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.658 -0.651 . . . . 0.0 110.698 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.409 ' SG ' ' HA ' ' A' ' 45' ' ' ALA . 15.3 t -120.26 136.45 25.15 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.148 -0.97 . . . . 0.0 110.343 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.04 133.34 19.57 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.971 1.511 . . . . 0.0 110.417 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -51.34 -43.01 51.16 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -49.86 -22.89 1.63 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -1.145 . . . . 0.0 110.155 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.458 ' CE2' ' HD3' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -145.68 59.29 1.26 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -0.884 . . . . 0.0 109.932 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.409 ' HA ' ' SG ' ' A' ' 40' ' ' CYS . . . -122.12 87.65 2.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.238 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.334 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.827 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.771 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.513 ' N ' ' OG1' ' A' ' 1' ' ' THR . 0.6 OUTLIER -74.9 145.09 42.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.277 -0.889 . . . . 0.0 110.298 . . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 44' ' ' TYR . 1.8 m -148.75 99.95 3.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 110.397 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.448 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 0.6 OUTLIER -105.8 142.33 24.57 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.271 -0.893 . . . . 0.0 110.139 179.853 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.448 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 45.8 Cg_endo -73.47 -93.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.004 1.528 . . . . 0.0 110.561 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.457 ' O ' ' HB1' ' A' ' 9' ' ' ALA . 0.9 OUTLIER -42.92 121.22 2.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.484 -0.76 . . . . 0.0 110.432 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.455 HD13 ' HB3' ' A' ' 46' ' ' ASN . 38.8 mm -55.13 -44.98 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.92 . . . . 0.0 110.108 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.9 t -53.54 -42.42 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 109.839 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' A' ' 6' ' ' SER . . . -53.48 -50.7 64.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.195 -0.941 . . . . 0.0 109.942 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -47.86 -46.25 31.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.247 -0.908 . . . . 0.0 109.857 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.79 -36.45 83.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.882 . . . . 0.0 109.912 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -71.1 -19.04 62.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.935 . . . . 0.0 109.878 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 23' ' ' GLU . 12.3 t80 -75.11 -44.41 47.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.325 -0.859 . . . . 0.0 109.848 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.424 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 76.7 m-20 -68.14 -43.85 77.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -0.907 . . . . 0.0 109.421 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.436 ' CG1' ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -53.02 -48.19 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.447 -0.783 . . . . 0.0 109.344 179.35 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.473 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 13.7 t -68.38 -15.27 63.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.494 -0.754 . . . . 0.0 110.049 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -87.07 -12.26 47.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.242 -0.911 . . . . 0.0 109.969 179.606 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.589 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 3.2 tm? -67.37 -41.67 34.02 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.291 -0.88 . . . . 0.0 111.507 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 48.0 Cg_endo -74.66 -155.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.264 1.139 . . . . 0.0 110.325 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.94 52.86 2.92 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.4 m -129.69 137.49 31.03 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.146 -1.208 . . . . 0.0 110.145 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.449 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 43.6 Cg_endo -71.43 167.78 25.37 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.053 1.554 . . . . 0.0 110.549 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.437 ' O ' ' C ' ' A' ' 24' ' ' ALA . 32.5 mp0 -68.42 -52.79 28.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.285 -0.884 . . . . 0.0 110.336 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 23' ' ' GLU . . . -41.04 -41.48 1.7 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.378 -0.826 . . . . 0.0 110.474 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.449 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -68.81 -45.41 71.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.351 -0.843 . . . . 0.0 110.177 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 59.9 m -74.85 -51.69 13.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.344 -0.847 . . . . 0.0 110.27 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.425 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -49.77 -48.31 50.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.0 110.423 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.7 m -63.26 -35.03 79.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.227 -0.921 . . . . 0.0 110.334 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -78.56 -0.98 31.83 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.304 -0.873 . . . . 0.0 110.486 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.3 p -120.88 -25.61 5.37 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.196 -0.94 . . . . 0.0 110.226 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.92 6.4 22.81 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 27' ' ' ALA . 22.5 m -84.35 139.71 32.08 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.149 -1.207 . . . . 0.0 110.266 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.53 HG12 ' CE1' ' A' ' 44' ' ' TYR . 1.1 pp -111.8 149.56 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 110.037 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.4 mt -120.74 117.39 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 110.349 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 1' ' ' THR . 12.7 pt -122.19 140.38 32.31 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.387 -0.82 . . . . 0.0 110.081 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -75.11 -14.72 20.82 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.086 1.572 . . . . 0.0 110.619 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -165.08 -145.58 4.46 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.434 ' O ' ' C ' ' A' ' 39' ' ' THR . . . 56.6 92.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -1.139 . . . . 0.0 110.084 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.434 ' C ' ' O ' ' A' ' 38' ' ' ALA . 1.2 t -41.63 145.73 0.28 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.257 -0.902 . . . . 0.0 110.379 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -81.89 159.4 65.99 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.155 -0.965 . . . . 0.0 110.045 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.504 ' O ' ' N ' ' A' ' 43' ' ' ASP . 47.7 Cg_endo -82.53 26.41 0.64 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.89 1.468 . . . . 0.0 111.378 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.45 -66.26 0.1 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 41' ' ' PRO . 22.5 p-10 -48.33 -32.22 7.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.186 -1.185 . . . . 0.0 110.496 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.53 ' CE1' HG12 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -81.38 -31.3 33.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.27 -0.894 . . . . 0.0 110.283 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.44 88.03 0.89 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.322 -0.861 . . . . 0.0 110.047 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.455 ' HB3' HD13 ' A' ' 7' ' ' ILE . 5.8 m120 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.296 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.835 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.216 -0.662 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.524 ' N ' ' CB ' ' A' ' 1' ' ' THR . 0.2 OUTLIER -83.81 133.27 34.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.231 -0.918 . . . . 0.0 110.176 . . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 17.1 m -135.49 141.83 45.37 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.339 -0.851 . . . . 0.0 109.832 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -126.82 154.89 76.02 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.131 -0.981 . . . . 0.0 110.557 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -75.76 -94.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.195 1.629 . . . . 0.0 110.435 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.76 136.07 34.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.481 -0.762 . . . . 0.0 110.695 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.426 ' O ' ' HB3' ' A' ' 10' ' ' ARG . 13.8 mm -55.36 -53.27 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.342 -0.849 . . . . 0.0 110.077 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.414 ' C ' ' O ' ' A' ' 7' ' ' ILE . 53.0 t -44.15 -51.43 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 110.023 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -45.65 -52.15 11.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.102 -0.999 . . . . 0.0 109.786 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.469 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -50.48 -47.07 57.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.405 -0.809 . . . . 0.0 109.867 179.63 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.477 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 4.6 t -59.85 -40.99 90.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.303 -0.873 . . . . 0.0 110.073 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -76.19 -8.32 56.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.33 -0.856 . . . . 0.0 110.254 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.469 ' HB3' ' O ' ' A' ' 10' ' ' ARG . 53.9 t80 -77.05 -62.24 1.72 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.242 -0.912 . . . . 0.0 110.154 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -60.83 -34.35 74.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.149 -0.969 . . . . 0.0 108.899 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.494 HG13 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -60.98 -46.77 95.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.945 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.494 ' N ' HG13 ' A' ' 15' ' ' VAL . 7.0 t -55.92 -25.23 42.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.424 -0.798 . . . . 0.0 109.92 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -85.62 -13.19 49.46 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.304 -0.872 . . . . 0.0 110.554 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.597 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 4.0 tp -57.66 -43.58 98.9 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.198 -0.939 . . . . 0.0 111.416 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 45.0 Cg_endo -72.98 -30.42 10.95 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.309 1.163 . . . . 0.0 110.5 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.44 6.28 4.31 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.464 HG21 ' HD2' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -67.07 143.28 97.74 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.094 -1.239 . . . . 0.0 110.093 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.464 ' HD2' HG21 ' A' ' 21' ' ' THR . 43.9 Cg_endo -71.96 158.46 52.58 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.889 1.468 . . . . 0.0 110.814 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.45 -47.16 76.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.434 -0.791 . . . . 0.0 110.524 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.54 -45.25 26.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.232 -0.918 . . . . 0.0 110.627 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.412 ' HB3' HG21 ' A' ' 21' ' ' THR . 0.3 OUTLIER -67.14 -42.65 84.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.156 -0.965 . . . . 0.0 110.365 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 39.7 m -70.75 -52.85 18.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.208 -0.933 . . . . 0.0 110.179 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.414 ' HA ' ' HB2' ' A' ' 32' ' ' CYS . . . -53.12 -22.37 6.19 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 110.37 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.9 m -86.99 -34.44 19.26 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.211 -0.931 . . . . 0.0 110.324 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -79.08 -20.34 49.01 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.197 -0.939 . . . . 0.0 110.197 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.0 p -110.28 -24.49 10.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.156 -0.965 . . . . 0.0 110.202 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.34 61.0 1.34 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.428 ' SG ' ' O ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -117.32 174.94 5.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -1.131 . . . . 0.0 110.418 -179.85 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 2' ' ' THR . 1.0 OUTLIER -135.92 147.43 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.369 -0.832 . . . . 0.0 110.29 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.1 mt -116.17 108.88 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 110.156 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.533 ' CD1' ' O ' ' A' ' 39' ' ' THR . 18.1 pt -88.78 145.05 34.09 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.268 -0.895 . . . . 0.0 110.342 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -74.99 -5.38 16.72 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.997 1.525 . . . . 0.0 110.345 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.447 ' O ' ' CB ' ' A' ' 38' ' ' ALA . . . 168.15 -160.0 33.4 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.511 ' O ' ' CG2' ' A' ' 39' ' ' THR . . . 66.85 15.66 10.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.251 -1.147 . . . . 0.0 110.19 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.533 ' O ' ' CD1' ' A' ' 35' ' ' ILE . 6.7 t 39.65 -163.87 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.52 -0.738 . . . . 0.0 110.751 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.464 ' SG ' ' HD2' ' A' ' 41' ' ' PRO . 4.4 t -122.74 140.44 33.12 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.95 . . . . 0.0 110.38 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.464 ' HD2' ' SG ' ' A' ' 40' ' ' CYS . 43.6 Cg_endo -71.08 -160.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.927 1.488 . . . . 0.0 110.311 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -113.52 4.75 24.77 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -96.78 -29.95 13.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.101 -1.235 . . . . 0.0 110.241 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.46 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 5.9 t80 -119.26 7.98 11.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.268 -0.895 . . . . 0.0 110.435 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 41' ' ' PRO . . . -94.81 87.47 5.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -0.99 . . . . 0.0 110.138 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.227 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.832 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.747 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.575 HG22 ' CE1' ' A' ' 13' ' ' PHE . 2.1 m -95.94 132.39 41.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.247 -0.908 . . . . 0.0 110.143 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.449 ' HB3' ' HA ' ' A' ' 45' ' ' ALA . 57.7 m -146.19 156.34 43.34 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.139 -0.976 . . . . 0.0 110.716 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.434 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -134.34 174.26 4.85 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.386 -0.821 . . . . 0.0 109.95 179.672 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.434 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 46.2 Cg_endo -72.99 -93.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.993 1.523 . . . . 0.0 109.913 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 7' ' ' ILE . 5.8 t -75.33 143.65 42.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.528 -0.732 . . . . 0.0 109.789 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.417 ' C ' ' O ' ' A' ' 6' ' ' SER . 71.2 mt -42.79 -47.9 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.223 -0.923 . . . . 0.0 110.125 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 33.4 t -50.36 -51.19 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -0.924 . . . . 0.0 110.047 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.85 -34.95 13.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.169 -0.957 . . . . 0.0 110.214 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 11' ' ' SER . 0.1 OUTLIER -65.64 -58.74 5.0 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 110.2 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 10' ' ' ARG . 4.9 p -42.38 -45.07 4.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.231 -0.918 . . . . 0.0 110.323 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -57.49 -51.47 69.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.199 -0.938 . . . . 0.0 110.322 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.575 ' CE1' HG22 ' A' ' 2' ' ' THR . 6.1 t80 -54.44 -39.04 67.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.21 -0.931 . . . . 0.0 110.19 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -67.93 -23.01 65.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -0.895 . . . . 0.0 109.129 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.5 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -85.34 -46.9 17.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.302 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.5 ' N ' HG12 ' A' ' 15' ' ' VAL . 9.6 t -60.2 -14.33 16.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.594 -0.691 . . . . 0.0 110.312 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.498 ' HB3' ' NH2' ' A' ' 17' ' ' ARG . 7.5 mmm180 -86.98 -7.74 57.86 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.156 -0.965 . . . . 0.0 109.957 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.589 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 2.4 tp -81.18 -43.68 1.17 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.367 -0.833 . . . . 0.0 111.248 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 46.3 Cg_endo -73.34 -155.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.228 1.12 . . . . 0.0 110.214 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.99 6.36 62.03 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.37 129.85 88.4 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.186 -1.185 . . . . 0.0 110.047 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.0 157.76 53.88 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.921 1.485 . . . . 0.0 110.513 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -52.91 -33.84 52.27 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.363 -0.836 . . . . 0.0 110.433 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.56 -65.08 0.69 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.954 . . . . 0.0 110.328 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.97 -27.33 18.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.322 -0.861 . . . . 0.0 110.436 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 82.0 m -81.1 -56.52 4.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.963 . . . . 0.0 110.392 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -47.99 -22.92 0.67 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.332 -0.855 . . . . 0.0 110.509 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.9 m -82.09 -58.57 2.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.133 -0.979 . . . . 0.0 110.535 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.7 -21.4 40.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.291 -0.881 . . . . 0.0 110.315 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.6 p -109.42 -29.13 8.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -0.897 . . . . 0.0 110.209 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 85.98 20.53 55.33 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.99 173.19 8.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.214 -1.168 . . . . 0.0 110.393 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.409 ' C ' HG13 ' A' ' 34' ' ' ILE . 4.5 pt -130.64 152.86 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.359 -0.838 . . . . 0.0 109.774 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.409 HG13 ' C ' ' A' ' 33' ' ' ILE . 34.3 mt -131.96 118.19 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.034 -1.041 . . . . 0.0 110.749 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.518 ' CG1' ' HA ' ' A' ' 1' ' ' THR . 9.2 pt -105.14 159.91 27.78 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.313 -0.867 . . . . 0.0 109.952 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -76.46 -35.65 2.07 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.925 1.487 . . . . 0.0 110.817 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -76.94 -175.6 42.2 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.0 19.7 18.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.246 -1.15 . . . . 0.0 110.149 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.464 ' O ' ' CD1' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -121.26 134.92 55.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 110.167 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.83 135.8 21.19 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.256 -0.903 . . . . 0.0 110.468 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.443 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 47.7 Cg_endo -73.92 149.48 42.22 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.029 1.541 . . . . 0.0 110.286 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.78 -19.01 66.95 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -59.47 -34.9 73.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -1.188 . . . . 0.0 110.293 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -147.35 55.57 1.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.933 . . . . 0.0 110.239 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.449 ' HA ' ' HB3' ' A' ' 3' ' ' CYS . . . -129.32 87.61 2.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.874 . . . . 0.0 110.181 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.251 179.988 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.842 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.738 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.55 HG21 ' CE2' ' A' ' 13' ' ' PHE . 2.0 m -104.72 134.32 48.07 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.261 -0.899 . . . . 0.0 110.43 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.423 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 83.8 m -133.55 116.21 15.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 110.172 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 0.7 OUTLIER -108.86 149.86 40.11 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.308 -0.87 . . . . 0.0 110.646 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.499 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 48.9 Cg_endo -79.07 -91.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.299 1.684 . . . . 0.0 110.479 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.2 t -50.18 133.24 23.72 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 110.303 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.5 mt -52.81 -54.3 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.174 -0.954 . . . . 0.0 109.898 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 9' ' ' ALA . 2.5 t -46.86 -47.49 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -0.935 . . . . 0.0 109.36 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 8' ' ' VAL . . . -43.96 -48.5 8.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.276 -0.89 . . . . 0.0 109.445 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -58.34 -41.55 84.88 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.285 -0.884 . . . . 0.0 109.666 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.415 ' HB3' ' O ' ' A' ' 8' ' ' VAL . 0.3 OUTLIER -60.14 -59.38 5.51 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.345 -0.847 . . . . 0.0 109.621 179.553 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -59.23 -25.6 64.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.558 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.55 ' CE2' HG21 ' A' ' 2' ' ' THR . 24.1 t80 -71.4 -25.35 62.31 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.43 -0.794 . . . . 0.0 109.809 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.17 -46.41 34.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.314 -0.866 . . . . 0.0 109.053 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.525 ' O ' ' CD ' ' A' ' 19' ' ' PRO . 1.1 t -56.61 -38.77 58.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.1 t -69.13 -27.65 65.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.485 -0.759 . . . . 0.0 110.455 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.521 ' CZ ' ' HB3' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -86.0 -11.84 51.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.102 -0.999 . . . . 0.0 110.616 -179.719 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.566 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -69.41 -50.03 20.92 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.206 -0.934 . . . . 0.0 110.824 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 45.4 Cg_endo -73.04 -155.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.553 1.291 . . . . 0.0 110.351 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.21 75.36 0.29 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 m -135.93 138.71 28.45 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.247 -1.149 . . . . 0.0 109.887 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.463 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 43.8 Cg_endo -72.19 150.76 54.07 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.982 1.517 . . . . 0.0 110.372 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.1 -49.23 66.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.325 -0.859 . . . . 0.0 110.462 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -44.19 -54.26 5.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.378 -0.826 . . . . 0.0 110.695 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.463 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.6 OUTLIER -56.7 -37.87 71.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.182 -0.949 . . . . 0.0 110.646 -179.626 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 83.7 m -78.88 -44.28 23.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.167 -0.958 . . . . 0.0 110.261 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.94 -24.98 7.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 110.408 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.1 m -89.5 -48.54 7.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.214 -0.929 . . . . 0.0 110.064 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -63.66 -22.2 66.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.352 -0.842 . . . . 0.0 110.38 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.6 p -110.79 -47.02 3.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.201 -0.937 . . . . 0.0 110.378 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.75 56.89 0.34 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.487 ' CB ' ' CE1' ' A' ' 13' ' ' PHE . 0.1 OUTLIER -120.36 176.37 5.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.259 -1.142 . . . . 0.0 110.063 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -136.85 148.51 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.181 -0.949 . . . . 0.0 110.316 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 23.9 mt -104.68 132.67 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 110.132 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.522 ' CD1' ' O ' ' A' ' 39' ' ' THR . 2.5 pt -103.83 155.39 37.08 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.132 -0.98 . . . . 0.0 110.392 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -79.82 44.94 1.82 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.061 1.558 . . . . 0.0 110.809 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.496 ' O ' ' CB ' ' A' ' 38' ' ' ALA . . . 94.55 -169.1 28.49 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.496 ' CB ' ' O ' ' A' ' 37' ' ' GLY . . . 69.69 32.72 3.19 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.372 -1.075 . . . . 0.0 110.442 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.522 ' O ' ' CD1' ' A' ' 35' ' ' ILE . 6.2 t 37.61 -156.32 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.524 -0.735 . . . . 0.0 110.486 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.492 ' N ' HG23 ' A' ' 39' ' ' THR . 4.2 t -114.77 137.17 22.64 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.071 -1.018 . . . . 0.0 110.581 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.463 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 47.2 Cg_endo -72.27 -163.51 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.941 1.495 . . . . 0.0 110.322 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.44 -14.62 29.68 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.01 -32.63 67.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.312 -1.111 . . . . 0.0 110.33 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.461 ' O ' ' SG ' ' A' ' 40' ' ' CYS . 0.2 OUTLIER -135.5 68.32 1.46 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.313 -0.867 . . . . 0.0 110.096 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 41' ' ' PRO . . . -130.45 88.93 2.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.111 -0.993 . . . . 0.0 110.793 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.499 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 1.2 m120 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.039 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.85 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.721 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.549 HG22 ' CZ ' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -96.48 124.0 40.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.15 -0.969 . . . . 0.0 110.447 . . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 26.7 m -129.48 97.08 4.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 0.0 109.922 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.422 ' N ' ' SG ' ' A' ' 32' ' ' CYS . 22.0 m -99.2 158.02 33.01 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.295 -0.878 . . . . 0.0 110.391 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -77.08 -95.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 124.075 1.566 . . . . 0.0 110.469 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.7 t -54.68 134.34 47.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.462 -0.773 . . . . 0.0 110.255 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.4 mt -57.93 -44.25 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -0.918 . . . . 0.0 109.852 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.3 t -50.45 -49.17 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.364 -0.835 . . . . 0.0 109.835 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.93 -43.52 63.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 109.749 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.451 ' HG3' ' OXT' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -53.81 -58.27 7.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.202 -0.936 . . . . 0.0 109.842 179.652 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -45.97 -51.11 13.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.193 -0.942 . . . . 0.0 109.477 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -55.17 -36.73 66.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.329 -0.857 . . . . 0.0 109.137 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.549 ' CZ ' HG22 ' A' ' 2' ' ' THR . 38.4 t80 -74.6 -28.58 60.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.444 -0.785 . . . . 0.0 109.435 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -68.14 -27.39 66.4 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.454 -0.779 . . . . 0.0 109.147 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.504 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -82.46 -49.3 17.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.184 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.504 ' N ' HG12 ' A' ' 15' ' ' VAL . 42.7 t -58.92 -20.84 55.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.383 -0.823 . . . . 0.0 109.973 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.511 ' CD ' ' HG3' ' A' ' 23' ' ' GLU . 2.7 tpt85 -89.61 -20.11 24.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.217 -0.927 . . . . 0.0 110.179 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.585 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 15.4 tp -56.75 -41.71 92.66 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.882 . . . . 0.0 110.841 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 18' ' ' LEU . 47.9 Cg_endo -76.11 -156.17 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.324 1.171 . . . . 0.0 110.293 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.84 14.35 65.33 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 m -75.5 137.65 71.01 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.11 -1.229 . . . . 0.0 110.008 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.427 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 47.9 Cg_endo -73.44 158.56 47.88 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.968 1.509 . . . . 0.0 110.587 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.511 ' HG3' ' CD ' ' A' ' 17' ' ' ARG . 1.0 OUTLIER -60.45 -49.06 79.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.34 -0.85 . . . . 0.0 110.354 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' GLU . . . -43.37 -49.02 7.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 110.306 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.427 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -59.84 -47.28 86.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.278 -0.889 . . . . 0.0 110.398 -179.798 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.407 ' HB2' ' CE1' ' A' ' 13' ' ' PHE . 25.9 m -72.38 -43.86 63.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.175 -0.953 . . . . 0.0 110.21 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.6 -38.94 70.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.158 -0.963 . . . . 0.0 110.103 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.4 m -80.32 -21.83 42.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 0.0 110.157 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -85.32 -11.07 55.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.202 -0.936 . . . . 0.0 110.131 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 55.4 p -123.87 -31.77 3.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.321 -0.862 . . . . 0.0 110.126 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.58 60.05 0.52 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.422 ' SG ' ' N ' ' A' ' 4' ' ' CYS . 8.4 t -131.76 173.42 11.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.285 -1.127 . . . . 0.0 110.185 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.0 pt -135.02 157.81 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.289 -0.882 . . . . 0.0 110.33 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 1' ' ' THR . 26.2 mt -114.29 144.72 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.349 -0.845 . . . . 0.0 110.059 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.443 HG13 ' HA ' ' A' ' 1' ' ' THR . 3.8 pt -120.11 150.42 51.18 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.913 . . . . 0.0 110.259 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.16 56.62 3.18 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.103 1.581 . . . . 0.0 110.434 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 166.52 -168.43 40.06 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.56 31.21 6.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.17 -1.194 . . . . 0.0 110.336 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.524 ' O ' ' CG2' ' A' ' 39' ' ' THR . 12.0 t -130.21 104.16 7.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.259 -0.9 . . . . 0.0 110.108 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.37 152.74 44.09 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.241 -0.912 . . . . 0.0 110.271 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 42' ' ' GLY . 46.8 Cg_endo -74.7 127.1 10.63 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.967 1.509 . . . . 0.0 110.402 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 41' ' ' PRO . . . -44.68 -28.49 1.64 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -51.82 -35.88 46.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.304 -1.116 . . . . 0.0 110.367 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.443 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 1.1 t80 -134.0 31.76 3.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 0.0 110.332 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -110.07 98.03 7.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.189 -0.944 . . . . 0.0 110.276 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.451 ' OXT' ' HG3' ' A' ' 10' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.261 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.845 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.78 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.467 ' CG2' ' HB3' ' A' ' 32' ' ' CYS . 99.5 m -131.18 145.2 51.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.885 . . . . 0.0 110.451 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.501 ' SG ' ' CD1' ' A' ' 35' ' ' ILE . 61.5 m -120.28 112.25 18.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.375 -0.828 . . . . 0.0 109.93 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.457 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -122.34 146.56 47.43 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.167 -0.958 . . . . 0.0 110.193 -179.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.562 ' HG3' ' CE2' ' A' ' 44' ' ' TYR . 48.0 Cg_endo -72.95 -93.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.983 1.517 . . . . 0.0 110.42 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 5' ' ' PRO . 1.6 t -42.21 109.51 0.13 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.527 -0.733 . . . . 0.0 110.334 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.2 mt -44.23 -50.83 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.167 -0.958 . . . . 0.0 110.178 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 69.7 t -47.13 -41.79 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -0.953 . . . . 0.0 109.885 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.09 -47.71 77.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.92 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.46 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 0.9 OUTLIER -60.93 -42.01 97.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.317 -0.864 . . . . 0.0 110.295 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.73 -48.43 72.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.179 -0.951 . . . . 0.0 110.223 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -65.71 -22.44 66.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.153 -0.967 . . . . 0.0 110.016 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.46 ' HB3' ' O ' ' A' ' 10' ' ' ARG . 49.6 t80 -74.83 -35.07 62.42 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.318 -0.864 . . . . 0.0 109.945 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -64.18 -51.3 64.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 0.0 109.477 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.508 ' CG1' ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -55.57 -51.06 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.408 -0.807 . . . . 0.0 109.33 179.422 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.508 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 53.4 t -48.39 -28.55 3.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.371 -0.831 . . . . 0.0 109.944 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.444 ' C ' ' HD2' ' A' ' 19' ' ' PRO . 11.1 tpt180 -83.99 -20.99 31.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.344 -0.847 . . . . 0.0 110.07 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.574 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 3.4 tm? -49.61 -45.37 78.53 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 110.934 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 47.3 Cg_endo -73.02 -155.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.254 1.134 . . . . 0.0 110.033 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.46 50.74 1.26 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.449 HG23 ' HD2' ' A' ' 22' ' ' PRO . 93.2 m -115.5 140.06 25.45 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.21 -1.17 . . . . 0.0 110.099 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.474 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 43.8 Cg_endo -71.63 165.92 31.02 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.846 1.445 . . . . 0.0 110.315 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -69.4 -46.36 67.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -0.906 . . . . 0.0 110.424 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.76 -45.34 19.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 0.0 110.372 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.474 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -62.6 -48.29 80.07 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.157 -0.964 . . . . 0.0 110.281 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.453 ' O ' ' OG1' ' A' ' 30' ' ' THR . 73.0 m -68.44 -44.81 74.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.136 -0.978 . . . . 0.0 110.047 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.58 -37.13 26.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.181 -0.949 . . . . 0.0 109.867 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.1 m -72.73 -40.63 65.93 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.322 -0.861 . . . . 0.0 109.967 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -78.37 -9.75 59.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.855 . . . . 0.0 110.045 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 26' ' ' CYS . 17.3 p -110.54 -19.57 12.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.297 -0.877 . . . . 0.0 110.169 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.23 23.42 48.35 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.467 ' HB3' ' CG2' ' A' ' 2' ' ' THR . 33.4 m -101.02 171.1 7.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -1.181 . . . . 0.0 110.231 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 3' ' ' CYS . 23.8 pt -123.47 156.04 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.917 . . . . 0.0 109.985 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.438 HD11 ' OG1' ' A' ' 2' ' ' THR . 20.9 mm -106.09 152.37 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 110.404 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.508 ' CD1' ' O ' ' A' ' 37' ' ' GLY . 4.6 pt -156.18 150.73 20.23 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.336 -0.852 . . . . 0.0 110.331 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.89 5.26 4.54 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.15 1.605 . . . . 0.0 110.957 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.508 ' O ' ' CD1' ' A' ' 35' ' ' ILE . . . -141.7 155.88 25.57 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.07 40.23 0.9 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.375 -1.073 . . . . 0.0 109.947 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.524 ' O ' ' CG2' ' A' ' 39' ' ' THR . 11.2 t -120.85 95.64 4.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.901 . . . . 0.0 110.332 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.412 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . 8.2 m -81.88 166.21 38.79 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 109.699 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.525 ' O ' ' N ' ' A' ' 43' ' ' ASP . 52.8 Cg_endo -79.78 32.77 0.49 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.843 1.444 . . . . 0.0 111.593 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.422 ' CA ' ' HB3' ' A' ' 45' ' ' ALA . . . 65.06 -68.21 0.08 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 41' ' ' PRO . 0.3 OUTLIER -48.67 -41.44 31.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.111 -1.229 . . . . 0.0 109.774 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.562 ' CE2' ' HG3' ' A' ' 5' ' ' PRO . 0.5 OUTLIER -106.34 32.78 4.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -0.837 . . . . 0.0 109.887 179.629 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.51 ' O ' ' CB ' ' A' ' 46' ' ' ASN . . . -105.31 96.33 6.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.324 -0.86 . . . . 0.0 110.243 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 45' ' ' ALA . 1.3 m-20 . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.111 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.834 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.762 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.45 ' O ' ' SG ' ' A' ' 3' ' ' CYS . 91.9 m -117.97 152.99 34.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.247 -0.908 . . . . 0.0 110.363 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.451 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 49.1 m -153.63 154.7 34.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.344 -0.847 . . . . 0.0 110.321 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.13 171.31 9.15 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 109.983 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.1 -95.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.99 1.521 . . . . 0.0 110.707 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.4 t -76.11 157.77 32.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.496 -0.753 . . . . 0.0 110.423 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.409 ' O ' ' C ' ' A' ' 8' ' ' VAL . 2.4 mp -58.33 -50.07 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.882 . . . . 0.0 109.874 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.409 ' C ' ' O ' ' A' ' 7' ' ' ILE . 91.1 t -44.69 -47.97 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.312 -0.868 . . . . 0.0 109.901 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.91 -45.17 71.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 109.915 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.419 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 9.5 ttm-85 -63.45 -48.6 77.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.388 -0.82 . . . . 0.0 110.271 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -50.11 -59.26 4.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.141 -0.975 . . . . 0.0 110.132 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -55.2 -40.45 70.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.912 . . . . 0.0 110.016 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.46 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 51.0 t80 -56.88 -43.8 81.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 0.0 110.097 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -58.4 -42.08 86.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.241 -0.912 . . . . 0.0 109.263 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.515 ' CG1' ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -61.89 -50.65 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.599 -0.688 . . . . 0.0 109.282 179.25 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.515 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 13.9 t -48.25 -25.61 1.61 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.443 -0.786 . . . . 0.0 110.099 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.549 ' NH2' ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -91.16 10.53 26.6 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.428 -0.795 . . . . 0.0 109.585 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.618 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 2.3 tt -84.04 -36.87 0.64 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.517 -0.739 . . . . 0.0 112.349 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 43.8 Cg_endo -72.54 -37.61 4.01 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 O-C-N 122.994 0.997 . . . . 0.0 111.356 -178.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 135.38 1.22 3.19 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.526 -1.321 . . . . 0.0 110.429 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.549 ' O ' ' NH2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -66.4 157.04 83.81 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 120.97 -1.312 . . . . 0.0 109.486 179.733 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.536 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 47.7 Cg_endo -74.98 149.5 36.86 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.795 1.418 . . . . 0.0 110.71 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.54 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 1.6 pt-20 -54.84 -25.4 28.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.349 -0.844 . . . . 0.0 110.14 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.17 -44.22 84.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.311 -0.868 . . . . 0.0 110.44 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.461 HD22 ' O ' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -68.55 -33.69 74.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 110.444 -179.782 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.45 ' O ' ' OG1' ' A' ' 30' ' ' THR . 69.6 m -87.45 -32.83 19.29 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.052 -1.03 . . . . 0.0 110.581 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.58 -30.35 70.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.098 -1.001 . . . . 0.0 110.035 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.86 -28.1 17.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 0.0 110.15 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.452 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -68.84 -28.9 67.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.216 -0.928 . . . . 0.0 110.324 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -101.68 -30.52 11.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.214 -0.929 . . . . 0.0 110.092 179.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.52 19.05 9.04 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -76.43 -177.55 4.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -1.135 . . . . 0.0 110.003 179.936 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.443 HG23 ' O ' ' A' ' 32' ' ' CYS . 1.6 pp -145.81 159.53 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.154 -0.966 . . . . 0.0 110.485 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 53.4 mt -125.58 121.37 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.354 -0.842 . . . . 0.0 110.061 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.443 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 12.1 pt -93.46 163.79 23.38 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.935 . . . . 0.0 110.361 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.443 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 48.7 Cg_endo -73.48 -40.09 1.71 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.008 1.531 . . . . 0.0 110.584 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 1' ' ' THR . . . -82.77 -159.8 27.32 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -125.74 -0.08 7.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.279 -1.13 . . . . 0.0 110.258 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.503 ' O ' ' CG2' ' A' ' 39' ' ' THR . 14.3 t -105.42 118.29 36.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.309 -0.869 . . . . 0.0 109.995 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.21 146.21 31.48 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.251 -0.906 . . . . 0.0 110.314 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.448 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 46.4 Cg_endo -72.98 -166.56 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.152 1.606 . . . . 0.0 110.866 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.47 -5.62 39.48 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.517 ' OD2' ' N ' ' A' ' 44' ' ' TYR . 4.3 p30 -82.35 -24.42 34.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -1.14 . . . . 0.0 110.038 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.517 ' N ' ' OD2' ' A' ' 43' ' ' ASP . 0.2 OUTLIER -144.64 47.15 1.37 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 110.311 -179.817 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -118.61 89.42 3.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 110.065 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.1 m120 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.258 -179.94 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.847 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.216 -0.71 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.448 ' CG2' ' O ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -127.85 172.66 10.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.908 . . . . 0.0 110.256 . . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 44' ' ' TYR . 1.8 t -142.49 121.68 13.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.323 -0.861 . . . . 0.0 110.107 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.443 ' O ' ' OXT' ' A' ' 46' ' ' ASN . 57.8 m -120.71 150.11 51.9 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.246 -0.909 . . . . 0.0 110.214 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.525 ' HD3' ' CE2' ' A' ' 44' ' ' TYR . 52.6 Cg_endo -77.79 -94.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.125 1.592 . . . . 0.0 110.614 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 t -50.29 129.54 21.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.476 -0.765 . . . . 0.0 110.593 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.3 mm -50.71 -41.05 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.212 -0.93 . . . . 0.0 109.369 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 56.1 t -53.32 -47.3 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.436 -0.79 . . . . 0.0 109.715 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.47 -52.72 27.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.344 -0.847 . . . . 0.0 109.91 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.9 ttm-85 -55.64 -43.85 76.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.266 -0.896 . . . . 0.0 109.941 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.55 -56.97 6.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.0 109.933 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -60.08 -33.1 71.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.332 -0.855 . . . . 0.0 109.903 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.444 ' CZ ' ' HD3' ' A' ' 17' ' ' ARG . 16.1 t80 -70.96 -35.91 72.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.0 109.804 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -73.51 -44.57 57.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.346 -0.846 . . . . 0.0 109.447 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -54.91 -47.3 76.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.459 -0.775 . . . . 0.0 109.197 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.453 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 29.7 t -68.78 -25.53 64.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.464 -0.772 . . . . 0.0 109.93 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.444 ' HD3' ' CZ ' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -88.74 -8.44 54.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.384 -0.822 . . . . 0.0 109.879 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.577 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -61.94 -45.62 91.95 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.462 -0.774 . . . . 0.0 110.654 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 18' ' ' LEU . 47.4 Cg_endo -78.29 -157.41 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.759 1.4 . . . . 0.0 110.075 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.6 61.77 2.75 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.448 HG22 ' SG ' ' A' ' 16' ' ' CYS . 99.1 m -119.47 140.67 29.55 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.237 -1.155 . . . . 0.0 110.306 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.31 170.37 19.36 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.006 1.53 . . . . 0.0 110.841 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.463 ' O ' ' N ' ' A' ' 25' ' ' LEU . 1.4 mt-10 -72.44 -55.27 7.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.358 -0.839 . . . . 0.0 110.477 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 23' ' ' GLU . . . -39.8 -28.48 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.355 -0.84 . . . . 0.0 110.603 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.463 ' N ' ' O ' ' A' ' 23' ' ' GLU . 0.7 OUTLIER -81.3 -50.13 9.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.169 -0.957 . . . . 0.0 110.599 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.446 ' O ' HG21 ' A' ' 30' ' ' THR . 13.2 m -83.5 -27.6 29.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.141 -0.975 . . . . 0.0 110.666 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -74.14 -49.31 24.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.168 -0.957 . . . . 0.0 110.561 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.2 m -76.17 -23.41 54.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.224 -0.922 . . . . 0.0 110.503 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.428 ' CB ' ' O ' ' A' ' 25' ' ' LEU . 48.1 t80 -81.44 -6.41 58.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.931 . . . . 0.0 110.413 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.446 HG21 ' O ' ' A' ' 26' ' ' CYS . 31.3 p -119.19 -21.71 7.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 0.0 110.189 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.85 38.93 3.26 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 57.0 m -108.86 -179.34 3.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.18 -1.188 . . . . 0.0 110.23 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.448 ' O ' ' CG2' ' A' ' 2' ' ' THR . 9.1 pt -126.17 149.26 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.271 -0.893 . . . . 0.0 110.398 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.7 mt -109.0 124.65 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.265 -0.897 . . . . 0.0 109.957 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.419 ' CD1' ' O ' ' A' ' 39' ' ' THR . 23.5 pt -123.44 135.34 25.96 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.161 -0.962 . . . . 0.0 110.51 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -77.79 53.98 4.62 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.958 1.504 . . . . 0.0 110.489 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -164.08 -155.97 8.59 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -134.31 29.25 3.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -1.141 . . . . 0.0 110.218 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.419 ' O ' ' CD1' ' A' ' 35' ' ' ILE . 13.1 t -130.02 161.93 29.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.0 110.085 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.6 m -138.93 166.62 23.65 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.247 -0.908 . . . . 0.0 110.197 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.427 ' HG2' ' OD1' ' A' ' 43' ' ' ASP . 50.0 Cg_endo -79.27 15.51 1.54 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.937 1.493 . . . . 0.0 111.189 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.32 -64.16 3.53 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.433 ' CG ' ' N ' ' A' ' 44' ' ' TYR . 4.6 p-10 -52.77 -44.14 66.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.272 -1.134 . . . . 0.0 110.971 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.525 ' CE2' ' HD3' ' A' ' 5' ' ' PRO . 1.8 m-85 -89.87 -2.13 58.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.066 -1.021 . . . . 0.0 110.5 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.501 ' O ' ' ND2' ' A' ' 46' ' ' ASN . . . -75.31 87.93 2.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.214 -0.929 . . . . 0.0 110.407 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 45' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.136 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.851 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.776 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.1 m -138.23 145.73 41.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 109.991 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 29.9 m -139.21 128.58 24.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.201 -0.937 . . . . 0.0 110.345 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -123.25 165.24 23.34 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.294 -0.879 . . . . 0.0 110.214 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.456 ' O ' ' CB ' ' A' ' 46' ' ' ASN . 47.8 Cg_endo -73.87 -93.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.924 1.486 . . . . 0.0 110.524 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.9 t -62.38 154.99 26.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.583 -0.698 . . . . 0.0 110.339 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.43 HD13 ' HB3' ' A' ' 46' ' ' ASN . 48.7 mm -66.28 -30.01 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.333 -0.854 . . . . 0.0 109.776 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.7 t -69.44 -44.1 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.329 -0.857 . . . . 0.0 109.794 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.76 -42.1 67.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.394 -0.816 . . . . 0.0 110.067 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.452 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 5.2 ttp180 -67.22 -50.96 58.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 0.0 110.154 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.1 t -50.84 -46.26 60.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.256 -0.902 . . . . 0.0 110.334 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -61.71 -30.49 70.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.296 -0.877 . . . . 0.0 110.329 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.452 ' HB3' ' O ' ' A' ' 10' ' ' ARG . 48.5 t80 -67.9 -40.47 83.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.918 . . . . 0.0 110.232 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -58.05 -47.46 83.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -0.941 . . . . 0.0 109.381 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.529 ' CG1' ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -54.31 -51.57 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.494 -0.754 . . . . 0.0 109.278 179.319 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.529 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 35.4 t -48.66 -28.23 3.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.573 -0.704 . . . . 0.0 110.217 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.492 ' NE ' ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -88.6 -14.06 38.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.243 -0.911 . . . . 0.0 110.35 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.569 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.8 tm? -54.89 -43.56 98.88 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.241 -0.912 . . . . 0.0 111.182 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 47.7 Cg_endo -75.86 -90.11 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.382 1.201 . . . . 0.0 110.495 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -175.12 55.7 0.12 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.492 ' O ' ' NE ' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -106.76 146.18 32.57 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.293 -1.122 . . . . 0.0 110.059 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.47 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 44.0 Cg_endo -72.04 136.0 26.35 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.903 1.475 . . . . 0.0 110.404 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 22' ' ' PRO . 3.9 mt-10 -39.7 -46.13 1.81 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.461 -0.774 . . . . 0.0 110.779 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.11 -38.51 52.27 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.324 -0.86 . . . . 0.0 111.038 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.47 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -72.51 -42.71 64.53 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.112 -0.993 . . . . 0.0 110.81 -179.248 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.42 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 73.8 m -74.49 -39.95 62.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.156 -0.965 . . . . 0.0 110.319 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.428 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -59.8 -41.81 92.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.139 -0.975 . . . . 0.0 110.238 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 38.7 m -75.09 -21.02 59.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.24 -0.913 . . . . 0.0 110.281 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -85.04 -20.9 29.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.283 -0.885 . . . . 0.0 110.24 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.7 p -120.01 -16.16 8.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.888 . . . . 0.0 110.342 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 80.96 53.58 3.9 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.53 -175.17 2.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.207 -1.172 . . . . 0.0 110.168 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 pt -142.04 147.42 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 110.41 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.407 ' O ' ' CG2' ' A' ' 35' ' ' ILE . 2.2 mp -115.11 139.69 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.445 -0.785 . . . . 0.0 110.129 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.407 ' CG2' ' O ' ' A' ' 34' ' ' ILE . 0.9 OUTLIER -154.68 121.15 2.74 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.199 -0.938 . . . . 0.0 110.367 -179.848 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.32 55.52 3.04 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.896 1.472 . . . . 0.0 110.686 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -118.83 -175.69 16.33 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.26 -85.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.182 -1.187 . . . . 0.0 110.298 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.3 t -116.04 175.0 5.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 110.286 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.94 160.7 27.89 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.239 -0.913 . . . . 0.0 110.258 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.403 ' O ' ' N ' ' A' ' 45' ' ' ALA . 44.9 Cg_endo -72.27 135.04 23.99 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.94 1.495 . . . . 0.0 110.424 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.468 ' HA2' ' HB3' ' A' ' 45' ' ' ALA . . . -46.25 -38.73 9.02 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -48.15 -27.1 2.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.164 -1.198 . . . . 0.0 110.314 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.58 6.41 2.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.27 -0.894 . . . . 0.0 110.392 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.468 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . . . -90.94 89.45 7.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.111 -0.993 . . . . 0.0 110.147 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.456 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 43.0 m-20 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.131 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.845 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.725 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 99.3 m -135.44 148.59 49.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -0.883 . . . . 0.0 110.225 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.487 ' SG ' ' CD1' ' A' ' 35' ' ' ILE . 19.0 m -128.94 131.23 47.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.269 -0.894 . . . . 0.0 110.174 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.472 ' CB ' ' OXT' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -122.02 153.48 60.93 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.225 -0.922 . . . . 0.0 110.324 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.559 ' HD3' ' CE1' ' A' ' 44' ' ' TYR . 50.9 Cg_endo -78.1 -93.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.08 1.568 . . . . 0.0 110.719 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.81 138.05 58.31 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.547 -0.721 . . . . 0.0 110.914 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.401 ' O ' ' HB3' ' A' ' 10' ' ' ARG . 89.0 mt -47.92 -38.9 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.265 -0.897 . . . . 0.0 109.808 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.463 ' O ' ' OG ' ' A' ' 11' ' ' SER . 94.4 t -51.71 -61.49 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.381 -0.824 . . . . 0.0 110.285 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.442 ' O ' ' OD1' ' A' ' 12' ' ' ASN . . . -45.91 -32.3 2.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.159 -0.963 . . . . 0.0 110.251 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 46' ' ' ASN . 0.3 OUTLIER -74.87 -46.96 32.72 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.306 -0.871 . . . . 0.0 110.748 -179.734 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 8' ' ' VAL . 10.6 p -54.88 -69.05 0.14 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.091 -1.006 . . . . 0.0 110.534 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 13' ' ' PHE . 9.4 p30 -51.15 -37.6 47.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.167 -0.958 . . . . 0.0 110.656 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.516 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 37.0 t80 -50.82 -50.04 57.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.146 -0.971 . . . . 0.0 110.538 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.509 ' OD1' ' NH2' ' A' ' 17' ' ' ARG . 18.9 m-80 -63.91 -41.84 97.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.191 -0.943 . . . . 0.0 109.604 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.484 HG11 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -59.61 -48.84 85.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.52 -0.737 . . . . 0.0 109.424 179.369 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.484 ' N ' HG11 ' A' ' 15' ' ' VAL . 44.8 t -57.16 -22.8 42.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.588 -0.695 . . . . 0.0 110.342 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.509 ' NH2' ' OD1' ' A' ' 14' ' ' ASN . 9.7 mtm180 -83.78 -3.98 58.28 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.1 -1.0 . . . . 0.0 110.244 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.592 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 16.6 tp -71.68 -47.75 12.2 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 110.749 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 46.1 Cg_endo -71.33 -155.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.352 1.185 . . . . 0.0 110.39 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.98 2.55 87.12 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.83 125.49 91.13 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.092 -1.24 . . . . 0.0 109.982 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.29 146.95 46.52 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.883 1.465 . . . . 0.0 110.521 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.506 ' HG3' ' N ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -50.21 -22.56 1.78 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.274 -0.891 . . . . 0.0 110.176 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.506 ' N ' ' HG3' ' A' ' 23' ' ' GLU . . . -67.27 -48.78 66.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.932 . . . . 0.0 110.013 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.416 ' O ' ' HB2' ' A' ' 29' ' ' TYR . 1.0 OUTLIER -69.25 -30.52 68.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.873 . . . . 0.0 109.843 179.707 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 78.7 m -75.97 -49.67 17.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -0.885 . . . . 0.0 109.967 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.39 -25.62 50.37 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.155 -0.965 . . . . 0.0 109.819 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.6 m -89.91 -18.85 25.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.307 -0.871 . . . . 0.0 110.025 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.416 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 1.6 t80 -89.01 -20.36 24.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.395 -0.816 . . . . 0.0 110.402 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.6 p -108.42 -39.86 5.3 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.153 -0.967 . . . . 0.0 110.394 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.22 32.51 1.05 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.89 174.58 6.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -1.13 . . . . 0.0 110.14 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.439 HD12 ' HB2' ' A' ' 3' ' ' CYS . 2.6 pt -138.62 147.54 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 110.362 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.9 mp -109.17 138.36 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.329 -0.857 . . . . 0.0 110.259 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.487 ' CD1' ' SG ' ' A' ' 3' ' ' CYS . 21.8 pt -134.24 143.94 49.17 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.317 -0.864 . . . . 0.0 110.203 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.72 -10.84 23.73 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.014 1.534 . . . . 0.0 110.435 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -71.75 -169.49 11.28 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -113.54 -25.48 8.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.238 -1.154 . . . . 0.0 110.248 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.0 t -117.27 159.85 22.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 110.266 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.485 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 87.6 m -98.9 165.83 14.22 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 109.976 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 40' ' ' CYS . 43.1 Cg_endo -70.98 -166.23 0.22 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.88 1.463 . . . . 0.0 110.272 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.72 -1.94 43.03 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -108.64 -6.5 15.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -1.159 . . . . 0.0 110.218 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.559 ' CE1' ' HD3' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -143.59 36.46 1.32 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.217 -0.927 . . . . 0.0 110.155 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -99.51 88.23 3.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.288 -0.882 . . . . 0.0 110.297 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.472 ' OXT' ' CB ' ' A' ' 4' ' ' CYS . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.25 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.85 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.216 -0.685 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.48 HG22 ' CE1' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -114.31 151.36 33.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 110.378 . . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.412 ' C ' ' SG ' ' A' ' 32' ' ' CYS . 77.4 m -144.85 113.42 6.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.39 -0.819 . . . . 0.0 109.644 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.514 ' O ' ' CB ' ' A' ' 46' ' ' ASN . 65.6 m -99.41 151.21 37.35 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.929 . . . . 0.0 110.513 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 44' ' ' TYR . 50.8 Cg_endo -76.72 -93.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.998 1.525 . . . . 0.0 110.503 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.67 137.5 58.28 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.595 -0.69 . . . . 0.0 110.598 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.453 ' O ' ' HB3' ' A' ' 10' ' ' ARG . 10.0 mt -54.39 -33.64 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.18 -0.95 . . . . 0.0 109.789 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.6 t -48.98 -53.08 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.13 -0.981 . . . . 0.0 109.581 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.11 -40.43 73.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.268 -0.895 . . . . 0.0 109.48 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.491 ' CZ ' ' OXT' ' A' ' 46' ' ' ASN . 0.6 OUTLIER -52.9 -57.02 11.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.41 -0.806 . . . . 0.0 109.932 179.581 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 14' ' ' ASN . 9.6 m -51.42 -40.86 60.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.255 -0.903 . . . . 0.0 109.921 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -64.25 -43.98 93.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.331 -0.856 . . . . 0.0 109.867 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.48 ' CE1' HG22 ' A' ' 2' ' ' THR . 10.9 t80 -53.72 -26.79 24.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -0.855 . . . . 0.0 109.828 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 11' ' ' SER . 48.5 m-80 -74.83 -43.7 53.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.377 -0.827 . . . . 0.0 109.598 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.462 ' O ' ' HB3' ' A' ' 18' ' ' LEU . 0.8 OUTLIER -63.9 -49.17 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.406 -0.809 . . . . 0.0 109.41 179.594 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.457 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 42.3 t -52.4 -41.81 63.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.362 -0.836 . . . . 0.0 110.222 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -80.93 -2.0 45.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.284 -0.885 . . . . 0.0 110.531 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.558 ' HB3' ' HD3' ' A' ' 19' ' ' PRO . 3.9 tp -51.75 -54.17 42.9 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.085 -1.009 . . . . 0.0 110.259 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' A' ' 18' ' ' LEU . 43.9 Cg_endo -69.6 -52.72 0.32 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.38 1.2 . . . . 0.0 110.396 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.19 39.43 0.05 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.485 HG23 ' HD2' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -87.37 152.0 51.79 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.19 -1.182 . . . . 0.0 109.768 179.769 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.485 ' HD2' HG23 ' A' ' 21' ' ' THR . 43.5 Cg_endo -70.93 155.21 62.5 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.823 1.433 . . . . 0.0 110.57 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 24' ' ' ALA . 1.5 mp0 -53.64 -49.67 67.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.316 -0.865 . . . . 0.0 110.511 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.456 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -42.33 -49.74 5.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.225 -0.922 . . . . 0.0 110.341 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.82 -42.6 93.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 110.506 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.5 m -77.93 -50.12 12.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.163 -0.961 . . . . 0.0 110.472 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.51 -20.23 64.41 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.239 -0.913 . . . . 0.0 110.366 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 46.3 m -88.04 -26.27 22.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.894 . . . . 0.0 110.378 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -101.77 -10.49 19.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.152 -0.968 . . . . 0.0 110.399 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 76.4 p -103.66 -27.16 12.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 110.274 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.48 28.97 5.82 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.412 ' SG ' ' C ' ' A' ' 3' ' ' CYS . 1.6 t -99.73 -178.17 3.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.349 -1.089 . . . . 0.0 110.306 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.7 pt -139.43 148.79 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.879 . . . . 0.0 110.23 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.4 mt -112.25 133.97 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 109.976 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.428 ' CD1' ' O ' ' A' ' 39' ' ' THR . 17.3 pt -119.38 154.14 53.96 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 110.119 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.63 -16.79 30.17 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.145 1.603 . . . . 0.0 110.645 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -72.16 -160.17 4.67 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.13 10.25 5.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.167 -1.196 . . . . 0.0 110.222 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.428 ' O ' ' CD1' ' A' ' 35' ' ' ILE . 11.7 t -140.38 169.92 16.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.199 -0.938 . . . . 0.0 110.308 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.467 ' HB3' ' HA ' ' A' ' 45' ' ' ALA . 23.4 m -104.23 166.58 11.37 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.235 -0.916 . . . . 0.0 109.971 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.492 ' O ' ' CB ' ' A' ' 45' ' ' ALA . 43.1 Cg_endo -70.35 -178.25 2.47 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.984 1.518 . . . . 0.0 110.552 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.21 -8.56 57.64 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -114.97 -29.17 6.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -1.156 . . . . 0.0 110.04 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.569 ' CZ ' ' HB3' ' A' ' 5' ' ' PRO . 0.5 OUTLIER -107.47 9.36 29.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 110.151 179.889 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.492 ' CB ' ' O ' ' A' ' 41' ' ' PRO . . . -72.75 90.9 1.44 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.352 -0.842 . . . . 0.0 110.271 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.514 ' CB ' ' O ' ' A' ' 4' ' ' CYS . 1.6 m-20 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.156 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.838 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.726 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.507 HG23 ' CE2' ' A' ' 13' ' ' PHE . 1.1 m -85.88 145.19 27.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.182 -0.949 . . . . 0.0 109.986 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.412 ' C ' ' SG ' ' A' ' 32' ' ' CYS . 0.5 OUTLIER -139.69 91.99 2.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.21 -0.931 . . . . 0.0 110.297 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.478 ' N ' ' SG ' ' A' ' 32' ' ' CYS . 25.7 m -96.5 165.64 15.72 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.28 -0.887 . . . . 0.0 110.09 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 46' ' ' ASN . 49.3 Cg_endo -78.59 -92.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.31 1.689 . . . . 0.0 110.442 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 7' ' ' ILE . 1.4 t -75.55 143.29 42.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.499 -0.75 . . . . 0.0 109.932 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.401 ' C ' ' O ' ' A' ' 6' ' ' SER . 11.8 mt -42.76 -52.91 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.188 -0.945 . . . . 0.0 110.198 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.7 t -43.09 -54.03 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 109.985 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.64 -40.4 19.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.306 -0.871 . . . . 0.0 109.962 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -63.78 -49.87 71.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.327 -0.858 . . . . 0.0 110.077 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.61 -50.53 65.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.875 . . . . 0.0 110.021 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.474 ' O ' HG11 ' A' ' 15' ' ' VAL . 38.5 m-80 -51.3 -40.02 58.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.883 . . . . 0.0 110.07 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.568 ' CZ ' ' HB2' ' A' ' 23' ' ' GLU . 71.7 t80 -60.15 -54.04 50.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.921 . . . . 0.0 110.043 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -62.91 -24.89 68.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.295 -0.878 . . . . 0.0 109.19 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.5 ' CG1' ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -78.59 -50.72 18.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.404 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.5 ' N ' ' CG1' ' A' ' 15' ' ' VAL . 46.3 t -51.64 -20.97 2.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.412 -0.805 . . . . 0.0 110.118 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.45 10.12 23.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.211 -0.931 . . . . 0.0 110.167 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.594 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 2.3 tp -83.44 -42.0 0.81 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.199 -0.938 . . . . 0.0 111.575 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 46.1 Cg_endo -73.9 -94.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.331 1.174 . . . . 0.0 111.0 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -160.82 33.46 0.4 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -107.13 141.58 23.22 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.229 -1.159 . . . . 0.0 110.087 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.433 ' O ' ' C ' ' A' ' 23' ' ' GLU . 44.9 Cg_endo -70.96 136.25 29.38 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.984 1.518 . . . . 0.0 110.313 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.568 ' HB2' ' CZ ' ' A' ' 13' ' ' PHE . 5.7 pt-20 -42.35 -32.23 0.49 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.24 -0.913 . . . . 0.0 110.205 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.43 -59.54 3.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.171 -0.956 . . . . 0.0 109.945 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.96 -28.52 69.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.183 -0.948 . . . . 0.0 109.938 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.408 ' O ' ' OG1' ' A' ' 30' ' ' THR . 58.6 m -73.62 -50.88 18.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 110.381 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.63 -43.12 79.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 0.0 110.348 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.8 m -64.69 -28.67 69.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.221 -0.924 . . . . 0.0 110.511 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -97.91 -34.0 11.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.105 -0.997 . . . . 0.0 110.565 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 26' ' ' CYS . 63.9 p -77.62 -8.13 57.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.198 -0.939 . . . . 0.0 110.161 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.443 ' O ' ' HD3' ' A' ' 5' ' ' PRO . . . 70.95 42.71 59.36 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.478 ' SG ' ' N ' ' A' ' 4' ' ' CYS . 14.3 t -127.26 170.15 12.75 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.103 -1.233 . . . . 0.0 110.081 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.445 HG21 ' O ' ' A' ' 32' ' ' CYS . 1.1 pt -140.32 156.98 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.099 -1.0 . . . . 0.0 110.439 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 1' ' ' THR . 8.3 mt -110.84 127.31 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.342 -0.849 . . . . 0.0 110.092 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.423 HD12 ' O ' ' A' ' 39' ' ' THR . 2.0 pt -119.25 140.9 29.63 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.155 -0.966 . . . . 0.0 110.586 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -78.2 57.29 6.12 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 124.109 1.584 . . . . 0.0 110.516 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 171.32 166.93 30.87 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.49 10.86 18.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.339 -1.095 . . . . 0.0 110.248 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.423 ' O ' HD12 ' A' ' 35' ' ' ILE . 7.7 t -98.62 136.19 39.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.183 -0.948 . . . . 0.0 110.082 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.456 ' SG ' ' HD2' ' A' ' 41' ' ' PRO . 0.5 OUTLIER -152.2 145.05 17.19 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.298 -0.876 . . . . 0.0 110.279 -179.769 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.456 ' HD2' ' SG ' ' A' ' 40' ' ' CYS . 47.7 Cg_endo -74.08 166.68 29.01 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.979 1.515 . . . . 0.0 110.276 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.98 -22.75 75.98 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -61.67 -34.18 75.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.235 -1.156 . . . . 0.0 110.208 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -136.38 66.13 1.5 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 110.173 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.477 ' O ' ' CB ' ' A' ' 46' ' ' ASN . . . -121.87 86.71 2.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.097 -1.002 . . . . 0.0 110.648 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.553 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 1.5 m-20 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.084 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.844 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.728 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.3 m -94.26 134.04 37.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.215 -0.928 . . . . 0.0 110.231 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 59.4 m -128.31 113.78 16.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.885 . . . . 0.0 110.182 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -105.88 169.01 7.44 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 0.0 110.28 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 9' ' ' ALA . 48.4 Cg_endo -72.77 -94.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.973 1.512 . . . . 0.0 110.986 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 30.6 t -78.89 156.7 28.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.463 -0.773 . . . . 0.0 110.699 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.9 mt -49.29 -54.48 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -0.874 . . . . 0.0 109.836 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.5 t -46.7 -42.87 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.893 . . . . 0.0 109.492 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.413 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . . . -50.44 -40.62 51.01 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.312 -0.868 . . . . 0.0 109.413 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.47 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 0.8 OUTLIER -70.69 -43.99 67.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.436 -0.79 . . . . 0.0 109.67 179.518 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.9 t -48.99 -63.15 1.18 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 109.735 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -47.1 -47.01 23.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.783 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.47 ' HB3' ' O ' ' A' ' 10' ' ' ARG . 11.2 t80 -54.41 -38.29 66.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.387 -0.821 . . . . 0.0 109.769 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.66 -30.09 66.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 108.999 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.484 HG13 ' N ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -65.22 -44.3 95.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.523 0.678 . . . . 0.0 109.24 179.242 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.484 ' N ' HG13 ' A' ' 15' ' ' VAL . 37.9 t -65.45 -26.16 67.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.465 -0.772 . . . . 0.0 110.435 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -75.61 -33.17 60.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.468 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.532 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -50.51 -52.51 54.81 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.16 -0.963 . . . . 0.0 110.541 -179.775 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 47.6 Cg_endo -71.65 -156.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.413 1.217 . . . . 0.0 110.299 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.93 59.22 0.42 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.49 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 6.7 m -113.24 144.26 30.85 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.354 -1.086 . . . . 0.0 110.08 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.49 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 45.6 Cg_endo -71.98 151.4 56.19 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 124.038 1.547 . . . . 0.0 110.382 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -53.69 -32.88 53.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.301 -0.874 . . . . 0.0 110.154 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.45 ' O ' ' HB ' ' A' ' 28' ' ' THR . . . -57.93 -50.65 72.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.323 -0.861 . . . . 0.0 110.542 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.455 ' HB3' ' CG2' ' A' ' 21' ' ' THR . 0.1 OUTLIER -65.69 -26.88 67.97 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.074 -1.016 . . . . 0.0 110.358 -179.65 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.433 ' O ' ' OG1' ' A' ' 30' ' ' THR . 19.0 m -81.64 -49.13 10.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.235 -0.916 . . . . 0.0 110.412 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -72.2 -50.14 29.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.148 -0.97 . . . . 0.0 110.622 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 80.4 m -59.62 -44.97 93.25 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.23 -0.919 . . . . 0.0 110.85 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -67.37 -15.62 63.79 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.104 -0.997 . . . . 0.0 110.637 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.433 ' OG1' ' O ' ' A' ' 26' ' ' CYS . 30.3 p -110.98 -22.16 11.64 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.114 -0.991 . . . . 0.0 110.512 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 98.89 23.21 11.96 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.44 175.01 9.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.329 -1.101 . . . . 0.0 109.922 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.449 ' CD1' HG22 ' A' ' 35' ' ' ILE . 2.3 pp -138.93 152.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.134 -0.979 . . . . 0.0 110.484 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.3 mt -115.19 124.46 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.39 -0.819 . . . . 0.0 110.363 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.463 ' O ' HG13 ' A' ' 35' ' ' ILE . 11.8 pt -110.89 148.01 37.71 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.18 -0.95 . . . . 0.0 110.207 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.09 51.62 3.2 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.951 1.501 . . . . 0.0 110.627 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -176.42 -173.38 42.0 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -116.75 31.6 6.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.266 -1.138 . . . . 0.0 110.169 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.0 113.1 7.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.951 . . . . 0.0 110.255 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -106.94 163.1 17.67 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.894 . . . . 0.0 110.131 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.452 ' O ' ' HB3' ' A' ' 45' ' ' ALA . 45.2 Cg_endo -72.42 162.99 39.94 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.918 1.483 . . . . 0.0 110.462 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.29 11.61 57.61 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -99.79 -21.69 15.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -1.148 . . . . 0.0 110.185 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.458 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 1.7 t80 -150.08 48.08 0.92 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.24 -0.912 . . . . 0.0 110.092 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 41' ' ' PRO . . . -121.83 101.45 7.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.324 -0.86 . . . . 0.0 110.275 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.068 179.891 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.831 HG21 ' CE2' ' A' ' 13' ' ' PHE . 50.8 m . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.334 0.588 . . . . 0.0 110.409 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 32.7 m -134.5 124.95 26.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.316 -0.865 . . . . 0.0 109.897 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.11 146.82 49.98 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.08 -1.013 . . . . 0.0 110.519 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.574 ' HD3' ' CE1' ' A' ' 44' ' ' TYR . 50.3 Cg_endo -75.83 -94.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.091 1.574 . . . . 0.0 110.547 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.477 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 7.1 t -48.25 123.24 6.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.5 -0.75 . . . . 0.0 110.363 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.407 ' O ' ' C ' ' A' ' 8' ' ' VAL . 2.5 mp -47.71 -54.83 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 110.108 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.407 ' C ' ' O ' ' A' ' 7' ' ' ILE . 21.6 t -44.34 -45.93 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 109.847 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 6' ' ' SER . . . -50.74 -42.87 57.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.2 -0.938 . . . . 0.0 109.721 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.406 ' O ' ' C ' ' A' ' 11' ' ' SER . 0.1 OUTLIER -68.77 -48.32 63.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 0.0 109.994 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -43.71 -42.12 5.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.89 . . . . 0.0 109.824 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 -75.3 -36.08 61.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.898 . . . . 0.0 109.853 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.831 ' CE2' HG21 ' A' ' 2' ' ' THR . 27.1 t80 -62.32 -33.26 74.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.331 -0.856 . . . . 0.0 109.923 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.73 -26.74 37.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.298 -0.876 . . . . 0.0 109.021 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 16' ' ' CYS . 1.2 t -82.49 -42.66 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.661 -0.649 . . . . 0.0 109.249 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.472 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 30.7 t -66.74 -24.34 66.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.314 -0.867 . . . . 0.0 109.767 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 17' ' ' ARG . 0.7 OUTLIER -88.07 -12.48 44.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.322 -0.861 . . . . 0.0 109.785 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.578 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -54.97 -46.88 99.55 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.393 -0.817 . . . . 0.0 110.254 179.672 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 18' ' ' LEU . 49.7 Cg_endo -80.11 -157.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.927 1.488 . . . . 0.0 110.148 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.92 72.65 1.85 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.509 HG22 ' HB3' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -130.93 134.1 25.57 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.272 -1.134 . . . . 0.0 110.153 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.46 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 44.5 Cg_endo -72.98 139.16 29.56 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.95 1.5 . . . . 0.0 110.576 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -44.35 -31.64 1.1 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.406 -0.809 . . . . 0.0 110.412 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.89 -41.78 99.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.192 -0.943 . . . . 0.0 110.342 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.509 ' HB3' HG22 ' A' ' 21' ' ' THR . 0.1 OUTLIER -66.81 -37.16 83.98 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.313 -0.867 . . . . 0.0 110.259 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.604 ' O ' HG23 ' A' ' 30' ' ' THR . 47.3 m -85.8 -45.89 11.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.278 -0.889 . . . . 0.0 110.185 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -45.3 -36.05 3.85 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.203 -0.936 . . . . 0.0 109.888 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.0 m -79.09 -49.46 12.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.922 . . . . 0.0 109.912 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -64.54 -26.61 68.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.358 -0.839 . . . . 0.0 109.926 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.74 HG21 ' HA ' ' A' ' 13' ' ' PHE . 26.5 p -96.53 -51.36 4.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.324 -0.86 . . . . 0.0 110.218 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.42 22.08 3.2 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.414 ' HB3' ' CG2' ' A' ' 2' ' ' THR . 27.2 m -97.56 168.12 10.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.247 -1.149 . . . . 0.0 110.225 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.0 pt -121.04 155.71 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.212 -0.93 . . . . 0.0 110.273 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.9 mt -104.4 125.63 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.209 -0.932 . . . . 0.0 110.219 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.45 ' O ' HG13 ' A' ' 35' ' ' ILE . 3.9 pt -128.17 136.91 29.76 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.336 -0.853 . . . . 0.0 110.016 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 C--N 1.305 -1.751 0 O-C-N 124.029 1.541 . . . . 0.0 110.795 -179.762 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.473 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 86.8 m . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.548 ' HG2' ' CB ' ' A' ' 44' ' ' TYR . 43.1 Cg_endo -68.8 -161.4 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.917 1.482 . . . . 0.0 110.315 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.82 -3.83 34.23 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.73 -5.07 6.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.192 -1.181 . . . . 0.0 110.224 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.574 ' CE1' ' HD3' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -120.9 18.8 11.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.359 -0.838 . . . . 0.0 110.039 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.64 93.6 8.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.284 -0.885 . . . . 0.0 110.161 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.502 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.258 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.826 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 2.2 m . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.282 0.563 . . . . 0.0 110.018 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.5 m -151.5 130.31 12.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.196 -0.94 . . . . 0.0 110.276 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.738 ' SG ' ' HB1' ' A' ' 9' ' ' ALA . 0.5 OUTLIER -131.05 148.76 71.55 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.314 -0.866 . . . . 0.0 110.112 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.546 ' HG3' ' CE1' ' A' ' 44' ' ' TYR . 50.0 Cg_endo -84.3 -91.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.103 1.58 . . . . 0.0 110.894 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.512 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 3.8 t -39.05 127.66 1.65 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.505 0.669 . . . . 0.0 110.992 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.3 mt -49.92 -54.44 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.266 -0.897 . . . . 0.0 109.627 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.421 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 50.0 t -45.69 -48.88 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.324 -0.86 . . . . 0.0 109.701 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.738 ' HB1' ' SG ' ' A' ' 4' ' ' CYS . . . -45.79 -39.57 8.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.261 -0.899 . . . . 0.0 109.646 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -67.57 -44.37 78.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.234 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.403 ' O ' ' C ' ' A' ' 12' ' ' ASN . 10.2 t -57.12 -77.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.214 -0.929 . . . . 0.0 110.182 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.492 ' OD1' ' N ' ' A' ' 13' ' ' PHE . 10.2 p30 -44.52 -35.8 2.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.177 -0.952 . . . . 0.0 110.053 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.934 ' HA ' HG21 ' A' ' 30' ' ' THR . 19.5 t80 -64.99 -56.04 15.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.919 . . . . 0.0 110.096 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -62.62 -43.72 98.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.207 -0.933 . . . . 0.0 109.26 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -61.6 -45.58 98.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.539 -0.726 . . . . 0.0 109.246 179.156 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.505 ' N ' HG12 ' A' ' 15' ' ' VAL . 34.8 t -50.87 -29.99 13.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.572 -0.705 . . . . 0.0 110.304 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -85.23 -4.12 59.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.203 -0.935 . . . . 0.0 110.328 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.596 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 3.7 tt -69.88 -46.28 23.66 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.959 . . . . 0.0 110.633 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 47.8 Cg_endo -74.27 -155.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.382 0 O-C-N 123.289 1.152 . . . . 0.0 109.998 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.39 27.47 7.71 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.458 ' OG1' ' HG2' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -93.56 137.32 23.38 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.146 -1.208 . . . . 0.0 110.029 179.759 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.446 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 48.3 Cg_endo -75.42 166.78 28.01 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.988 1.52 . . . . 0.0 110.658 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 24' ' ' ALA . 4.1 tt0 -65.39 -50.34 65.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.329 -0.857 . . . . 0.0 110.228 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 23' ' ' GLU . . . -43.56 -51.66 6.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 0.0 110.382 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.447 HD13 ' CG2' ' A' ' 21' ' ' THR . 0.9 OUTLIER -57.22 -37.71 72.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 110.35 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 28' ' ' THR . 39.5 m -74.96 -63.04 1.35 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.887 . . . . 0.0 110.527 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 26' ' ' CYS . . . -41.91 -26.87 0.1 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.908 . . . . 0.0 110.441 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.439 ' N ' ' O ' ' A' ' 26' ' ' CYS . 20.2 m -90.08 -49.0 6.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.144 -0.973 . . . . 0.0 110.43 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -68.42 -27.09 65.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.186 -0.946 . . . . 0.0 110.268 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.934 HG21 ' HA ' ' A' ' 13' ' ' PHE . 26.4 p -87.03 -48.44 8.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.192 -0.942 . . . . 0.0 110.245 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.21 14.04 5.14 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.412 ' C ' HG23 ' A' ' 33' ' ' ILE . 56.8 m -86.7 -166.91 1.7 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.182 -1.187 . . . . 0.0 109.961 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.412 HG23 ' C ' ' A' ' 32' ' ' CYS . 11.4 pt -149.2 150.57 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.072 -1.017 . . . . 0.0 110.612 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.0 mt -100.53 138.38 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.347 -0.846 . . . . 0.0 109.981 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 27.1 pt -125.12 143.73 45.13 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.16 -0.962 . . . . 0.0 110.365 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo . . . . . 0 C--N 1.305 -1.734 0 O-C-N 124.015 1.534 . . . . 0.0 110.265 179.857 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 44' ' ' TYR . 5.4 t . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.08 -174.43 1.94 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.957 1.504 . . . . 0.0 110.706 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.6 -29.06 12.62 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -60.06 -26.0 65.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.281 -1.129 . . . . 0.0 110.184 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.546 ' CE1' ' HG3' ' A' ' 5' ' ' PRO . 0.8 OUTLIER -144.91 77.42 1.53 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.328 -0.857 . . . . 0.0 109.934 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.418 ' O ' ' ND2' ' A' ' 46' ' ' ASN . . . -120.2 90.87 3.41 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.229 -0.919 . . . . 0.0 110.781 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.529 ' CB ' ' O ' ' A' ' 4' ' ' CYS . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 117.925 -1.036 . . . . 0.0 110.125 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' THR . . . . . 1.057 HG21 ' CE1' ' A' ' 13' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.192 0.52 . . . . 0.0 109.979 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.479 ' O ' ' CG1' ' A' ' 33' ' ' ILE . 5.1 m -132.44 108.48 9.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.192 -0.943 . . . . 0.0 109.905 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.411 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 13.2 m -109.32 162.99 18.08 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.413 -0.804 . . . . 0.0 110.021 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 47.7 Cg_endo -73.22 -95.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.903 1.475 . . . . 0.0 110.534 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.6 t -68.78 139.44 55.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.39 -0.819 . . . . 0.0 110.266 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.4 mt -46.42 -41.72 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.174 -0.954 . . . . 0.0 109.769 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.509 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 44.1 t -49.14 -57.45 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.464 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 8' ' ' VAL . . . -44.76 -37.03 3.5 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.366 -0.834 . . . . 0.0 109.443 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.448 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -75.5 -41.06 56.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.386 -0.822 . . . . 0.0 109.864 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.2 t -48.73 -72.31 0.05 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.0 109.919 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 8' ' ' VAL . 2.2 p30 -48.74 -42.96 37.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.358 -0.839 . . . . 0.0 109.955 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 1.057 ' CE1' HG21 ' A' ' 2' ' ' THR . 53.4 t80 -51.79 -47.93 64.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.244 -0.91 . . . . 0.0 110.182 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 10' ' ' ARG . 11.2 m120 -60.81 -27.21 67.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.139 -0.976 . . . . 0.0 109.433 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.575 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -78.93 -49.58 19.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 121.587 0.708 . . . . 0.0 109.453 179.704 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.575 ' N ' HG12 ' A' ' 15' ' ' VAL . 14.2 t -55.33 -16.41 3.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.564 -0.71 . . . . 0.0 110.741 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.521 ' HD2' ' HG3' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -88.42 -3.13 58.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.191 -0.943 . . . . 0.0 110.721 -179.671 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.607 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.5 tt -76.4 -41.62 3.04 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.131 -0.981 . . . . 0.0 111.031 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 47.1 Cg_endo -76.16 -156.19 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.35 1.184 . . . . 0.0 110.042 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.56 27.2 19.82 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.449 ' CG2' ' SG ' ' A' ' 26' ' ' CYS . 29.8 m -90.41 133.19 33.49 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.057 -1.261 . . . . 0.0 109.928 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.493 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 44.2 Cg_endo -72.22 141.8 36.52 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.948 1.499 . . . . 0.0 110.594 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.521 ' HG3' ' HD2' ' A' ' 17' ' ' ARG . 7.2 mt-10 -43.31 -52.13 5.94 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.317 -0.864 . . . . 0.0 110.548 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 23' ' ' GLU . . . -41.98 -62.03 1.01 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 0.0 110.541 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.493 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -53.73 -36.91 62.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.286 -0.884 . . . . 0.0 110.562 -179.618 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.449 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 91.2 m -76.68 -34.86 58.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.166 -0.959 . . . . 0.0 110.235 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.85 -16.6 63.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.173 -0.954 . . . . 0.0 110.326 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 45.6 m -91.01 -47.9 7.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.191 -0.943 . . . . 0.0 110.362 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -63.89 -23.22 67.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.198 -0.939 . . . . 0.0 110.226 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 37.0 p -101.19 -48.35 4.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 110.205 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.84 69.59 0.62 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 48.8 t -140.46 163.87 31.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.214 -1.168 . . . . 0.0 110.128 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.479 ' CG1' ' O ' ' A' ' 3' ' ' CYS . 5.8 pt -112.4 147.13 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.083 -1.011 . . . . 0.0 110.334 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.0 mt -119.12 145.73 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.328 -0.857 . . . . 0.0 109.968 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.5 pt -127.15 153.61 76.75 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 0.0 110.463 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo . . . . . 0 C--N 1.306 -1.706 0 O-C-N 124.02 1.537 . . . . 0.0 110.014 179.555 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 70.9 m . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.05 139.3 32.54 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.952 1.501 . . . . 0.0 110.28 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.17 -18.01 12.1 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -93.71 7.97 42.77 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.142 -1.21 . . . . 0.0 110.357 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.401 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 0.3 OUTLIER -166.85 52.81 0.08 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.211 -0.931 . . . . 0.0 110.2 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -124.75 87.72 2.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.334 -0.854 . . . . 0.0 110.107 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.055 -179.98 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.7 m . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.164 0.507 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.495 ' O ' HG12 ' A' ' 33' ' ' ILE . 19.7 m -134.06 121.07 21.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.896 . . . . 0.0 110.252 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.484 ' HB2' ' OXT' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -116.75 165.43 15.28 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.327 -0.858 . . . . 0.0 110.083 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 49.3 Cg_endo -75.36 -94.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.116 1.588 . . . . 0.0 111.265 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.4 t -92.62 168.5 11.19 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.699 0.761 . . . . 0.0 111.28 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.422 ' O ' ' C ' ' A' ' 8' ' ' VAL . 3.0 mt -51.67 -51.17 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.487 -0.758 . . . . 0.0 110.302 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.422 ' C ' ' O ' ' A' ' 7' ' ' ILE . 51.6 t -40.88 -53.26 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.383 -0.823 . . . . 0.0 110.139 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.451 ' O ' ' OD1' ' A' ' 12' ' ' ASN . . . -50.3 -40.8 49.65 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.292 -0.88 . . . . 0.0 109.557 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 46' ' ' ASN . 6.0 ttm180 -66.17 -37.61 86.05 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.268 -0.895 . . . . 0.0 110.276 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.4 t -60.67 -78.13 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.243 -0.911 . . . . 0.0 110.343 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 13' ' ' PHE . 12.1 p30 -45.91 -33.71 3.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.296 -0.878 . . . . 0.0 110.379 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.527 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 24.7 t80 -64.54 -48.15 76.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.394 -0.816 . . . . 0.0 110.4 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -65.13 -55.07 20.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -0.953 . . . . 0.0 110.063 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.624 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -49.77 -53.15 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.367 -0.833 . . . . 0.0 109.658 179.699 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.624 ' N ' HG12 ' A' ' 15' ' ' VAL . 42.2 t -49.51 -31.47 10.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -0.848 . . . . 0.0 110.297 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.93 -17.59 50.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.148 -0.97 . . . . 0.0 110.058 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.601 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.6 tp -56.21 -49.91 90.56 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.287 -0.883 . . . . 0.0 110.983 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 45.1 Cg_endo -71.51 -155.36 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.551 1.29 . . . . 0.0 110.282 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.08 61.86 1.07 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.0 m -129.84 132.55 24.23 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.279 -1.13 . . . . 0.0 109.893 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.8 148.76 59.06 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.993 1.523 . . . . 0.0 110.739 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.478 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 15.9 pt-20 -53.53 -19.91 4.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.366 -0.834 . . . . 0.0 110.342 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.56 -48.55 76.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.226 -0.921 . . . . 0.0 110.22 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.09 -26.92 60.64 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.281 -0.887 . . . . 0.0 110.359 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 72.9 m -88.86 -29.26 19.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -0.918 . . . . 0.0 110.445 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.478 ' CB ' ' O ' ' A' ' 23' ' ' GLU . . . -74.42 -24.61 59.12 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.271 -0.893 . . . . 0.0 110.209 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.4 m -87.56 -50.34 6.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 110.258 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.06 -23.78 21.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.946 . . . . 0.0 110.124 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 67.5 p -98.27 -39.23 8.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 110.174 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.37 16.19 10.58 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -77.23 175.86 9.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -1.162 . . . . 0.0 110.01 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 3' ' ' CYS . 15.0 pt -136.43 163.51 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.174 -0.954 . . . . 0.0 110.294 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 58.0 mt -132.6 141.61 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.884 . . . . 0.0 110.253 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.474 ' O ' HG13 ' A' ' 35' ' ' ILE . 8.9 pt -145.41 127.18 7.79 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 110.265 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo . . . . . 0 C--N 1.306 -1.683 0 O-C-N 123.834 1.439 . . . . 0.0 110.089 179.873 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.462 ' SG ' ' HD2' ' A' ' 41' ' ' PRO . 7.7 t . . . . . 0 N--CA 1.493 1.715 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.462 ' HD2' ' SG ' ' A' ' 40' ' ' CYS . 44.7 Cg_endo -70.92 151.21 62.25 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.967 1.509 . . . . 0.0 110.467 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.05 -8.79 62.15 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.439 ' OD2' ' HB2' ' A' ' 41' ' ' PRO . 56.8 p30 -89.88 -1.51 58.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -1.173 . . . . 0.0 110.044 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.93 48.45 0.79 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.361 -0.837 . . . . 0.0 110.088 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.556 ' O ' ' ND2' ' A' ' 46' ' ' ASN . . . -114.57 87.78 2.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 0.0 110.099 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.556 ' ND2' ' O ' ' A' ' 45' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.103 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.692 HG21 ' CE2' ' A' ' 13' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.245 0.545 . . . . 0.0 110.295 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.3 m -154.56 128.27 8.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.856 . . . . 0.0 109.937 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.42 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 61.1 m -115.29 163.28 20.69 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.23 -0.919 . . . . 0.0 110.328 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 49.4 Cg_endo -75.75 -94.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.021 1.537 . . . . 0.0 110.764 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.17 148.61 51.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.56 -0.713 . . . . 0.0 110.586 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.7 mt -60.0 -45.95 94.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.331 -0.856 . . . . 0.0 110.095 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.8 t -49.36 -43.73 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.185 -0.947 . . . . 0.0 109.786 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.02 -37.99 81.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 110.006 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.476 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 5.6 ttm180 -61.24 -55.66 29.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.23 -0.919 . . . . 0.0 110.106 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -45.52 -60.06 2.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.293 -0.88 . . . . 0.0 110.001 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -52.21 -22.93 4.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.334 -0.854 . . . . 0.0 110.114 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.692 ' CE2' HG21 ' A' ' 2' ' ' THR . 17.9 t80 -75.83 -29.97 58.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 110.37 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -74.24 -31.17 62.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 109.363 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.9 OUTLIER -69.3 -41.15 80.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.593 -0.692 . . . . 0.0 109.501 179.627 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.464 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 49.5 t -68.64 -32.14 71.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.555 -0.716 . . . . 0.0 110.998 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -84.77 -0.31 53.32 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.053 -1.029 . . . . 0.0 110.722 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.579 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -70.85 -48.9 14.57 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.086 -1.009 . . . . 0.0 110.208 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 48.2 Cg_endo -74.15 -155.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.584 1.308 . . . . 0.0 110.09 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.11 53.48 2.19 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.4 m -113.35 135.11 21.82 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.194 -1.18 . . . . 0.0 110.248 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.476 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 45.7 Cg_endo -73.64 158.56 47.15 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.876 1.461 . . . . 0.0 110.509 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.8 -35.86 77.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.303 -0.873 . . . . 0.0 110.327 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.34 -43.55 88.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.35 -0.844 . . . . 0.0 110.619 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.476 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -66.69 -34.42 77.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.109 -0.994 . . . . 0.0 110.285 -179.745 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 65.6 m -81.48 -47.93 12.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.193 -0.942 . . . . 0.0 110.066 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.93 -28.22 6.41 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.197 -0.939 . . . . 0.0 110.111 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.1 m -85.77 -37.8 18.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 110.251 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.84 -19.86 60.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.193 -0.942 . . . . 0.0 110.209 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.0 p -112.35 -58.94 2.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -0.914 . . . . 0.0 110.266 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.91 34.98 0.46 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 64.0 m -101.3 162.93 12.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.315 -1.109 . . . . 0.0 110.09 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.408 ' O ' HG13 ' A' ' 33' ' ' ILE . 1.1 pp -122.99 149.55 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.218 -0.926 . . . . 0.0 110.176 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.9 mt -115.14 134.68 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.153 -0.967 . . . . 0.0 110.225 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 41.4 pt -119.39 151.68 51.67 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 110.175 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo . . . . . 0 C--N 1.305 -1.744 0 O-C-N 124.009 1.531 . . . . 0.0 110.487 -179.927 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.89 131.85 18.99 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.997 1.525 . . . . 0.0 110.61 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -48.31 -35.37 14.66 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.61 -47.12 58.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.206 -1.173 . . . . 0.0 110.049 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.92 62.48 0.68 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.333 -0.854 . . . . 0.0 110.054 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.432 ' O ' ' CG ' ' A' ' 46' ' ' ASN . . . -130.19 88.01 2.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 110.253 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.432 ' CG ' ' O ' ' A' ' 45' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.146 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.32 0.581 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.7 m -147.78 107.19 3.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.357 -0.84 . . . . 0.0 110.198 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.518 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 24.9 m -99.96 166.25 13.09 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.253 -0.904 . . . . 0.0 110.412 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.542 ' HG2' ' CB ' ' A' ' 9' ' ' ALA . 40.0 Cg_endo -71.41 -153.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 124.034 1.544 . . . . 0.0 110.353 179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.492 ' C ' ' O ' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -31.0 150.24 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.51 0.671 . . . . 0.0 111.548 -179.286 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.439 ' O ' ' C ' ' A' ' 8' ' ' VAL . 2.3 mt -48.44 -54.54 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.426 -0.796 . . . . 0.0 110.639 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.439 ' C ' ' O ' ' A' ' 7' ' ' ILE . 77.0 t -40.87 -55.29 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.437 -0.79 . . . . 0.0 110.322 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.542 ' CB ' ' HG2' ' A' ' 5' ' ' PRO . . . -53.22 -41.52 65.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.899 . . . . 0.0 109.961 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.485 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -67.39 -49.75 62.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.892 . . . . 0.0 109.951 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 p -47.66 -38.0 13.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -0.934 . . . . 0.0 109.969 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 13' ' ' PHE . 10.9 m-80 -70.72 -42.61 70.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.922 . . . . 0.0 110.007 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.485 ' HB3' ' O ' ' A' ' 10' ' ' ARG . 9.6 t80 -44.14 -46.43 8.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 0.0 109.764 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -69.55 -50.03 48.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.321 -0.862 . . . . 0.0 109.225 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.489 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.7 OUTLIER -51.64 -45.35 36.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.512 -0.742 . . . . 0.0 109.094 179.2 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.489 ' N ' HG12 ' A' ' 15' ' ' VAL . 40.0 t -66.4 -23.47 66.32 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.453 -0.779 . . . . 0.0 109.853 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.492 ' NH2' ' OE2' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -85.21 1.65 47.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 110.241 -179.819 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.568 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -60.87 -50.26 85.74 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.047 -1.033 . . . . 0.0 110.223 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 49.8 Cg_endo -73.65 -154.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.495 1.261 . . . . 0.0 109.621 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.9 64.01 0.88 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.556 HG23 HD22 ' A' ' 25' ' ' LEU . 18.6 m -115.12 140.28 25.45 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.242 -1.152 . . . . 0.0 110.453 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.61 ' HG2' HD13 ' A' ' 25' ' ' LEU . 47.8 Cg_endo -76.09 157.86 38.08 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.1 1.579 . . . . 0.0 110.279 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.492 ' OE2' ' NH2' ' A' ' 17' ' ' ARG . 1.2 mt-10 -58.3 -54.59 45.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.197 -0.94 . . . . 0.0 110.27 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 23' ' ' GLU . . . -42.06 -32.34 0.45 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.284 -0.885 . . . . 0.0 110.644 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.61 HD13 ' HG2' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -76.94 -52.14 9.93 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.195 -0.941 . . . . 0.0 110.735 -179.502 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 73.0 m -76.82 -28.5 55.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.112 -0.992 . . . . 0.0 110.156 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.73 -48.2 80.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -0.891 . . . . 0.0 109.879 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 93.8 m -66.55 -43.09 86.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.312 -0.867 . . . . 0.0 109.657 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -54.92 -26.64 37.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.361 -0.837 . . . . 0.0 109.909 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.3 p -105.27 -11.98 16.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.33 -0.856 . . . . 0.0 110.082 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.88 14.47 60.89 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 7.5 t -78.57 167.94 20.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.155 -1.203 . . . . 0.0 110.167 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.2 pt -136.24 159.16 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.234 -0.916 . . . . 0.0 110.234 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.2 mt -124.51 122.95 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.857 . . . . 0.0 110.498 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 35' ' ' ILE . 23.1 pt -126.08 142.99 44.13 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.297 -0.877 . . . . 0.0 109.948 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo . . . . . 0 C--N 1.305 -1.755 0 O-C-N 123.98 1.516 . . . . 0.0 110.309 -179.945 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.429 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 46.3 Cg_endo -72.94 -174.2 1.47 Allowed 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.018 1.536 . . . . 0.0 110.413 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.88 10.87 41.19 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 43' ' ' ASP . 32.4 p-10 -104.86 -18.61 14.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.183 -1.187 . . . . 0.0 110.148 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.403 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 0.1 OUTLIER -131.71 13.02 4.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -0.924 . . . . 0.0 110.117 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -93.83 88.65 5.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.246 -0.909 . . . . 0.0 110.17 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.181 179.958 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' THR . . . . . 1.134 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 17.4 m . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.313 0.578 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.3 m -146.81 158.48 43.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.294 -0.879 . . . . 0.0 110.237 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.518 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -150.66 162.45 27.21 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.3 -0.875 . . . . 0.0 110.023 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.518 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 49.7 Cg_endo -81.34 -92.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.892 1.47 . . . . 0.0 110.645 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -50.99 133.08 27.51 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.566 -0.708 . . . . 0.0 110.805 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.469 ' O ' ' HB3' ' A' ' 10' ' ' ARG . 11.7 mm -52.45 -38.46 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.393 -0.817 . . . . 0.0 110.046 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.1 t -58.21 -53.12 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.911 . . . . 0.0 110.103 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -46.6 -37.1 7.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.167 -0.958 . . . . 0.0 110.019 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.469 ' HB3' ' O ' ' A' ' 7' ' ' ILE . 2.1 tpp180 -65.02 -48.39 74.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.356 -0.84 . . . . 0.0 110.323 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 12' ' ' ASN . 0.5 OUTLIER -52.76 -64.6 0.76 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.152 -0.967 . . . . 0.0 110.176 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.419 ' C ' ' O ' ' A' ' 11' ' ' SER . 71.8 m-20 -43.18 -41.7 3.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.908 . . . . 0.0 110.22 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 1.134 ' CZ ' HG21 ' A' ' 2' ' ' THR . 33.0 t80 -62.03 -38.13 87.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.178 -0.951 . . . . 0.0 110.063 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -67.22 -32.6 73.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.933 . . . . 0.0 109.717 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.609 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -71.8 -52.33 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.518 -0.739 . . . . 0.0 109.688 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.609 ' N ' HG12 ' A' ' 15' ' ' VAL . 41.0 t -54.54 -28.59 46.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.408 -0.808 . . . . 0.0 110.432 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.437 ' HD2' ' HG3' ' A' ' 23' ' ' GLU . 2.3 ttp85 -83.96 -12.42 55.35 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.203 -0.936 . . . . 0.0 110.132 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.581 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -59.34 -48.97 94.93 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.374 -0.829 . . . . 0.0 110.485 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 47.6 Cg_endo -74.94 -155.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.731 1.385 . . . . 0.0 110.117 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.86 69.14 0.72 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.643 HG22 ' HD2' ' A' ' 22' ' ' PRO . 0.7 OUTLIER -130.38 145.28 56.76 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.207 -1.172 . . . . 0.0 110.134 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.643 ' HD2' HG22 ' A' ' 21' ' ' THR . 46.0 Cg_endo -73.4 135.13 21.85 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.917 1.483 . . . . 0.0 110.561 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.437 ' HG3' ' HD2' ' A' ' 17' ' ' ARG . 39.4 mt-10 -43.15 -46.57 5.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.348 -0.845 . . . . 0.0 110.053 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.409 ' HA ' HD11 ' A' ' 34' ' ' ILE . . . -42.8 -64.86 0.55 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.236 -0.915 . . . . 0.0 110.401 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.421 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -50.31 -33.12 19.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 110.461 -179.844 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 85.7 m -80.49 -53.68 6.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.179 -0.951 . . . . 0.0 110.197 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.485 ' HA ' ' OG1' ' A' ' 30' ' ' THR . . . -57.85 -16.24 11.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 109.725 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 51.6 m -79.19 -60.31 2.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.391 -0.818 . . . . 0.0 110.215 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -66.83 -16.24 64.15 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.296 -0.877 . . . . 0.0 110.51 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.485 ' OG1' ' HA ' ' A' ' 27' ' ' ALA . 24.1 p -92.67 -38.98 11.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.892 . . . . 0.0 110.097 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.37 18.56 10.93 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 83.9 m -89.74 167.57 12.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.137 -1.213 . . . . 0.0 110.109 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 pt -115.37 152.08 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.888 . . . . 0.0 110.174 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.409 HD11 ' HA ' ' A' ' 24' ' ' ALA . 85.7 mt -118.74 121.99 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.283 -0.886 . . . . 0.0 110.291 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.3 pt -117.84 157.02 49.27 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.188 -0.945 . . . . 0.0 110.416 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo . . . . . 0 C--N 1.306 -1.673 0 O-C-N 124.091 1.574 . . . . 0.0 110.546 -179.828 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 120.763 0.316 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.04 133.34 19.57 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.971 1.511 . . . . 0.0 110.417 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -51.34 -43.01 51.16 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -49.86 -22.89 1.63 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -1.145 . . . . 0.0 110.155 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.45 ' CE2' ' HD3' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -145.68 59.29 1.26 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -0.884 . . . . 0.0 109.932 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -122.12 87.65 2.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.238 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.492 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.334 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.27 0.557 . . . . 0.0 110.298 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 44' ' ' TYR . 1.8 m -148.75 99.95 3.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 110.397 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.457 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 0.6 OUTLIER -105.8 142.33 24.57 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.271 -0.893 . . . . 0.0 110.139 179.853 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.457 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 45.8 Cg_endo -73.47 -93.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.004 1.528 . . . . 0.0 110.561 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -42.92 121.22 2.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.484 -0.76 . . . . 0.0 110.432 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.415 HD13 ' HB3' ' A' ' 46' ' ' ASN . 38.8 mm -55.13 -44.98 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.92 . . . . 0.0 110.108 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.9 t -53.54 -42.42 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 109.839 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.48 -50.7 64.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.195 -0.941 . . . . 0.0 109.942 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -47.86 -46.25 31.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.247 -0.908 . . . . 0.0 109.857 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.79 -36.45 83.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.882 . . . . 0.0 109.912 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -71.1 -19.04 62.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.935 . . . . 0.0 109.878 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.407 ' CZ ' ' HB3' ' A' ' 23' ' ' GLU . 12.3 t80 -75.11 -44.41 47.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.325 -0.859 . . . . 0.0 109.848 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 76.7 m-20 -68.14 -43.85 77.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -0.907 . . . . 0.0 109.421 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.535 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -53.02 -48.19 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.447 -0.783 . . . . 0.0 109.344 179.35 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.535 ' N ' HG12 ' A' ' 15' ' ' VAL . 13.7 t -68.38 -15.27 63.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.494 -0.754 . . . . 0.0 110.049 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -87.07 -12.26 47.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.242 -0.911 . . . . 0.0 109.969 179.606 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.672 HD13 ' C ' ' A' ' 18' ' ' LEU . 3.2 tm? -67.37 -41.67 34.02 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.291 -0.88 . . . . 0.0 111.507 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 48.0 Cg_endo -74.66 -155.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.264 1.139 . . . . 0.0 110.325 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.94 52.86 2.92 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.4 m -129.69 137.49 31.03 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.146 -1.208 . . . . 0.0 110.145 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.467 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 43.6 Cg_endo -71.43 167.78 25.37 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.053 1.554 . . . . 0.0 110.549 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.448 ' HG3' ' HD3' ' A' ' 17' ' ' ARG . 32.5 mp0 -68.42 -52.79 28.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.285 -0.884 . . . . 0.0 110.336 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 23' ' ' GLU . . . -41.04 -41.48 1.7 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.378 -0.826 . . . . 0.0 110.474 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.467 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -68.81 -45.41 71.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.351 -0.843 . . . . 0.0 110.177 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 59.9 m -74.85 -51.69 13.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.344 -0.847 . . . . 0.0 110.27 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.77 -48.31 50.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.0 110.423 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.7 m -63.26 -35.03 79.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.227 -0.921 . . . . 0.0 110.334 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -78.56 -0.98 31.83 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.304 -0.873 . . . . 0.0 110.486 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.3 p -120.88 -25.61 5.37 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.196 -0.94 . . . . 0.0 110.226 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.92 6.4 22.81 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 22.5 m -84.35 139.71 32.08 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.149 -1.207 . . . . 0.0 110.266 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.525 HG12 ' CE1' ' A' ' 44' ' ' TYR . 1.1 pp -111.8 149.56 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 110.037 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.4 mt -120.74 117.39 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 110.349 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.7 pt -122.19 140.38 32.31 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.387 -0.82 . . . . 0.0 110.081 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo . . . . . 0 C--N 1.305 -1.742 0 O-C-N 124.086 1.572 . . . . 0.0 110.619 -179.834 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.504 ' O ' ' N ' ' A' ' 43' ' ' ASP . 47.7 Cg_endo -82.53 26.41 0.64 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.89 1.468 . . . . 0.0 111.378 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.45 -66.26 0.1 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 41' ' ' PRO . 22.5 p-10 -48.33 -32.22 7.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.186 -1.185 . . . . 0.0 110.496 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.525 ' CE1' HG12 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -81.38 -31.3 33.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.27 -0.894 . . . . 0.0 110.283 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.44 88.03 0.89 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.322 -0.861 . . . . 0.0 110.047 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 4' ' ' CYS . 5.8 m120 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.296 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.667 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.313 0.577 . . . . 0.0 110.176 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 17.1 m -135.49 141.83 45.37 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.339 -0.851 . . . . 0.0 109.832 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -126.82 154.89 76.02 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.131 -0.981 . . . . 0.0 110.557 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -75.76 -94.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.195 1.629 . . . . 0.0 110.435 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.76 136.07 34.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.481 -0.762 . . . . 0.0 110.695 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.436 ' O ' ' HB3' ' A' ' 10' ' ' ARG . 13.8 mm -55.36 -53.27 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.342 -0.849 . . . . 0.0 110.077 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.414 ' C ' ' O ' ' A' ' 7' ' ' ILE . 53.0 t -44.15 -51.43 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 110.023 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -45.65 -52.15 11.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.102 -0.999 . . . . 0.0 109.786 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.486 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -50.48 -47.07 57.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.405 -0.809 . . . . 0.0 109.867 179.63 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.483 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 4.6 t -59.85 -40.99 90.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.303 -0.873 . . . . 0.0 110.073 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -76.19 -8.32 56.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.33 -0.856 . . . . 0.0 110.254 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.667 ' CZ ' HG21 ' A' ' 2' ' ' THR . 53.9 t80 -77.05 -62.24 1.72 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.242 -0.912 . . . . 0.0 110.154 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -60.83 -34.35 74.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.149 -0.969 . . . . 0.0 108.899 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.533 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -60.98 -46.77 95.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.945 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.533 ' N ' HG12 ' A' ' 15' ' ' VAL . 7.0 t -55.92 -25.23 42.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.424 -0.798 . . . . 0.0 109.92 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -85.62 -13.19 49.46 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.304 -0.872 . . . . 0.0 110.554 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.616 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 4.0 tp -57.66 -43.58 98.9 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.198 -0.939 . . . . 0.0 111.416 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 45.0 Cg_endo -72.98 -30.42 10.95 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.309 1.163 . . . . 0.0 110.5 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.44 6.28 4.31 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.571 HG22 ' HD2' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -67.07 143.28 97.74 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.094 -1.239 . . . . 0.0 110.093 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.571 ' HD2' HG22 ' A' ' 21' ' ' THR . 43.9 Cg_endo -71.96 158.46 52.58 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.889 1.468 . . . . 0.0 110.814 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.413 ' HG3' ' CZ ' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -55.45 -47.16 76.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.434 -0.791 . . . . 0.0 110.524 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.54 -45.25 26.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.232 -0.918 . . . . 0.0 110.627 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.462 HD13 ' CG2' ' A' ' 21' ' ' THR . 0.3 OUTLIER -67.14 -42.65 84.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.156 -0.965 . . . . 0.0 110.365 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 39.7 m -70.75 -52.85 18.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.208 -0.933 . . . . 0.0 110.179 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.449 ' HA ' ' HB2' ' A' ' 32' ' ' CYS . . . -53.12 -22.37 6.19 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 110.37 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.9 m -86.99 -34.44 19.26 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.211 -0.931 . . . . 0.0 110.324 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -79.08 -20.34 49.01 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.197 -0.939 . . . . 0.0 110.197 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.0 p -110.28 -24.49 10.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.156 -0.965 . . . . 0.0 110.202 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.34 61.0 1.34 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.449 ' HB2' ' HA ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -117.32 174.94 5.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -1.131 . . . . 0.0 110.418 -179.85 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 2' ' ' THR . 1.0 OUTLIER -135.92 147.43 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.369 -0.832 . . . . 0.0 110.29 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.1 mt -116.17 108.88 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 110.156 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.455 ' O ' HG13 ' A' ' 35' ' ' ILE . 18.1 pt -88.78 145.05 34.09 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.268 -0.895 . . . . 0.0 110.342 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo . . . . . 0 C--N 1.306 -1.705 0 O-C-N 123.997 1.525 . . . . 0.0 110.345 179.957 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.469 ' SG ' ' HD2' ' A' ' 41' ' ' PRO . 4.4 t . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 120.634 0.254 . . . . 0.0 110.38 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.469 ' HD2' ' SG ' ' A' ' 40' ' ' CYS . 43.6 Cg_endo -71.08 -160.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.927 1.488 . . . . 0.0 110.311 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -113.52 4.75 24.77 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -96.78 -29.95 13.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.101 -1.235 . . . . 0.0 110.241 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.482 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 5.9 t80 -119.26 7.98 11.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.268 -0.895 . . . . 0.0 110.435 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.81 87.47 5.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -0.99 . . . . 0.0 110.138 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.227 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.588 HG21 ' CE1' ' A' ' 13' ' ' PHE . 2.1 m . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.202 0.525 . . . . 0.0 110.143 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.46 ' HB3' ' HA ' ' A' ' 45' ' ' ALA . 57.7 m -146.19 156.34 43.34 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.139 -0.976 . . . . 0.0 110.716 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.46 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -134.34 174.26 4.85 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.386 -0.821 . . . . 0.0 109.95 179.672 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.46 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 46.2 Cg_endo -72.99 -93.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.993 1.523 . . . . 0.0 109.913 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 7' ' ' ILE . 5.8 t -75.33 143.65 42.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.528 -0.732 . . . . 0.0 109.789 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.417 ' C ' ' O ' ' A' ' 6' ' ' SER . 71.2 mt -42.79 -47.9 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.223 -0.923 . . . . 0.0 110.125 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.426 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 33.4 t -50.36 -51.19 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -0.924 . . . . 0.0 110.047 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.85 -34.95 13.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.169 -0.957 . . . . 0.0 110.214 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 11' ' ' SER . 0.1 OUTLIER -65.64 -58.74 5.0 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 110.2 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 10' ' ' ARG . 4.9 p -42.38 -45.07 4.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.231 -0.918 . . . . 0.0 110.323 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 8' ' ' VAL . 61.1 m-80 -57.49 -51.47 69.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.199 -0.938 . . . . 0.0 110.322 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.588 ' CE1' HG21 ' A' ' 2' ' ' THR . 6.1 t80 -54.44 -39.04 67.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.21 -0.931 . . . . 0.0 110.19 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -67.93 -23.01 65.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -0.895 . . . . 0.0 109.129 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.533 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -85.34 -46.9 17.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.302 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.533 ' N ' HG12 ' A' ' 15' ' ' VAL . 9.6 t -60.2 -14.33 16.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.594 -0.691 . . . . 0.0 110.312 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.504 ' HB3' ' NH2' ' A' ' 17' ' ' ARG . 7.5 mmm180 -86.98 -7.74 57.86 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.156 -0.965 . . . . 0.0 109.957 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.614 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 2.4 tp -81.18 -43.68 1.17 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.367 -0.833 . . . . 0.0 111.248 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 46.3 Cg_endo -73.34 -155.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.228 1.12 . . . . 0.0 110.214 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.99 6.36 62.03 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.615 HG22 ' HB3' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -71.37 129.85 88.4 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.186 -1.185 . . . . 0.0 110.047 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.0 157.76 53.88 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.921 1.485 . . . . 0.0 110.513 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.422 ' HG2' ' HD3' ' A' ' 17' ' ' ARG . 88.0 mt-10 -52.91 -33.84 52.27 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.363 -0.836 . . . . 0.0 110.433 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.56 -65.08 0.69 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.954 . . . . 0.0 110.328 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.615 ' HB3' HG22 ' A' ' 21' ' ' THR . 0.6 OUTLIER -52.97 -27.33 18.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.322 -0.861 . . . . 0.0 110.436 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 82.0 m -81.1 -56.52 4.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.963 . . . . 0.0 110.392 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.402 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -47.99 -22.92 0.67 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.332 -0.855 . . . . 0.0 110.509 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.9 m -82.09 -58.57 2.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.133 -0.979 . . . . 0.0 110.535 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.7 -21.4 40.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.291 -0.881 . . . . 0.0 110.315 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.6 p -109.42 -29.13 8.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -0.897 . . . . 0.0 110.209 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 85.98 20.53 55.33 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.99 173.19 8.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.214 -1.168 . . . . 0.0 110.393 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.423 ' C ' HG13 ' A' ' 34' ' ' ILE . 4.5 pt -130.64 152.86 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.359 -0.838 . . . . 0.0 109.774 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.423 HG13 ' C ' ' A' ' 33' ' ' ILE . 34.3 mt -131.96 118.19 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.034 -1.041 . . . . 0.0 110.749 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.2 pt -105.14 159.91 27.78 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.313 -0.867 . . . . 0.0 109.952 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo . . . . . 0 C--N 1.306 -1.675 0 O-C-N 123.925 1.487 . . . . 0.0 110.817 -179.902 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 120.744 0.307 . . . . 0.0 110.468 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 47.7 Cg_endo -73.92 149.48 42.22 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.029 1.541 . . . . 0.0 110.286 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.78 -19.01 66.95 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -59.47 -34.9 73.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -1.188 . . . . 0.0 110.293 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.414 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 0.3 OUTLIER -147.35 55.57 1.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.933 . . . . 0.0 110.239 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -129.32 87.61 2.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.874 . . . . 0.0 110.181 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.251 179.988 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.706 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 2.0 m . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.407 0.623 . . . . 0.0 110.43 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.456 ' HB2' HD11 ' A' ' 33' ' ' ILE . 83.8 m -133.55 116.21 15.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 110.172 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 0.7 OUTLIER -108.86 149.86 40.11 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.308 -0.87 . . . . 0.0 110.646 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.525 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 48.9 Cg_endo -79.07 -91.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.299 1.684 . . . . 0.0 110.479 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.542 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 6.2 t -50.18 133.24 23.72 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 110.303 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.5 mt -52.81 -54.3 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.174 -0.954 . . . . 0.0 109.898 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 9' ' ' ALA . 2.5 t -46.86 -47.49 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -0.935 . . . . 0.0 109.36 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 6' ' ' SER . . . -43.96 -48.5 8.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.276 -0.89 . . . . 0.0 109.445 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -58.34 -41.55 84.88 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.285 -0.884 . . . . 0.0 109.666 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 8' ' ' VAL . 0.3 OUTLIER -60.14 -59.38 5.51 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.345 -0.847 . . . . 0.0 109.621 179.553 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -59.23 -25.6 64.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.558 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.706 ' CZ ' HG21 ' A' ' 2' ' ' THR . 24.1 t80 -71.4 -25.35 62.31 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.43 -0.794 . . . . 0.0 109.809 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.17 -46.41 34.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.314 -0.866 . . . . 0.0 109.053 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.525 ' O ' ' CD ' ' A' ' 19' ' ' PRO . 1.1 t -56.61 -38.77 58.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.1 t -69.13 -27.65 65.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.485 -0.759 . . . . 0.0 110.455 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.518 ' CZ ' ' HB3' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -86.0 -11.84 51.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.102 -0.999 . . . . 0.0 110.616 -179.719 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.587 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -69.41 -50.03 20.92 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.206 -0.934 . . . . 0.0 110.824 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 45.4 Cg_endo -73.04 -155.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.553 1.291 . . . . 0.0 110.351 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.21 75.36 0.29 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 m -135.93 138.71 28.45 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.247 -1.149 . . . . 0.0 109.887 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.478 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 43.8 Cg_endo -72.19 150.76 54.07 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.982 1.517 . . . . 0.0 110.372 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.1 -49.23 66.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.325 -0.859 . . . . 0.0 110.462 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -44.19 -54.26 5.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.378 -0.826 . . . . 0.0 110.695 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.478 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.6 OUTLIER -56.7 -37.87 71.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.182 -0.949 . . . . 0.0 110.646 -179.626 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 83.7 m -78.88 -44.28 23.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.167 -0.958 . . . . 0.0 110.261 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.94 -24.98 7.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 110.408 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.1 m -89.5 -48.54 7.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.214 -0.929 . . . . 0.0 110.064 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -63.66 -22.2 66.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.352 -0.842 . . . . 0.0 110.38 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.6 p -110.79 -47.02 3.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.201 -0.937 . . . . 0.0 110.378 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.75 56.89 0.34 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.487 ' CB ' ' CE1' ' A' ' 13' ' ' PHE . 0.1 OUTLIER -120.36 176.37 5.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.259 -1.142 . . . . 0.0 110.063 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.456 HD11 ' HB2' ' A' ' 3' ' ' CYS . 1.0 OUTLIER -136.85 148.51 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.181 -0.949 . . . . 0.0 110.316 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 23.9 mt -104.68 132.67 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 110.132 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.5 pt -103.83 155.39 37.08 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.132 -0.98 . . . . 0.0 110.392 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 C--N 1.305 -1.729 0 O-C-N 124.061 1.558 . . . . 0.0 110.809 179.988 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 44' ' ' TYR . 4.2 t . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 120.86 0.362 . . . . 0.0 110.581 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.49 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 47.2 Cg_endo -72.27 -163.51 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.941 1.495 . . . . 0.0 110.322 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.44 -14.62 29.68 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.01 -32.63 67.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.312 -1.111 . . . . 0.0 110.33 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.461 ' O ' ' SG ' ' A' ' 40' ' ' CYS . 0.2 OUTLIER -135.5 68.32 1.46 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.313 -0.867 . . . . 0.0 110.096 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -130.45 88.93 2.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.111 -0.993 . . . . 0.0 110.793 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.525 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.039 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.866 HG21 ' CE2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.328 0.585 . . . . 0.0 110.447 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 26.7 m -129.48 97.08 4.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 0.0 109.922 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.422 ' N ' ' SG ' ' A' ' 32' ' ' CYS . 22.0 m -99.2 158.02 33.01 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.295 -0.878 . . . . 0.0 110.391 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -77.08 -95.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 124.075 1.566 . . . . 0.0 110.469 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.7 t -54.68 134.34 47.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.462 -0.773 . . . . 0.0 110.255 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.4 mt -57.93 -44.25 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -0.918 . . . . 0.0 109.852 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.3 t -50.45 -49.17 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.364 -0.835 . . . . 0.0 109.835 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.93 -43.52 63.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 109.749 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.464 ' HG3' ' OXT' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -53.81 -58.27 7.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.202 -0.936 . . . . 0.0 109.842 179.652 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -45.97 -51.11 13.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.193 -0.942 . . . . 0.0 109.477 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -55.17 -36.73 66.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.329 -0.857 . . . . 0.0 109.137 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.866 ' CE2' HG21 ' A' ' 2' ' ' THR . 38.4 t80 -74.6 -28.58 60.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.444 -0.785 . . . . 0.0 109.435 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -68.14 -27.39 66.4 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.454 -0.779 . . . . 0.0 109.147 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.559 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -82.46 -49.3 17.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.184 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.559 ' N ' HG12 ' A' ' 15' ' ' VAL . 42.7 t -58.92 -20.84 55.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.383 -0.823 . . . . 0.0 109.973 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.534 ' CD ' ' HG3' ' A' ' 23' ' ' GLU . 2.7 tpt85 -89.61 -20.11 24.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.217 -0.927 . . . . 0.0 110.179 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.606 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 15.4 tp -56.75 -41.71 92.66 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.882 . . . . 0.0 110.841 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 47.9 Cg_endo -76.11 -156.17 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.324 1.171 . . . . 0.0 110.293 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.84 14.35 65.33 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 m -75.5 137.65 71.01 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.11 -1.229 . . . . 0.0 110.008 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.433 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 47.9 Cg_endo -73.44 158.56 47.88 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.968 1.509 . . . . 0.0 110.587 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.534 ' HG3' ' CD ' ' A' ' 17' ' ' ARG . 1.0 OUTLIER -60.45 -49.06 79.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.34 -0.85 . . . . 0.0 110.354 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' GLU . . . -43.37 -49.02 7.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 110.306 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.433 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -59.84 -47.28 86.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.278 -0.889 . . . . 0.0 110.398 -179.798 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.43 ' HB2' ' CE1' ' A' ' 13' ' ' PHE . 25.9 m -72.38 -43.86 63.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.175 -0.953 . . . . 0.0 110.21 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.6 -38.94 70.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.158 -0.963 . . . . 0.0 110.103 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.4 m -80.32 -21.83 42.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 0.0 110.157 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -85.32 -11.07 55.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.202 -0.936 . . . . 0.0 110.131 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 55.4 p -123.87 -31.77 3.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.321 -0.862 . . . . 0.0 110.126 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.58 60.05 0.52 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.422 ' SG ' ' N ' ' A' ' 4' ' ' CYS . 8.4 t -131.76 173.42 11.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.285 -1.127 . . . . 0.0 110.185 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.0 pt -135.02 157.81 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.289 -0.882 . . . . 0.0 110.33 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.2 mt -114.29 144.72 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.349 -0.845 . . . . 0.0 110.059 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.436 ' O ' HG13 ' A' ' 35' ' ' ILE . 3.8 pt -120.11 150.42 51.18 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.913 . . . . 0.0 110.259 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo . . . . . 0 C--N 1.305 -1.742 0 O-C-N 124.103 1.581 . . . . 0.0 110.434 179.98 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 120.721 0.296 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 42' ' ' GLY . 46.8 Cg_endo -74.7 127.1 10.63 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.967 1.509 . . . . 0.0 110.402 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 45' ' ' ALA . . . -44.68 -28.49 1.64 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -51.82 -35.88 46.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.304 -1.116 . . . . 0.0 110.367 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.458 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 1.1 t80 -134.0 31.76 3.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 0.0 110.332 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.463 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . . . -110.07 98.03 7.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.189 -0.944 . . . . 0.0 110.276 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.464 ' OXT' ' HG3' ' A' ' 10' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.261 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.491 ' CG2' ' HB3' ' A' ' 32' ' ' CYS . 99.5 m . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.435 0.636 . . . . 0.0 110.451 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.734 ' SG ' HD11 ' A' ' 35' ' ' ILE . 61.5 m -120.28 112.25 18.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.375 -0.828 . . . . 0.0 109.93 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.472 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -122.34 146.56 47.43 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.167 -0.958 . . . . 0.0 110.193 -179.904 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.547 ' HG3' ' CE2' ' A' ' 44' ' ' TYR . 48.0 Cg_endo -72.95 -93.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.983 1.517 . . . . 0.0 110.42 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.442 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 1.6 t -42.21 109.51 0.13 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.527 -0.733 . . . . 0.0 110.334 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.2 mt -44.23 -50.83 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.167 -0.958 . . . . 0.0 110.178 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 69.7 t -47.13 -41.79 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -0.953 . . . . 0.0 109.885 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 6' ' ' SER . . . -56.09 -47.71 77.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.92 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.47 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 0.9 OUTLIER -60.93 -42.01 97.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.317 -0.864 . . . . 0.0 110.295 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.73 -48.43 72.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.179 -0.951 . . . . 0.0 110.223 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -65.71 -22.44 66.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.153 -0.967 . . . . 0.0 110.016 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.586 ' HA ' HG21 ' A' ' 30' ' ' THR . 49.6 t80 -74.83 -35.07 62.42 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.318 -0.864 . . . . 0.0 109.945 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -64.18 -51.3 64.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 0.0 109.477 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.593 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -55.57 -51.06 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.408 -0.807 . . . . 0.0 109.33 179.422 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.593 ' N ' HG12 ' A' ' 15' ' ' VAL . 53.4 t -48.39 -28.55 3.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.371 -0.831 . . . . 0.0 109.944 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.453 ' C ' ' HD2' ' A' ' 19' ' ' PRO . 11.1 tpt180 -83.99 -20.99 31.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.344 -0.847 . . . . 0.0 110.07 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.75 HD13 ' C ' ' A' ' 18' ' ' LEU . 3.4 tm? -49.61 -45.37 78.53 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 110.934 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 47.3 Cg_endo -73.02 -155.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.254 1.134 . . . . 0.0 110.033 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.46 50.74 1.26 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.2 m -115.5 140.06 25.45 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.21 -1.17 . . . . 0.0 110.099 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.485 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 43.8 Cg_endo -71.63 165.92 31.02 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.846 1.445 . . . . 0.0 110.315 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -69.4 -46.36 67.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -0.906 . . . . 0.0 110.424 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.76 -45.34 19.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 0.0 110.372 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.485 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -62.6 -48.29 80.07 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.157 -0.964 . . . . 0.0 110.281 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.414 ' HB2' ' CE1' ' A' ' 13' ' ' PHE . 73.0 m -68.44 -44.81 74.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.136 -0.978 . . . . 0.0 110.047 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.58 -37.13 26.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.181 -0.949 . . . . 0.0 109.867 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.1 m -72.73 -40.63 65.93 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.322 -0.861 . . . . 0.0 109.967 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -78.37 -9.75 59.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.855 . . . . 0.0 110.045 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.586 HG21 ' HA ' ' A' ' 13' ' ' PHE . 17.3 p -110.54 -19.57 12.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.297 -0.877 . . . . 0.0 110.169 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.23 23.42 48.35 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.491 ' HB3' ' CG2' ' A' ' 2' ' ' THR . 33.4 m -101.02 171.1 7.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -1.181 . . . . 0.0 110.231 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 3' ' ' CYS . 23.8 pt -123.47 156.04 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.917 . . . . 0.0 109.985 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.607 ' O ' HG23 ' A' ' 35' ' ' ILE . 20.9 mm -106.09 152.37 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 110.404 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.734 HD11 ' SG ' ' A' ' 3' ' ' CYS . 4.6 pt -156.18 150.73 20.23 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.336 -0.852 . . . . 0.0 110.331 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo . . . . . 0 C--N 1.305 -1.712 0 O-C-N 124.15 1.605 . . . . 0.0 110.957 -179.665 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.548 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 8.2 m . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.525 ' O ' ' N ' ' A' ' 43' ' ' ASP . 52.8 Cg_endo -79.78 32.77 0.49 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.843 1.444 . . . . 0.0 111.593 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.06 -68.21 0.08 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 41' ' ' PRO . 0.3 OUTLIER -48.67 -41.44 31.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.111 -1.229 . . . . 0.0 109.774 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.547 ' CE2' ' HG3' ' A' ' 5' ' ' PRO . 0.5 OUTLIER -106.34 32.78 4.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -0.837 . . . . 0.0 109.887 179.629 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.548 ' HB2' ' HB2' ' A' ' 40' ' ' CYS . . . -105.31 96.33 6.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.324 -0.86 . . . . 0.0 110.243 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 45' ' ' ALA . 1.3 m-20 . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.111 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.45 ' O ' ' SG ' ' A' ' 3' ' ' CYS . 91.9 m . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.168 0.508 . . . . 0.0 110.363 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.451 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 49.1 m -153.63 154.7 34.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.344 -0.847 . . . . 0.0 110.321 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.13 171.31 9.15 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 109.983 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.1 -95.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.99 1.521 . . . . 0.0 110.707 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.4 t -76.11 157.77 32.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.496 -0.753 . . . . 0.0 110.423 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.409 ' O ' ' C ' ' A' ' 8' ' ' VAL . 2.4 mp -58.33 -50.07 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.882 . . . . 0.0 109.874 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.409 ' C ' ' O ' ' A' ' 7' ' ' ILE . 91.1 t -44.69 -47.97 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.312 -0.868 . . . . 0.0 109.901 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.91 -45.17 71.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 109.915 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.425 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 9.5 ttm-85 -63.45 -48.6 77.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.388 -0.82 . . . . 0.0 110.271 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -50.11 -59.26 4.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.141 -0.975 . . . . 0.0 110.132 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -55.2 -40.45 70.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.912 . . . . 0.0 110.016 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.486 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 51.0 t80 -56.88 -43.8 81.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 0.0 110.097 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -58.4 -42.08 86.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.241 -0.912 . . . . 0.0 109.263 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.595 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -61.89 -50.65 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.599 -0.688 . . . . 0.0 109.282 179.25 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.595 ' N ' HG12 ' A' ' 15' ' ' VAL . 13.9 t -48.25 -25.61 1.61 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.443 -0.786 . . . . 0.0 110.099 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.549 ' NH2' ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -91.16 10.53 26.6 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.428 -0.795 . . . . 0.0 109.585 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.646 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 2.3 tt -84.04 -36.87 0.64 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.517 -0.739 . . . . 0.0 112.349 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 43.8 Cg_endo -72.54 -37.61 4.01 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 O-C-N 122.994 0.997 . . . . 0.0 111.356 -178.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 135.38 1.22 3.19 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.526 -1.321 . . . . 0.0 110.429 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.966 HG22 ' HD2' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -66.4 157.04 83.81 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 120.97 -1.312 . . . . 0.0 109.486 179.733 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.966 ' HD2' HG22 ' A' ' 21' ' ' THR . 47.7 Cg_endo -74.98 149.5 36.86 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.795 1.418 . . . . 0.0 110.71 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.484 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 1.6 pt-20 -54.84 -25.4 28.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.349 -0.844 . . . . 0.0 110.14 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.17 -44.22 84.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.311 -0.868 . . . . 0.0 110.44 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.484 HD13 ' CG2' ' A' ' 21' ' ' THR . 0.5 OUTLIER -68.55 -33.69 74.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 110.444 -179.782 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.449 ' O ' ' OG1' ' A' ' 30' ' ' THR . 69.6 m -87.45 -32.83 19.29 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.052 -1.03 . . . . 0.0 110.581 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.58 -30.35 70.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.098 -1.001 . . . . 0.0 110.035 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.86 -28.1 17.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 0.0 110.15 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.462 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -68.84 -28.9 67.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.216 -0.928 . . . . 0.0 110.324 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -101.68 -30.52 11.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.214 -0.929 . . . . 0.0 110.092 179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.52 19.05 9.04 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -76.43 -177.55 4.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -1.135 . . . . 0.0 110.003 179.936 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 pp -145.81 159.53 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.154 -0.966 . . . . 0.0 110.485 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 53.4 mt -125.58 121.37 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.354 -0.842 . . . . 0.0 110.061 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.463 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 12.1 pt -93.46 163.79 23.38 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.935 . . . . 0.0 110.361 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.463 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 48.7 Cg_endo . . . . . 0 C--N 1.306 -1.701 0 O-C-N 124.008 1.531 . . . . 0.0 110.584 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 120.937 0.398 . . . . 0.0 110.314 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.699 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 46.4 Cg_endo -72.98 -166.56 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.152 1.606 . . . . 0.0 110.866 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.47 -5.62 39.48 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.517 ' OD2' ' N ' ' A' ' 44' ' ' TYR . 4.3 p30 -82.35 -24.42 34.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -1.14 . . . . 0.0 110.038 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.517 ' N ' ' OD2' ' A' ' 43' ' ' ASP . 0.2 OUTLIER -144.64 47.15 1.37 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 110.311 -179.817 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -118.61 89.42 3.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 110.065 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.1 m120 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.258 -179.94 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.573 HG22 ' O ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.273 0.559 . . . . 0.0 110.256 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.586 ' HB3' HD11 ' A' ' 33' ' ' ILE . 1.8 t -142.49 121.68 13.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.323 -0.861 . . . . 0.0 110.107 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.443 ' O ' ' OXT' ' A' ' 46' ' ' ASN . 57.8 m -120.71 150.11 51.9 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.246 -0.909 . . . . 0.0 110.214 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.518 ' HD3' ' CE2' ' A' ' 44' ' ' TYR . 52.6 Cg_endo -77.79 -94.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.125 1.592 . . . . 0.0 110.614 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 t -50.29 129.54 21.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.476 -0.765 . . . . 0.0 110.593 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' A' ' 7' ' ' ILE . 14.3 mm -50.71 -41.05 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.212 -0.93 . . . . 0.0 109.369 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 56.1 t -53.32 -47.3 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.436 -0.79 . . . . 0.0 109.715 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.47 -52.72 27.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.344 -0.847 . . . . 0.0 109.91 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.9 ttm-85 -55.64 -43.85 76.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.266 -0.896 . . . . 0.0 109.941 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.55 -56.97 6.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.0 109.933 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -60.08 -33.1 71.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.332 -0.855 . . . . 0.0 109.903 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.464 ' CZ ' ' HD3' ' A' ' 17' ' ' ARG . 16.1 t80 -70.96 -35.91 72.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.0 109.804 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -73.51 -44.57 57.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.346 -0.846 . . . . 0.0 109.447 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.519 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -54.91 -47.3 76.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.459 -0.775 . . . . 0.0 109.197 179.372 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.519 ' N ' HG12 ' A' ' 15' ' ' VAL . 29.7 t -68.78 -25.53 64.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.464 -0.772 . . . . 0.0 109.93 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.464 ' HD3' ' CZ ' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -88.74 -8.44 54.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.384 -0.822 . . . . 0.0 109.879 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.577 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -61.94 -45.62 91.95 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.462 -0.774 . . . . 0.0 110.654 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 18' ' ' LEU . 47.4 Cg_endo -78.29 -157.41 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.759 1.4 . . . . 0.0 110.075 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.6 61.77 2.75 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.577 HG23 HD13 ' A' ' 25' ' ' LEU . 99.1 m -119.47 140.67 29.55 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.237 -1.155 . . . . 0.0 110.306 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.47 ' HD2' HG23 ' A' ' 21' ' ' THR . 46.9 Cg_endo -72.31 170.37 19.36 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.006 1.53 . . . . 0.0 110.841 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.463 ' O ' ' N ' ' A' ' 25' ' ' LEU . 1.4 mt-10 -72.44 -55.27 7.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.358 -0.839 . . . . 0.0 110.477 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 23' ' ' GLU . . . -39.8 -28.48 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.355 -0.84 . . . . 0.0 110.603 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.577 HD13 HG23 ' A' ' 21' ' ' THR . 0.7 OUTLIER -81.3 -50.13 9.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.169 -0.957 . . . . 0.0 110.599 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.2 m -83.5 -27.6 29.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.141 -0.975 . . . . 0.0 110.666 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -74.14 -49.31 24.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.168 -0.957 . . . . 0.0 110.561 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.2 m -76.17 -23.41 54.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.224 -0.922 . . . . 0.0 110.503 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.428 ' CB ' ' O ' ' A' ' 25' ' ' LEU . 48.1 t80 -81.44 -6.41 58.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.931 . . . . 0.0 110.413 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 31.3 p -119.19 -21.71 7.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 0.0 110.189 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.85 38.93 3.26 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 57.0 m -108.86 -179.34 3.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.18 -1.188 . . . . 0.0 110.23 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.586 HD11 ' HB3' ' A' ' 3' ' ' CYS . 9.1 pt -126.17 149.26 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.271 -0.893 . . . . 0.0 110.398 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.7 mt -109.0 124.65 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.265 -0.897 . . . . 0.0 109.957 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 23.5 pt -123.44 135.34 25.96 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.161 -0.962 . . . . 0.0 110.51 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 C--N 1.305 -1.738 0 O-C-N 123.958 1.504 . . . . 0.0 110.489 -179.941 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.43 ' HG2' ' OD1' ' A' ' 43' ' ' ASP . 50.0 Cg_endo -79.27 15.51 1.54 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.937 1.493 . . . . 0.0 111.189 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.32 -64.16 3.53 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.433 ' CG ' ' N ' ' A' ' 44' ' ' TYR . 4.6 p-10 -52.77 -44.14 66.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.272 -1.134 . . . . 0.0 110.971 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.518 ' CE2' ' HD3' ' A' ' 5' ' ' PRO . 1.8 m-85 -89.87 -2.13 58.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.066 -1.021 . . . . 0.0 110.5 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.501 ' O ' ' ND2' ' A' ' 46' ' ' ASN . . . -75.31 87.93 2.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.214 -0.929 . . . . 0.0 110.407 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.502 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.136 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.17 0.51 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.511 ' HB2' HD11 ' A' ' 33' ' ' ILE . 29.9 m -139.21 128.58 24.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.201 -0.937 . . . . 0.0 110.345 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -123.25 165.24 23.34 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.294 -0.879 . . . . 0.0 110.214 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.456 ' O ' ' CB ' ' A' ' 46' ' ' ASN . 47.8 Cg_endo -73.87 -93.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.924 1.486 . . . . 0.0 110.524 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.9 t -62.38 154.99 26.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.583 -0.698 . . . . 0.0 110.339 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.549 HD13 ' O ' ' A' ' 46' ' ' ASN . 48.7 mm -66.28 -30.01 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.333 -0.854 . . . . 0.0 109.776 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.7 t -69.44 -44.1 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.329 -0.857 . . . . 0.0 109.794 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.76 -42.1 67.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.394 -0.816 . . . . 0.0 110.067 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.459 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 5.2 ttp180 -67.22 -50.96 58.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 0.0 110.154 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.1 t -50.84 -46.26 60.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.256 -0.902 . . . . 0.0 110.334 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -61.71 -30.49 70.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.296 -0.877 . . . . 0.0 110.329 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.459 ' HB3' ' O ' ' A' ' 10' ' ' ARG . 48.5 t80 -67.9 -40.47 83.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.918 . . . . 0.0 110.232 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -58.05 -47.46 83.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -0.941 . . . . 0.0 109.381 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.604 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -54.31 -51.57 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.494 -0.754 . . . . 0.0 109.278 179.319 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.604 ' N ' HG12 ' A' ' 15' ' ' VAL . 35.4 t -48.66 -28.23 3.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.573 -0.704 . . . . 0.0 110.217 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.492 ' NE ' ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -88.6 -14.06 38.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.243 -0.911 . . . . 0.0 110.35 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.797 HD13 ' O ' ' A' ' 18' ' ' LEU . 1.8 tm? -54.89 -43.56 98.88 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.241 -0.912 . . . . 0.0 111.182 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 47.7 Cg_endo -75.86 -90.11 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.382 1.201 . . . . 0.0 110.495 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -175.12 55.7 0.12 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.671 HG22 ' HD2' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -106.76 146.18 32.57 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.293 -1.122 . . . . 0.0 110.059 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.671 ' HD2' HG22 ' A' ' 21' ' ' THR . 44.0 Cg_endo -72.04 136.0 26.35 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.903 1.475 . . . . 0.0 110.404 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 22' ' ' PRO . 3.9 mt-10 -39.7 -46.13 1.81 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.461 -0.774 . . . . 0.0 110.779 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.11 -38.51 52.27 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.324 -0.86 . . . . 0.0 111.038 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.472 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -72.51 -42.71 64.53 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.112 -0.993 . . . . 0.0 110.81 -179.248 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.429 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 73.8 m -74.49 -39.95 62.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.156 -0.965 . . . . 0.0 110.319 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.8 -41.81 92.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.139 -0.975 . . . . 0.0 110.238 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 38.7 m -75.09 -21.02 59.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.24 -0.913 . . . . 0.0 110.281 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -85.04 -20.9 29.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.283 -0.885 . . . . 0.0 110.24 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.7 p -120.01 -16.16 8.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.888 . . . . 0.0 110.342 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.96 53.58 3.9 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.53 -175.17 2.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.207 -1.172 . . . . 0.0 110.168 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' A' ' 3' ' ' CYS . 1.2 pt -142.04 147.42 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 110.41 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.543 ' O ' HG23 ' A' ' 35' ' ' ILE . 2.2 mp -115.11 139.69 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.445 -0.785 . . . . 0.0 110.129 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.543 HG23 ' O ' ' A' ' 34' ' ' ILE . 0.9 OUTLIER -154.68 121.15 2.74 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.199 -0.938 . . . . 0.0 110.367 -179.848 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo . . . . . 0 C--N 1.308 -1.605 0 O-C-N 123.896 1.472 . . . . 0.0 110.686 -179.957 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 120.684 0.278 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.403 ' O ' ' N ' ' A' ' 45' ' ' ALA . 44.9 Cg_endo -72.27 135.04 23.99 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.94 1.495 . . . . 0.0 110.424 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.475 ' HA2' ' HB3' ' A' ' 45' ' ' ALA . . . -46.25 -38.73 9.02 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -48.15 -27.1 2.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.164 -1.198 . . . . 0.0 110.314 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.58 6.41 2.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.27 -0.894 . . . . 0.0 110.392 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.475 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . . . -90.94 89.45 7.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.111 -0.993 . . . . 0.0 110.147 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.549 ' O ' HD13 ' A' ' 7' ' ' ILE . 43.0 m-20 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.131 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 99.3 m . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.264 0.554 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.503 ' SG ' HD11 ' A' ' 35' ' ' ILE . 19.0 m -128.94 131.23 47.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.269 -0.894 . . . . 0.0 110.174 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.472 ' CB ' ' OXT' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -122.02 153.48 60.93 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.225 -0.922 . . . . 0.0 110.324 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.551 ' HD3' ' CE1' ' A' ' 44' ' ' TYR . 50.9 Cg_endo -78.1 -93.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.08 1.568 . . . . 0.0 110.719 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.81 138.05 58.31 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.547 -0.721 . . . . 0.0 110.914 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.416 ' O ' ' HB3' ' A' ' 10' ' ' ARG . 89.0 mt -47.92 -38.9 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.265 -0.897 . . . . 0.0 109.808 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.458 ' O ' ' OG ' ' A' ' 11' ' ' SER . 94.4 t -51.71 -61.49 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.381 -0.824 . . . . 0.0 110.285 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.442 ' O ' ' OD1' ' A' ' 12' ' ' ASN . . . -45.91 -32.3 2.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.159 -0.963 . . . . 0.0 110.251 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 46' ' ' ASN . 0.3 OUTLIER -74.87 -46.96 32.72 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.306 -0.871 . . . . 0.0 110.748 -179.734 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 8' ' ' VAL . 10.6 p -54.88 -69.05 0.14 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.091 -1.006 . . . . 0.0 110.534 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 13' ' ' PHE . 9.4 p30 -51.15 -37.6 47.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.167 -0.958 . . . . 0.0 110.656 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.516 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 37.0 t80 -50.82 -50.04 57.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.146 -0.971 . . . . 0.0 110.538 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.509 ' OD1' ' NH2' ' A' ' 17' ' ' ARG . 18.9 m-80 -63.91 -41.84 97.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.191 -0.943 . . . . 0.0 109.604 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.561 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -59.61 -48.84 85.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.52 -0.737 . . . . 0.0 109.424 179.369 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.561 ' N ' HG12 ' A' ' 15' ' ' VAL . 44.8 t -57.16 -22.8 42.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.588 -0.695 . . . . 0.0 110.342 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.509 ' NH2' ' OD1' ' A' ' 14' ' ' ASN . 9.7 mtm180 -83.78 -3.98 58.28 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.1 -1.0 . . . . 0.0 110.244 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.611 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 16.6 tp -71.68 -47.75 12.2 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 110.749 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 46.1 Cg_endo -71.33 -155.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.352 1.185 . . . . 0.0 110.39 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.98 2.55 87.12 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.511 HG22 ' HB3' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -72.83 125.49 91.13 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.092 -1.24 . . . . 0.0 109.982 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.29 146.95 46.52 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.883 1.465 . . . . 0.0 110.521 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.496 ' HG3' ' N ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -50.21 -22.56 1.78 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.274 -0.891 . . . . 0.0 110.176 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.496 ' N ' ' HG3' ' A' ' 23' ' ' GLU . . . -67.27 -48.78 66.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.932 . . . . 0.0 110.013 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.511 ' HB3' HG22 ' A' ' 21' ' ' THR . 1.0 OUTLIER -69.25 -30.52 68.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.873 . . . . 0.0 109.843 179.707 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 78.7 m -75.97 -49.67 17.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -0.885 . . . . 0.0 109.967 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.39 -25.62 50.37 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.155 -0.965 . . . . 0.0 109.819 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.6 m -89.91 -18.85 25.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.307 -0.871 . . . . 0.0 110.025 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.427 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 1.6 t80 -89.01 -20.36 24.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.395 -0.816 . . . . 0.0 110.402 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.6 p -108.42 -39.86 5.3 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.153 -0.967 . . . . 0.0 110.394 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.22 32.51 1.05 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.89 174.58 6.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -1.13 . . . . 0.0 110.14 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.408 HG12 ' CD1' ' A' ' 44' ' ' TYR . 2.6 pt -138.62 147.54 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 110.362 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.9 mp -109.17 138.36 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.329 -0.857 . . . . 0.0 110.259 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.503 HD11 ' SG ' ' A' ' 3' ' ' CYS . 21.8 pt -134.24 143.94 49.17 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.317 -0.864 . . . . 0.0 110.203 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo . . . . . 0 C--N 1.306 -1.675 0 O-C-N 124.014 1.534 . . . . 0.0 110.435 -179.915 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.479 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 87.6 m . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 40' ' ' CYS . 43.1 Cg_endo -70.98 -166.23 0.22 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.88 1.463 . . . . 0.0 110.272 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.72 -1.94 43.03 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -108.64 -6.5 15.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -1.159 . . . . 0.0 110.218 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.551 ' CE1' ' HD3' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -143.59 36.46 1.32 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.217 -0.927 . . . . 0.0 110.155 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -99.51 88.23 3.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.288 -0.882 . . . . 0.0 110.297 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.25 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.491 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.282 0.563 . . . . 0.0 110.378 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.412 ' C ' ' SG ' ' A' ' 32' ' ' CYS . 77.4 m -144.85 113.42 6.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.39 -0.819 . . . . 0.0 109.644 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.514 ' O ' ' CB ' ' A' ' 46' ' ' ASN . 65.6 m -99.41 151.21 37.35 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.929 . . . . 0.0 110.513 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 44' ' ' TYR . 50.8 Cg_endo -76.72 -93.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.998 1.525 . . . . 0.0 110.503 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.67 137.5 58.28 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.595 -0.69 . . . . 0.0 110.598 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.471 ' O ' ' HB3' ' A' ' 10' ' ' ARG . 10.0 mt -54.39 -33.64 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.18 -0.95 . . . . 0.0 109.789 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.6 t -48.98 -53.08 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.13 -0.981 . . . . 0.0 109.581 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.11 -40.43 73.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.268 -0.895 . . . . 0.0 109.48 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.491 ' CZ ' ' OXT' ' A' ' 46' ' ' ASN . 0.6 OUTLIER -52.9 -57.02 11.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.41 -0.806 . . . . 0.0 109.932 179.581 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 14' ' ' ASN . 9.6 m -51.42 -40.86 60.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.255 -0.903 . . . . 0.0 109.921 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -64.25 -43.98 93.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.331 -0.856 . . . . 0.0 109.867 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.491 ' CZ ' HG21 ' A' ' 2' ' ' THR . 10.9 t80 -53.72 -26.79 24.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -0.855 . . . . 0.0 109.828 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 11' ' ' SER . 48.5 m-80 -74.83 -43.7 53.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.377 -0.827 . . . . 0.0 109.598 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.557 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -63.9 -49.17 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.406 -0.809 . . . . 0.0 109.41 179.594 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.557 ' N ' HG12 ' A' ' 15' ' ' VAL . 42.3 t -52.4 -41.81 63.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.362 -0.836 . . . . 0.0 110.222 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -80.93 -2.0 45.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.284 -0.885 . . . . 0.0 110.531 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.586 ' HB3' ' HD3' ' A' ' 19' ' ' PRO . 3.9 tp -51.75 -54.17 42.9 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.085 -1.009 . . . . 0.0 110.259 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.586 ' HD3' ' HB3' ' A' ' 18' ' ' LEU . 43.9 Cg_endo -69.6 -52.72 0.32 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.38 1.2 . . . . 0.0 110.396 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.19 39.43 0.05 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.65 HG21 HD22 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -87.37 152.0 51.79 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.19 -1.182 . . . . 0.0 109.768 179.769 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.62 ' HD2' HG22 ' A' ' 21' ' ' THR . 43.5 Cg_endo -70.93 155.21 62.5 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.823 1.433 . . . . 0.0 110.57 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 24' ' ' ALA . 1.5 mp0 -53.64 -49.67 67.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.316 -0.865 . . . . 0.0 110.511 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.456 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -42.33 -49.74 5.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.225 -0.922 . . . . 0.0 110.341 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.65 HD22 HG21 ' A' ' 21' ' ' THR . 0.2 OUTLIER -59.82 -42.6 93.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 110.506 -179.841 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.546 ' O ' HG23 ' A' ' 30' ' ' THR . 27.5 m -77.93 -50.12 12.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.163 -0.961 . . . . 0.0 110.472 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.51 -20.23 64.41 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.239 -0.913 . . . . 0.0 110.366 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 46.3 m -88.04 -26.27 22.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.894 . . . . 0.0 110.378 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -101.77 -10.49 19.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.152 -0.968 . . . . 0.0 110.399 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.546 HG23 ' O ' ' A' ' 26' ' ' CYS . 76.4 p -103.66 -27.16 12.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 110.274 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.48 28.97 5.82 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.412 ' SG ' ' C ' ' A' ' 3' ' ' CYS . 1.6 t -99.73 -178.17 3.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.349 -1.089 . . . . 0.0 110.306 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.7 pt -139.43 148.79 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.879 . . . . 0.0 110.23 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.4 mt -112.25 133.97 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 109.976 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.3 pt -119.38 154.14 53.96 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 110.119 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 C--N 1.304 -1.796 0 O-C-N 124.145 1.603 . . . . 0.0 110.645 -179.736 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 2' ' ' THR . 23.4 m . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.979 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 43.1 Cg_endo -70.35 -178.25 2.47 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.984 1.518 . . . . 0.0 110.552 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.21 -8.56 57.64 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -114.97 -29.17 6.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -1.156 . . . . 0.0 110.04 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 5' ' ' PRO . 0.5 OUTLIER -107.47 9.36 29.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 110.151 179.889 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.979 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -72.75 90.9 1.44 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.352 -0.842 . . . . 0.0 110.271 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.514 ' CB ' ' O ' ' A' ' 4' ' ' CYS . 1.6 m-20 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.156 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.436 HG22 ' SG ' ' A' ' 32' ' ' CYS . 1.1 m . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.14 0.495 . . . . 0.0 109.986 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.412 ' C ' ' SG ' ' A' ' 32' ' ' CYS . 0.5 OUTLIER -139.69 91.99 2.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.21 -0.931 . . . . 0.0 110.297 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.478 ' N ' ' SG ' ' A' ' 32' ' ' CYS . 25.7 m -96.5 165.64 15.72 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.28 -0.887 . . . . 0.0 110.09 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 46' ' ' ASN . 49.3 Cg_endo -78.59 -92.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.31 1.689 . . . . 0.0 110.442 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 7' ' ' ILE . 1.4 t -75.55 143.29 42.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.499 -0.75 . . . . 0.0 109.932 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.401 ' C ' ' O ' ' A' ' 6' ' ' SER . 11.8 mt -42.76 -52.91 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.188 -0.945 . . . . 0.0 110.198 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.7 t -43.09 -54.03 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 109.985 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.64 -40.4 19.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.306 -0.871 . . . . 0.0 109.962 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -63.78 -49.87 71.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.327 -0.858 . . . . 0.0 110.077 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.61 -50.53 65.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.875 . . . . 0.0 110.021 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.444 ' O ' HG12 ' A' ' 15' ' ' VAL . 38.5 m-80 -51.3 -40.02 58.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.883 . . . . 0.0 110.07 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.58 ' CZ ' ' HB2' ' A' ' 23' ' ' GLU . 71.7 t80 -60.15 -54.04 50.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.921 . . . . 0.0 110.043 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -62.91 -24.89 68.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.295 -0.878 . . . . 0.0 109.19 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.601 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -78.59 -50.72 18.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.404 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.601 ' N ' HG12 ' A' ' 15' ' ' VAL . 46.3 t -51.64 -20.97 2.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.412 -0.805 . . . . 0.0 110.118 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.407 ' HD2' ' HB3' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -89.45 10.12 23.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.211 -0.931 . . . . 0.0 110.167 179.829 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.62 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 2.3 tp -83.44 -42.0 0.81 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.199 -0.938 . . . . 0.0 111.575 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 46.1 Cg_endo -73.9 -94.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.331 1.174 . . . . 0.0 111.0 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -160.82 33.46 0.4 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.495 HG22 ' HD2' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -107.13 141.58 23.22 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.229 -1.159 . . . . 0.0 110.087 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.495 ' HD2' HG22 ' A' ' 21' ' ' THR . 44.9 Cg_endo -70.96 136.25 29.38 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.984 1.518 . . . . 0.0 110.313 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.58 ' HB2' ' CZ ' ' A' ' 13' ' ' PHE . 5.7 pt-20 -42.35 -32.23 0.49 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.24 -0.913 . . . . 0.0 110.205 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.43 -59.54 3.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.171 -0.956 . . . . 0.0 109.945 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.502 ' O ' HD23 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -61.96 -28.52 69.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.183 -0.948 . . . . 0.0 109.938 179.806 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.471 ' O ' HG23 ' A' ' 30' ' ' THR . 58.6 m -73.62 -50.88 18.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 110.381 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.63 -43.12 79.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 0.0 110.348 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.8 m -64.69 -28.67 69.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.221 -0.924 . . . . 0.0 110.511 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -97.91 -34.0 11.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.105 -0.997 . . . . 0.0 110.565 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.471 HG23 ' O ' ' A' ' 26' ' ' CYS . 63.9 p -77.62 -8.13 57.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.198 -0.939 . . . . 0.0 110.161 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.464 ' O ' ' HD3' ' A' ' 5' ' ' PRO . . . 70.95 42.71 59.36 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.478 ' SG ' ' N ' ' A' ' 4' ' ' CYS . 14.3 t -127.26 170.15 12.75 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.103 -1.233 . . . . 0.0 110.081 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.575 HD12 HG23 ' A' ' 35' ' ' ILE . 1.1 pt -140.32 156.98 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.099 -1.0 . . . . 0.0 110.439 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.3 mt -110.84 127.31 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.342 -0.849 . . . . 0.0 110.092 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.575 HG23 HD12 ' A' ' 33' ' ' ILE . 2.0 pt -119.25 140.9 29.63 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.155 -0.966 . . . . 0.0 110.586 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 C--N 1.307 -1.642 0 O-C-N 124.109 1.584 . . . . 0.0 110.516 179.929 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.47 ' SG ' ' HD2' ' A' ' 41' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 120.711 0.291 . . . . 0.0 110.279 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.47 ' HD2' ' SG ' ' A' ' 40' ' ' CYS . 47.7 Cg_endo -74.08 166.68 29.01 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.979 1.515 . . . . 0.0 110.276 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.98 -22.75 75.98 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -61.67 -34.18 75.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.235 -1.156 . . . . 0.0 110.208 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -136.38 66.13 1.5 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 110.173 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.477 ' O ' ' CB ' ' A' ' 46' ' ' ASN . . . -121.87 86.71 2.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.097 -1.002 . . . . 0.0 110.648 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.553 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 1.5 m-20 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.084 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.435 HG22 ' SG ' ' A' ' 32' ' ' CYS . 1.3 m . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.243 0.544 . . . . 0.0 110.231 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 59.4 m -128.31 113.78 16.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.885 . . . . 0.0 110.182 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -105.88 169.01 7.44 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 0.0 110.28 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.537 ' HD2' ' HB1' ' A' ' 9' ' ' ALA . 48.4 Cg_endo -72.77 -94.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.973 1.512 . . . . 0.0 110.986 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.6 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 30.6 t -78.89 156.7 28.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.463 -0.773 . . . . 0.0 110.699 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.9 mt -49.29 -54.48 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -0.874 . . . . 0.0 109.836 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.5 t -46.7 -42.87 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.893 . . . . 0.0 109.492 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.6 ' HB3' ' O ' ' A' ' 6' ' ' SER . . . -50.44 -40.62 51.01 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.312 -0.868 . . . . 0.0 109.413 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.471 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 0.8 OUTLIER -70.69 -43.99 67.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.436 -0.79 . . . . 0.0 109.67 179.518 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.9 t -48.99 -63.15 1.18 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 109.735 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -47.1 -47.01 23.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.783 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.471 ' HB3' ' O ' ' A' ' 10' ' ' ARG . 11.2 t80 -54.41 -38.29 66.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.387 -0.821 . . . . 0.0 109.769 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -70.66 -30.09 66.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 108.999 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -65.22 -44.3 95.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.523 0.678 . . . . 0.0 109.24 179.242 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.482 ' N ' HG12 ' A' ' 15' ' ' VAL . 37.9 t -65.45 -26.16 67.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.465 -0.772 . . . . 0.0 110.435 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -75.61 -33.17 60.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.468 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.55 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -50.51 -52.51 54.81 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.16 -0.963 . . . . 0.0 110.541 -179.775 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 47.6 Cg_endo -71.65 -156.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.413 1.217 . . . . 0.0 110.299 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.93 59.22 0.42 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.494 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 6.7 m -113.24 144.26 30.85 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.354 -1.086 . . . . 0.0 110.08 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.494 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 45.6 Cg_endo -71.98 151.4 56.19 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 124.038 1.547 . . . . 0.0 110.382 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -53.69 -32.88 53.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.301 -0.874 . . . . 0.0 110.154 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.456 ' O ' ' HB ' ' A' ' 28' ' ' THR . . . -57.93 -50.65 72.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.323 -0.861 . . . . 0.0 110.542 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.474 ' HB3' ' CG2' ' A' ' 21' ' ' THR . 0.1 OUTLIER -65.69 -26.88 67.97 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.074 -1.016 . . . . 0.0 110.358 -179.65 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 19.0 m -81.64 -49.13 10.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.235 -0.916 . . . . 0.0 110.412 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -72.2 -50.14 29.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.148 -0.97 . . . . 0.0 110.622 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.456 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 80.4 m -59.62 -44.97 93.25 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.23 -0.919 . . . . 0.0 110.85 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -67.37 -15.62 63.79 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.104 -0.997 . . . . 0.0 110.637 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.3 p -110.98 -22.16 11.64 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.114 -0.991 . . . . 0.0 110.512 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 98.89 23.21 11.96 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.435 ' SG ' HG22 ' A' ' 2' ' ' THR . 0.1 OUTLIER -84.44 175.01 9.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.329 -1.101 . . . . 0.0 109.922 179.837 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.502 ' CD1' HG23 ' A' ' 35' ' ' ILE . 2.3 pp -138.93 152.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.134 -0.979 . . . . 0.0 110.484 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.3 mt -115.19 124.46 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.39 -0.819 . . . . 0.0 110.363 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.502 HG23 ' CD1' ' A' ' 33' ' ' ILE . 11.8 pt -110.89 148.01 37.71 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.18 -0.95 . . . . 0.0 110.207 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 C--N 1.305 -1.719 0 O-C-N 123.951 1.501 . . . . 0.0 110.627 -179.876 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.455 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.454 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 45.2 Cg_endo -72.42 162.99 39.94 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.918 1.483 . . . . 0.0 110.462 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.29 11.61 57.61 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -99.79 -21.69 15.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -1.148 . . . . 0.0 110.185 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.479 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 1.7 t80 -150.08 48.08 0.92 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.24 -0.912 . . . . 0.0 110.092 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.455 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . . . -121.83 101.45 7.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.324 -0.86 . . . . 0.0 110.275 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.068 179.891 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.842 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.216 -0.693 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.831 HG21 ' CE2' ' A' ' 13' ' ' PHE . 50.8 m -136.69 149.77 48.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 110.409 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 32.7 m -134.5 124.95 26.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.316 -0.865 . . . . 0.0 109.897 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.11 146.82 49.98 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.08 -1.013 . . . . 0.0 110.519 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.574 ' HD3' ' CE1' ' A' ' 44' ' ' TYR . 50.3 Cg_endo -75.83 -94.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.091 1.574 . . . . 0.0 110.547 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.477 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 7.1 t -48.25 123.24 6.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.5 -0.75 . . . . 0.0 110.363 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.407 ' O ' ' C ' ' A' ' 8' ' ' VAL . 2.5 mp -47.71 -54.83 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 110.108 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.407 ' C ' ' O ' ' A' ' 7' ' ' ILE . 21.6 t -44.34 -45.93 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 109.847 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 6' ' ' SER . . . -50.74 -42.87 57.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.2 -0.938 . . . . 0.0 109.721 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.406 ' O ' ' C ' ' A' ' 11' ' ' SER . 0.1 OUTLIER -68.77 -48.32 63.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 0.0 109.994 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -43.71 -42.12 5.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.89 . . . . 0.0 109.824 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 -75.3 -36.08 61.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.898 . . . . 0.0 109.853 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.831 ' CE2' HG21 ' A' ' 2' ' ' THR . 27.1 t80 -62.32 -33.26 74.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.331 -0.856 . . . . 0.0 109.923 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.73 -26.74 37.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.298 -0.876 . . . . 0.0 109.021 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 16' ' ' CYS . 1.2 t -82.49 -42.66 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.661 -0.649 . . . . 0.0 109.249 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.472 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 30.7 t -66.74 -24.34 66.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.314 -0.867 . . . . 0.0 109.767 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.447 ' HG3' ' O ' ' A' ' 17' ' ' ARG . 0.7 OUTLIER -88.07 -12.48 44.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.322 -0.861 . . . . 0.0 109.785 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.578 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -54.97 -46.88 99.55 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.393 -0.817 . . . . 0.0 110.254 179.672 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 18' ' ' LEU . 49.7 Cg_endo -80.11 -157.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.927 1.488 . . . . 0.0 110.148 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.92 72.65 1.85 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.509 HG22 ' HB3' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -130.93 134.1 25.57 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.272 -1.134 . . . . 0.0 110.153 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.46 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 44.5 Cg_endo -72.98 139.16 29.56 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.95 1.5 . . . . 0.0 110.576 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -44.35 -31.64 1.1 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.406 -0.809 . . . . 0.0 110.412 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.89 -41.78 99.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.192 -0.943 . . . . 0.0 110.342 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.509 ' HB3' HG22 ' A' ' 21' ' ' THR . 0.1 OUTLIER -66.81 -37.16 83.98 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.313 -0.867 . . . . 0.0 110.259 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.604 ' O ' HG23 ' A' ' 30' ' ' THR . 47.3 m -85.8 -45.89 11.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.278 -0.889 . . . . 0.0 110.185 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -45.3 -36.05 3.85 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.203 -0.936 . . . . 0.0 109.888 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.0 m -79.09 -49.46 12.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.922 . . . . 0.0 109.912 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -64.54 -26.61 68.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.358 -0.839 . . . . 0.0 109.926 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.74 HG21 ' HA ' ' A' ' 13' ' ' PHE . 26.5 p -96.53 -51.36 4.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.324 -0.86 . . . . 0.0 110.218 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.42 22.08 3.2 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.414 ' HB3' ' CG2' ' A' ' 2' ' ' THR . 27.2 m -97.56 168.12 10.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.247 -1.149 . . . . 0.0 110.225 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.0 pt -121.04 155.71 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.212 -0.93 . . . . 0.0 110.273 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.9 mt -104.4 125.63 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.209 -0.932 . . . . 0.0 110.219 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.45 ' O ' HG13 ' A' ' 35' ' ' ILE . 3.9 pt -128.17 136.91 29.76 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.336 -0.853 . . . . 0.0 110.016 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.8 -12.77 24.28 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.029 1.541 . . . . 0.0 110.795 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.591 ' O ' ' HB3' ' A' ' 38' ' ' ALA . . . 173.34 -154.38 20.14 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.695 ' O ' HG22 ' A' ' 39' ' ' THR . . . 62.99 28.18 16.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.3 -1.118 . . . . 0.0 110.184 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.695 HG22 ' O ' ' A' ' 38' ' ' ALA . 9.0 t 38.91 -159.62 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.554 -0.716 . . . . 0.0 110.636 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.473 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 86.8 m -96.53 165.36 16.26 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.31 -0.868 . . . . 0.0 109.96 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.548 ' HG2' ' CB ' ' A' ' 44' ' ' TYR . 43.1 Cg_endo -68.8 -161.4 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.917 1.482 . . . . 0.0 110.315 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.82 -3.83 34.23 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.73 -5.07 6.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.192 -1.181 . . . . 0.0 110.224 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.574 ' CE1' ' HD3' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -120.9 18.8 11.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.359 -0.838 . . . . 0.0 110.039 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.64 93.6 8.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.284 -0.885 . . . . 0.0 110.161 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.502 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.258 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.851 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.728 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.826 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 2.2 m -130.21 154.82 47.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.0 110.018 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.5 m -151.5 130.31 12.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.196 -0.94 . . . . 0.0 110.276 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.738 ' SG ' ' HB1' ' A' ' 9' ' ' ALA . 0.5 OUTLIER -131.05 148.76 71.55 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.314 -0.866 . . . . 0.0 110.112 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.546 ' HG3' ' CE1' ' A' ' 44' ' ' TYR . 50.0 Cg_endo -84.3 -91.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.103 1.58 . . . . 0.0 110.894 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.512 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 3.8 t -39.05 127.66 1.65 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.505 0.669 . . . . 0.0 110.992 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.3 mt -49.92 -54.44 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.266 -0.897 . . . . 0.0 109.627 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.421 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 50.0 t -45.69 -48.88 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.324 -0.86 . . . . 0.0 109.701 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.738 ' HB1' ' SG ' ' A' ' 4' ' ' CYS . . . -45.79 -39.57 8.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.261 -0.899 . . . . 0.0 109.646 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -67.57 -44.37 78.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.234 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.403 ' O ' ' C ' ' A' ' 12' ' ' ASN . 10.2 t -57.12 -77.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.214 -0.929 . . . . 0.0 110.182 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.492 ' OD1' ' N ' ' A' ' 13' ' ' PHE . 10.2 p30 -44.52 -35.8 2.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.177 -0.952 . . . . 0.0 110.053 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.934 ' HA ' HG21 ' A' ' 30' ' ' THR . 19.5 t80 -64.99 -56.04 15.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.919 . . . . 0.0 110.096 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -62.62 -43.72 98.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.207 -0.933 . . . . 0.0 109.26 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -61.6 -45.58 98.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.539 -0.726 . . . . 0.0 109.246 179.156 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.505 ' N ' HG12 ' A' ' 15' ' ' VAL . 34.8 t -50.87 -29.99 13.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.572 -0.705 . . . . 0.0 110.304 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -85.23 -4.12 59.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.203 -0.935 . . . . 0.0 110.328 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.596 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 3.7 tt -69.88 -46.28 23.66 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.959 . . . . 0.0 110.633 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 47.8 Cg_endo -74.27 -155.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.382 0 O-C-N 123.289 1.152 . . . . 0.0 109.998 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.39 27.47 7.71 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.458 ' OG1' ' HG2' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -93.56 137.32 23.38 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.146 -1.208 . . . . 0.0 110.029 179.759 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.446 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 48.3 Cg_endo -75.42 166.78 28.01 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.988 1.52 . . . . 0.0 110.658 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 24' ' ' ALA . 4.1 tt0 -65.39 -50.34 65.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.329 -0.857 . . . . 0.0 110.228 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 23' ' ' GLU . . . -43.56 -51.66 6.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 0.0 110.382 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.447 HD13 ' CG2' ' A' ' 21' ' ' THR . 0.9 OUTLIER -57.22 -37.71 72.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 110.35 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 28' ' ' THR . 39.5 m -74.96 -63.04 1.35 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.887 . . . . 0.0 110.527 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 26' ' ' CYS . . . -41.91 -26.87 0.1 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.908 . . . . 0.0 110.441 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.439 ' N ' ' O ' ' A' ' 26' ' ' CYS . 20.2 m -90.08 -49.0 6.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.144 -0.973 . . . . 0.0 110.43 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -68.42 -27.09 65.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.186 -0.946 . . . . 0.0 110.268 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.934 HG21 ' HA ' ' A' ' 13' ' ' PHE . 26.4 p -87.03 -48.44 8.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.192 -0.942 . . . . 0.0 110.245 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.21 14.04 5.14 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.412 ' C ' HG23 ' A' ' 33' ' ' ILE . 56.8 m -86.7 -166.91 1.7 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.182 -1.187 . . . . 0.0 109.961 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.412 HG23 ' C ' ' A' ' 32' ' ' CYS . 11.4 pt -149.2 150.57 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.072 -1.017 . . . . 0.0 110.612 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.0 mt -100.53 138.38 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.347 -0.846 . . . . 0.0 109.981 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 27.1 pt -125.12 143.73 45.13 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.16 -0.962 . . . . 0.0 110.365 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.27 -16.5 24.9 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.015 1.534 . . . . 0.0 110.265 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -78.83 177.05 54.31 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -114.87 15.69 17.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.163 -1.198 . . . . 0.0 110.288 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.0 t -136.03 155.23 50.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 110.092 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 44' ' ' TYR . 5.4 t -107.72 135.31 19.8 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.271 -0.893 . . . . 0.0 110.086 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.08 -174.43 1.94 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.957 1.504 . . . . 0.0 110.706 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.6 -29.06 12.62 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -60.06 -26.0 65.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.281 -1.129 . . . . 0.0 110.184 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.546 ' CE1' ' HG3' ' A' ' 5' ' ' PRO . 0.8 OUTLIER -144.91 77.42 1.53 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.328 -0.857 . . . . 0.0 109.934 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.418 ' O ' ' ND2' ' A' ' 46' ' ' ASN . . . -120.2 90.87 3.41 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.229 -0.919 . . . . 0.0 110.781 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.529 ' CB ' ' O ' ' A' ' 4' ' ' CYS . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 117.925 -1.036 . . . . 0.0 110.125 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.827 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.213 -0.832 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . 1.057 HG21 ' CE1' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -89.88 140.37 29.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.03 -1.044 . . . . 0.0 109.979 . . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.479 ' O ' ' CG1' ' A' ' 33' ' ' ILE . 5.1 m -132.44 108.48 9.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.192 -0.943 . . . . 0.0 109.905 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.411 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 13.2 m -109.32 162.99 18.08 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.413 -0.804 . . . . 0.0 110.021 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 47.7 Cg_endo -73.22 -95.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.903 1.475 . . . . 0.0 110.534 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.6 t -68.78 139.44 55.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.39 -0.819 . . . . 0.0 110.266 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.4 mt -46.42 -41.72 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.174 -0.954 . . . . 0.0 109.769 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.509 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 44.1 t -49.14 -57.45 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.464 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 8' ' ' VAL . . . -44.76 -37.03 3.5 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.366 -0.834 . . . . 0.0 109.443 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.448 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -75.5 -41.06 56.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.386 -0.822 . . . . 0.0 109.864 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.2 t -48.73 -72.31 0.05 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.0 109.919 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 8' ' ' VAL . 2.2 p30 -48.74 -42.96 37.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.358 -0.839 . . . . 0.0 109.955 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 1.057 ' CE1' HG21 ' A' ' 2' ' ' THR . 53.4 t80 -51.79 -47.93 64.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.244 -0.91 . . . . 0.0 110.182 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 10' ' ' ARG . 11.2 m120 -60.81 -27.21 67.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.139 -0.976 . . . . 0.0 109.433 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.575 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -78.93 -49.58 19.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 121.587 0.708 . . . . 0.0 109.453 179.704 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.575 ' N ' HG12 ' A' ' 15' ' ' VAL . 14.2 t -55.33 -16.41 3.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.564 -0.71 . . . . 0.0 110.741 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.521 ' HD2' ' HG3' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -88.42 -3.13 58.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.191 -0.943 . . . . 0.0 110.721 -179.671 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.607 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.5 tt -76.4 -41.62 3.04 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.131 -0.981 . . . . 0.0 111.031 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 47.1 Cg_endo -76.16 -156.19 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.35 1.184 . . . . 0.0 110.042 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.56 27.2 19.82 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.449 ' CG2' ' SG ' ' A' ' 26' ' ' CYS . 29.8 m -90.41 133.19 33.49 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.057 -1.261 . . . . 0.0 109.928 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.493 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 44.2 Cg_endo -72.22 141.8 36.52 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.948 1.499 . . . . 0.0 110.594 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.521 ' HG3' ' HD2' ' A' ' 17' ' ' ARG . 7.2 mt-10 -43.31 -52.13 5.94 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.317 -0.864 . . . . 0.0 110.548 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 23' ' ' GLU . . . -41.98 -62.03 1.01 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 0.0 110.541 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.493 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -53.73 -36.91 62.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.286 -0.884 . . . . 0.0 110.562 -179.618 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.449 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 91.2 m -76.68 -34.86 58.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.166 -0.959 . . . . 0.0 110.235 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.85 -16.6 63.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.173 -0.954 . . . . 0.0 110.326 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 45.6 m -91.01 -47.9 7.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.191 -0.943 . . . . 0.0 110.362 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -63.89 -23.22 67.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.198 -0.939 . . . . 0.0 110.226 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 37.0 p -101.19 -48.35 4.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 110.205 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.84 69.59 0.62 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 48.8 t -140.46 163.87 31.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.214 -1.168 . . . . 0.0 110.128 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.479 ' CG1' ' O ' ' A' ' 3' ' ' CYS . 5.8 pt -112.4 147.13 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.083 -1.011 . . . . 0.0 110.334 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.0 mt -119.12 145.73 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.328 -0.857 . . . . 0.0 109.968 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.492 HG12 ' O ' ' A' ' 1' ' ' THR . 15.5 pt -127.15 153.61 76.75 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 0.0 110.463 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.91 -7.91 20.58 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.02 1.537 . . . . 0.0 110.014 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.64 -145.9 16.43 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.1 18.98 1.76 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -1.183 . . . . 0.0 110.478 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.422 ' O ' ' CD1' ' A' ' 35' ' ' ILE . 6.5 t -141.57 145.91 35.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.133 -0.98 . . . . 0.0 110.556 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 70.9 m -103.49 156.7 35.15 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.337 -0.852 . . . . 0.0 109.925 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.05 139.3 32.54 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.952 1.501 . . . . 0.0 110.28 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.17 -18.01 12.1 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -93.71 7.97 42.77 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.142 -1.21 . . . . 0.0 110.357 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.401 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 0.3 OUTLIER -166.85 52.81 0.08 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.211 -0.931 . . . . 0.0 110.2 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -124.75 87.72 2.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.334 -0.854 . . . . 0.0 110.107 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.055 -179.98 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.838 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.734 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.7 m -121.65 142.89 49.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 110.329 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.495 ' O ' HG12 ' A' ' 33' ' ' ILE . 19.7 m -134.06 121.07 21.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.896 . . . . 0.0 110.252 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.484 ' HB2' ' OXT' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -116.75 165.43 15.28 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.327 -0.858 . . . . 0.0 110.083 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 49.3 Cg_endo -75.36 -94.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.116 1.588 . . . . 0.0 111.265 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.4 t -92.62 168.5 11.19 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.699 0.761 . . . . 0.0 111.28 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.422 ' O ' ' C ' ' A' ' 8' ' ' VAL . 3.0 mt -51.67 -51.17 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.487 -0.758 . . . . 0.0 110.302 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.422 ' C ' ' O ' ' A' ' 7' ' ' ILE . 51.6 t -40.88 -53.26 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.383 -0.823 . . . . 0.0 110.139 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.451 ' O ' ' OD1' ' A' ' 12' ' ' ASN . . . -50.3 -40.8 49.65 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.292 -0.88 . . . . 0.0 109.557 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 46' ' ' ASN . 6.0 ttm180 -66.17 -37.61 86.05 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.268 -0.895 . . . . 0.0 110.276 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.4 t -60.67 -78.13 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.243 -0.911 . . . . 0.0 110.343 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 13' ' ' PHE . 12.1 p30 -45.91 -33.71 3.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.296 -0.878 . . . . 0.0 110.379 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.527 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 24.7 t80 -64.54 -48.15 76.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.394 -0.816 . . . . 0.0 110.4 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -65.13 -55.07 20.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -0.953 . . . . 0.0 110.063 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.624 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -49.77 -53.15 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.367 -0.833 . . . . 0.0 109.658 179.699 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.624 ' N ' HG12 ' A' ' 15' ' ' VAL . 42.2 t -49.51 -31.47 10.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -0.848 . . . . 0.0 110.297 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.93 -17.59 50.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.148 -0.97 . . . . 0.0 110.058 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.601 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.6 tp -56.21 -49.91 90.56 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.287 -0.883 . . . . 0.0 110.983 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 45.1 Cg_endo -71.51 -155.36 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.551 1.29 . . . . 0.0 110.282 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.08 61.86 1.07 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.0 m -129.84 132.55 24.23 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.279 -1.13 . . . . 0.0 109.893 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.8 148.76 59.06 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.993 1.523 . . . . 0.0 110.739 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.478 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 15.9 pt-20 -53.53 -19.91 4.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.366 -0.834 . . . . 0.0 110.342 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.56 -48.55 76.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.226 -0.921 . . . . 0.0 110.22 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.09 -26.92 60.64 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.281 -0.887 . . . . 0.0 110.359 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 72.9 m -88.86 -29.26 19.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -0.918 . . . . 0.0 110.445 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.478 ' CB ' ' O ' ' A' ' 23' ' ' GLU . . . -74.42 -24.61 59.12 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.271 -0.893 . . . . 0.0 110.209 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.4 m -87.56 -50.34 6.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 110.258 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.06 -23.78 21.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.946 . . . . 0.0 110.124 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 67.5 p -98.27 -39.23 8.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 110.174 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.37 16.19 10.58 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -77.23 175.86 9.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -1.162 . . . . 0.0 110.01 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 3' ' ' CYS . 15.0 pt -136.43 163.51 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.174 -0.954 . . . . 0.0 110.294 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 58.0 mt -132.6 141.61 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.884 . . . . 0.0 110.253 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.65 HD12 ' O ' ' A' ' 37' ' ' GLY . 8.9 pt -145.41 127.18 7.79 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 110.265 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.13 57.47 3.33 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.834 1.439 . . . . 0.0 110.089 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.65 ' O ' HD12 ' A' ' 35' ' ' ILE . . . 119.27 -151.9 17.41 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 37' ' ' GLY . . . 61.1 103.03 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.156 -1.203 . . . . 0.0 109.904 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.433 ' C ' ' O ' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -40.98 149.26 0.09 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.415 -0.803 . . . . 0.0 110.418 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.462 ' SG ' ' HD2' ' A' ' 41' ' ' PRO . 7.7 t -88.18 140.19 30.58 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.338 -0.851 . . . . 0.0 110.266 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.462 ' HD2' ' SG ' ' A' ' 40' ' ' CYS . 44.7 Cg_endo -70.92 151.21 62.25 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.967 1.509 . . . . 0.0 110.467 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.05 -8.79 62.15 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.439 ' OD2' ' HB2' ' A' ' 41' ' ' PRO . 56.8 p30 -89.88 -1.51 58.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -1.173 . . . . 0.0 110.044 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.93 48.45 0.79 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.361 -0.837 . . . . 0.0 110.088 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.556 ' O ' ' ND2' ' A' ' 46' ' ' ASN . . . -114.57 87.78 2.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 0.0 110.099 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.556 ' ND2' ' O ' ' A' ' 45' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.103 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.851 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.777 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.692 HG21 ' CE2' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -111.7 163.38 14.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.181 -0.95 . . . . 0.0 110.295 . . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.3 m -154.56 128.27 8.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.856 . . . . 0.0 109.937 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.42 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 61.1 m -115.29 163.28 20.69 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.23 -0.919 . . . . 0.0 110.328 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 49.4 Cg_endo -75.75 -94.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.021 1.537 . . . . 0.0 110.764 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.17 148.61 51.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.56 -0.713 . . . . 0.0 110.586 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.7 mt -60.0 -45.95 94.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.331 -0.856 . . . . 0.0 110.095 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.8 t -49.36 -43.73 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.185 -0.947 . . . . 0.0 109.786 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.02 -37.99 81.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 110.006 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.476 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 5.6 ttm180 -61.24 -55.66 29.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.23 -0.919 . . . . 0.0 110.106 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -45.52 -60.06 2.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.293 -0.88 . . . . 0.0 110.001 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -52.21 -22.93 4.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.334 -0.854 . . . . 0.0 110.114 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.692 ' CE2' HG21 ' A' ' 2' ' ' THR . 17.9 t80 -75.83 -29.97 58.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 110.37 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -74.24 -31.17 62.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 109.363 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.9 OUTLIER -69.3 -41.15 80.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.593 -0.692 . . . . 0.0 109.501 179.627 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.464 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 49.5 t -68.64 -32.14 71.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.555 -0.716 . . . . 0.0 110.998 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -84.77 -0.31 53.32 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.053 -1.029 . . . . 0.0 110.722 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.579 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -70.85 -48.9 14.57 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.086 -1.009 . . . . 0.0 110.208 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 48.2 Cg_endo -74.15 -155.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.584 1.308 . . . . 0.0 110.09 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.11 53.48 2.19 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.4 m -113.35 135.11 21.82 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.194 -1.18 . . . . 0.0 110.248 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.476 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 45.7 Cg_endo -73.64 158.56 47.15 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.876 1.461 . . . . 0.0 110.509 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.8 -35.86 77.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.303 -0.873 . . . . 0.0 110.327 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.34 -43.55 88.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.35 -0.844 . . . . 0.0 110.619 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.476 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -66.69 -34.42 77.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.109 -0.994 . . . . 0.0 110.285 -179.745 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 65.6 m -81.48 -47.93 12.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.193 -0.942 . . . . 0.0 110.066 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.93 -28.22 6.41 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.197 -0.939 . . . . 0.0 110.111 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.1 m -85.77 -37.8 18.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 110.251 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.84 -19.86 60.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.193 -0.942 . . . . 0.0 110.209 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.0 p -112.35 -58.94 2.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -0.914 . . . . 0.0 110.266 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.91 34.98 0.46 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 64.0 m -101.3 162.93 12.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.315 -1.109 . . . . 0.0 110.09 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.408 ' O ' HG13 ' A' ' 33' ' ' ILE . 1.1 pp -122.99 149.55 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.218 -0.926 . . . . 0.0 110.176 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.9 mt -115.14 134.68 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.153 -0.967 . . . . 0.0 110.225 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 37' ' ' GLY . 41.4 pt -119.39 151.68 51.67 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 110.175 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.07 -16.83 25.31 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.009 1.531 . . . . 0.0 110.487 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.442 ' O ' HG13 ' A' ' 35' ' ' ILE . . . -98.52 173.92 27.71 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.7 -22.07 15.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.233 -1.157 . . . . 0.0 110.405 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.6 t -79.62 151.88 30.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.173 -0.955 . . . . 0.0 110.44 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -138.45 145.85 48.55 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.334 -0.854 . . . . 0.0 110.016 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.89 131.85 18.99 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.997 1.525 . . . . 0.0 110.61 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -48.31 -35.37 14.66 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.61 -47.12 58.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.206 -1.173 . . . . 0.0 110.049 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.92 62.48 0.68 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.333 -0.854 . . . . 0.0 110.054 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.432 ' O ' ' CG ' ' A' ' 46' ' ' ASN . . . -130.19 88.01 2.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 110.253 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.432 ' CG ' ' O ' ' A' ' 45' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.146 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.852 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.729 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.64 150.75 45.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.151 -0.968 . . . . 0.0 110.253 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.7 m -147.78 107.19 3.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.357 -0.84 . . . . 0.0 110.198 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.518 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 24.9 m -99.96 166.25 13.09 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.253 -0.904 . . . . 0.0 110.412 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.542 ' HG2' ' CB ' ' A' ' 9' ' ' ALA . 40.0 Cg_endo -71.41 -153.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 124.034 1.544 . . . . 0.0 110.353 179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.492 ' C ' ' O ' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -31.0 150.24 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.51 0.671 . . . . 0.0 111.548 -179.286 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.439 ' O ' ' C ' ' A' ' 8' ' ' VAL . 2.3 mt -48.44 -54.54 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.426 -0.796 . . . . 0.0 110.639 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.439 ' C ' ' O ' ' A' ' 7' ' ' ILE . 77.0 t -40.87 -55.29 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.437 -0.79 . . . . 0.0 110.322 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.542 ' CB ' ' HG2' ' A' ' 5' ' ' PRO . . . -53.22 -41.52 65.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.899 . . . . 0.0 109.961 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.485 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -67.39 -49.75 62.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.892 . . . . 0.0 109.951 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 p -47.66 -38.0 13.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -0.934 . . . . 0.0 109.969 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 13' ' ' PHE . 10.9 m-80 -70.72 -42.61 70.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.922 . . . . 0.0 110.007 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.485 ' HB3' ' O ' ' A' ' 10' ' ' ARG . 9.6 t80 -44.14 -46.43 8.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 0.0 109.764 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -69.55 -50.03 48.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.321 -0.862 . . . . 0.0 109.225 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.489 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.7 OUTLIER -51.64 -45.35 36.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.512 -0.742 . . . . 0.0 109.094 179.2 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.489 ' N ' HG12 ' A' ' 15' ' ' VAL . 40.0 t -66.4 -23.47 66.32 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.453 -0.779 . . . . 0.0 109.853 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.492 ' NH2' ' OE2' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -85.21 1.65 47.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 110.241 -179.819 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.568 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -60.87 -50.26 85.74 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.047 -1.033 . . . . 0.0 110.223 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 49.8 Cg_endo -73.65 -154.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.495 1.261 . . . . 0.0 109.621 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.9 64.01 0.88 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.556 HG23 HD22 ' A' ' 25' ' ' LEU . 18.6 m -115.12 140.28 25.45 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.242 -1.152 . . . . 0.0 110.453 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.61 ' HG2' HD13 ' A' ' 25' ' ' LEU . 47.8 Cg_endo -76.09 157.86 38.08 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.1 1.579 . . . . 0.0 110.279 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.492 ' OE2' ' NH2' ' A' ' 17' ' ' ARG . 1.2 mt-10 -58.3 -54.59 45.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.197 -0.94 . . . . 0.0 110.27 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 23' ' ' GLU . . . -42.06 -32.34 0.45 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.284 -0.885 . . . . 0.0 110.644 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.61 HD13 ' HG2' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -76.94 -52.14 9.93 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.195 -0.941 . . . . 0.0 110.735 -179.502 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 73.0 m -76.82 -28.5 55.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.112 -0.992 . . . . 0.0 110.156 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.73 -48.2 80.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -0.891 . . . . 0.0 109.879 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 93.8 m -66.55 -43.09 86.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.312 -0.867 . . . . 0.0 109.657 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -54.92 -26.64 37.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.361 -0.837 . . . . 0.0 109.909 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.3 p -105.27 -11.98 16.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.33 -0.856 . . . . 0.0 110.082 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.88 14.47 60.89 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 7.5 t -78.57 167.94 20.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.155 -1.203 . . . . 0.0 110.167 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.2 pt -136.24 159.16 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.234 -0.916 . . . . 0.0 110.234 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.2 mt -124.51 122.95 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.857 . . . . 0.0 110.498 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 35' ' ' ILE . 23.1 pt -126.08 142.99 44.13 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.297 -0.877 . . . . 0.0 109.948 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.14 -7.39 20.91 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.98 1.516 . . . . 0.0 110.309 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.449 ' O ' ' OG1' ' A' ' 1' ' ' THR . . . -81.87 170.96 52.05 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -116.18 13.93 15.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.284 -1.127 . . . . 0.0 109.986 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.606 HG23 ' O ' ' A' ' 39' ' ' THR . 10.8 t -120.92 123.22 41.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 110.303 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.77 151.91 52.87 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.17 -0.956 . . . . 0.0 110.177 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.429 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 46.3 Cg_endo -72.94 -174.2 1.47 Allowed 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.018 1.536 . . . . 0.0 110.413 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.88 10.87 41.19 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 43' ' ' ASP . 32.4 p-10 -104.86 -18.61 14.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.183 -1.187 . . . . 0.0 110.148 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.403 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 0.1 OUTLIER -131.71 13.02 4.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -0.924 . . . . 0.0 110.117 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -93.83 88.65 5.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.246 -0.909 . . . . 0.0 110.17 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.181 179.958 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.83 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.808 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . 1.134 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 17.4 m -83.94 140.63 31.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.371 -0.831 . . . . 0.0 110.228 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.3 m -146.81 158.48 43.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.294 -0.879 . . . . 0.0 110.237 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.518 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -150.66 162.45 27.21 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.3 -0.875 . . . . 0.0 110.023 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.518 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 49.7 Cg_endo -81.34 -92.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.892 1.47 . . . . 0.0 110.645 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -50.99 133.08 27.51 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.566 -0.708 . . . . 0.0 110.805 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.469 ' O ' ' HB3' ' A' ' 10' ' ' ARG . 11.7 mm -52.45 -38.46 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.393 -0.817 . . . . 0.0 110.046 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.1 t -58.21 -53.12 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.911 . . . . 0.0 110.103 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -46.6 -37.1 7.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.167 -0.958 . . . . 0.0 110.019 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.469 ' HB3' ' O ' ' A' ' 7' ' ' ILE . 2.1 tpp180 -65.02 -48.39 74.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.356 -0.84 . . . . 0.0 110.323 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 12' ' ' ASN . 0.5 OUTLIER -52.76 -64.6 0.76 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.152 -0.967 . . . . 0.0 110.176 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.419 ' C ' ' O ' ' A' ' 11' ' ' SER . 71.8 m-20 -43.18 -41.7 3.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.908 . . . . 0.0 110.22 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 1.134 ' CZ ' HG21 ' A' ' 2' ' ' THR . 33.0 t80 -62.03 -38.13 87.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.178 -0.951 . . . . 0.0 110.063 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -67.22 -32.6 73.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.933 . . . . 0.0 109.717 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.609 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -71.8 -52.33 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.518 -0.739 . . . . 0.0 109.688 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.609 ' N ' HG12 ' A' ' 15' ' ' VAL . 41.0 t -54.54 -28.59 46.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.408 -0.808 . . . . 0.0 110.432 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.437 ' HD2' ' HG3' ' A' ' 23' ' ' GLU . 2.3 ttp85 -83.96 -12.42 55.35 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.203 -0.936 . . . . 0.0 110.132 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.581 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -59.34 -48.97 94.93 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.374 -0.829 . . . . 0.0 110.485 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 47.6 Cg_endo -74.94 -155.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.731 1.385 . . . . 0.0 110.117 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.86 69.14 0.72 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.643 HG22 ' HD2' ' A' ' 22' ' ' PRO . 0.7 OUTLIER -130.38 145.28 56.76 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.207 -1.172 . . . . 0.0 110.134 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.643 ' HD2' HG22 ' A' ' 21' ' ' THR . 46.0 Cg_endo -73.4 135.13 21.85 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.917 1.483 . . . . 0.0 110.561 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.437 ' HG3' ' HD2' ' A' ' 17' ' ' ARG . 39.4 mt-10 -43.15 -46.57 5.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.348 -0.845 . . . . 0.0 110.053 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.409 ' HA ' HD11 ' A' ' 34' ' ' ILE . . . -42.8 -64.86 0.55 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.236 -0.915 . . . . 0.0 110.401 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.421 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -50.31 -33.12 19.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 110.461 -179.844 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 85.7 m -80.49 -53.68 6.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.179 -0.951 . . . . 0.0 110.197 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.485 ' HA ' ' OG1' ' A' ' 30' ' ' THR . . . -57.85 -16.24 11.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 109.725 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 51.6 m -79.19 -60.31 2.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.391 -0.818 . . . . 0.0 110.215 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -66.83 -16.24 64.15 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.296 -0.877 . . . . 0.0 110.51 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.485 ' OG1' ' HA ' ' A' ' 27' ' ' ALA . 24.1 p -92.67 -38.98 11.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.892 . . . . 0.0 110.097 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.37 18.56 10.93 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 83.9 m -89.74 167.57 12.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.137 -1.213 . . . . 0.0 110.109 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 pt -115.37 152.08 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.888 . . . . 0.0 110.174 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.409 HD11 ' HA ' ' A' ' 24' ' ' ALA . 85.7 mt -118.74 121.99 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.283 -0.886 . . . . 0.0 110.291 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.747 HD12 ' O ' ' A' ' 37' ' ' GLY . 4.3 pt -117.84 157.02 49.27 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.188 -0.945 . . . . 0.0 110.416 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -77.2 -13.51 17.01 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 124.091 1.574 . . . . 0.0 110.546 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.747 ' O ' HD12 ' A' ' 35' ' ' ILE . . . 165.18 -146.11 10.88 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 37' ' ' GLY . . . 63.14 42.95 6.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.329 -1.101 . . . . 0.0 110.293 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.607 HG22 ' C ' ' A' ' 38' ' ' ALA . 7.0 t 36.74 -153.14 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.658 -0.651 . . . . 0.0 110.698 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 15.3 t -120.26 136.45 25.15 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.148 -0.97 . . . . 0.0 110.343 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.04 133.34 19.57 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.971 1.511 . . . . 0.0 110.417 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -51.34 -43.01 51.16 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -49.86 -22.89 1.63 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -1.145 . . . . 0.0 110.155 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.45 ' CE2' ' HD3' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -145.68 59.29 1.26 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -0.884 . . . . 0.0 109.932 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -122.12 87.65 2.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.238 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.492 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.334 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.827 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.771 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.513 ' N ' ' OG1' ' A' ' 1' ' ' THR . 0.6 OUTLIER -74.9 145.09 42.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.277 -0.889 . . . . 0.0 110.298 . . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 44' ' ' TYR . 1.8 m -148.75 99.95 3.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 110.397 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.457 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 0.6 OUTLIER -105.8 142.33 24.57 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.271 -0.893 . . . . 0.0 110.139 179.853 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.457 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 45.8 Cg_endo -73.47 -93.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.004 1.528 . . . . 0.0 110.561 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -42.92 121.22 2.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.484 -0.76 . . . . 0.0 110.432 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.415 HD13 ' HB3' ' A' ' 46' ' ' ASN . 38.8 mm -55.13 -44.98 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.92 . . . . 0.0 110.108 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.9 t -53.54 -42.42 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 109.839 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.48 -50.7 64.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.195 -0.941 . . . . 0.0 109.942 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -47.86 -46.25 31.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.247 -0.908 . . . . 0.0 109.857 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.79 -36.45 83.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.882 . . . . 0.0 109.912 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -71.1 -19.04 62.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.935 . . . . 0.0 109.878 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.407 ' CZ ' ' HB3' ' A' ' 23' ' ' GLU . 12.3 t80 -75.11 -44.41 47.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.325 -0.859 . . . . 0.0 109.848 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 76.7 m-20 -68.14 -43.85 77.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -0.907 . . . . 0.0 109.421 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.535 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -53.02 -48.19 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.447 -0.783 . . . . 0.0 109.344 179.35 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.535 ' N ' HG12 ' A' ' 15' ' ' VAL . 13.7 t -68.38 -15.27 63.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.494 -0.754 . . . . 0.0 110.049 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -87.07 -12.26 47.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.242 -0.911 . . . . 0.0 109.969 179.606 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.672 HD13 ' C ' ' A' ' 18' ' ' LEU . 3.2 tm? -67.37 -41.67 34.02 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.291 -0.88 . . . . 0.0 111.507 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 48.0 Cg_endo -74.66 -155.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.264 1.139 . . . . 0.0 110.325 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.94 52.86 2.92 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.4 m -129.69 137.49 31.03 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.146 -1.208 . . . . 0.0 110.145 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.467 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 43.6 Cg_endo -71.43 167.78 25.37 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.053 1.554 . . . . 0.0 110.549 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.448 ' HG3' ' HD3' ' A' ' 17' ' ' ARG . 32.5 mp0 -68.42 -52.79 28.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.285 -0.884 . . . . 0.0 110.336 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 23' ' ' GLU . . . -41.04 -41.48 1.7 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.378 -0.826 . . . . 0.0 110.474 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.467 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -68.81 -45.41 71.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.351 -0.843 . . . . 0.0 110.177 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 59.9 m -74.85 -51.69 13.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.344 -0.847 . . . . 0.0 110.27 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.77 -48.31 50.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.0 110.423 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.7 m -63.26 -35.03 79.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.227 -0.921 . . . . 0.0 110.334 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -78.56 -0.98 31.83 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.304 -0.873 . . . . 0.0 110.486 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.3 p -120.88 -25.61 5.37 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.196 -0.94 . . . . 0.0 110.226 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.92 6.4 22.81 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 22.5 m -84.35 139.71 32.08 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.149 -1.207 . . . . 0.0 110.266 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.525 HG12 ' CE1' ' A' ' 44' ' ' TYR . 1.1 pp -111.8 149.56 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 110.037 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.4 mt -120.74 117.39 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 110.349 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.649 HD12 ' O ' ' A' ' 37' ' ' GLY . 12.7 pt -122.19 140.38 32.31 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.387 -0.82 . . . . 0.0 110.081 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -75.11 -14.72 20.82 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.086 1.572 . . . . 0.0 110.619 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.649 ' O ' HD12 ' A' ' 35' ' ' ILE . . . -165.08 -145.58 4.46 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 37' ' ' GLY . . . 56.6 92.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -1.139 . . . . 0.0 110.084 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.434 ' C ' ' O ' ' A' ' 38' ' ' ALA . 1.2 t -41.63 145.73 0.28 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.257 -0.902 . . . . 0.0 110.379 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -81.89 159.4 65.99 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.155 -0.965 . . . . 0.0 110.045 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.504 ' O ' ' N ' ' A' ' 43' ' ' ASP . 47.7 Cg_endo -82.53 26.41 0.64 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.89 1.468 . . . . 0.0 111.378 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.45 -66.26 0.1 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 41' ' ' PRO . 22.5 p-10 -48.33 -32.22 7.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.186 -1.185 . . . . 0.0 110.496 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.525 ' CE1' HG12 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -81.38 -31.3 33.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.27 -0.894 . . . . 0.0 110.283 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.44 88.03 0.89 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.322 -0.861 . . . . 0.0 110.047 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 4' ' ' CYS . 5.8 m120 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.296 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.835 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.216 -0.662 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.667 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -83.81 133.27 34.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.231 -0.918 . . . . 0.0 110.176 . . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 17.1 m -135.49 141.83 45.37 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.339 -0.851 . . . . 0.0 109.832 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -126.82 154.89 76.02 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.131 -0.981 . . . . 0.0 110.557 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -75.76 -94.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.195 1.629 . . . . 0.0 110.435 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.76 136.07 34.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.481 -0.762 . . . . 0.0 110.695 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.436 ' O ' ' HB3' ' A' ' 10' ' ' ARG . 13.8 mm -55.36 -53.27 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.342 -0.849 . . . . 0.0 110.077 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.414 ' C ' ' O ' ' A' ' 7' ' ' ILE . 53.0 t -44.15 -51.43 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 110.023 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -45.65 -52.15 11.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.102 -0.999 . . . . 0.0 109.786 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.486 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -50.48 -47.07 57.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.405 -0.809 . . . . 0.0 109.867 179.63 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.483 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 4.6 t -59.85 -40.99 90.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.303 -0.873 . . . . 0.0 110.073 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -76.19 -8.32 56.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.33 -0.856 . . . . 0.0 110.254 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.667 ' CZ ' HG21 ' A' ' 2' ' ' THR . 53.9 t80 -77.05 -62.24 1.72 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.242 -0.912 . . . . 0.0 110.154 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -60.83 -34.35 74.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.149 -0.969 . . . . 0.0 108.899 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.533 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -60.98 -46.77 95.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.945 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.533 ' N ' HG12 ' A' ' 15' ' ' VAL . 7.0 t -55.92 -25.23 42.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.424 -0.798 . . . . 0.0 109.92 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -85.62 -13.19 49.46 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.304 -0.872 . . . . 0.0 110.554 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.616 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 4.0 tp -57.66 -43.58 98.9 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.198 -0.939 . . . . 0.0 111.416 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 45.0 Cg_endo -72.98 -30.42 10.95 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.309 1.163 . . . . 0.0 110.5 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.44 6.28 4.31 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.571 HG22 ' HD2' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -67.07 143.28 97.74 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.094 -1.239 . . . . 0.0 110.093 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.571 ' HD2' HG22 ' A' ' 21' ' ' THR . 43.9 Cg_endo -71.96 158.46 52.58 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.889 1.468 . . . . 0.0 110.814 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.413 ' HG3' ' CZ ' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -55.45 -47.16 76.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.434 -0.791 . . . . 0.0 110.524 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.54 -45.25 26.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.232 -0.918 . . . . 0.0 110.627 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.462 HD13 ' CG2' ' A' ' 21' ' ' THR . 0.3 OUTLIER -67.14 -42.65 84.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.156 -0.965 . . . . 0.0 110.365 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 39.7 m -70.75 -52.85 18.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.208 -0.933 . . . . 0.0 110.179 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.449 ' HA ' ' HB2' ' A' ' 32' ' ' CYS . . . -53.12 -22.37 6.19 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 110.37 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.9 m -86.99 -34.44 19.26 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.211 -0.931 . . . . 0.0 110.324 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -79.08 -20.34 49.01 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.197 -0.939 . . . . 0.0 110.197 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.0 p -110.28 -24.49 10.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.156 -0.965 . . . . 0.0 110.202 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.34 61.0 1.34 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.449 ' HB2' ' HA ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -117.32 174.94 5.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -1.131 . . . . 0.0 110.418 -179.85 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 2' ' ' THR . 1.0 OUTLIER -135.92 147.43 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.369 -0.832 . . . . 0.0 110.29 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.1 mt -116.17 108.88 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 110.156 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.998 HD12 ' O ' ' A' ' 37' ' ' GLY . 18.1 pt -88.78 145.05 34.09 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.268 -0.895 . . . . 0.0 110.342 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -74.99 -5.38 16.72 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.997 1.525 . . . . 0.0 110.345 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.998 ' O ' HD12 ' A' ' 35' ' ' ILE . . . 168.15 -160.0 33.4 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.701 ' O ' HG22 ' A' ' 39' ' ' THR . . . 66.85 15.66 10.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.251 -1.147 . . . . 0.0 110.19 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.701 HG22 ' O ' ' A' ' 38' ' ' ALA . 6.7 t 39.65 -163.87 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.52 -0.738 . . . . 0.0 110.751 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.469 ' SG ' ' HD2' ' A' ' 41' ' ' PRO . 4.4 t -122.74 140.44 33.12 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.95 . . . . 0.0 110.38 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.469 ' HD2' ' SG ' ' A' ' 40' ' ' CYS . 43.6 Cg_endo -71.08 -160.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.927 1.488 . . . . 0.0 110.311 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -113.52 4.75 24.77 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -96.78 -29.95 13.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.101 -1.235 . . . . 0.0 110.241 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.482 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 5.9 t80 -119.26 7.98 11.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.268 -0.895 . . . . 0.0 110.435 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.81 87.47 5.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -0.99 . . . . 0.0 110.138 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.227 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.832 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.747 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.588 HG21 ' CE1' ' A' ' 13' ' ' PHE . 2.1 m -95.94 132.39 41.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.247 -0.908 . . . . 0.0 110.143 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.46 ' HB3' ' HA ' ' A' ' 45' ' ' ALA . 57.7 m -146.19 156.34 43.34 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.139 -0.976 . . . . 0.0 110.716 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.46 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -134.34 174.26 4.85 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.386 -0.821 . . . . 0.0 109.95 179.672 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.46 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 46.2 Cg_endo -72.99 -93.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.993 1.523 . . . . 0.0 109.913 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 7' ' ' ILE . 5.8 t -75.33 143.65 42.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.528 -0.732 . . . . 0.0 109.789 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.417 ' C ' ' O ' ' A' ' 6' ' ' SER . 71.2 mt -42.79 -47.9 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.223 -0.923 . . . . 0.0 110.125 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.426 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 33.4 t -50.36 -51.19 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -0.924 . . . . 0.0 110.047 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.85 -34.95 13.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.169 -0.957 . . . . 0.0 110.214 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 11' ' ' SER . 0.1 OUTLIER -65.64 -58.74 5.0 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 110.2 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 10' ' ' ARG . 4.9 p -42.38 -45.07 4.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.231 -0.918 . . . . 0.0 110.323 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 8' ' ' VAL . 61.1 m-80 -57.49 -51.47 69.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.199 -0.938 . . . . 0.0 110.322 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.588 ' CE1' HG21 ' A' ' 2' ' ' THR . 6.1 t80 -54.44 -39.04 67.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.21 -0.931 . . . . 0.0 110.19 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -67.93 -23.01 65.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -0.895 . . . . 0.0 109.129 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.533 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -85.34 -46.9 17.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.302 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.533 ' N ' HG12 ' A' ' 15' ' ' VAL . 9.6 t -60.2 -14.33 16.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.594 -0.691 . . . . 0.0 110.312 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.504 ' HB3' ' NH2' ' A' ' 17' ' ' ARG . 7.5 mmm180 -86.98 -7.74 57.86 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.156 -0.965 . . . . 0.0 109.957 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.614 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 2.4 tp -81.18 -43.68 1.17 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.367 -0.833 . . . . 0.0 111.248 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 46.3 Cg_endo -73.34 -155.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.228 1.12 . . . . 0.0 110.214 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.99 6.36 62.03 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.615 HG22 ' HB3' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -71.37 129.85 88.4 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.186 -1.185 . . . . 0.0 110.047 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.0 157.76 53.88 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.921 1.485 . . . . 0.0 110.513 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.422 ' HG2' ' HD3' ' A' ' 17' ' ' ARG . 88.0 mt-10 -52.91 -33.84 52.27 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.363 -0.836 . . . . 0.0 110.433 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.56 -65.08 0.69 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.954 . . . . 0.0 110.328 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.615 ' HB3' HG22 ' A' ' 21' ' ' THR . 0.6 OUTLIER -52.97 -27.33 18.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.322 -0.861 . . . . 0.0 110.436 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 82.0 m -81.1 -56.52 4.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.963 . . . . 0.0 110.392 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.402 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -47.99 -22.92 0.67 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.332 -0.855 . . . . 0.0 110.509 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.9 m -82.09 -58.57 2.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.133 -0.979 . . . . 0.0 110.535 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.7 -21.4 40.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.291 -0.881 . . . . 0.0 110.315 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.6 p -109.42 -29.13 8.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -0.897 . . . . 0.0 110.209 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 85.98 20.53 55.33 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.99 173.19 8.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.214 -1.168 . . . . 0.0 110.393 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.423 ' C ' HG13 ' A' ' 34' ' ' ILE . 4.5 pt -130.64 152.86 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.359 -0.838 . . . . 0.0 109.774 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.423 HG13 ' C ' ' A' ' 33' ' ' ILE . 34.3 mt -131.96 118.19 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.034 -1.041 . . . . 0.0 110.749 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 1' ' ' THR . 9.2 pt -105.14 159.91 27.78 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.313 -0.867 . . . . 0.0 109.952 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -76.46 -35.65 2.07 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.925 1.487 . . . . 0.0 110.817 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -76.94 -175.6 42.2 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.0 19.7 18.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.246 -1.15 . . . . 0.0 110.149 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.464 ' O ' ' CD1' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -121.26 134.92 55.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 110.167 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.83 135.8 21.19 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.256 -0.903 . . . . 0.0 110.468 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 47.7 Cg_endo -73.92 149.48 42.22 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.029 1.541 . . . . 0.0 110.286 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.78 -19.01 66.95 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -59.47 -34.9 73.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -1.188 . . . . 0.0 110.293 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.414 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 0.3 OUTLIER -147.35 55.57 1.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.933 . . . . 0.0 110.239 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -129.32 87.61 2.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.874 . . . . 0.0 110.181 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.251 179.988 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.842 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.738 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.706 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 2.0 m -104.72 134.32 48.07 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.261 -0.899 . . . . 0.0 110.43 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.456 ' HB2' HD11 ' A' ' 33' ' ' ILE . 83.8 m -133.55 116.21 15.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 110.172 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 0.7 OUTLIER -108.86 149.86 40.11 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.308 -0.87 . . . . 0.0 110.646 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.525 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 48.9 Cg_endo -79.07 -91.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.299 1.684 . . . . 0.0 110.479 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.542 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 6.2 t -50.18 133.24 23.72 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 110.303 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.5 mt -52.81 -54.3 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.174 -0.954 . . . . 0.0 109.898 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 9' ' ' ALA . 2.5 t -46.86 -47.49 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -0.935 . . . . 0.0 109.36 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 6' ' ' SER . . . -43.96 -48.5 8.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.276 -0.89 . . . . 0.0 109.445 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -58.34 -41.55 84.88 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.285 -0.884 . . . . 0.0 109.666 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 8' ' ' VAL . 0.3 OUTLIER -60.14 -59.38 5.51 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.345 -0.847 . . . . 0.0 109.621 179.553 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -59.23 -25.6 64.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.558 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.706 ' CZ ' HG21 ' A' ' 2' ' ' THR . 24.1 t80 -71.4 -25.35 62.31 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.43 -0.794 . . . . 0.0 109.809 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.17 -46.41 34.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.314 -0.866 . . . . 0.0 109.053 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.525 ' O ' ' CD ' ' A' ' 19' ' ' PRO . 1.1 t -56.61 -38.77 58.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.1 t -69.13 -27.65 65.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.485 -0.759 . . . . 0.0 110.455 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.518 ' CZ ' ' HB3' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -86.0 -11.84 51.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.102 -0.999 . . . . 0.0 110.616 -179.719 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.587 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -69.41 -50.03 20.92 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.206 -0.934 . . . . 0.0 110.824 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 45.4 Cg_endo -73.04 -155.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.553 1.291 . . . . 0.0 110.351 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.21 75.36 0.29 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 m -135.93 138.71 28.45 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.247 -1.149 . . . . 0.0 109.887 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.478 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 43.8 Cg_endo -72.19 150.76 54.07 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.982 1.517 . . . . 0.0 110.372 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.1 -49.23 66.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.325 -0.859 . . . . 0.0 110.462 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -44.19 -54.26 5.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.378 -0.826 . . . . 0.0 110.695 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.478 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.6 OUTLIER -56.7 -37.87 71.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.182 -0.949 . . . . 0.0 110.646 -179.626 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 83.7 m -78.88 -44.28 23.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.167 -0.958 . . . . 0.0 110.261 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.94 -24.98 7.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 110.408 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.1 m -89.5 -48.54 7.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.214 -0.929 . . . . 0.0 110.064 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -63.66 -22.2 66.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.352 -0.842 . . . . 0.0 110.38 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.6 p -110.79 -47.02 3.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.201 -0.937 . . . . 0.0 110.378 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.75 56.89 0.34 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.487 ' CB ' ' CE1' ' A' ' 13' ' ' PHE . 0.1 OUTLIER -120.36 176.37 5.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.259 -1.142 . . . . 0.0 110.063 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.456 HD11 ' HB2' ' A' ' 3' ' ' CYS . 1.0 OUTLIER -136.85 148.51 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.181 -0.949 . . . . 0.0 110.316 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 23.9 mt -104.68 132.67 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 110.132 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.867 HD12 ' O ' ' A' ' 37' ' ' GLY . 2.5 pt -103.83 155.39 37.08 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.132 -0.98 . . . . 0.0 110.392 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -79.82 44.94 1.82 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.061 1.558 . . . . 0.0 110.809 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.867 ' O ' HD12 ' A' ' 35' ' ' ILE . . . 94.55 -169.1 28.49 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.695 ' HB3' ' O ' ' A' ' 37' ' ' GLY . . . 69.69 32.72 3.19 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.372 -1.075 . . . . 0.0 110.442 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.74 ' O ' HD13 ' A' ' 35' ' ' ILE . 6.2 t 37.61 -156.32 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.524 -0.735 . . . . 0.0 110.486 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.482 ' N ' HG23 ' A' ' 39' ' ' THR . 4.2 t -114.77 137.17 22.64 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.071 -1.018 . . . . 0.0 110.581 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.49 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 47.2 Cg_endo -72.27 -163.51 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.941 1.495 . . . . 0.0 110.322 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.44 -14.62 29.68 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.01 -32.63 67.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.312 -1.111 . . . . 0.0 110.33 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.461 ' O ' ' SG ' ' A' ' 40' ' ' CYS . 0.2 OUTLIER -135.5 68.32 1.46 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.313 -0.867 . . . . 0.0 110.096 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -130.45 88.93 2.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.111 -0.993 . . . . 0.0 110.793 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.525 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.039 179.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.85 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.721 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.866 HG21 ' CE2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -96.48 124.0 40.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.15 -0.969 . . . . 0.0 110.447 . . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 26.7 m -129.48 97.08 4.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 0.0 109.922 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.422 ' N ' ' SG ' ' A' ' 32' ' ' CYS . 22.0 m -99.2 158.02 33.01 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.295 -0.878 . . . . 0.0 110.391 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -77.08 -95.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 124.075 1.566 . . . . 0.0 110.469 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.7 t -54.68 134.34 47.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.462 -0.773 . . . . 0.0 110.255 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.4 mt -57.93 -44.25 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -0.918 . . . . 0.0 109.852 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.3 t -50.45 -49.17 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.364 -0.835 . . . . 0.0 109.835 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.93 -43.52 63.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 109.749 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.464 ' HG3' ' OXT' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -53.81 -58.27 7.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.202 -0.936 . . . . 0.0 109.842 179.652 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -45.97 -51.11 13.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.193 -0.942 . . . . 0.0 109.477 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -55.17 -36.73 66.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.329 -0.857 . . . . 0.0 109.137 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.866 ' CE2' HG21 ' A' ' 2' ' ' THR . 38.4 t80 -74.6 -28.58 60.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.444 -0.785 . . . . 0.0 109.435 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -68.14 -27.39 66.4 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.454 -0.779 . . . . 0.0 109.147 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.559 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -82.46 -49.3 17.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.184 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.559 ' N ' HG12 ' A' ' 15' ' ' VAL . 42.7 t -58.92 -20.84 55.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.383 -0.823 . . . . 0.0 109.973 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.534 ' CD ' ' HG3' ' A' ' 23' ' ' GLU . 2.7 tpt85 -89.61 -20.11 24.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.217 -0.927 . . . . 0.0 110.179 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.606 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 15.4 tp -56.75 -41.71 92.66 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.882 . . . . 0.0 110.841 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 47.9 Cg_endo -76.11 -156.17 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.324 1.171 . . . . 0.0 110.293 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.84 14.35 65.33 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 m -75.5 137.65 71.01 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.11 -1.229 . . . . 0.0 110.008 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.433 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 47.9 Cg_endo -73.44 158.56 47.88 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.968 1.509 . . . . 0.0 110.587 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.534 ' HG3' ' CD ' ' A' ' 17' ' ' ARG . 1.0 OUTLIER -60.45 -49.06 79.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.34 -0.85 . . . . 0.0 110.354 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' GLU . . . -43.37 -49.02 7.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 110.306 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.433 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -59.84 -47.28 86.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.278 -0.889 . . . . 0.0 110.398 -179.798 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.43 ' HB2' ' CE1' ' A' ' 13' ' ' PHE . 25.9 m -72.38 -43.86 63.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.175 -0.953 . . . . 0.0 110.21 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.6 -38.94 70.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.158 -0.963 . . . . 0.0 110.103 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.4 m -80.32 -21.83 42.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 0.0 110.157 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -85.32 -11.07 55.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.202 -0.936 . . . . 0.0 110.131 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 55.4 p -123.87 -31.77 3.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.321 -0.862 . . . . 0.0 110.126 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.58 60.05 0.52 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.422 ' SG ' ' N ' ' A' ' 4' ' ' CYS . 8.4 t -131.76 173.42 11.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.285 -1.127 . . . . 0.0 110.185 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.0 pt -135.02 157.81 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.289 -0.882 . . . . 0.0 110.33 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 1' ' ' THR . 26.2 mt -114.29 144.72 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.349 -0.845 . . . . 0.0 110.059 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.436 ' O ' HG13 ' A' ' 35' ' ' ILE . 3.8 pt -120.11 150.42 51.18 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.913 . . . . 0.0 110.259 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.16 56.62 3.18 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.103 1.581 . . . . 0.0 110.434 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 166.52 -168.43 40.06 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.56 31.21 6.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.17 -1.194 . . . . 0.0 110.336 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.769 HG23 ' O ' ' A' ' 39' ' ' THR . 12.0 t -130.21 104.16 7.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.259 -0.9 . . . . 0.0 110.108 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.37 152.74 44.09 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.241 -0.912 . . . . 0.0 110.271 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 42' ' ' GLY . 46.8 Cg_endo -74.7 127.1 10.63 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.967 1.509 . . . . 0.0 110.402 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 45' ' ' ALA . . . -44.68 -28.49 1.64 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -51.82 -35.88 46.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.304 -1.116 . . . . 0.0 110.367 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.458 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 1.1 t80 -134.0 31.76 3.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 0.0 110.332 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.463 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . . . -110.07 98.03 7.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.189 -0.944 . . . . 0.0 110.276 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.464 ' OXT' ' HG3' ' A' ' 10' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.261 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.845 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.78 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.491 ' CG2' ' HB3' ' A' ' 32' ' ' CYS . 99.5 m -131.18 145.2 51.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.885 . . . . 0.0 110.451 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.734 ' SG ' HD11 ' A' ' 35' ' ' ILE . 61.5 m -120.28 112.25 18.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.375 -0.828 . . . . 0.0 109.93 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.472 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -122.34 146.56 47.43 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.167 -0.958 . . . . 0.0 110.193 -179.904 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.547 ' HG3' ' CE2' ' A' ' 44' ' ' TYR . 48.0 Cg_endo -72.95 -93.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.983 1.517 . . . . 0.0 110.42 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.442 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 1.6 t -42.21 109.51 0.13 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.527 -0.733 . . . . 0.0 110.334 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.2 mt -44.23 -50.83 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.167 -0.958 . . . . 0.0 110.178 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 69.7 t -47.13 -41.79 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -0.953 . . . . 0.0 109.885 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 6' ' ' SER . . . -56.09 -47.71 77.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.92 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.47 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 0.9 OUTLIER -60.93 -42.01 97.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.317 -0.864 . . . . 0.0 110.295 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.73 -48.43 72.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.179 -0.951 . . . . 0.0 110.223 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -65.71 -22.44 66.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.153 -0.967 . . . . 0.0 110.016 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.586 ' HA ' HG21 ' A' ' 30' ' ' THR . 49.6 t80 -74.83 -35.07 62.42 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.318 -0.864 . . . . 0.0 109.945 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -64.18 -51.3 64.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 0.0 109.477 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.593 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -55.57 -51.06 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.408 -0.807 . . . . 0.0 109.33 179.422 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.593 ' N ' HG12 ' A' ' 15' ' ' VAL . 53.4 t -48.39 -28.55 3.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.371 -0.831 . . . . 0.0 109.944 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.453 ' C ' ' HD2' ' A' ' 19' ' ' PRO . 11.1 tpt180 -83.99 -20.99 31.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.344 -0.847 . . . . 0.0 110.07 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.75 HD13 ' C ' ' A' ' 18' ' ' LEU . 3.4 tm? -49.61 -45.37 78.53 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 110.934 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 47.3 Cg_endo -73.02 -155.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.254 1.134 . . . . 0.0 110.033 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.46 50.74 1.26 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.2 m -115.5 140.06 25.45 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.21 -1.17 . . . . 0.0 110.099 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.485 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 43.8 Cg_endo -71.63 165.92 31.02 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.846 1.445 . . . . 0.0 110.315 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -69.4 -46.36 67.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -0.906 . . . . 0.0 110.424 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.76 -45.34 19.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 0.0 110.372 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.485 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -62.6 -48.29 80.07 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.157 -0.964 . . . . 0.0 110.281 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.414 ' HB2' ' CE1' ' A' ' 13' ' ' PHE . 73.0 m -68.44 -44.81 74.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.136 -0.978 . . . . 0.0 110.047 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.58 -37.13 26.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.181 -0.949 . . . . 0.0 109.867 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.1 m -72.73 -40.63 65.93 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.322 -0.861 . . . . 0.0 109.967 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -78.37 -9.75 59.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.855 . . . . 0.0 110.045 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.586 HG21 ' HA ' ' A' ' 13' ' ' PHE . 17.3 p -110.54 -19.57 12.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.297 -0.877 . . . . 0.0 110.169 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.23 23.42 48.35 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.491 ' HB3' ' CG2' ' A' ' 2' ' ' THR . 33.4 m -101.02 171.1 7.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -1.181 . . . . 0.0 110.231 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 3' ' ' CYS . 23.8 pt -123.47 156.04 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.917 . . . . 0.0 109.985 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.607 ' O ' HG23 ' A' ' 35' ' ' ILE . 20.9 mm -106.09 152.37 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 110.404 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.792 HD12 ' O ' ' A' ' 37' ' ' GLY . 4.6 pt -156.18 150.73 20.23 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.336 -0.852 . . . . 0.0 110.331 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.89 5.26 4.54 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.15 1.605 . . . . 0.0 110.957 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.792 ' O ' HD12 ' A' ' 35' ' ' ILE . . . -141.7 155.88 25.57 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.07 40.23 0.9 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.375 -1.073 . . . . 0.0 109.947 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.777 HG23 ' O ' ' A' ' 39' ' ' THR . 11.2 t -120.85 95.64 4.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.901 . . . . 0.0 110.332 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.548 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 8.2 m -81.88 166.21 38.79 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 109.699 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.525 ' O ' ' N ' ' A' ' 43' ' ' ASP . 52.8 Cg_endo -79.78 32.77 0.49 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.843 1.444 . . . . 0.0 111.593 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.06 -68.21 0.08 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 41' ' ' PRO . 0.3 OUTLIER -48.67 -41.44 31.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.111 -1.229 . . . . 0.0 109.774 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.547 ' CE2' ' HG3' ' A' ' 5' ' ' PRO . 0.5 OUTLIER -106.34 32.78 4.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -0.837 . . . . 0.0 109.887 179.629 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.548 ' HB2' ' HB2' ' A' ' 40' ' ' CYS . . . -105.31 96.33 6.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.324 -0.86 . . . . 0.0 110.243 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 45' ' ' ALA . 1.3 m-20 . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.111 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.834 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.762 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.45 ' O ' ' SG ' ' A' ' 3' ' ' CYS . 91.9 m -117.97 152.99 34.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.247 -0.908 . . . . 0.0 110.363 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.451 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 49.1 m -153.63 154.7 34.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.344 -0.847 . . . . 0.0 110.321 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.13 171.31 9.15 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 109.983 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.1 -95.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.99 1.521 . . . . 0.0 110.707 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.4 t -76.11 157.77 32.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.496 -0.753 . . . . 0.0 110.423 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.409 ' O ' ' C ' ' A' ' 8' ' ' VAL . 2.4 mp -58.33 -50.07 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.882 . . . . 0.0 109.874 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.409 ' C ' ' O ' ' A' ' 7' ' ' ILE . 91.1 t -44.69 -47.97 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.312 -0.868 . . . . 0.0 109.901 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.91 -45.17 71.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 109.915 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.425 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 9.5 ttm-85 -63.45 -48.6 77.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.388 -0.82 . . . . 0.0 110.271 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -50.11 -59.26 4.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.141 -0.975 . . . . 0.0 110.132 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 30.2 m120 -55.2 -40.45 70.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.912 . . . . 0.0 110.016 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.486 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 51.0 t80 -56.88 -43.8 81.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 0.0 110.097 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -58.4 -42.08 86.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.241 -0.912 . . . . 0.0 109.263 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.595 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -61.89 -50.65 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.599 -0.688 . . . . 0.0 109.282 179.25 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.595 ' N ' HG12 ' A' ' 15' ' ' VAL . 13.9 t -48.25 -25.61 1.61 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.443 -0.786 . . . . 0.0 110.099 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.549 ' NH2' ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -91.16 10.53 26.6 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.428 -0.795 . . . . 0.0 109.585 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.646 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 2.3 tt -84.04 -36.87 0.64 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.517 -0.739 . . . . 0.0 112.349 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 43.8 Cg_endo -72.54 -37.61 4.01 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 O-C-N 122.994 0.997 . . . . 0.0 111.356 -178.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 135.38 1.22 3.19 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.526 -1.321 . . . . 0.0 110.429 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.966 HG22 ' HD2' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -66.4 157.04 83.81 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 120.97 -1.312 . . . . 0.0 109.486 179.733 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.966 ' HD2' HG22 ' A' ' 21' ' ' THR . 47.7 Cg_endo -74.98 149.5 36.86 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.795 1.418 . . . . 0.0 110.71 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.484 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 1.6 pt-20 -54.84 -25.4 28.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.349 -0.844 . . . . 0.0 110.14 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.17 -44.22 84.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.311 -0.868 . . . . 0.0 110.44 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.484 HD13 ' CG2' ' A' ' 21' ' ' THR . 0.5 OUTLIER -68.55 -33.69 74.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 110.444 -179.782 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.449 ' O ' ' OG1' ' A' ' 30' ' ' THR . 69.6 m -87.45 -32.83 19.29 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.052 -1.03 . . . . 0.0 110.581 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.58 -30.35 70.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.098 -1.001 . . . . 0.0 110.035 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.86 -28.1 17.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 0.0 110.15 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.462 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -68.84 -28.9 67.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.216 -0.928 . . . . 0.0 110.324 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -101.68 -30.52 11.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.214 -0.929 . . . . 0.0 110.092 179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.52 19.05 9.04 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -76.43 -177.55 4.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -1.135 . . . . 0.0 110.003 179.936 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 pp -145.81 159.53 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.154 -0.966 . . . . 0.0 110.485 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 53.4 mt -125.58 121.37 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.354 -0.842 . . . . 0.0 110.061 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.463 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 12.1 pt -93.46 163.79 23.38 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.935 . . . . 0.0 110.361 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.463 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 48.7 Cg_endo -73.48 -40.09 1.71 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.008 1.531 . . . . 0.0 110.584 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 1' ' ' THR . . . -82.77 -159.8 27.32 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -125.74 -0.08 7.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.279 -1.13 . . . . 0.0 110.258 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.668 HG23 ' O ' ' A' ' 39' ' ' THR . 14.3 t -105.42 118.29 36.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.309 -0.869 . . . . 0.0 109.995 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.21 146.21 31.48 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.251 -0.906 . . . . 0.0 110.314 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.699 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 46.4 Cg_endo -72.98 -166.56 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.152 1.606 . . . . 0.0 110.866 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.47 -5.62 39.48 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.517 ' OD2' ' N ' ' A' ' 44' ' ' TYR . 4.3 p30 -82.35 -24.42 34.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -1.14 . . . . 0.0 110.038 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.517 ' N ' ' OD2' ' A' ' 43' ' ' ASP . 0.2 OUTLIER -144.64 47.15 1.37 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 110.311 -179.817 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -118.61 89.42 3.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 110.065 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.1 m120 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.258 -179.94 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.847 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.216 -0.71 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.573 HG22 ' O ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -127.85 172.66 10.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.908 . . . . 0.0 110.256 . . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.586 ' HB3' HD11 ' A' ' 33' ' ' ILE . 1.8 t -142.49 121.68 13.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.323 -0.861 . . . . 0.0 110.107 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.443 ' O ' ' OXT' ' A' ' 46' ' ' ASN . 57.8 m -120.71 150.11 51.9 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.246 -0.909 . . . . 0.0 110.214 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.518 ' HD3' ' CE2' ' A' ' 44' ' ' TYR . 52.6 Cg_endo -77.79 -94.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.125 1.592 . . . . 0.0 110.614 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 t -50.29 129.54 21.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.476 -0.765 . . . . 0.0 110.593 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' A' ' 7' ' ' ILE . 14.3 mm -50.71 -41.05 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.212 -0.93 . . . . 0.0 109.369 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 56.1 t -53.32 -47.3 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.436 -0.79 . . . . 0.0 109.715 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.47 -52.72 27.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.344 -0.847 . . . . 0.0 109.91 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.9 ttm-85 -55.64 -43.85 76.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.266 -0.896 . . . . 0.0 109.941 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.55 -56.97 6.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.0 109.933 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -60.08 -33.1 71.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.332 -0.855 . . . . 0.0 109.903 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.464 ' CZ ' ' HD3' ' A' ' 17' ' ' ARG . 16.1 t80 -70.96 -35.91 72.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.0 109.804 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -73.51 -44.57 57.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.346 -0.846 . . . . 0.0 109.447 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.519 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -54.91 -47.3 76.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.459 -0.775 . . . . 0.0 109.197 179.372 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.519 ' N ' HG12 ' A' ' 15' ' ' VAL . 29.7 t -68.78 -25.53 64.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.464 -0.772 . . . . 0.0 109.93 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.464 ' HD3' ' CZ ' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -88.74 -8.44 54.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.384 -0.822 . . . . 0.0 109.879 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.577 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -61.94 -45.62 91.95 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.462 -0.774 . . . . 0.0 110.654 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 18' ' ' LEU . 47.4 Cg_endo -78.29 -157.41 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.759 1.4 . . . . 0.0 110.075 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.6 61.77 2.75 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.577 HG23 HD13 ' A' ' 25' ' ' LEU . 99.1 m -119.47 140.67 29.55 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.237 -1.155 . . . . 0.0 110.306 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.47 ' HD2' HG23 ' A' ' 21' ' ' THR . 46.9 Cg_endo -72.31 170.37 19.36 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.006 1.53 . . . . 0.0 110.841 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.463 ' O ' ' N ' ' A' ' 25' ' ' LEU . 1.4 mt-10 -72.44 -55.27 7.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.358 -0.839 . . . . 0.0 110.477 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 23' ' ' GLU . . . -39.8 -28.48 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.355 -0.84 . . . . 0.0 110.603 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.577 HD13 HG23 ' A' ' 21' ' ' THR . 0.7 OUTLIER -81.3 -50.13 9.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.169 -0.957 . . . . 0.0 110.599 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.2 m -83.5 -27.6 29.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.141 -0.975 . . . . 0.0 110.666 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -74.14 -49.31 24.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.168 -0.957 . . . . 0.0 110.561 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.2 m -76.17 -23.41 54.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.224 -0.922 . . . . 0.0 110.503 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.428 ' CB ' ' O ' ' A' ' 25' ' ' LEU . 48.1 t80 -81.44 -6.41 58.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.931 . . . . 0.0 110.413 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 31.3 p -119.19 -21.71 7.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 0.0 110.189 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.85 38.93 3.26 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 57.0 m -108.86 -179.34 3.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.18 -1.188 . . . . 0.0 110.23 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.586 HD11 ' HB3' ' A' ' 3' ' ' CYS . 9.1 pt -126.17 149.26 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.271 -0.893 . . . . 0.0 110.398 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.7 mt -109.0 124.65 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.265 -0.897 . . . . 0.0 109.957 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.419 ' CD1' ' O ' ' A' ' 39' ' ' THR . 23.5 pt -123.44 135.34 25.96 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.161 -0.962 . . . . 0.0 110.51 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -77.79 53.98 4.62 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.958 1.504 . . . . 0.0 110.489 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -164.08 -155.97 8.59 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -134.31 29.25 3.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -1.141 . . . . 0.0 110.218 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.419 ' O ' ' CD1' ' A' ' 35' ' ' ILE . 13.1 t -130.02 161.93 29.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.0 110.085 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.6 m -138.93 166.62 23.65 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.247 -0.908 . . . . 0.0 110.197 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.43 ' HG2' ' OD1' ' A' ' 43' ' ' ASP . 50.0 Cg_endo -79.27 15.51 1.54 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.937 1.493 . . . . 0.0 111.189 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.32 -64.16 3.53 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.433 ' CG ' ' N ' ' A' ' 44' ' ' TYR . 4.6 p-10 -52.77 -44.14 66.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.272 -1.134 . . . . 0.0 110.971 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.518 ' CE2' ' HD3' ' A' ' 5' ' ' PRO . 1.8 m-85 -89.87 -2.13 58.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.066 -1.021 . . . . 0.0 110.5 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.501 ' O ' ' ND2' ' A' ' 46' ' ' ASN . . . -75.31 87.93 2.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.214 -0.929 . . . . 0.0 110.407 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.502 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.136 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.851 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.776 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.1 m -138.23 145.73 41.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 109.991 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.511 ' HB2' HD11 ' A' ' 33' ' ' ILE . 29.9 m -139.21 128.58 24.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.201 -0.937 . . . . 0.0 110.345 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -123.25 165.24 23.34 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.294 -0.879 . . . . 0.0 110.214 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.456 ' O ' ' CB ' ' A' ' 46' ' ' ASN . 47.8 Cg_endo -73.87 -93.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.924 1.486 . . . . 0.0 110.524 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.9 t -62.38 154.99 26.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.583 -0.698 . . . . 0.0 110.339 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.549 HD13 ' O ' ' A' ' 46' ' ' ASN . 48.7 mm -66.28 -30.01 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.333 -0.854 . . . . 0.0 109.776 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.7 t -69.44 -44.1 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.329 -0.857 . . . . 0.0 109.794 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.76 -42.1 67.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.394 -0.816 . . . . 0.0 110.067 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.459 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 5.2 ttp180 -67.22 -50.96 58.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 0.0 110.154 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.1 t -50.84 -46.26 60.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.256 -0.902 . . . . 0.0 110.334 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -61.71 -30.49 70.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.296 -0.877 . . . . 0.0 110.329 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.459 ' HB3' ' O ' ' A' ' 10' ' ' ARG . 48.5 t80 -67.9 -40.47 83.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.918 . . . . 0.0 110.232 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -58.05 -47.46 83.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -0.941 . . . . 0.0 109.381 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.604 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -54.31 -51.57 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.494 -0.754 . . . . 0.0 109.278 179.319 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.604 ' N ' HG12 ' A' ' 15' ' ' VAL . 35.4 t -48.66 -28.23 3.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.573 -0.704 . . . . 0.0 110.217 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.492 ' NE ' ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -88.6 -14.06 38.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.243 -0.911 . . . . 0.0 110.35 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.797 HD13 ' O ' ' A' ' 18' ' ' LEU . 1.8 tm? -54.89 -43.56 98.88 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.241 -0.912 . . . . 0.0 111.182 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 47.7 Cg_endo -75.86 -90.11 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.382 1.201 . . . . 0.0 110.495 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -175.12 55.7 0.12 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.671 HG22 ' HD2' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -106.76 146.18 32.57 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.293 -1.122 . . . . 0.0 110.059 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.671 ' HD2' HG22 ' A' ' 21' ' ' THR . 44.0 Cg_endo -72.04 136.0 26.35 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.903 1.475 . . . . 0.0 110.404 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 22' ' ' PRO . 3.9 mt-10 -39.7 -46.13 1.81 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.461 -0.774 . . . . 0.0 110.779 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.11 -38.51 52.27 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.324 -0.86 . . . . 0.0 111.038 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.472 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -72.51 -42.71 64.53 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.112 -0.993 . . . . 0.0 110.81 -179.248 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.429 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 73.8 m -74.49 -39.95 62.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.156 -0.965 . . . . 0.0 110.319 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.8 -41.81 92.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.139 -0.975 . . . . 0.0 110.238 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 38.7 m -75.09 -21.02 59.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.24 -0.913 . . . . 0.0 110.281 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -85.04 -20.9 29.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.283 -0.885 . . . . 0.0 110.24 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.7 p -120.01 -16.16 8.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.888 . . . . 0.0 110.342 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.96 53.58 3.9 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.53 -175.17 2.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.207 -1.172 . . . . 0.0 110.168 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' A' ' 3' ' ' CYS . 1.2 pt -142.04 147.42 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 110.41 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.543 ' O ' HG23 ' A' ' 35' ' ' ILE . 2.2 mp -115.11 139.69 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.445 -0.785 . . . . 0.0 110.129 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.543 HG23 ' O ' ' A' ' 34' ' ' ILE . 0.9 OUTLIER -154.68 121.15 2.74 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.199 -0.938 . . . . 0.0 110.367 -179.848 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.32 55.52 3.04 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.896 1.472 . . . . 0.0 110.686 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -118.83 -175.69 16.33 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.26 -85.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.182 -1.187 . . . . 0.0 110.298 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.3 t -116.04 175.0 5.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 110.286 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.94 160.7 27.89 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.239 -0.913 . . . . 0.0 110.258 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.403 ' O ' ' N ' ' A' ' 45' ' ' ALA . 44.9 Cg_endo -72.27 135.04 23.99 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.94 1.495 . . . . 0.0 110.424 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.475 ' HA2' ' HB3' ' A' ' 45' ' ' ALA . . . -46.25 -38.73 9.02 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -48.15 -27.1 2.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.164 -1.198 . . . . 0.0 110.314 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.58 6.41 2.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.27 -0.894 . . . . 0.0 110.392 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.475 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . . . -90.94 89.45 7.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.111 -0.993 . . . . 0.0 110.147 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.549 ' O ' HD13 ' A' ' 7' ' ' ILE . 43.0 m-20 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.131 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.845 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.725 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 99.3 m -135.44 148.59 49.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -0.883 . . . . 0.0 110.225 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.503 ' SG ' HD11 ' A' ' 35' ' ' ILE . 19.0 m -128.94 131.23 47.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.269 -0.894 . . . . 0.0 110.174 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.472 ' CB ' ' OXT' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -122.02 153.48 60.93 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.225 -0.922 . . . . 0.0 110.324 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.551 ' HD3' ' CE1' ' A' ' 44' ' ' TYR . 50.9 Cg_endo -78.1 -93.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.08 1.568 . . . . 0.0 110.719 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.81 138.05 58.31 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.547 -0.721 . . . . 0.0 110.914 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.416 ' O ' ' HB3' ' A' ' 10' ' ' ARG . 89.0 mt -47.92 -38.9 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.265 -0.897 . . . . 0.0 109.808 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.458 ' O ' ' OG ' ' A' ' 11' ' ' SER . 94.4 t -51.71 -61.49 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.381 -0.824 . . . . 0.0 110.285 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.442 ' O ' ' OD1' ' A' ' 12' ' ' ASN . . . -45.91 -32.3 2.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.159 -0.963 . . . . 0.0 110.251 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 46' ' ' ASN . 0.3 OUTLIER -74.87 -46.96 32.72 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.306 -0.871 . . . . 0.0 110.748 -179.734 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 8' ' ' VAL . 10.6 p -54.88 -69.05 0.14 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.091 -1.006 . . . . 0.0 110.534 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 13' ' ' PHE . 9.4 p30 -51.15 -37.6 47.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.167 -0.958 . . . . 0.0 110.656 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.516 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 37.0 t80 -50.82 -50.04 57.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.146 -0.971 . . . . 0.0 110.538 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.509 ' OD1' ' NH2' ' A' ' 17' ' ' ARG . 18.9 m-80 -63.91 -41.84 97.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.191 -0.943 . . . . 0.0 109.604 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.561 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -59.61 -48.84 85.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.52 -0.737 . . . . 0.0 109.424 179.369 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.561 ' N ' HG12 ' A' ' 15' ' ' VAL . 44.8 t -57.16 -22.8 42.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.588 -0.695 . . . . 0.0 110.342 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.509 ' NH2' ' OD1' ' A' ' 14' ' ' ASN . 9.7 mtm180 -83.78 -3.98 58.28 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.1 -1.0 . . . . 0.0 110.244 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.611 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 16.6 tp -71.68 -47.75 12.2 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 110.749 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 46.1 Cg_endo -71.33 -155.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.352 1.185 . . . . 0.0 110.39 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.98 2.55 87.12 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.511 HG22 ' HB3' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -72.83 125.49 91.13 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.092 -1.24 . . . . 0.0 109.982 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.29 146.95 46.52 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.883 1.465 . . . . 0.0 110.521 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.496 ' HG3' ' N ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -50.21 -22.56 1.78 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.274 -0.891 . . . . 0.0 110.176 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.496 ' N ' ' HG3' ' A' ' 23' ' ' GLU . . . -67.27 -48.78 66.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.932 . . . . 0.0 110.013 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.511 ' HB3' HG22 ' A' ' 21' ' ' THR . 1.0 OUTLIER -69.25 -30.52 68.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.873 . . . . 0.0 109.843 179.707 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 78.7 m -75.97 -49.67 17.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -0.885 . . . . 0.0 109.967 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.39 -25.62 50.37 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.155 -0.965 . . . . 0.0 109.819 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.6 m -89.91 -18.85 25.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.307 -0.871 . . . . 0.0 110.025 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.427 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 1.6 t80 -89.01 -20.36 24.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.395 -0.816 . . . . 0.0 110.402 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.6 p -108.42 -39.86 5.3 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.153 -0.967 . . . . 0.0 110.394 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.22 32.51 1.05 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.89 174.58 6.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -1.13 . . . . 0.0 110.14 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.408 HG12 ' CD1' ' A' ' 44' ' ' TYR . 2.6 pt -138.62 147.54 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 110.362 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.9 mp -109.17 138.36 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.329 -0.857 . . . . 0.0 110.259 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.503 HD11 ' SG ' ' A' ' 3' ' ' CYS . 21.8 pt -134.24 143.94 49.17 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.317 -0.864 . . . . 0.0 110.203 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.72 -10.84 23.73 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.014 1.534 . . . . 0.0 110.435 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -71.75 -169.49 11.28 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -113.54 -25.48 8.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.238 -1.154 . . . . 0.0 110.248 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.0 t -117.27 159.85 22.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 110.266 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.479 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 87.6 m -98.9 165.83 14.22 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 109.976 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 40' ' ' CYS . 43.1 Cg_endo -70.98 -166.23 0.22 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.88 1.463 . . . . 0.0 110.272 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.72 -1.94 43.03 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -108.64 -6.5 15.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -1.159 . . . . 0.0 110.218 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.551 ' CE1' ' HD3' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -143.59 36.46 1.32 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.217 -0.927 . . . . 0.0 110.155 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -99.51 88.23 3.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.288 -0.882 . . . . 0.0 110.297 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.25 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.85 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.216 -0.685 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.491 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -114.31 151.36 33.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 110.378 . . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.412 ' C ' ' SG ' ' A' ' 32' ' ' CYS . 77.4 m -144.85 113.42 6.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.39 -0.819 . . . . 0.0 109.644 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.514 ' O ' ' CB ' ' A' ' 46' ' ' ASN . 65.6 m -99.41 151.21 37.35 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.929 . . . . 0.0 110.513 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 44' ' ' TYR . 50.8 Cg_endo -76.72 -93.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.998 1.525 . . . . 0.0 110.503 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.67 137.5 58.28 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.595 -0.69 . . . . 0.0 110.598 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.471 ' O ' ' HB3' ' A' ' 10' ' ' ARG . 10.0 mt -54.39 -33.64 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.18 -0.95 . . . . 0.0 109.789 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.6 t -48.98 -53.08 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.13 -0.981 . . . . 0.0 109.581 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.11 -40.43 73.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.268 -0.895 . . . . 0.0 109.48 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.491 ' CZ ' ' OXT' ' A' ' 46' ' ' ASN . 0.6 OUTLIER -52.9 -57.02 11.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.41 -0.806 . . . . 0.0 109.932 179.581 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 14' ' ' ASN . 9.6 m -51.42 -40.86 60.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.255 -0.903 . . . . 0.0 109.921 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -64.25 -43.98 93.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.331 -0.856 . . . . 0.0 109.867 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.491 ' CZ ' HG21 ' A' ' 2' ' ' THR . 10.9 t80 -53.72 -26.79 24.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -0.855 . . . . 0.0 109.828 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 11' ' ' SER . 48.5 m-80 -74.83 -43.7 53.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.377 -0.827 . . . . 0.0 109.598 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.557 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -63.9 -49.17 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.406 -0.809 . . . . 0.0 109.41 179.594 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.557 ' N ' HG12 ' A' ' 15' ' ' VAL . 42.3 t -52.4 -41.81 63.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.362 -0.836 . . . . 0.0 110.222 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -80.93 -2.0 45.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.284 -0.885 . . . . 0.0 110.531 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.586 ' HB3' ' HD3' ' A' ' 19' ' ' PRO . 3.9 tp -51.75 -54.17 42.9 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.085 -1.009 . . . . 0.0 110.259 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.586 ' HD3' ' HB3' ' A' ' 18' ' ' LEU . 43.9 Cg_endo -69.6 -52.72 0.32 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.38 1.2 . . . . 0.0 110.396 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.19 39.43 0.05 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.65 HG21 HD22 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -87.37 152.0 51.79 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.19 -1.182 . . . . 0.0 109.768 179.769 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.62 ' HD2' HG22 ' A' ' 21' ' ' THR . 43.5 Cg_endo -70.93 155.21 62.5 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.823 1.433 . . . . 0.0 110.57 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 24' ' ' ALA . 1.5 mp0 -53.64 -49.67 67.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.316 -0.865 . . . . 0.0 110.511 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.456 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -42.33 -49.74 5.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.225 -0.922 . . . . 0.0 110.341 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.65 HD22 HG21 ' A' ' 21' ' ' THR . 0.2 OUTLIER -59.82 -42.6 93.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 110.506 -179.841 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.546 ' O ' HG23 ' A' ' 30' ' ' THR . 27.5 m -77.93 -50.12 12.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.163 -0.961 . . . . 0.0 110.472 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.51 -20.23 64.41 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.239 -0.913 . . . . 0.0 110.366 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 46.3 m -88.04 -26.27 22.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.894 . . . . 0.0 110.378 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -101.77 -10.49 19.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.152 -0.968 . . . . 0.0 110.399 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.546 HG23 ' O ' ' A' ' 26' ' ' CYS . 76.4 p -103.66 -27.16 12.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 110.274 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.48 28.97 5.82 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.412 ' SG ' ' C ' ' A' ' 3' ' ' CYS . 1.6 t -99.73 -178.17 3.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.349 -1.089 . . . . 0.0 110.306 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.7 pt -139.43 148.79 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.879 . . . . 0.0 110.23 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.4 mt -112.25 133.97 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 109.976 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.654 HD11 ' O ' ' A' ' 39' ' ' THR . 17.3 pt -119.38 154.14 53.96 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 110.119 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.63 -16.79 30.17 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.145 1.603 . . . . 0.0 110.645 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -72.16 -160.17 4.67 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.13 10.25 5.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.167 -1.196 . . . . 0.0 110.222 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.654 ' O ' HD11 ' A' ' 35' ' ' ILE . 11.7 t -140.38 169.92 16.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.199 -0.938 . . . . 0.0 110.308 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 2' ' ' THR . 23.4 m -104.23 166.58 11.37 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.235 -0.916 . . . . 0.0 109.971 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.979 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 43.1 Cg_endo -70.35 -178.25 2.47 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.984 1.518 . . . . 0.0 110.552 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.21 -8.56 57.64 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -114.97 -29.17 6.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -1.156 . . . . 0.0 110.04 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 5' ' ' PRO . 0.5 OUTLIER -107.47 9.36 29.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 110.151 179.889 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.979 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -72.75 90.9 1.44 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.352 -0.842 . . . . 0.0 110.271 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.514 ' CB ' ' O ' ' A' ' 4' ' ' CYS . 1.6 m-20 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.156 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.838 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.726 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.436 HG22 ' SG ' ' A' ' 32' ' ' CYS . 1.1 m -85.88 145.19 27.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.182 -0.949 . . . . 0.0 109.986 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.412 ' C ' ' SG ' ' A' ' 32' ' ' CYS . 0.5 OUTLIER -139.69 91.99 2.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.21 -0.931 . . . . 0.0 110.297 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.478 ' N ' ' SG ' ' A' ' 32' ' ' CYS . 25.7 m -96.5 165.64 15.72 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.28 -0.887 . . . . 0.0 110.09 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 46' ' ' ASN . 49.3 Cg_endo -78.59 -92.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.31 1.689 . . . . 0.0 110.442 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 7' ' ' ILE . 1.4 t -75.55 143.29 42.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.499 -0.75 . . . . 0.0 109.932 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.401 ' C ' ' O ' ' A' ' 6' ' ' SER . 11.8 mt -42.76 -52.91 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.188 -0.945 . . . . 0.0 110.198 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.7 t -43.09 -54.03 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 109.985 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.64 -40.4 19.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.306 -0.871 . . . . 0.0 109.962 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -63.78 -49.87 71.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.327 -0.858 . . . . 0.0 110.077 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.61 -50.53 65.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.875 . . . . 0.0 110.021 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.444 ' O ' HG12 ' A' ' 15' ' ' VAL . 38.5 m-80 -51.3 -40.02 58.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.883 . . . . 0.0 110.07 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.58 ' CZ ' ' HB2' ' A' ' 23' ' ' GLU . 71.7 t80 -60.15 -54.04 50.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.921 . . . . 0.0 110.043 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -62.91 -24.89 68.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.295 -0.878 . . . . 0.0 109.19 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.601 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -78.59 -50.72 18.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.404 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.601 ' N ' HG12 ' A' ' 15' ' ' VAL . 46.3 t -51.64 -20.97 2.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.412 -0.805 . . . . 0.0 110.118 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.407 ' HD2' ' HB3' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -89.45 10.12 23.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.211 -0.931 . . . . 0.0 110.167 179.829 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.62 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 2.3 tp -83.44 -42.0 0.81 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.199 -0.938 . . . . 0.0 111.575 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 46.1 Cg_endo -73.9 -94.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.331 1.174 . . . . 0.0 111.0 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -160.82 33.46 0.4 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.495 HG22 ' HD2' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -107.13 141.58 23.22 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.229 -1.159 . . . . 0.0 110.087 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.495 ' HD2' HG22 ' A' ' 21' ' ' THR . 44.9 Cg_endo -70.96 136.25 29.38 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.984 1.518 . . . . 0.0 110.313 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.58 ' HB2' ' CZ ' ' A' ' 13' ' ' PHE . 5.7 pt-20 -42.35 -32.23 0.49 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.24 -0.913 . . . . 0.0 110.205 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.43 -59.54 3.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.171 -0.956 . . . . 0.0 109.945 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.502 ' O ' HD23 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -61.96 -28.52 69.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.183 -0.948 . . . . 0.0 109.938 179.806 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.471 ' O ' HG23 ' A' ' 30' ' ' THR . 58.6 m -73.62 -50.88 18.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 110.381 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.63 -43.12 79.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 0.0 110.348 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.8 m -64.69 -28.67 69.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.221 -0.924 . . . . 0.0 110.511 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -97.91 -34.0 11.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.105 -0.997 . . . . 0.0 110.565 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.471 HG23 ' O ' ' A' ' 26' ' ' CYS . 63.9 p -77.62 -8.13 57.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.198 -0.939 . . . . 0.0 110.161 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.464 ' O ' ' HD3' ' A' ' 5' ' ' PRO . . . 70.95 42.71 59.36 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.478 ' SG ' ' N ' ' A' ' 4' ' ' CYS . 14.3 t -127.26 170.15 12.75 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.103 -1.233 . . . . 0.0 110.081 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.575 HD12 HG23 ' A' ' 35' ' ' ILE . 1.1 pt -140.32 156.98 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.099 -1.0 . . . . 0.0 110.439 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.46 ' HA ' ' O ' ' A' ' 1' ' ' THR . 8.3 mt -110.84 127.31 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.342 -0.849 . . . . 0.0 110.092 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.575 HG23 HD12 ' A' ' 33' ' ' ILE . 2.0 pt -119.25 140.9 29.63 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.155 -0.966 . . . . 0.0 110.586 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -78.2 57.29 6.12 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 124.109 1.584 . . . . 0.0 110.516 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.553 ' O ' HD12 ' A' ' 35' ' ' ILE . . . 171.32 166.93 30.87 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.49 10.86 18.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.339 -1.095 . . . . 0.0 110.248 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.514 ' O ' HD13 ' A' ' 35' ' ' ILE . 7.7 t -98.62 136.19 39.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.183 -0.948 . . . . 0.0 110.082 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.47 ' SG ' ' HD2' ' A' ' 41' ' ' PRO . 0.5 OUTLIER -152.2 145.05 17.19 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.298 -0.876 . . . . 0.0 110.279 -179.769 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.47 ' HD2' ' SG ' ' A' ' 40' ' ' CYS . 47.7 Cg_endo -74.08 166.68 29.01 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.979 1.515 . . . . 0.0 110.276 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.98 -22.75 75.98 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -61.67 -34.18 75.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.235 -1.156 . . . . 0.0 110.208 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -136.38 66.13 1.5 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 110.173 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.477 ' O ' ' CB ' ' A' ' 46' ' ' ASN . . . -121.87 86.71 2.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.097 -1.002 . . . . 0.0 110.648 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.553 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 1.5 m-20 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.084 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.844 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.728 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.435 HG22 ' SG ' ' A' ' 32' ' ' CYS . 1.3 m -94.26 134.04 37.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.215 -0.928 . . . . 0.0 110.231 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 59.4 m -128.31 113.78 16.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.885 . . . . 0.0 110.182 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -105.88 169.01 7.44 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 0.0 110.28 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.537 ' HD2' ' HB1' ' A' ' 9' ' ' ALA . 48.4 Cg_endo -72.77 -94.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.973 1.512 . . . . 0.0 110.986 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.6 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 30.6 t -78.89 156.7 28.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.463 -0.773 . . . . 0.0 110.699 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.9 mt -49.29 -54.48 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -0.874 . . . . 0.0 109.836 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.5 t -46.7 -42.87 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.893 . . . . 0.0 109.492 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.6 ' HB3' ' O ' ' A' ' 6' ' ' SER . . . -50.44 -40.62 51.01 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.312 -0.868 . . . . 0.0 109.413 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.471 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 0.8 OUTLIER -70.69 -43.99 67.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.436 -0.79 . . . . 0.0 109.67 179.518 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.9 t -48.99 -63.15 1.18 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 109.735 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -47.1 -47.01 23.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.783 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.471 ' HB3' ' O ' ' A' ' 10' ' ' ARG . 11.2 t80 -54.41 -38.29 66.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.387 -0.821 . . . . 0.0 109.769 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -70.66 -30.09 66.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 108.999 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -65.22 -44.3 95.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.523 0.678 . . . . 0.0 109.24 179.242 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.482 ' N ' HG12 ' A' ' 15' ' ' VAL . 37.9 t -65.45 -26.16 67.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.465 -0.772 . . . . 0.0 110.435 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -75.61 -33.17 60.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.468 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.55 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -50.51 -52.51 54.81 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.16 -0.963 . . . . 0.0 110.541 -179.775 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 47.6 Cg_endo -71.65 -156.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.413 1.217 . . . . 0.0 110.299 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.93 59.22 0.42 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.494 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 6.7 m -113.24 144.26 30.85 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.354 -1.086 . . . . 0.0 110.08 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.494 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 45.6 Cg_endo -71.98 151.4 56.19 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 124.038 1.547 . . . . 0.0 110.382 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -53.69 -32.88 53.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.301 -0.874 . . . . 0.0 110.154 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.456 ' O ' ' HB ' ' A' ' 28' ' ' THR . . . -57.93 -50.65 72.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.323 -0.861 . . . . 0.0 110.542 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.474 ' HB3' ' CG2' ' A' ' 21' ' ' THR . 0.1 OUTLIER -65.69 -26.88 67.97 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.074 -1.016 . . . . 0.0 110.358 -179.65 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 19.0 m -81.64 -49.13 10.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.235 -0.916 . . . . 0.0 110.412 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -72.2 -50.14 29.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.148 -0.97 . . . . 0.0 110.622 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.456 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 80.4 m -59.62 -44.97 93.25 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.23 -0.919 . . . . 0.0 110.85 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -67.37 -15.62 63.79 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.104 -0.997 . . . . 0.0 110.637 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.3 p -110.98 -22.16 11.64 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.114 -0.991 . . . . 0.0 110.512 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 98.89 23.21 11.96 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.435 ' SG ' HG22 ' A' ' 2' ' ' THR . 0.1 OUTLIER -84.44 175.01 9.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.329 -1.101 . . . . 0.0 109.922 179.837 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.502 ' CD1' HG23 ' A' ' 35' ' ' ILE . 2.3 pp -138.93 152.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.134 -0.979 . . . . 0.0 110.484 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.3 mt -115.19 124.46 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.39 -0.819 . . . . 0.0 110.363 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.502 HG23 ' CD1' ' A' ' 33' ' ' ILE . 11.8 pt -110.89 148.01 37.71 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.18 -0.95 . . . . 0.0 110.207 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.09 51.62 3.2 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.951 1.501 . . . . 0.0 110.627 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -176.42 -173.38 42.0 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -116.75 31.6 6.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.266 -1.138 . . . . 0.0 110.169 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.0 113.1 7.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.951 . . . . 0.0 110.255 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.455 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -106.94 163.1 17.67 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.894 . . . . 0.0 110.131 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.454 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 45.2 Cg_endo -72.42 162.99 39.94 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.918 1.483 . . . . 0.0 110.462 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.29 11.61 57.61 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -99.79 -21.69 15.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -1.148 . . . . 0.0 110.185 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.479 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 1.7 t80 -150.08 48.08 0.92 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.24 -0.912 . . . . 0.0 110.092 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.455 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . . . -121.83 101.45 7.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.324 -0.86 . . . . 0.0 110.275 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.068 179.891 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.831 HG21 ' CE2' ' A' ' 13' ' ' PHE . 50.8 m . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.334 0.588 . . . . 0.0 110.409 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 32.7 m -134.5 124.95 26.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.316 -0.865 . . . . 0.0 109.897 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.11 146.82 49.98 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.08 -1.013 . . . . 0.0 110.519 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.574 ' HD3' ' CE1' ' A' ' 44' ' ' TYR . 50.3 Cg_endo -75.83 -94.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.091 1.574 . . . . 0.0 110.547 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.477 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 7.1 t -48.25 123.24 6.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.5 -0.75 . . . . 0.0 110.363 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.407 ' O ' ' C ' ' A' ' 8' ' ' VAL . 2.5 mp -47.71 -54.83 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 110.108 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.407 ' C ' ' O ' ' A' ' 7' ' ' ILE . 21.6 t -44.34 -45.93 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 109.847 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 6' ' ' SER . . . -50.74 -42.87 57.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.2 -0.938 . . . . 0.0 109.721 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.406 ' O ' ' C ' ' A' ' 11' ' ' SER . 0.1 OUTLIER -68.77 -48.32 63.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 0.0 109.994 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -43.71 -42.12 5.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.89 . . . . 0.0 109.824 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 -75.3 -36.08 61.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.898 . . . . 0.0 109.853 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.831 ' CE2' HG21 ' A' ' 2' ' ' THR . 27.1 t80 -62.32 -33.26 74.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.331 -0.856 . . . . 0.0 109.923 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.73 -26.74 37.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.298 -0.876 . . . . 0.0 109.021 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 16' ' ' CYS . 1.2 t -82.49 -42.66 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.661 -0.649 . . . . 0.0 109.249 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.472 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 30.7 t -66.74 -24.34 66.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.314 -0.867 . . . . 0.0 109.767 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.447 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 0.7 OUTLIER -88.07 -12.48 44.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.322 -0.861 . . . . 0.0 109.785 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.578 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -54.97 -46.88 99.55 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.393 -0.817 . . . . 0.0 110.254 179.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 18' ' ' LEU . 49.7 Cg_endo -80.11 -157.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.927 1.488 . . . . 0.0 110.148 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.92 72.65 1.85 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.509 HG22 ' HB3' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -130.93 134.1 25.57 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.272 -1.134 . . . . 0.0 110.153 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.46 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 44.5 Cg_endo -72.98 139.16 29.56 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.95 1.5 . . . . 0.0 110.576 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -44.35 -31.64 1.1 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.406 -0.809 . . . . 0.0 110.412 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.89 -41.78 99.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.192 -0.943 . . . . 0.0 110.342 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.509 ' HB3' HG22 ' A' ' 21' ' ' THR . 0.1 OUTLIER -66.81 -37.16 83.98 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.313 -0.867 . . . . 0.0 110.259 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.604 ' O ' HG23 ' A' ' 30' ' ' THR . 47.3 m -85.8 -45.89 11.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.278 -0.889 . . . . 0.0 110.185 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -45.3 -36.05 3.85 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.203 -0.936 . . . . 0.0 109.888 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.0 m -79.09 -49.46 12.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.922 . . . . 0.0 109.912 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -64.54 -26.61 68.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.358 -0.839 . . . . 0.0 109.926 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.74 HG21 ' HA ' ' A' ' 13' ' ' PHE . 26.5 p -96.53 -51.36 4.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.324 -0.86 . . . . 0.0 110.218 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.42 22.08 3.2 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.414 ' HB3' ' CG2' ' A' ' 2' ' ' THR . 27.2 m -97.56 168.12 10.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.247 -1.149 . . . . 0.0 110.225 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.0 pt -121.04 155.71 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.212 -0.93 . . . . 0.0 110.273 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.9 mt -104.4 125.63 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.209 -0.932 . . . . 0.0 110.219 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.45 ' O ' HG13 ' A' ' 35' ' ' ILE . 3.9 pt -128.17 136.91 29.76 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.336 -0.853 . . . . 0.0 110.016 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 C--N 1.305 -1.751 0 O-C-N 124.029 1.541 . . . . 0.0 110.795 -179.762 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.473 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 86.8 m . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.548 ' HG2' ' CB ' ' A' ' 44' ' ' TYR . 43.1 Cg_endo -68.8 -161.4 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.917 1.482 . . . . 0.0 110.315 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.82 -3.83 34.23 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.73 -5.07 6.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.192 -1.181 . . . . 0.0 110.224 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.574 ' CE1' ' HD3' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -120.9 18.8 11.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.359 -0.838 . . . . 0.0 110.039 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.64 93.6 8.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.284 -0.885 . . . . 0.0 110.161 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.502 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.258 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.826 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 2.2 m . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.282 0.563 . . . . 0.0 110.018 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.5 m -151.5 130.31 12.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.196 -0.94 . . . . 0.0 110.276 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.738 ' SG ' ' HB1' ' A' ' 9' ' ' ALA . 0.5 OUTLIER -131.05 148.76 71.55 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.314 -0.866 . . . . 0.0 110.112 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.546 ' HG3' ' CE1' ' A' ' 44' ' ' TYR . 50.0 Cg_endo -84.3 -91.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.103 1.58 . . . . 0.0 110.894 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.512 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 3.8 t -39.05 127.66 1.65 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.505 0.669 . . . . 0.0 110.992 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.3 mt -49.92 -54.44 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.266 -0.897 . . . . 0.0 109.627 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.421 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 50.0 t -45.69 -48.88 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.324 -0.86 . . . . 0.0 109.701 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.738 ' HB1' ' SG ' ' A' ' 4' ' ' CYS . . . -45.79 -39.57 8.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.261 -0.899 . . . . 0.0 109.646 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -67.57 -44.37 78.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.234 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.403 ' O ' ' C ' ' A' ' 12' ' ' ASN . 10.2 t -57.12 -77.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.214 -0.929 . . . . 0.0 110.182 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.492 ' OD1' ' N ' ' A' ' 13' ' ' PHE . 10.2 p30 -44.52 -35.8 2.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.177 -0.952 . . . . 0.0 110.053 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.934 ' HA ' HG21 ' A' ' 30' ' ' THR . 19.5 t80 -64.99 -56.04 15.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.919 . . . . 0.0 110.096 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -62.62 -43.72 98.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.207 -0.933 . . . . 0.0 109.26 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -61.6 -45.58 98.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.539 -0.726 . . . . 0.0 109.246 179.156 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.505 ' N ' HG12 ' A' ' 15' ' ' VAL . 34.8 t -50.87 -29.99 13.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.572 -0.705 . . . . 0.0 110.304 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -85.23 -4.12 59.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.203 -0.935 . . . . 0.0 110.328 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.596 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 3.7 tt -69.88 -46.28 23.66 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.959 . . . . 0.0 110.633 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 47.8 Cg_endo -74.27 -155.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.382 0 O-C-N 123.289 1.152 . . . . 0.0 109.998 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.39 27.47 7.71 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.458 ' OG1' ' HG2' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -93.56 137.32 23.38 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.146 -1.208 . . . . 0.0 110.029 179.759 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.446 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 48.3 Cg_endo -75.42 166.78 28.01 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.988 1.52 . . . . 0.0 110.658 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 24' ' ' ALA . 4.1 tt0 -65.39 -50.34 65.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.329 -0.857 . . . . 0.0 110.228 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 23' ' ' GLU . . . -43.56 -51.66 6.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 0.0 110.382 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.447 HD13 ' CG2' ' A' ' 21' ' ' THR . 0.9 OUTLIER -57.22 -37.71 72.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 110.35 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 28' ' ' THR . 39.5 m -74.96 -63.04 1.35 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.887 . . . . 0.0 110.527 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 26' ' ' CYS . . . -41.91 -26.87 0.1 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.908 . . . . 0.0 110.441 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.439 ' N ' ' O ' ' A' ' 26' ' ' CYS . 20.2 m -90.08 -49.0 6.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.144 -0.973 . . . . 0.0 110.43 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -68.42 -27.09 65.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.186 -0.946 . . . . 0.0 110.268 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.934 HG21 ' HA ' ' A' ' 13' ' ' PHE . 26.4 p -87.03 -48.44 8.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.192 -0.942 . . . . 0.0 110.245 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.21 14.04 5.14 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.412 ' C ' HG23 ' A' ' 33' ' ' ILE . 56.8 m -86.7 -166.91 1.7 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.182 -1.187 . . . . 0.0 109.961 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.412 HG23 ' C ' ' A' ' 32' ' ' CYS . 11.4 pt -149.2 150.57 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.072 -1.017 . . . . 0.0 110.612 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.0 mt -100.53 138.38 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.347 -0.846 . . . . 0.0 109.981 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 27.1 pt -125.12 143.73 45.13 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.16 -0.962 . . . . 0.0 110.365 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo . . . . . 0 C--N 1.305 -1.734 0 O-C-N 124.015 1.534 . . . . 0.0 110.265 179.857 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 44' ' ' TYR . 5.4 t . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.08 -174.43 1.94 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.957 1.504 . . . . 0.0 110.706 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.6 -29.06 12.62 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -60.06 -26.0 65.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.281 -1.129 . . . . 0.0 110.184 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.546 ' CE1' ' HG3' ' A' ' 5' ' ' PRO . 0.8 OUTLIER -144.91 77.42 1.53 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.328 -0.857 . . . . 0.0 109.934 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -120.2 90.87 3.41 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.229 -0.919 . . . . 0.0 110.781 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.529 ' CB ' ' O ' ' A' ' 4' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 117.925 -1.036 . . . . 0.0 110.125 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 1.057 HG21 ' CE1' ' A' ' 13' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.192 0.52 . . . . 0.0 109.979 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.479 ' O ' ' CG1' ' A' ' 33' ' ' ILE . 5.1 m -132.44 108.48 9.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.192 -0.943 . . . . 0.0 109.905 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.411 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 13.2 m -109.32 162.99 18.08 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.413 -0.804 . . . . 0.0 110.021 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 47.7 Cg_endo -73.22 -95.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.903 1.475 . . . . 0.0 110.534 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.6 t -68.78 139.44 55.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.39 -0.819 . . . . 0.0 110.266 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.4 mt -46.42 -41.72 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.174 -0.954 . . . . 0.0 109.769 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.509 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 44.1 t -49.14 -57.45 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.464 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 8' ' ' VAL . . . -44.76 -37.03 3.5 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.366 -0.834 . . . . 0.0 109.443 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.448 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -75.5 -41.06 56.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.386 -0.822 . . . . 0.0 109.864 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.2 t -48.73 -72.31 0.05 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.0 109.919 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 8' ' ' VAL . 2.2 p30 -48.74 -42.96 37.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.358 -0.839 . . . . 0.0 109.955 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 1.057 ' CE1' HG21 ' A' ' 2' ' ' THR . 53.4 t80 -51.79 -47.93 64.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.244 -0.91 . . . . 0.0 110.182 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 10' ' ' ARG . 11.2 m120 -60.81 -27.21 67.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.139 -0.976 . . . . 0.0 109.433 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.575 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -78.93 -49.58 19.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 121.587 0.708 . . . . 0.0 109.453 179.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.575 ' N ' HG12 ' A' ' 15' ' ' VAL . 14.2 t -55.33 -16.41 3.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.564 -0.71 . . . . 0.0 110.741 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.521 ' HD2' ' HG3' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -88.42 -3.13 58.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.191 -0.943 . . . . 0.0 110.721 -179.671 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.607 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.5 tt -76.4 -41.62 3.04 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.131 -0.981 . . . . 0.0 111.031 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 47.1 Cg_endo -76.16 -156.19 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.35 1.184 . . . . 0.0 110.042 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.56 27.2 19.82 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.449 ' CG2' ' SG ' ' A' ' 26' ' ' CYS . 29.8 m -90.41 133.19 33.49 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.057 -1.261 . . . . 0.0 109.928 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.493 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 44.2 Cg_endo -72.22 141.8 36.52 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.948 1.499 . . . . 0.0 110.594 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.521 ' HG3' ' HD2' ' A' ' 17' ' ' ARG . 7.2 mt-10 -43.31 -52.13 5.94 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.317 -0.864 . . . . 0.0 110.548 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 23' ' ' GLU . . . -41.98 -62.03 1.01 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 0.0 110.541 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.493 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -53.73 -36.91 62.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.286 -0.884 . . . . 0.0 110.562 -179.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.449 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 91.2 m -76.68 -34.86 58.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.166 -0.959 . . . . 0.0 110.235 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.85 -16.6 63.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.173 -0.954 . . . . 0.0 110.326 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 45.6 m -91.01 -47.9 7.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.191 -0.943 . . . . 0.0 110.362 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -63.89 -23.22 67.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.198 -0.939 . . . . 0.0 110.226 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 37.0 p -101.19 -48.35 4.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 110.205 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.84 69.59 0.62 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 48.8 t -140.46 163.87 31.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.214 -1.168 . . . . 0.0 110.128 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.479 ' CG1' ' O ' ' A' ' 3' ' ' CYS . 5.8 pt -112.4 147.13 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.083 -1.011 . . . . 0.0 110.334 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.0 mt -119.12 145.73 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.328 -0.857 . . . . 0.0 109.968 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.5 pt -127.15 153.61 76.75 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 0.0 110.463 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo . . . . . 0 C--N 1.306 -1.706 0 O-C-N 124.02 1.537 . . . . 0.0 110.014 179.555 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 70.9 m . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.05 139.3 32.54 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.952 1.501 . . . . 0.0 110.28 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.17 -18.01 12.1 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -93.71 7.97 42.77 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.142 -1.21 . . . . 0.0 110.357 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.401 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 0.3 OUTLIER -166.85 52.81 0.08 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.211 -0.931 . . . . 0.0 110.2 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -124.75 87.72 2.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.334 -0.854 . . . . 0.0 110.107 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.055 -179.98 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.7 m . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.164 0.507 . . . . 0.0 110.329 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.495 ' O ' HG12 ' A' ' 33' ' ' ILE . 19.7 m -134.06 121.07 21.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.896 . . . . 0.0 110.252 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.484 ' HB2' ' OXT' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -116.75 165.43 15.28 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.327 -0.858 . . . . 0.0 110.083 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 49.3 Cg_endo -75.36 -94.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.116 1.588 . . . . 0.0 111.265 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.4 t -92.62 168.5 11.19 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.699 0.761 . . . . 0.0 111.28 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.558 HG13 ' ND2' ' A' ' 46' ' ' ASN . 3.0 mt -51.67 -51.17 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.487 -0.758 . . . . 0.0 110.302 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.422 ' C ' ' O ' ' A' ' 7' ' ' ILE . 51.6 t -40.88 -53.26 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.383 -0.823 . . . . 0.0 110.139 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.451 ' O ' ' OD1' ' A' ' 12' ' ' ASN . . . -50.3 -40.8 49.65 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.292 -0.88 . . . . 0.0 109.557 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 46' ' ' ASN . 6.0 ttm180 -66.17 -37.61 86.05 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.268 -0.895 . . . . 0.0 110.276 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.4 t -60.67 -78.13 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.243 -0.911 . . . . 0.0 110.343 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 13' ' ' PHE . 12.1 p30 -45.91 -33.71 3.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.296 -0.878 . . . . 0.0 110.379 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.527 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 24.7 t80 -64.54 -48.15 76.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.394 -0.816 . . . . 0.0 110.4 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -65.13 -55.07 20.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -0.953 . . . . 0.0 110.063 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.624 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -49.77 -53.15 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.367 -0.833 . . . . 0.0 109.658 179.699 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.624 ' N ' HG12 ' A' ' 15' ' ' VAL . 42.2 t -49.51 -31.47 10.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -0.848 . . . . 0.0 110.297 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.93 -17.59 50.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.148 -0.97 . . . . 0.0 110.058 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.601 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.6 tp -56.21 -49.91 90.56 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.287 -0.883 . . . . 0.0 110.983 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 45.1 Cg_endo -71.51 -155.36 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.551 1.29 . . . . 0.0 110.282 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.08 61.86 1.07 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.0 m -129.84 132.55 24.23 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.279 -1.13 . . . . 0.0 109.893 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.8 148.76 59.06 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.993 1.523 . . . . 0.0 110.739 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.478 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 15.9 pt-20 -53.53 -19.91 4.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.366 -0.834 . . . . 0.0 110.342 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.56 -48.55 76.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.226 -0.921 . . . . 0.0 110.22 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.09 -26.92 60.64 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.281 -0.887 . . . . 0.0 110.359 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 72.9 m -88.86 -29.26 19.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -0.918 . . . . 0.0 110.445 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.478 ' CB ' ' O ' ' A' ' 23' ' ' GLU . . . -74.42 -24.61 59.12 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.271 -0.893 . . . . 0.0 110.209 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.4 m -87.56 -50.34 6.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 110.258 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.06 -23.78 21.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.946 . . . . 0.0 110.124 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 67.5 p -98.27 -39.23 8.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 110.174 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.37 16.19 10.58 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -77.23 175.86 9.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -1.162 . . . . 0.0 110.01 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 3' ' ' CYS . 15.0 pt -136.43 163.51 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.174 -0.954 . . . . 0.0 110.294 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 58.0 mt -132.6 141.61 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.884 . . . . 0.0 110.253 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.474 ' O ' HG13 ' A' ' 35' ' ' ILE . 8.9 pt -145.41 127.18 7.79 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 110.265 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo . . . . . 0 C--N 1.306 -1.683 0 O-C-N 123.834 1.439 . . . . 0.0 110.089 179.873 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.462 ' SG ' ' HD2' ' A' ' 41' ' ' PRO . 7.7 t . . . . . 0 N--CA 1.493 1.715 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.462 ' HD2' ' SG ' ' A' ' 40' ' ' CYS . 44.7 Cg_endo -70.92 151.21 62.25 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.967 1.509 . . . . 0.0 110.467 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.05 -8.79 62.15 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.439 ' OD2' ' HB2' ' A' ' 41' ' ' PRO . 56.8 p30 -89.88 -1.51 58.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -1.173 . . . . 0.0 110.044 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.93 48.45 0.79 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.361 -0.837 . . . . 0.0 110.088 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.477 ' O ' ' OD1' ' A' ' 46' ' ' ASN . . . -114.57 87.78 2.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 0.0 110.099 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.558 ' ND2' HG13 ' A' ' 7' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.103 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.692 HG21 ' CE2' ' A' ' 13' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.245 0.545 . . . . 0.0 110.295 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.3 m -154.56 128.27 8.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.856 . . . . 0.0 109.937 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.42 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 61.1 m -115.29 163.28 20.69 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.23 -0.919 . . . . 0.0 110.328 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 49.4 Cg_endo -75.75 -94.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.021 1.537 . . . . 0.0 110.764 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.17 148.61 51.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.56 -0.713 . . . . 0.0 110.586 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.7 mt -60.0 -45.95 94.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.331 -0.856 . . . . 0.0 110.095 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.8 t -49.36 -43.73 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.185 -0.947 . . . . 0.0 109.786 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.02 -37.99 81.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 110.006 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.476 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 5.6 ttm180 -61.24 -55.66 29.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.23 -0.919 . . . . 0.0 110.106 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -45.52 -60.06 2.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.293 -0.88 . . . . 0.0 110.001 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -52.21 -22.93 4.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.334 -0.854 . . . . 0.0 110.114 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.692 ' CE2' HG21 ' A' ' 2' ' ' THR . 17.9 t80 -75.83 -29.97 58.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 110.37 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -74.24 -31.17 62.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 109.363 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.9 OUTLIER -69.3 -41.15 80.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.593 -0.692 . . . . 0.0 109.501 179.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.464 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 49.5 t -68.64 -32.14 71.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.555 -0.716 . . . . 0.0 110.998 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -84.77 -0.31 53.32 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.053 -1.029 . . . . 0.0 110.722 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.579 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -70.85 -48.9 14.57 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.086 -1.009 . . . . 0.0 110.208 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 48.2 Cg_endo -74.15 -155.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.584 1.308 . . . . 0.0 110.09 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.11 53.48 2.19 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.4 m -113.35 135.11 21.82 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.194 -1.18 . . . . 0.0 110.248 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.476 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 45.7 Cg_endo -73.64 158.56 47.15 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.876 1.461 . . . . 0.0 110.509 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.8 -35.86 77.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.303 -0.873 . . . . 0.0 110.327 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.34 -43.55 88.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.35 -0.844 . . . . 0.0 110.619 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.476 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -66.69 -34.42 77.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.109 -0.994 . . . . 0.0 110.285 -179.745 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 65.6 m -81.48 -47.93 12.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.193 -0.942 . . . . 0.0 110.066 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.93 -28.22 6.41 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.197 -0.939 . . . . 0.0 110.111 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.1 m -85.77 -37.8 18.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 110.251 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.84 -19.86 60.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.193 -0.942 . . . . 0.0 110.209 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.0 p -112.35 -58.94 2.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -0.914 . . . . 0.0 110.266 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.91 34.98 0.46 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 64.0 m -101.3 162.93 12.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.315 -1.109 . . . . 0.0 110.09 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.408 ' O ' HG13 ' A' ' 33' ' ' ILE . 1.1 pp -122.99 149.55 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.218 -0.926 . . . . 0.0 110.176 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.9 mt -115.14 134.68 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.153 -0.967 . . . . 0.0 110.225 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 41.4 pt -119.39 151.68 51.67 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 110.175 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo . . . . . 0 C--N 1.305 -1.744 0 O-C-N 124.009 1.531 . . . . 0.0 110.487 -179.927 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.89 131.85 18.99 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.997 1.525 . . . . 0.0 110.61 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -48.31 -35.37 14.66 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.61 -47.12 58.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.206 -1.173 . . . . 0.0 110.049 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.92 62.48 0.68 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.333 -0.854 . . . . 0.0 110.054 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.432 ' O ' ' CG ' ' A' ' 46' ' ' ASN . . . -130.19 88.01 2.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 110.253 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.432 ' CG ' ' O ' ' A' ' 45' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.146 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.32 0.581 . . . . 0.0 110.253 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.7 m -147.78 107.19 3.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.357 -0.84 . . . . 0.0 110.198 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.518 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 24.9 m -99.96 166.25 13.09 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.253 -0.904 . . . . 0.0 110.412 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.542 ' HG2' ' CB ' ' A' ' 9' ' ' ALA . 40.0 Cg_endo -71.41 -153.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 124.034 1.544 . . . . 0.0 110.353 179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.492 ' C ' ' O ' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -31.0 150.24 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.51 0.671 . . . . 0.0 111.548 -179.286 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.439 ' O ' ' C ' ' A' ' 8' ' ' VAL . 2.3 mt -48.44 -54.54 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.426 -0.796 . . . . 0.0 110.639 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.439 ' C ' ' O ' ' A' ' 7' ' ' ILE . 77.0 t -40.87 -55.29 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.437 -0.79 . . . . 0.0 110.322 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.542 ' CB ' ' HG2' ' A' ' 5' ' ' PRO . . . -53.22 -41.52 65.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.899 . . . . 0.0 109.961 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.485 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -67.39 -49.75 62.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.892 . . . . 0.0 109.951 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 p -47.66 -38.0 13.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -0.934 . . . . 0.0 109.969 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 13' ' ' PHE . 10.9 m-80 -70.72 -42.61 70.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.922 . . . . 0.0 110.007 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.485 ' HB3' ' O ' ' A' ' 10' ' ' ARG . 9.6 t80 -44.14 -46.43 8.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 0.0 109.764 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -69.55 -50.03 48.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.321 -0.862 . . . . 0.0 109.225 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.489 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.7 OUTLIER -51.64 -45.35 36.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.512 -0.742 . . . . 0.0 109.094 179.2 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.489 ' N ' HG12 ' A' ' 15' ' ' VAL . 40.0 t -66.4 -23.47 66.32 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.453 -0.779 . . . . 0.0 109.853 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.492 ' NH2' ' OE2' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -85.21 1.65 47.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 110.241 -179.819 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.568 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -60.87 -50.26 85.74 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.047 -1.033 . . . . 0.0 110.223 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 49.8 Cg_endo -73.65 -154.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.495 1.261 . . . . 0.0 109.621 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.9 64.01 0.88 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.556 HG23 HD22 ' A' ' 25' ' ' LEU . 18.6 m -115.12 140.28 25.45 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.242 -1.152 . . . . 0.0 110.453 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.61 ' HG2' HD13 ' A' ' 25' ' ' LEU . 47.8 Cg_endo -76.09 157.86 38.08 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.1 1.579 . . . . 0.0 110.279 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.492 ' OE2' ' NH2' ' A' ' 17' ' ' ARG . 1.2 mt-10 -58.3 -54.59 45.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.197 -0.94 . . . . 0.0 110.27 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 23' ' ' GLU . . . -42.06 -32.34 0.45 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.284 -0.885 . . . . 0.0 110.644 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.61 HD13 ' HG2' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -76.94 -52.14 9.93 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.195 -0.941 . . . . 0.0 110.735 -179.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 73.0 m -76.82 -28.5 55.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.112 -0.992 . . . . 0.0 110.156 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.73 -48.2 80.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -0.891 . . . . 0.0 109.879 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 93.8 m -66.55 -43.09 86.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.312 -0.867 . . . . 0.0 109.657 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -54.92 -26.64 37.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.361 -0.837 . . . . 0.0 109.909 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.3 p -105.27 -11.98 16.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.33 -0.856 . . . . 0.0 110.082 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.88 14.47 60.89 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 7.5 t -78.57 167.94 20.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.155 -1.203 . . . . 0.0 110.167 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.2 pt -136.24 159.16 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.234 -0.916 . . . . 0.0 110.234 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.2 mt -124.51 122.95 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.857 . . . . 0.0 110.498 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 35' ' ' ILE . 23.1 pt -126.08 142.99 44.13 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.297 -0.877 . . . . 0.0 109.948 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo . . . . . 0 C--N 1.305 -1.755 0 O-C-N 123.98 1.516 . . . . 0.0 110.309 -179.945 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.429 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 46.3 Cg_endo -72.94 -174.2 1.47 Allowed 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.018 1.536 . . . . 0.0 110.413 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.88 10.87 41.19 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 43' ' ' ASP . 32.4 p-10 -104.86 -18.61 14.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.183 -1.187 . . . . 0.0 110.148 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.403 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 0.1 OUTLIER -131.71 13.02 4.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -0.924 . . . . 0.0 110.117 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -93.83 88.65 5.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.246 -0.909 . . . . 0.0 110.17 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.181 179.958 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 1.134 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 17.4 m . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.313 0.578 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.3 m -146.81 158.48 43.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.294 -0.879 . . . . 0.0 110.237 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.518 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -150.66 162.45 27.21 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.3 -0.875 . . . . 0.0 110.023 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.518 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 49.7 Cg_endo -81.34 -92.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.892 1.47 . . . . 0.0 110.645 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -50.99 133.08 27.51 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.566 -0.708 . . . . 0.0 110.805 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.469 ' O ' ' HB3' ' A' ' 10' ' ' ARG . 11.7 mm -52.45 -38.46 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.393 -0.817 . . . . 0.0 110.046 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.1 t -58.21 -53.12 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.911 . . . . 0.0 110.103 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -46.6 -37.1 7.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.167 -0.958 . . . . 0.0 110.019 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.469 ' HB3' ' O ' ' A' ' 7' ' ' ILE . 2.1 tpp180 -65.02 -48.39 74.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.356 -0.84 . . . . 0.0 110.323 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 12' ' ' ASN . 0.5 OUTLIER -52.76 -64.6 0.76 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.152 -0.967 . . . . 0.0 110.176 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.419 ' C ' ' O ' ' A' ' 11' ' ' SER . 71.8 m-20 -43.18 -41.7 3.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.908 . . . . 0.0 110.22 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 1.134 ' CZ ' HG21 ' A' ' 2' ' ' THR . 33.0 t80 -62.03 -38.13 87.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.178 -0.951 . . . . 0.0 110.063 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -67.22 -32.6 73.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.933 . . . . 0.0 109.717 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.609 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -71.8 -52.33 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.518 -0.739 . . . . 0.0 109.688 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.609 ' N ' HG12 ' A' ' 15' ' ' VAL . 41.0 t -54.54 -28.59 46.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.408 -0.808 . . . . 0.0 110.432 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.437 ' HD2' ' HG3' ' A' ' 23' ' ' GLU . 2.3 ttp85 -83.96 -12.42 55.35 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.203 -0.936 . . . . 0.0 110.132 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.581 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -59.34 -48.97 94.93 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.374 -0.829 . . . . 0.0 110.485 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 47.6 Cg_endo -74.94 -155.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.731 1.385 . . . . 0.0 110.117 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.86 69.14 0.72 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.643 HG22 ' HD2' ' A' ' 22' ' ' PRO . 0.7 OUTLIER -130.38 145.28 56.76 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.207 -1.172 . . . . 0.0 110.134 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.643 ' HD2' HG22 ' A' ' 21' ' ' THR . 46.0 Cg_endo -73.4 135.13 21.85 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.917 1.483 . . . . 0.0 110.561 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.437 ' HG3' ' HD2' ' A' ' 17' ' ' ARG . 39.4 mt-10 -43.15 -46.57 5.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.348 -0.845 . . . . 0.0 110.053 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.409 ' HA ' HD11 ' A' ' 34' ' ' ILE . . . -42.8 -64.86 0.55 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.236 -0.915 . . . . 0.0 110.401 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.421 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -50.31 -33.12 19.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 110.461 -179.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 85.7 m -80.49 -53.68 6.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.179 -0.951 . . . . 0.0 110.197 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.485 ' HA ' ' OG1' ' A' ' 30' ' ' THR . . . -57.85 -16.24 11.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 109.725 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 51.6 m -79.19 -60.31 2.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.391 -0.818 . . . . 0.0 110.215 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -66.83 -16.24 64.15 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.296 -0.877 . . . . 0.0 110.51 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.485 ' OG1' ' HA ' ' A' ' 27' ' ' ALA . 24.1 p -92.67 -38.98 11.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.892 . . . . 0.0 110.097 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.37 18.56 10.93 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 83.9 m -89.74 167.57 12.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.137 -1.213 . . . . 0.0 110.109 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 pt -115.37 152.08 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.888 . . . . 0.0 110.174 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.409 HD11 ' HA ' ' A' ' 24' ' ' ALA . 85.7 mt -118.74 121.99 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.283 -0.886 . . . . 0.0 110.291 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.3 pt -117.84 157.02 49.27 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.188 -0.945 . . . . 0.0 110.416 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo . . . . . 0 C--N 1.306 -1.673 0 O-C-N 124.091 1.574 . . . . 0.0 110.546 -179.828 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 120.763 0.316 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.04 133.34 19.57 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.971 1.511 . . . . 0.0 110.417 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -51.34 -43.01 51.16 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -49.86 -22.89 1.63 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -1.145 . . . . 0.0 110.155 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.45 ' CE2' ' HD3' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -145.68 59.29 1.26 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -0.884 . . . . 0.0 109.932 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -122.12 87.65 2.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.238 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.492 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.334 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.27 0.557 . . . . 0.0 110.298 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 44' ' ' TYR . 1.8 m -148.75 99.95 3.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 110.397 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.457 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 0.6 OUTLIER -105.8 142.33 24.57 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.271 -0.893 . . . . 0.0 110.139 179.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.457 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 45.8 Cg_endo -73.47 -93.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.004 1.528 . . . . 0.0 110.561 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -42.92 121.22 2.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.484 -0.76 . . . . 0.0 110.432 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.415 HD13 ' HB3' ' A' ' 46' ' ' ASN . 38.8 mm -55.13 -44.98 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.92 . . . . 0.0 110.108 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.9 t -53.54 -42.42 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 109.839 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.48 -50.7 64.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.195 -0.941 . . . . 0.0 109.942 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -47.86 -46.25 31.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.247 -0.908 . . . . 0.0 109.857 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.79 -36.45 83.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.882 . . . . 0.0 109.912 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -71.1 -19.04 62.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.935 . . . . 0.0 109.878 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.407 ' CZ ' ' HB3' ' A' ' 23' ' ' GLU . 12.3 t80 -75.11 -44.41 47.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.325 -0.859 . . . . 0.0 109.848 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 76.7 m-20 -68.14 -43.85 77.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -0.907 . . . . 0.0 109.421 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.535 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -53.02 -48.19 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.447 -0.783 . . . . 0.0 109.344 179.35 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.535 ' N ' HG12 ' A' ' 15' ' ' VAL . 13.7 t -68.38 -15.27 63.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.494 -0.754 . . . . 0.0 110.049 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.474 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -87.07 -12.26 47.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.242 -0.911 . . . . 0.0 109.969 179.606 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.672 ' C ' HD13 ' A' ' 18' ' ' LEU . 3.2 tm? -67.37 -41.67 34.02 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.291 -0.88 . . . . 0.0 111.507 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 48.0 Cg_endo -74.66 -155.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.264 1.139 . . . . 0.0 110.325 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.94 52.86 2.92 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.4 m -129.69 137.49 31.03 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.146 -1.208 . . . . 0.0 110.145 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.467 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 43.6 Cg_endo -71.43 167.78 25.37 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.053 1.554 . . . . 0.0 110.549 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.448 ' HG3' ' HD3' ' A' ' 17' ' ' ARG . 32.5 mp0 -68.42 -52.79 28.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.285 -0.884 . . . . 0.0 110.336 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 23' ' ' GLU . . . -41.04 -41.48 1.7 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.378 -0.826 . . . . 0.0 110.474 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.467 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -68.81 -45.41 71.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.351 -0.843 . . . . 0.0 110.177 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 59.9 m -74.85 -51.69 13.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.344 -0.847 . . . . 0.0 110.27 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.77 -48.31 50.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.0 110.423 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.7 m -63.26 -35.03 79.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.227 -0.921 . . . . 0.0 110.334 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -78.56 -0.98 31.83 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.304 -0.873 . . . . 0.0 110.486 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.3 p -120.88 -25.61 5.37 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.196 -0.94 . . . . 0.0 110.226 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.92 6.4 22.81 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 22.5 m -84.35 139.71 32.08 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.149 -1.207 . . . . 0.0 110.266 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.525 HG12 ' CE1' ' A' ' 44' ' ' TYR . 1.1 pp -111.8 149.56 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 110.037 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.4 mt -120.74 117.39 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 110.349 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 12.7 pt -122.19 140.38 32.31 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.387 -0.82 . . . . 0.0 110.081 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo . . . . . 0 C--N 1.305 -1.742 0 O-C-N 124.086 1.572 . . . . 0.0 110.619 -179.834 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.504 ' O ' ' N ' ' A' ' 43' ' ' ASP . 47.7 Cg_endo -82.53 26.41 0.64 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.89 1.468 . . . . 0.0 111.378 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.45 -66.26 0.1 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 41' ' ' PRO . 22.5 p-10 -48.33 -32.22 7.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.186 -1.185 . . . . 0.0 110.496 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.525 ' CE1' HG12 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -81.38 -31.3 33.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.27 -0.894 . . . . 0.0 110.283 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.44 88.03 0.89 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.322 -0.861 . . . . 0.0 110.047 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 4' ' ' CYS . 5.8 m120 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.296 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.667 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.313 0.577 . . . . 0.0 110.176 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 17.1 m -135.49 141.83 45.37 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.339 -0.851 . . . . 0.0 109.832 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -126.82 154.89 76.02 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.131 -0.981 . . . . 0.0 110.557 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -75.76 -94.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.195 1.629 . . . . 0.0 110.435 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.76 136.07 34.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.481 -0.762 . . . . 0.0 110.695 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.436 ' O ' ' HB3' ' A' ' 10' ' ' ARG . 13.8 mm -55.36 -53.27 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.342 -0.849 . . . . 0.0 110.077 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.414 ' C ' ' O ' ' A' ' 7' ' ' ILE . 53.0 t -44.15 -51.43 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 110.023 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -45.65 -52.15 11.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.102 -0.999 . . . . 0.0 109.786 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.486 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -50.48 -47.07 57.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.405 -0.809 . . . . 0.0 109.867 179.63 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.483 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 4.6 t -59.85 -40.99 90.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.303 -0.873 . . . . 0.0 110.073 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -76.19 -8.32 56.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.33 -0.856 . . . . 0.0 110.254 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.667 ' CZ ' HG21 ' A' ' 2' ' ' THR . 53.9 t80 -77.05 -62.24 1.72 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.242 -0.912 . . . . 0.0 110.154 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -60.83 -34.35 74.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.149 -0.969 . . . . 0.0 108.899 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.533 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -60.98 -46.77 95.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.533 ' N ' HG12 ' A' ' 15' ' ' VAL . 7.0 t -55.92 -25.23 42.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.424 -0.798 . . . . 0.0 109.92 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -85.62 -13.19 49.46 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.304 -0.872 . . . . 0.0 110.554 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.616 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 4.0 tp -57.66 -43.58 98.9 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.198 -0.939 . . . . 0.0 111.416 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 45.0 Cg_endo -72.98 -30.42 10.95 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.309 1.163 . . . . 0.0 110.5 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.44 6.28 4.31 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.571 HG22 ' HD2' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -67.07 143.28 97.74 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.094 -1.239 . . . . 0.0 110.093 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.571 ' HD2' HG22 ' A' ' 21' ' ' THR . 43.9 Cg_endo -71.96 158.46 52.58 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.889 1.468 . . . . 0.0 110.814 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.413 ' HG3' ' CZ ' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -55.45 -47.16 76.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.434 -0.791 . . . . 0.0 110.524 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.54 -45.25 26.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.232 -0.918 . . . . 0.0 110.627 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.462 HD13 ' CG2' ' A' ' 21' ' ' THR . 0.3 OUTLIER -67.14 -42.65 84.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.156 -0.965 . . . . 0.0 110.365 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 39.7 m -70.75 -52.85 18.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.208 -0.933 . . . . 0.0 110.179 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.449 ' HA ' ' HB2' ' A' ' 32' ' ' CYS . . . -53.12 -22.37 6.19 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 110.37 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.9 m -86.99 -34.44 19.26 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.211 -0.931 . . . . 0.0 110.324 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -79.08 -20.34 49.01 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.197 -0.939 . . . . 0.0 110.197 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.0 p -110.28 -24.49 10.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.156 -0.965 . . . . 0.0 110.202 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.34 61.0 1.34 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.449 ' HB2' ' HA ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -117.32 174.94 5.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -1.131 . . . . 0.0 110.418 -179.85 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 2' ' ' THR . 1.0 OUTLIER -135.92 147.43 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.369 -0.832 . . . . 0.0 110.29 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.1 mt -116.17 108.88 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 110.156 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.455 ' O ' HG13 ' A' ' 35' ' ' ILE . 18.1 pt -88.78 145.05 34.09 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.268 -0.895 . . . . 0.0 110.342 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo . . . . . 0 C--N 1.306 -1.705 0 O-C-N 123.997 1.525 . . . . 0.0 110.345 179.957 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.469 ' SG ' ' HD2' ' A' ' 41' ' ' PRO . 4.4 t . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 120.634 0.254 . . . . 0.0 110.38 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.469 ' HD2' ' SG ' ' A' ' 40' ' ' CYS . 43.6 Cg_endo -71.08 -160.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.927 1.488 . . . . 0.0 110.311 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -113.52 4.75 24.77 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -96.78 -29.95 13.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.101 -1.235 . . . . 0.0 110.241 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.482 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 5.9 t80 -119.26 7.98 11.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.268 -0.895 . . . . 0.0 110.435 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.81 87.47 5.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -0.99 . . . . 0.0 110.138 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.227 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.588 HG21 ' CE1' ' A' ' 13' ' ' PHE . 2.1 m . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.202 0.525 . . . . 0.0 110.143 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.46 ' HB3' ' HA ' ' A' ' 45' ' ' ALA . 57.7 m -146.19 156.34 43.34 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.139 -0.976 . . . . 0.0 110.716 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.46 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -134.34 174.26 4.85 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.386 -0.821 . . . . 0.0 109.95 179.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.46 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 46.2 Cg_endo -72.99 -93.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.993 1.523 . . . . 0.0 109.913 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 7' ' ' ILE . 5.8 t -75.33 143.65 42.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.528 -0.732 . . . . 0.0 109.789 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.417 ' C ' ' O ' ' A' ' 6' ' ' SER . 71.2 mt -42.79 -47.9 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.223 -0.923 . . . . 0.0 110.125 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.426 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 33.4 t -50.36 -51.19 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -0.924 . . . . 0.0 110.047 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.85 -34.95 13.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.169 -0.957 . . . . 0.0 110.214 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 11' ' ' SER . 0.1 OUTLIER -65.64 -58.74 5.0 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 110.2 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 10' ' ' ARG . 4.9 p -42.38 -45.07 4.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.231 -0.918 . . . . 0.0 110.323 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 8' ' ' VAL . 61.1 m-80 -57.49 -51.47 69.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.199 -0.938 . . . . 0.0 110.322 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.588 ' CE1' HG21 ' A' ' 2' ' ' THR . 6.1 t80 -54.44 -39.04 67.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.21 -0.931 . . . . 0.0 110.19 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -67.93 -23.01 65.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -0.895 . . . . 0.0 109.129 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.533 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -85.34 -46.9 17.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.302 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.533 ' N ' HG12 ' A' ' 15' ' ' VAL . 9.6 t -60.2 -14.33 16.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.594 -0.691 . . . . 0.0 110.312 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.504 ' NH2' ' HB3' ' A' ' 17' ' ' ARG . 7.5 mmm180 -86.98 -7.74 57.86 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.156 -0.965 . . . . 0.0 109.957 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.614 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 2.4 tp -81.18 -43.68 1.17 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.367 -0.833 . . . . 0.0 111.248 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 46.3 Cg_endo -73.34 -155.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.228 1.12 . . . . 0.0 110.214 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.99 6.36 62.03 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.615 HG22 ' HB3' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -71.37 129.85 88.4 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.186 -1.185 . . . . 0.0 110.047 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.0 157.76 53.88 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.921 1.485 . . . . 0.0 110.513 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.422 ' HG2' ' HD3' ' A' ' 17' ' ' ARG . 88.0 mt-10 -52.91 -33.84 52.27 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.363 -0.836 . . . . 0.0 110.433 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.56 -65.08 0.69 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.954 . . . . 0.0 110.328 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.615 ' HB3' HG22 ' A' ' 21' ' ' THR . 0.6 OUTLIER -52.97 -27.33 18.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.322 -0.861 . . . . 0.0 110.436 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 82.0 m -81.1 -56.52 4.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.963 . . . . 0.0 110.392 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.402 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -47.99 -22.92 0.67 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.332 -0.855 . . . . 0.0 110.509 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.9 m -82.09 -58.57 2.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.133 -0.979 . . . . 0.0 110.535 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.7 -21.4 40.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.291 -0.881 . . . . 0.0 110.315 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.6 p -109.42 -29.13 8.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -0.897 . . . . 0.0 110.209 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 85.98 20.53 55.33 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.99 173.19 8.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.214 -1.168 . . . . 0.0 110.393 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.423 ' C ' HG13 ' A' ' 34' ' ' ILE . 4.5 pt -130.64 152.86 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.359 -0.838 . . . . 0.0 109.774 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.423 HG13 ' C ' ' A' ' 33' ' ' ILE . 34.3 mt -131.96 118.19 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.034 -1.041 . . . . 0.0 110.749 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 9.2 pt -105.14 159.91 27.78 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.313 -0.867 . . . . 0.0 109.952 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo . . . . . 0 C--N 1.306 -1.675 0 O-C-N 123.925 1.487 . . . . 0.0 110.817 -179.902 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 120.744 0.307 . . . . 0.0 110.468 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 47.7 Cg_endo -73.92 149.48 42.22 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.029 1.541 . . . . 0.0 110.286 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.78 -19.01 66.95 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -59.47 -34.9 73.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -1.188 . . . . 0.0 110.293 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.414 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 0.3 OUTLIER -147.35 55.57 1.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.933 . . . . 0.0 110.239 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -129.32 87.61 2.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.874 . . . . 0.0 110.181 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.251 179.988 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.706 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 2.0 m . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.407 0.623 . . . . 0.0 110.43 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.456 ' HB2' HD11 ' A' ' 33' ' ' ILE . 83.8 m -133.55 116.21 15.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 110.172 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 0.7 OUTLIER -108.86 149.86 40.11 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.308 -0.87 . . . . 0.0 110.646 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.525 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 48.9 Cg_endo -79.07 -91.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.299 1.684 . . . . 0.0 110.479 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.542 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 6.2 t -50.18 133.24 23.72 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 110.303 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.5 mt -52.81 -54.3 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.174 -0.954 . . . . 0.0 109.898 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 9' ' ' ALA . 2.5 t -46.86 -47.49 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -0.935 . . . . 0.0 109.36 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 6' ' ' SER . . . -43.96 -48.5 8.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.276 -0.89 . . . . 0.0 109.445 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -58.34 -41.55 84.88 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.285 -0.884 . . . . 0.0 109.666 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 8' ' ' VAL . 0.3 OUTLIER -60.14 -59.38 5.51 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.345 -0.847 . . . . 0.0 109.621 179.553 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -59.23 -25.6 64.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.558 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.706 ' CZ ' HG21 ' A' ' 2' ' ' THR . 24.1 t80 -71.4 -25.35 62.31 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.43 -0.794 . . . . 0.0 109.809 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.17 -46.41 34.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.314 -0.866 . . . . 0.0 109.053 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.525 ' O ' ' CD ' ' A' ' 19' ' ' PRO . 1.1 t -56.61 -38.77 58.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.1 t -69.13 -27.65 65.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.485 -0.759 . . . . 0.0 110.455 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.518 ' CZ ' ' HB3' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -86.0 -11.84 51.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.102 -0.999 . . . . 0.0 110.616 -179.719 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.587 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -69.41 -50.03 20.92 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.206 -0.934 . . . . 0.0 110.824 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 45.4 Cg_endo -73.04 -155.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.553 1.291 . . . . 0.0 110.351 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.21 75.36 0.29 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 m -135.93 138.71 28.45 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.247 -1.149 . . . . 0.0 109.887 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.478 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 43.8 Cg_endo -72.19 150.76 54.07 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.982 1.517 . . . . 0.0 110.372 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.1 -49.23 66.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.325 -0.859 . . . . 0.0 110.462 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -44.19 -54.26 5.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.378 -0.826 . . . . 0.0 110.695 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.478 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.6 OUTLIER -56.7 -37.87 71.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.182 -0.949 . . . . 0.0 110.646 -179.626 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 83.7 m -78.88 -44.28 23.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.167 -0.958 . . . . 0.0 110.261 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.94 -24.98 7.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 110.408 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.1 m -89.5 -48.54 7.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.214 -0.929 . . . . 0.0 110.064 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -63.66 -22.2 66.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.352 -0.842 . . . . 0.0 110.38 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.6 p -110.79 -47.02 3.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.201 -0.937 . . . . 0.0 110.378 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.75 56.89 0.34 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.487 ' CB ' ' CE1' ' A' ' 13' ' ' PHE . 0.1 OUTLIER -120.36 176.37 5.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.259 -1.142 . . . . 0.0 110.063 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.456 HD11 ' HB2' ' A' ' 3' ' ' CYS . 1.0 OUTLIER -136.85 148.51 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.181 -0.949 . . . . 0.0 110.316 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 23.9 mt -104.68 132.67 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 110.132 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.5 pt -103.83 155.39 37.08 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.132 -0.98 . . . . 0.0 110.392 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 C--N 1.305 -1.729 0 O-C-N 124.061 1.558 . . . . 0.0 110.809 179.988 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 44' ' ' TYR . 4.2 t . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 120.86 0.362 . . . . 0.0 110.581 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.49 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 47.2 Cg_endo -72.27 -163.51 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.941 1.495 . . . . 0.0 110.322 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.44 -14.62 29.68 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.01 -32.63 67.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.312 -1.111 . . . . 0.0 110.33 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.461 ' O ' ' SG ' ' A' ' 40' ' ' CYS . 0.2 OUTLIER -135.5 68.32 1.46 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.313 -0.867 . . . . 0.0 110.096 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -130.45 88.93 2.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.111 -0.993 . . . . 0.0 110.793 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.525 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 1.2 m120 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.039 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.866 HG21 ' CE2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.328 0.585 . . . . 0.0 110.447 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 26.7 m -129.48 97.08 4.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 0.0 109.922 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.422 ' N ' ' SG ' ' A' ' 32' ' ' CYS . 22.0 m -99.2 158.02 33.01 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.295 -0.878 . . . . 0.0 110.391 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -77.08 -95.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 124.075 1.566 . . . . 0.0 110.469 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.7 t -54.68 134.34 47.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.462 -0.773 . . . . 0.0 110.255 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.4 mt -57.93 -44.25 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -0.918 . . . . 0.0 109.852 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.3 t -50.45 -49.17 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.364 -0.835 . . . . 0.0 109.835 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.93 -43.52 63.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 109.749 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.464 ' HG3' ' OXT' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -53.81 -58.27 7.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.202 -0.936 . . . . 0.0 109.842 179.652 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -45.97 -51.11 13.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.193 -0.942 . . . . 0.0 109.477 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -55.17 -36.73 66.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.329 -0.857 . . . . 0.0 109.137 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.866 ' CE2' HG21 ' A' ' 2' ' ' THR . 38.4 t80 -74.6 -28.58 60.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.444 -0.785 . . . . 0.0 109.435 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -68.14 -27.39 66.4 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.454 -0.779 . . . . 0.0 109.147 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.559 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -82.46 -49.3 17.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.184 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.559 ' N ' HG12 ' A' ' 15' ' ' VAL . 42.7 t -58.92 -20.84 55.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.383 -0.823 . . . . 0.0 109.973 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.534 ' CD ' ' HG3' ' A' ' 23' ' ' GLU . 2.7 tpt85 -89.61 -20.11 24.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.217 -0.927 . . . . 0.0 110.179 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.606 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 15.4 tp -56.75 -41.71 92.66 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.882 . . . . 0.0 110.841 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 47.9 Cg_endo -76.11 -156.17 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.324 1.171 . . . . 0.0 110.293 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.84 14.35 65.33 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 m -75.5 137.65 71.01 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.11 -1.229 . . . . 0.0 110.008 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.433 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 47.9 Cg_endo -73.44 158.56 47.88 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.968 1.509 . . . . 0.0 110.587 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.534 ' HG3' ' CD ' ' A' ' 17' ' ' ARG . 1.0 OUTLIER -60.45 -49.06 79.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.34 -0.85 . . . . 0.0 110.354 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' GLU . . . -43.37 -49.02 7.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 110.306 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.433 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -59.84 -47.28 86.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.278 -0.889 . . . . 0.0 110.398 -179.798 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.43 ' HB2' ' CE1' ' A' ' 13' ' ' PHE . 25.9 m -72.38 -43.86 63.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.175 -0.953 . . . . 0.0 110.21 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.6 -38.94 70.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.158 -0.963 . . . . 0.0 110.103 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.4 m -80.32 -21.83 42.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 0.0 110.157 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -85.32 -11.07 55.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.202 -0.936 . . . . 0.0 110.131 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 55.4 p -123.87 -31.77 3.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.321 -0.862 . . . . 0.0 110.126 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.58 60.05 0.52 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.422 ' SG ' ' N ' ' A' ' 4' ' ' CYS . 8.4 t -131.76 173.42 11.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.285 -1.127 . . . . 0.0 110.185 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.0 pt -135.02 157.81 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.289 -0.882 . . . . 0.0 110.33 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.2 mt -114.29 144.72 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.349 -0.845 . . . . 0.0 110.059 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.436 ' O ' HG13 ' A' ' 35' ' ' ILE . 3.8 pt -120.11 150.42 51.18 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.913 . . . . 0.0 110.259 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo . . . . . 0 C--N 1.305 -1.742 0 O-C-N 124.103 1.581 . . . . 0.0 110.434 179.98 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 120.721 0.296 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 42' ' ' GLY . 46.8 Cg_endo -74.7 127.1 10.63 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.967 1.509 . . . . 0.0 110.402 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 45' ' ' ALA . . . -44.68 -28.49 1.64 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -51.82 -35.88 46.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.304 -1.116 . . . . 0.0 110.367 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.458 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 1.1 t80 -134.0 31.76 3.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 0.0 110.332 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.463 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . . . -110.07 98.03 7.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.189 -0.944 . . . . 0.0 110.276 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.464 ' OXT' ' HG3' ' A' ' 10' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.261 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.491 ' CG2' ' HB3' ' A' ' 32' ' ' CYS . 99.5 m . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.435 0.636 . . . . 0.0 110.451 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.734 ' SG ' HD11 ' A' ' 35' ' ' ILE . 61.5 m -120.28 112.25 18.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.375 -0.828 . . . . 0.0 109.93 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.472 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -122.34 146.56 47.43 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.167 -0.958 . . . . 0.0 110.193 -179.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.547 ' HG3' ' CE2' ' A' ' 44' ' ' TYR . 48.0 Cg_endo -72.95 -93.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.983 1.517 . . . . 0.0 110.42 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.442 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 1.6 t -42.21 109.51 0.13 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.527 -0.733 . . . . 0.0 110.334 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.2 mt -44.23 -50.83 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.167 -0.958 . . . . 0.0 110.178 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 69.7 t -47.13 -41.79 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -0.953 . . . . 0.0 109.885 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 6' ' ' SER . . . -56.09 -47.71 77.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.92 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.47 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 0.9 OUTLIER -60.93 -42.01 97.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.317 -0.864 . . . . 0.0 110.295 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.73 -48.43 72.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.179 -0.951 . . . . 0.0 110.223 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -65.71 -22.44 66.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.153 -0.967 . . . . 0.0 110.016 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.586 ' HA ' HG21 ' A' ' 30' ' ' THR . 49.6 t80 -74.83 -35.07 62.42 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.318 -0.864 . . . . 0.0 109.945 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -64.18 -51.3 64.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 0.0 109.477 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.593 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -55.57 -51.06 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.408 -0.807 . . . . 0.0 109.33 179.422 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.593 ' N ' HG12 ' A' ' 15' ' ' VAL . 53.4 t -48.39 -28.55 3.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.371 -0.831 . . . . 0.0 109.944 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.453 ' C ' ' HD2' ' A' ' 19' ' ' PRO . 11.1 tpt180 -83.99 -20.99 31.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.344 -0.847 . . . . 0.0 110.07 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.75 ' C ' HD13 ' A' ' 18' ' ' LEU . 3.4 tm? -49.61 -45.37 78.53 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 110.934 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 47.3 Cg_endo -73.02 -155.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.254 1.134 . . . . 0.0 110.033 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.46 50.74 1.26 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.2 m -115.5 140.06 25.45 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.21 -1.17 . . . . 0.0 110.099 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.485 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 43.8 Cg_endo -71.63 165.92 31.02 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.846 1.445 . . . . 0.0 110.315 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -69.4 -46.36 67.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -0.906 . . . . 0.0 110.424 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.76 -45.34 19.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 0.0 110.372 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.485 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -62.6 -48.29 80.07 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.157 -0.964 . . . . 0.0 110.281 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.414 ' HB2' ' CE1' ' A' ' 13' ' ' PHE . 73.0 m -68.44 -44.81 74.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.136 -0.978 . . . . 0.0 110.047 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.58 -37.13 26.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.181 -0.949 . . . . 0.0 109.867 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.1 m -72.73 -40.63 65.93 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.322 -0.861 . . . . 0.0 109.967 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -78.37 -9.75 59.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.855 . . . . 0.0 110.045 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.586 HG21 ' HA ' ' A' ' 13' ' ' PHE . 17.3 p -110.54 -19.57 12.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.297 -0.877 . . . . 0.0 110.169 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.23 23.42 48.35 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.491 ' HB3' ' CG2' ' A' ' 2' ' ' THR . 33.4 m -101.02 171.1 7.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -1.181 . . . . 0.0 110.231 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 3' ' ' CYS . 23.8 pt -123.47 156.04 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.917 . . . . 0.0 109.985 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.607 ' O ' HG23 ' A' ' 35' ' ' ILE . 20.9 mm -106.09 152.37 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 110.404 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.734 HD11 ' SG ' ' A' ' 3' ' ' CYS . 4.6 pt -156.18 150.73 20.23 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.336 -0.852 . . . . 0.0 110.331 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo . . . . . 0 C--N 1.305 -1.712 0 O-C-N 124.15 1.605 . . . . 0.0 110.957 -179.665 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.548 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 8.2 m . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.525 ' O ' ' N ' ' A' ' 43' ' ' ASP . 52.8 Cg_endo -79.78 32.77 0.49 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.843 1.444 . . . . 0.0 111.593 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.06 -68.21 0.08 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 41' ' ' PRO . 0.3 OUTLIER -48.67 -41.44 31.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.111 -1.229 . . . . 0.0 109.774 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.547 ' CE2' ' HG3' ' A' ' 5' ' ' PRO . 0.5 OUTLIER -106.34 32.78 4.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -0.837 . . . . 0.0 109.887 179.629 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.548 ' HB2' ' HB2' ' A' ' 40' ' ' CYS . . . -105.31 96.33 6.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.324 -0.86 . . . . 0.0 110.243 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 45' ' ' ALA . 1.3 m-20 . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.111 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.45 ' O ' ' SG ' ' A' ' 3' ' ' CYS . 91.9 m . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.168 0.508 . . . . 0.0 110.363 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.451 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 49.1 m -153.63 154.7 34.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.344 -0.847 . . . . 0.0 110.321 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.13 171.31 9.15 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 109.983 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.1 -95.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.99 1.521 . . . . 0.0 110.707 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.4 t -76.11 157.77 32.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.496 -0.753 . . . . 0.0 110.423 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.409 ' O ' ' C ' ' A' ' 8' ' ' VAL . 2.4 mp -58.33 -50.07 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.882 . . . . 0.0 109.874 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.409 ' C ' ' O ' ' A' ' 7' ' ' ILE . 91.1 t -44.69 -47.97 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.312 -0.868 . . . . 0.0 109.901 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.91 -45.17 71.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 109.915 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.425 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 9.5 ttm-85 -63.45 -48.6 77.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.388 -0.82 . . . . 0.0 110.271 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -50.11 -59.26 4.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.141 -0.975 . . . . 0.0 110.132 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -55.2 -40.45 70.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.912 . . . . 0.0 110.016 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.486 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 51.0 t80 -56.88 -43.8 81.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 0.0 110.097 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -58.4 -42.08 86.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.241 -0.912 . . . . 0.0 109.263 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.595 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -61.89 -50.65 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.599 -0.688 . . . . 0.0 109.282 179.25 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.595 ' N ' HG12 ' A' ' 15' ' ' VAL . 13.9 t -48.25 -25.61 1.61 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.443 -0.786 . . . . 0.0 110.099 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.549 ' NH2' ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -91.16 10.53 26.6 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.428 -0.795 . . . . 0.0 109.585 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.646 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 2.3 tt -84.04 -36.87 0.64 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.517 -0.739 . . . . 0.0 112.349 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 43.8 Cg_endo -72.54 -37.61 4.01 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 O-C-N 122.994 0.997 . . . . 0.0 111.356 -178.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 135.38 1.22 3.19 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.526 -1.321 . . . . 0.0 110.429 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.966 HG22 ' HD2' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -66.4 157.04 83.81 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 120.97 -1.312 . . . . 0.0 109.486 179.733 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.966 ' HD2' HG22 ' A' ' 21' ' ' THR . 47.7 Cg_endo -74.98 149.5 36.86 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.795 1.418 . . . . 0.0 110.71 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.484 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 1.6 pt-20 -54.84 -25.4 28.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.349 -0.844 . . . . 0.0 110.14 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.17 -44.22 84.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.311 -0.868 . . . . 0.0 110.44 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.484 HD13 ' CG2' ' A' ' 21' ' ' THR . 0.5 OUTLIER -68.55 -33.69 74.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 110.444 -179.782 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.449 ' O ' ' OG1' ' A' ' 30' ' ' THR . 69.6 m -87.45 -32.83 19.29 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.052 -1.03 . . . . 0.0 110.581 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.58 -30.35 70.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.098 -1.001 . . . . 0.0 110.035 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.86 -28.1 17.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 0.0 110.15 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.462 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -68.84 -28.9 67.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.216 -0.928 . . . . 0.0 110.324 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -101.68 -30.52 11.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.214 -0.929 . . . . 0.0 110.092 179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.52 19.05 9.04 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -76.43 -177.55 4.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -1.135 . . . . 0.0 110.003 179.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 pp -145.81 159.53 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.154 -0.966 . . . . 0.0 110.485 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 53.4 mt -125.58 121.37 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.354 -0.842 . . . . 0.0 110.061 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.463 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 12.1 pt -93.46 163.79 23.38 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.935 . . . . 0.0 110.361 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.463 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 48.7 Cg_endo . . . . . 0 C--N 1.306 -1.701 0 O-C-N 124.008 1.531 . . . . 0.0 110.584 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 120.937 0.398 . . . . 0.0 110.314 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.699 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 46.4 Cg_endo -72.98 -166.56 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.152 1.606 . . . . 0.0 110.866 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.47 -5.62 39.48 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.517 ' OD2' ' N ' ' A' ' 44' ' ' TYR . 4.3 p30 -82.35 -24.42 34.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -1.14 . . . . 0.0 110.038 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.517 ' N ' ' OD2' ' A' ' 43' ' ' ASP . 0.2 OUTLIER -144.64 47.15 1.37 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 110.311 -179.817 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -118.61 89.42 3.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 110.065 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.1 m120 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.258 -179.94 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.573 HG22 ' O ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.273 0.559 . . . . 0.0 110.256 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.586 ' HB3' HD11 ' A' ' 33' ' ' ILE . 1.8 t -142.49 121.68 13.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.323 -0.861 . . . . 0.0 110.107 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.443 ' O ' ' OXT' ' A' ' 46' ' ' ASN . 57.8 m -120.71 150.11 51.9 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.246 -0.909 . . . . 0.0 110.214 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.518 ' HD3' ' CE2' ' A' ' 44' ' ' TYR . 52.6 Cg_endo -77.79 -94.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.125 1.592 . . . . 0.0 110.614 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 t -50.29 129.54 21.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.476 -0.765 . . . . 0.0 110.593 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' A' ' 7' ' ' ILE . 14.3 mm -50.71 -41.05 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.212 -0.93 . . . . 0.0 109.369 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 56.1 t -53.32 -47.3 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.436 -0.79 . . . . 0.0 109.715 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.47 -52.72 27.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.344 -0.847 . . . . 0.0 109.91 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.9 ttm-85 -55.64 -43.85 76.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.266 -0.896 . . . . 0.0 109.941 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.55 -56.97 6.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.0 109.933 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -60.08 -33.1 71.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.332 -0.855 . . . . 0.0 109.903 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.464 ' CZ ' ' HD3' ' A' ' 17' ' ' ARG . 16.1 t80 -70.96 -35.91 72.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.0 109.804 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -73.51 -44.57 57.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.346 -0.846 . . . . 0.0 109.447 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.519 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -54.91 -47.3 76.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.459 -0.775 . . . . 0.0 109.197 179.372 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.519 ' N ' HG12 ' A' ' 15' ' ' VAL . 29.7 t -68.78 -25.53 64.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.464 -0.772 . . . . 0.0 109.93 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.464 ' HD3' ' CZ ' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -88.74 -8.44 54.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.384 -0.822 . . . . 0.0 109.879 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.577 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -61.94 -45.62 91.95 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.462 -0.774 . . . . 0.0 110.654 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 18' ' ' LEU . 47.4 Cg_endo -78.29 -157.41 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.759 1.4 . . . . 0.0 110.075 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.6 61.77 2.75 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.577 HG23 HD13 ' A' ' 25' ' ' LEU . 99.1 m -119.47 140.67 29.55 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.237 -1.155 . . . . 0.0 110.306 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.47 ' HD2' HG23 ' A' ' 21' ' ' THR . 46.9 Cg_endo -72.31 170.37 19.36 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.006 1.53 . . . . 0.0 110.841 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.463 ' O ' ' N ' ' A' ' 25' ' ' LEU . 1.4 mt-10 -72.44 -55.27 7.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.358 -0.839 . . . . 0.0 110.477 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 23' ' ' GLU . . . -39.8 -28.48 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.355 -0.84 . . . . 0.0 110.603 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.577 HD13 HG23 ' A' ' 21' ' ' THR . 0.7 OUTLIER -81.3 -50.13 9.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.169 -0.957 . . . . 0.0 110.599 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.2 m -83.5 -27.6 29.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.141 -0.975 . . . . 0.0 110.666 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -74.14 -49.31 24.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.168 -0.957 . . . . 0.0 110.561 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.2 m -76.17 -23.41 54.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.224 -0.922 . . . . 0.0 110.503 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.428 ' CB ' ' O ' ' A' ' 25' ' ' LEU . 48.1 t80 -81.44 -6.41 58.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.931 . . . . 0.0 110.413 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 31.3 p -119.19 -21.71 7.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 0.0 110.189 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.85 38.93 3.26 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 57.0 m -108.86 -179.34 3.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.18 -1.188 . . . . 0.0 110.23 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.586 HD11 ' HB3' ' A' ' 3' ' ' CYS . 9.1 pt -126.17 149.26 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.271 -0.893 . . . . 0.0 110.398 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.7 mt -109.0 124.65 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.265 -0.897 . . . . 0.0 109.957 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 23.5 pt -123.44 135.34 25.96 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.161 -0.962 . . . . 0.0 110.51 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo . . . . . 0 C--N 1.305 -1.738 0 O-C-N 123.958 1.504 . . . . 0.0 110.489 -179.941 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.492 1.633 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.43 ' HG2' ' OD1' ' A' ' 43' ' ' ASP . 50.0 Cg_endo -79.27 15.51 1.54 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.937 1.493 . . . . 0.0 111.189 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.32 -64.16 3.53 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.433 ' CG ' ' N ' ' A' ' 44' ' ' TYR . 4.6 p-10 -52.77 -44.14 66.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.272 -1.134 . . . . 0.0 110.971 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.518 ' CE2' ' HD3' ' A' ' 5' ' ' PRO . 1.8 m-85 -89.87 -2.13 58.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.066 -1.021 . . . . 0.0 110.5 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.501 ' O ' ' ND2' ' A' ' 46' ' ' ASN . . . -75.31 87.93 2.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.214 -0.929 . . . . 0.0 110.407 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.502 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.136 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.17 0.51 . . . . 0.0 109.991 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.511 ' HB2' HD11 ' A' ' 33' ' ' ILE . 29.9 m -139.21 128.58 24.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.201 -0.937 . . . . 0.0 110.345 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -123.25 165.24 23.34 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.294 -0.879 . . . . 0.0 110.214 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.456 ' O ' ' CB ' ' A' ' 46' ' ' ASN . 47.8 Cg_endo -73.87 -93.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.924 1.486 . . . . 0.0 110.524 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.9 t -62.38 154.99 26.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.583 -0.698 . . . . 0.0 110.339 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.549 HD13 ' O ' ' A' ' 46' ' ' ASN . 48.7 mm -66.28 -30.01 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.333 -0.854 . . . . 0.0 109.776 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.7 t -69.44 -44.1 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.329 -0.857 . . . . 0.0 109.794 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.76 -42.1 67.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.394 -0.816 . . . . 0.0 110.067 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.459 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 5.2 ttp180 -67.22 -50.96 58.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 0.0 110.154 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.1 t -50.84 -46.26 60.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.256 -0.902 . . . . 0.0 110.334 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -61.71 -30.49 70.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.296 -0.877 . . . . 0.0 110.329 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.459 ' HB3' ' O ' ' A' ' 10' ' ' ARG . 48.5 t80 -67.9 -40.47 83.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.918 . . . . 0.0 110.232 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -58.05 -47.46 83.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -0.941 . . . . 0.0 109.381 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.604 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -54.31 -51.57 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.494 -0.754 . . . . 0.0 109.278 179.319 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.604 ' N ' HG12 ' A' ' 15' ' ' VAL . 35.4 t -48.66 -28.23 3.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.573 -0.704 . . . . 0.0 110.217 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.492 ' NE ' ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -88.6 -14.06 38.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.243 -0.911 . . . . 0.0 110.35 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.797 HD13 ' O ' ' A' ' 18' ' ' LEU . 1.8 tm? -54.89 -43.56 98.88 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.241 -0.912 . . . . 0.0 111.182 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 47.7 Cg_endo -75.86 -90.11 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.382 1.201 . . . . 0.0 110.495 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -175.12 55.7 0.12 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.671 HG22 ' HD2' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -106.76 146.18 32.57 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.293 -1.122 . . . . 0.0 110.059 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.671 ' HD2' HG22 ' A' ' 21' ' ' THR . 44.0 Cg_endo -72.04 136.0 26.35 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.903 1.475 . . . . 0.0 110.404 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 22' ' ' PRO . 3.9 mt-10 -39.7 -46.13 1.81 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.461 -0.774 . . . . 0.0 110.779 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.11 -38.51 52.27 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.324 -0.86 . . . . 0.0 111.038 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.472 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -72.51 -42.71 64.53 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.112 -0.993 . . . . 0.0 110.81 -179.248 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.429 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 73.8 m -74.49 -39.95 62.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.156 -0.965 . . . . 0.0 110.319 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.8 -41.81 92.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.139 -0.975 . . . . 0.0 110.238 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 38.7 m -75.09 -21.02 59.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.24 -0.913 . . . . 0.0 110.281 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -85.04 -20.9 29.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.283 -0.885 . . . . 0.0 110.24 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.7 p -120.01 -16.16 8.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.888 . . . . 0.0 110.342 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.96 53.58 3.9 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.53 -175.17 2.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.207 -1.172 . . . . 0.0 110.168 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' A' ' 3' ' ' CYS . 1.2 pt -142.04 147.42 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 110.41 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.543 ' O ' HG23 ' A' ' 35' ' ' ILE . 2.2 mp -115.11 139.69 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.445 -0.785 . . . . 0.0 110.129 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.543 HG23 ' O ' ' A' ' 34' ' ' ILE . 0.9 OUTLIER -154.68 121.15 2.74 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.199 -0.938 . . . . 0.0 110.367 -179.848 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo . . . . . 0 C--N 1.308 -1.605 0 O-C-N 123.896 1.472 . . . . 0.0 110.686 -179.957 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 120.684 0.278 . . . . 0.0 110.258 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.403 ' O ' ' N ' ' A' ' 45' ' ' ALA . 44.9 Cg_endo -72.27 135.04 23.99 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.94 1.495 . . . . 0.0 110.424 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.475 ' HA2' ' HB3' ' A' ' 45' ' ' ALA . . . -46.25 -38.73 9.02 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -48.15 -27.1 2.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.164 -1.198 . . . . 0.0 110.314 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.58 6.41 2.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.27 -0.894 . . . . 0.0 110.392 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.475 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . . . -90.94 89.45 7.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.111 -0.993 . . . . 0.0 110.147 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.549 ' O ' HD13 ' A' ' 7' ' ' ILE . 43.0 m-20 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.131 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 99.3 m . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.264 0.554 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.503 ' SG ' HD11 ' A' ' 35' ' ' ILE . 19.0 m -128.94 131.23 47.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.269 -0.894 . . . . 0.0 110.174 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.472 ' CB ' ' OXT' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -122.02 153.48 60.93 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.225 -0.922 . . . . 0.0 110.324 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.551 ' HD3' ' CE1' ' A' ' 44' ' ' TYR . 50.9 Cg_endo -78.1 -93.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.08 1.568 . . . . 0.0 110.719 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.81 138.05 58.31 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.547 -0.721 . . . . 0.0 110.914 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.416 ' O ' ' HB3' ' A' ' 10' ' ' ARG . 89.0 mt -47.92 -38.9 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.265 -0.897 . . . . 0.0 109.808 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.458 ' O ' ' OG ' ' A' ' 11' ' ' SER . 94.4 t -51.71 -61.49 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.381 -0.824 . . . . 0.0 110.285 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.442 ' O ' ' OD1' ' A' ' 12' ' ' ASN . . . -45.91 -32.3 2.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.159 -0.963 . . . . 0.0 110.251 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 46' ' ' ASN . 0.3 OUTLIER -74.87 -46.96 32.72 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.306 -0.871 . . . . 0.0 110.748 -179.734 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 8' ' ' VAL . 10.6 p -54.88 -69.05 0.14 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.091 -1.006 . . . . 0.0 110.534 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 13' ' ' PHE . 9.4 p30 -51.15 -37.6 47.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.167 -0.958 . . . . 0.0 110.656 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.516 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 37.0 t80 -50.82 -50.04 57.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.146 -0.971 . . . . 0.0 110.538 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.509 ' OD1' ' NH2' ' A' ' 17' ' ' ARG . 18.9 m-80 -63.91 -41.84 97.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.191 -0.943 . . . . 0.0 109.604 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.561 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -59.61 -48.84 85.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.52 -0.737 . . . . 0.0 109.424 179.369 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.561 ' N ' HG12 ' A' ' 15' ' ' VAL . 44.8 t -57.16 -22.8 42.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.588 -0.695 . . . . 0.0 110.342 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.509 ' NH2' ' OD1' ' A' ' 14' ' ' ASN . 9.7 mtm180 -83.78 -3.98 58.28 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.1 -1.0 . . . . 0.0 110.244 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.611 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 16.6 tp -71.68 -47.75 12.2 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 110.749 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 46.1 Cg_endo -71.33 -155.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.352 1.185 . . . . 0.0 110.39 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.98 2.55 87.12 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.511 HG22 ' HB3' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -72.83 125.49 91.13 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.092 -1.24 . . . . 0.0 109.982 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.29 146.95 46.52 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.883 1.465 . . . . 0.0 110.521 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.496 ' HG3' ' N ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -50.21 -22.56 1.78 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.274 -0.891 . . . . 0.0 110.176 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.496 ' N ' ' HG3' ' A' ' 23' ' ' GLU . . . -67.27 -48.78 66.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.932 . . . . 0.0 110.013 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.511 ' HB3' HG22 ' A' ' 21' ' ' THR . 1.0 OUTLIER -69.25 -30.52 68.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.873 . . . . 0.0 109.843 179.707 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 78.7 m -75.97 -49.67 17.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -0.885 . . . . 0.0 109.967 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.39 -25.62 50.37 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.155 -0.965 . . . . 0.0 109.819 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.6 m -89.91 -18.85 25.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.307 -0.871 . . . . 0.0 110.025 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.427 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 1.6 t80 -89.01 -20.36 24.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.395 -0.816 . . . . 0.0 110.402 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.6 p -108.42 -39.86 5.3 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.153 -0.967 . . . . 0.0 110.394 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.22 32.51 1.05 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.89 174.58 6.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -1.13 . . . . 0.0 110.14 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.408 HG12 ' CD1' ' A' ' 44' ' ' TYR . 2.6 pt -138.62 147.54 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 110.362 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.9 mp -109.17 138.36 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.329 -0.857 . . . . 0.0 110.259 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.503 HD11 ' SG ' ' A' ' 3' ' ' CYS . 21.8 pt -134.24 143.94 49.17 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.317 -0.864 . . . . 0.0 110.203 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo . . . . . 0 C--N 1.306 -1.675 0 O-C-N 124.014 1.534 . . . . 0.0 110.435 -179.915 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.479 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 87.6 m . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 40' ' ' CYS . 43.1 Cg_endo -70.98 -166.23 0.22 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.88 1.463 . . . . 0.0 110.272 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.72 -1.94 43.03 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -108.64 -6.5 15.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -1.159 . . . . 0.0 110.218 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.551 ' CE1' ' HD3' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -143.59 36.46 1.32 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.217 -0.927 . . . . 0.0 110.155 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -99.51 88.23 3.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.288 -0.882 . . . . 0.0 110.297 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.25 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.491 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.282 0.563 . . . . 0.0 110.378 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.412 ' C ' ' SG ' ' A' ' 32' ' ' CYS . 77.4 m -144.85 113.42 6.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.39 -0.819 . . . . 0.0 109.644 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.514 ' O ' ' CB ' ' A' ' 46' ' ' ASN . 65.6 m -99.41 151.21 37.35 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.929 . . . . 0.0 110.513 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 44' ' ' TYR . 50.8 Cg_endo -76.72 -93.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.998 1.525 . . . . 0.0 110.503 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.67 137.5 58.28 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.595 -0.69 . . . . 0.0 110.598 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.471 ' O ' ' HB3' ' A' ' 10' ' ' ARG . 10.0 mt -54.39 -33.64 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.18 -0.95 . . . . 0.0 109.789 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.6 t -48.98 -53.08 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.13 -0.981 . . . . 0.0 109.581 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.11 -40.43 73.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.268 -0.895 . . . . 0.0 109.48 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.491 ' CZ ' ' OXT' ' A' ' 46' ' ' ASN . 0.6 OUTLIER -52.9 -57.02 11.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.41 -0.806 . . . . 0.0 109.932 179.581 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 14' ' ' ASN . 9.6 m -51.42 -40.86 60.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.255 -0.903 . . . . 0.0 109.921 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -64.25 -43.98 93.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.331 -0.856 . . . . 0.0 109.867 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.491 ' CZ ' HG21 ' A' ' 2' ' ' THR . 10.9 t80 -53.72 -26.79 24.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -0.855 . . . . 0.0 109.828 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 11' ' ' SER . 48.5 m-80 -74.83 -43.7 53.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.377 -0.827 . . . . 0.0 109.598 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.557 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -63.9 -49.17 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.406 -0.809 . . . . 0.0 109.41 179.594 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.557 ' N ' HG12 ' A' ' 15' ' ' VAL . 42.3 t -52.4 -41.81 63.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.362 -0.836 . . . . 0.0 110.222 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -80.93 -2.0 45.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.284 -0.885 . . . . 0.0 110.531 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.586 ' HB3' ' HD3' ' A' ' 19' ' ' PRO . 3.9 tp -51.75 -54.17 42.9 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.085 -1.009 . . . . 0.0 110.259 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.586 ' HD3' ' HB3' ' A' ' 18' ' ' LEU . 43.9 Cg_endo -69.6 -52.72 0.32 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.38 1.2 . . . . 0.0 110.396 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.19 39.43 0.05 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.65 HG21 HD22 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -87.37 152.0 51.79 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.19 -1.182 . . . . 0.0 109.768 179.769 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.62 ' HD2' HG22 ' A' ' 21' ' ' THR . 43.5 Cg_endo -70.93 155.21 62.5 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.823 1.433 . . . . 0.0 110.57 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 24' ' ' ALA . 1.5 mp0 -53.64 -49.67 67.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.316 -0.865 . . . . 0.0 110.511 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.456 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -42.33 -49.74 5.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.225 -0.922 . . . . 0.0 110.341 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.65 HD22 HG21 ' A' ' 21' ' ' THR . 0.2 OUTLIER -59.82 -42.6 93.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 110.506 -179.841 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.546 ' O ' HG23 ' A' ' 30' ' ' THR . 27.5 m -77.93 -50.12 12.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.163 -0.961 . . . . 0.0 110.472 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.51 -20.23 64.41 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.239 -0.913 . . . . 0.0 110.366 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 46.3 m -88.04 -26.27 22.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.894 . . . . 0.0 110.378 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -101.77 -10.49 19.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.152 -0.968 . . . . 0.0 110.399 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.546 HG23 ' O ' ' A' ' 26' ' ' CYS . 76.4 p -103.66 -27.16 12.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 110.274 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.48 28.97 5.82 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.412 ' SG ' ' C ' ' A' ' 3' ' ' CYS . 1.6 t -99.73 -178.17 3.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.349 -1.089 . . . . 0.0 110.306 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.7 pt -139.43 148.79 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.879 . . . . 0.0 110.23 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.4 mt -112.25 133.97 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 109.976 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.3 pt -119.38 154.14 53.96 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 110.119 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 C--N 1.304 -1.796 0 O-C-N 124.145 1.603 . . . . 0.0 110.645 -179.736 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 2' ' ' THR . 23.4 m . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.979 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 43.1 Cg_endo -70.35 -178.25 2.47 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.984 1.518 . . . . 0.0 110.552 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.21 -8.56 57.64 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -114.97 -29.17 6.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -1.156 . . . . 0.0 110.04 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 5' ' ' PRO . 0.5 OUTLIER -107.47 9.36 29.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 110.151 179.889 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.979 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -72.75 90.9 1.44 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.352 -0.842 . . . . 0.0 110.271 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.514 ' CB ' ' O ' ' A' ' 4' ' ' CYS . 1.6 m-20 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.156 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.436 HG22 ' SG ' ' A' ' 32' ' ' CYS . 1.1 m . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.14 0.495 . . . . 0.0 109.986 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.412 ' C ' ' SG ' ' A' ' 32' ' ' CYS . 0.5 OUTLIER -139.69 91.99 2.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.21 -0.931 . . . . 0.0 110.297 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.478 ' N ' ' SG ' ' A' ' 32' ' ' CYS . 25.7 m -96.5 165.64 15.72 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.28 -0.887 . . . . 0.0 110.09 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 46' ' ' ASN . 49.3 Cg_endo -78.59 -92.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.31 1.689 . . . . 0.0 110.442 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 7' ' ' ILE . 1.4 t -75.55 143.29 42.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.499 -0.75 . . . . 0.0 109.932 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.401 ' C ' ' O ' ' A' ' 6' ' ' SER . 11.8 mt -42.76 -52.91 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.188 -0.945 . . . . 0.0 110.198 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.7 t -43.09 -54.03 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 109.985 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.64 -40.4 19.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.306 -0.871 . . . . 0.0 109.962 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -63.78 -49.87 71.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.327 -0.858 . . . . 0.0 110.077 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.61 -50.53 65.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.875 . . . . 0.0 110.021 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.444 ' O ' HG12 ' A' ' 15' ' ' VAL . 38.5 m-80 -51.3 -40.02 58.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.883 . . . . 0.0 110.07 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.58 ' CZ ' ' HB2' ' A' ' 23' ' ' GLU . 71.7 t80 -60.15 -54.04 50.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.921 . . . . 0.0 110.043 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -62.91 -24.89 68.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.295 -0.878 . . . . 0.0 109.19 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.601 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -78.59 -50.72 18.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.404 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.601 ' N ' HG12 ' A' ' 15' ' ' VAL . 46.3 t -51.64 -20.97 2.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.412 -0.805 . . . . 0.0 110.118 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.407 ' HD2' ' HB3' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -89.45 10.12 23.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.211 -0.931 . . . . 0.0 110.167 179.829 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.62 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 2.3 tp -83.44 -42.0 0.81 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.199 -0.938 . . . . 0.0 111.575 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 46.1 Cg_endo -73.9 -94.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.331 1.174 . . . . 0.0 111.0 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -160.82 33.46 0.4 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.495 HG22 ' HD2' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -107.13 141.58 23.22 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.229 -1.159 . . . . 0.0 110.087 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.495 ' HD2' HG22 ' A' ' 21' ' ' THR . 44.9 Cg_endo -70.96 136.25 29.38 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.984 1.518 . . . . 0.0 110.313 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.58 ' HB2' ' CZ ' ' A' ' 13' ' ' PHE . 5.7 pt-20 -42.35 -32.23 0.49 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.24 -0.913 . . . . 0.0 110.205 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.43 -59.54 3.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.171 -0.956 . . . . 0.0 109.945 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.502 HD23 ' O ' ' A' ' 25' ' ' LEU . 1.0 OUTLIER -61.96 -28.52 69.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.183 -0.948 . . . . 0.0 109.938 179.806 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.471 ' O ' HG23 ' A' ' 30' ' ' THR . 58.6 m -73.62 -50.88 18.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 110.381 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.63 -43.12 79.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 0.0 110.348 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.8 m -64.69 -28.67 69.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.221 -0.924 . . . . 0.0 110.511 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -97.91 -34.0 11.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.105 -0.997 . . . . 0.0 110.565 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.471 HG23 ' O ' ' A' ' 26' ' ' CYS . 63.9 p -77.62 -8.13 57.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.198 -0.939 . . . . 0.0 110.161 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.464 ' O ' ' HD3' ' A' ' 5' ' ' PRO . . . 70.95 42.71 59.36 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.478 ' SG ' ' N ' ' A' ' 4' ' ' CYS . 14.3 t -127.26 170.15 12.75 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.103 -1.233 . . . . 0.0 110.081 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.575 HD12 HG23 ' A' ' 35' ' ' ILE . 1.1 pt -140.32 156.98 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.099 -1.0 . . . . 0.0 110.439 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.3 mt -110.84 127.31 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.342 -0.849 . . . . 0.0 110.092 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.575 HG23 HD12 ' A' ' 33' ' ' ILE . 2.0 pt -119.25 140.9 29.63 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.155 -0.966 . . . . 0.0 110.586 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 C--N 1.307 -1.642 0 O-C-N 124.109 1.584 . . . . 0.0 110.516 179.929 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.47 ' SG ' ' HD2' ' A' ' 41' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 120.711 0.291 . . . . 0.0 110.279 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.47 ' HD2' ' SG ' ' A' ' 40' ' ' CYS . 47.7 Cg_endo -74.08 166.68 29.01 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.979 1.515 . . . . 0.0 110.276 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.98 -22.75 75.98 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -61.67 -34.18 75.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.235 -1.156 . . . . 0.0 110.208 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -136.38 66.13 1.5 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 110.173 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.477 ' O ' ' CB ' ' A' ' 46' ' ' ASN . . . -121.87 86.71 2.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.097 -1.002 . . . . 0.0 110.648 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.553 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 1.5 m-20 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.084 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.435 HG22 ' SG ' ' A' ' 32' ' ' CYS . 1.3 m . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.243 0.544 . . . . 0.0 110.231 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 59.4 m -128.31 113.78 16.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.885 . . . . 0.0 110.182 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -105.88 169.01 7.44 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 0.0 110.28 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.537 ' HD2' ' HB1' ' A' ' 9' ' ' ALA . 48.4 Cg_endo -72.77 -94.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.973 1.512 . . . . 0.0 110.986 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.6 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 30.6 t -78.89 156.7 28.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.463 -0.773 . . . . 0.0 110.699 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.9 mt -49.29 -54.48 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -0.874 . . . . 0.0 109.836 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.5 t -46.7 -42.87 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.893 . . . . 0.0 109.492 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.6 ' HB3' ' O ' ' A' ' 6' ' ' SER . . . -50.44 -40.62 51.01 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.312 -0.868 . . . . 0.0 109.413 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.471 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 0.8 OUTLIER -70.69 -43.99 67.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.436 -0.79 . . . . 0.0 109.67 179.518 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.9 t -48.99 -63.15 1.18 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 109.735 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -47.1 -47.01 23.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.783 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.471 ' HB3' ' O ' ' A' ' 10' ' ' ARG . 11.2 t80 -54.41 -38.29 66.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.387 -0.821 . . . . 0.0 109.769 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.66 -30.09 66.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 108.999 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -65.22 -44.3 95.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.523 0.678 . . . . 0.0 109.24 179.242 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.482 ' N ' HG12 ' A' ' 15' ' ' VAL . 37.9 t -65.45 -26.16 67.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.465 -0.772 . . . . 0.0 110.435 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -75.61 -33.17 60.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.468 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.55 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -50.51 -52.51 54.81 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.16 -0.963 . . . . 0.0 110.541 -179.775 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 47.6 Cg_endo -71.65 -156.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.413 1.217 . . . . 0.0 110.299 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.93 59.22 0.42 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.494 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 6.7 m -113.24 144.26 30.85 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.354 -1.086 . . . . 0.0 110.08 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.494 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 45.6 Cg_endo -71.98 151.4 56.19 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 124.038 1.547 . . . . 0.0 110.382 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -53.69 -32.88 53.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.301 -0.874 . . . . 0.0 110.154 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.456 ' O ' ' HB ' ' A' ' 28' ' ' THR . . . -57.93 -50.65 72.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.323 -0.861 . . . . 0.0 110.542 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.474 ' HB3' ' CG2' ' A' ' 21' ' ' THR . 0.1 OUTLIER -65.69 -26.88 67.97 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.074 -1.016 . . . . 0.0 110.358 -179.65 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 19.0 m -81.64 -49.13 10.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.235 -0.916 . . . . 0.0 110.412 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -72.2 -50.14 29.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.148 -0.97 . . . . 0.0 110.622 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.456 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 80.4 m -59.62 -44.97 93.25 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.23 -0.919 . . . . 0.0 110.85 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -67.37 -15.62 63.79 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.104 -0.997 . . . . 0.0 110.637 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.3 p -110.98 -22.16 11.64 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.114 -0.991 . . . . 0.0 110.512 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 98.89 23.21 11.96 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.435 ' SG ' HG22 ' A' ' 2' ' ' THR . 0.1 OUTLIER -84.44 175.01 9.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.329 -1.101 . . . . 0.0 109.922 179.837 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.502 ' CD1' HG23 ' A' ' 35' ' ' ILE . 2.3 pp -138.93 152.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.134 -0.979 . . . . 0.0 110.484 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.3 mt -115.19 124.46 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.39 -0.819 . . . . 0.0 110.363 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.502 HG23 ' CD1' ' A' ' 33' ' ' ILE . 11.8 pt -110.89 148.01 37.71 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.18 -0.95 . . . . 0.0 110.207 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo . . . . . 0 C--N 1.305 -1.719 0 O-C-N 123.951 1.501 . . . . 0.0 110.627 -179.876 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.455 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.454 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 45.2 Cg_endo -72.42 162.99 39.94 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.918 1.483 . . . . 0.0 110.462 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.29 11.61 57.61 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -99.79 -21.69 15.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -1.148 . . . . 0.0 110.185 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.479 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 1.7 t80 -150.08 48.08 0.92 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.24 -0.912 . . . . 0.0 110.092 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.455 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . . . -121.83 101.45 7.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.324 -0.86 . . . . 0.0 110.275 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.068 179.891 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.842 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.216 -0.693 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.831 HG21 ' CE2' ' A' ' 13' ' ' PHE . 50.8 m -136.69 149.77 48.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -0.922 . . . . 0.0 110.409 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 32.7 m -134.5 124.95 26.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.316 -0.865 . . . . 0.0 109.897 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.11 146.82 49.98 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.08 -1.013 . . . . 0.0 110.519 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.574 ' HD3' ' CE1' ' A' ' 44' ' ' TYR . 50.3 Cg_endo -75.83 -94.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.091 1.574 . . . . 0.0 110.547 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.477 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 7.1 t -48.25 123.24 6.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.5 -0.75 . . . . 0.0 110.363 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.407 ' O ' ' C ' ' A' ' 8' ' ' VAL . 2.5 mp -47.71 -54.83 2.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 110.108 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.407 ' C ' ' O ' ' A' ' 7' ' ' ILE . 21.6 t -44.34 -45.93 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 109.847 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 6' ' ' SER . . . -50.74 -42.87 57.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.2 -0.938 . . . . 0.0 109.721 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.406 ' O ' ' C ' ' A' ' 11' ' ' SER . 0.1 OUTLIER -68.77 -48.32 63.98 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.204 -0.935 . . . . 0.0 109.994 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 10' ' ' ARG . 0.2 OUTLIER -43.71 -42.12 5.2 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.89 . . . . 0.0 109.824 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 -75.3 -36.08 61.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.262 -0.898 . . . . 0.0 109.853 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.831 ' CE2' HG21 ' A' ' 2' ' ' THR . 27.1 t80 -62.32 -33.26 74.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.331 -0.856 . . . . 0.0 109.923 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.73 -26.74 37.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.298 -0.876 . . . . 0.0 109.021 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.401 HG12 ' N ' ' A' ' 16' ' ' CYS . 1.2 t -82.49 -42.66 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.661 -0.649 . . . . 0.0 109.249 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.472 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 30.7 t -66.74 -24.34 66.21 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.314 -0.867 . . . . 0.0 109.767 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.447 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 0.7 OUTLIER -88.07 -12.48 44.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.322 -0.861 . . . . 0.0 109.785 179.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.578 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -54.97 -46.88 99.55 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.393 -0.817 . . . . 0.0 110.254 179.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 18' ' ' LEU . 49.7 Cg_endo -80.11 -157.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.927 1.488 . . . . 0.0 110.148 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -90.92 72.65 1.85 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.509 HG22 ' HB3' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -130.93 134.1 25.57 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.272 -1.134 . . . . 0.0 110.153 -179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.46 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 44.5 Cg_endo -72.98 139.16 29.56 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.95 1.5 . . . . 0.0 110.576 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -44.35 -31.64 1.1 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.406 -0.809 . . . . 0.0 110.412 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.89 -41.78 99.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.192 -0.943 . . . . 0.0 110.342 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.509 ' HB3' HG22 ' A' ' 21' ' ' THR . 0.1 OUTLIER -66.81 -37.16 83.98 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.313 -0.867 . . . . 0.0 110.259 -179.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.604 ' O ' HG23 ' A' ' 30' ' ' THR . 47.3 m -85.8 -45.89 11.17 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.278 -0.889 . . . . 0.0 110.185 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -45.3 -36.05 3.85 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.203 -0.936 . . . . 0.0 109.888 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.0 m -79.09 -49.46 12.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.922 . . . . 0.0 109.912 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -64.54 -26.61 68.49 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.358 -0.839 . . . . 0.0 109.926 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.74 HG21 ' HA ' ' A' ' 13' ' ' PHE . 26.5 p -96.53 -51.36 4.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.324 -0.86 . . . . 0.0 110.218 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.42 22.08 3.2 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.414 ' HB3' ' CG2' ' A' ' 2' ' ' THR . 27.2 m -97.56 168.12 10.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.247 -1.149 . . . . 0.0 110.225 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.0 pt -121.04 155.71 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.212 -0.93 . . . . 0.0 110.273 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.9 mt -104.4 125.63 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.209 -0.932 . . . . 0.0 110.219 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.45 ' O ' HG13 ' A' ' 35' ' ' ILE . 3.9 pt -128.17 136.91 29.76 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.336 -0.853 . . . . 0.0 110.016 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.8 -12.77 24.28 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.029 1.541 . . . . 0.0 110.795 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.591 ' O ' ' HB3' ' A' ' 38' ' ' ALA . . . 173.34 -154.38 20.14 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.695 ' O ' HG22 ' A' ' 39' ' ' THR . . . 62.99 28.18 16.18 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.3 -1.118 . . . . 0.0 110.184 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.695 HG22 ' O ' ' A' ' 38' ' ' ALA . 9.0 t 38.91 -159.62 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.554 -0.716 . . . . 0.0 110.636 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.473 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 86.8 m -96.53 165.36 16.26 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.31 -0.868 . . . . 0.0 109.96 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.548 ' HG2' ' CB ' ' A' ' 44' ' ' TYR . 43.1 Cg_endo -68.8 -161.4 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.917 1.482 . . . . 0.0 110.315 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.82 -3.83 34.23 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -126.73 -5.07 6.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.192 -1.181 . . . . 0.0 110.224 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.574 ' CE1' ' HD3' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -120.9 18.8 11.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.359 -0.838 . . . . 0.0 110.039 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.64 93.6 8.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.284 -0.885 . . . . 0.0 110.161 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.502 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.995 -1.002 . . . . 0.0 110.258 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.851 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.728 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.826 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 2.2 m -130.21 154.82 47.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.0 110.018 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 35.5 m -151.5 130.31 12.44 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.196 -0.94 . . . . 0.0 110.276 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.738 ' SG ' ' HB1' ' A' ' 9' ' ' ALA . 0.5 OUTLIER -131.05 148.76 71.55 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.314 -0.866 . . . . 0.0 110.112 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.546 ' HG3' ' CE1' ' A' ' 44' ' ' TYR . 50.0 Cg_endo -84.3 -91.59 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.103 1.58 . . . . 0.0 110.894 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.512 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 3.8 t -39.05 127.66 1.65 Allowed 'General case' 0 N--CA 1.493 1.712 0 CA-C-O 121.505 0.669 . . . . 0.0 110.992 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.3 mt -49.92 -54.44 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.266 -0.897 . . . . 0.0 109.627 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.421 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 50.0 t -45.69 -48.88 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.324 -0.86 . . . . 0.0 109.701 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.738 ' HB1' ' SG ' ' A' ' 4' ' ' CYS . . . -45.79 -39.57 8.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.261 -0.899 . . . . 0.0 109.646 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -67.57 -44.37 78.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.27 -0.894 . . . . 0.0 110.234 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.403 ' O ' ' C ' ' A' ' 12' ' ' ASN . 10.2 t -57.12 -77.1 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.214 -0.929 . . . . 0.0 110.182 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.492 ' OD1' ' N ' ' A' ' 13' ' ' PHE . 10.2 p30 -44.52 -35.8 2.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.177 -0.952 . . . . 0.0 110.053 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.934 ' HA ' HG21 ' A' ' 30' ' ' THR . 19.5 t80 -64.99 -56.04 15.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.229 -0.919 . . . . 0.0 110.096 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -62.62 -43.72 98.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.207 -0.933 . . . . 0.0 109.26 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -61.6 -45.58 98.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.539 -0.726 . . . . 0.0 109.246 179.156 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.505 ' N ' HG12 ' A' ' 15' ' ' VAL . 34.8 t -50.87 -29.99 13.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.572 -0.705 . . . . 0.0 110.304 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -85.23 -4.12 59.05 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.203 -0.935 . . . . 0.0 110.328 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.596 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 3.7 tt -69.88 -46.28 23.66 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.165 -0.959 . . . . 0.0 110.633 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 47.8 Cg_endo -74.27 -155.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.382 0 O-C-N 123.289 1.152 . . . . 0.0 109.998 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -89.39 27.47 7.71 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.875 -1.29 . . . . 0.0 109.875 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.458 ' OG1' ' HG2' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -93.56 137.32 23.38 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.146 -1.208 . . . . 0.0 110.029 179.759 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.446 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 48.3 Cg_endo -75.42 166.78 28.01 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.988 1.52 . . . . 0.0 110.658 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.41 ' O ' ' C ' ' A' ' 24' ' ' ALA . 4.1 tt0 -65.39 -50.34 65.88 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.329 -0.857 . . . . 0.0 110.228 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 23' ' ' GLU . . . -43.56 -51.66 6.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.214 -0.929 . . . . 0.0 110.382 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.447 HD13 ' CG2' ' A' ' 21' ' ' THR . 0.9 OUTLIER -57.22 -37.71 72.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.252 -0.905 . . . . 0.0 110.35 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.439 ' O ' ' N ' ' A' ' 28' ' ' THR . 39.5 m -74.96 -63.04 1.35 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.887 . . . . 0.0 110.527 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 26' ' ' CYS . . . -41.91 -26.87 0.1 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.908 . . . . 0.0 110.441 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.439 ' N ' ' O ' ' A' ' 26' ' ' CYS . 20.2 m -90.08 -49.0 6.83 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.144 -0.973 . . . . 0.0 110.43 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -68.42 -27.09 65.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.186 -0.946 . . . . 0.0 110.268 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.934 HG21 ' HA ' ' A' ' 13' ' ' PHE . 26.4 p -87.03 -48.44 8.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.192 -0.942 . . . . 0.0 110.245 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.21 14.04 5.14 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.412 ' C ' HG23 ' A' ' 33' ' ' ILE . 56.8 m -86.7 -166.91 1.7 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.182 -1.187 . . . . 0.0 109.961 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.412 HG23 ' C ' ' A' ' 32' ' ' CYS . 11.4 pt -149.2 150.57 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.072 -1.017 . . . . 0.0 110.612 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.0 mt -100.53 138.38 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.347 -0.846 . . . . 0.0 109.981 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 27.1 pt -125.12 143.73 45.13 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.16 -0.962 . . . . 0.0 110.365 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.27 -16.5 24.9 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.015 1.534 . . . . 0.0 110.265 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -78.83 177.05 54.31 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -114.87 15.69 17.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.163 -1.198 . . . . 0.0 110.288 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.0 t -136.03 155.23 50.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 110.092 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 44' ' ' TYR . 5.4 t -107.72 135.31 19.8 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.271 -0.893 . . . . 0.0 110.086 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.08 -174.43 1.94 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.957 1.504 . . . . 0.0 110.706 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -91.6 -29.06 12.62 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -60.06 -26.0 65.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.281 -1.129 . . . . 0.0 110.184 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.546 ' CE1' ' HG3' ' A' ' 5' ' ' PRO . 0.8 OUTLIER -144.91 77.42 1.53 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.328 -0.857 . . . . 0.0 109.934 -179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -120.2 90.87 3.41 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.229 -0.919 . . . . 0.0 110.781 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.529 ' CB ' ' O ' ' A' ' 4' ' ' CYS . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 117.925 -1.036 . . . . 0.0 110.125 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.827 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.213 -0.832 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 1.057 HG21 ' CE1' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -89.88 140.37 29.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.03 -1.044 . . . . 0.0 109.979 . . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.479 ' O ' ' CG1' ' A' ' 33' ' ' ILE . 5.1 m -132.44 108.48 9.17 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.192 -0.943 . . . . 0.0 109.905 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.411 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 13.2 m -109.32 162.99 18.08 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.413 -0.804 . . . . 0.0 110.021 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 47.7 Cg_endo -73.22 -95.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.903 1.475 . . . . 0.0 110.534 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.6 t -68.78 139.44 55.29 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.39 -0.819 . . . . 0.0 110.266 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 24.4 mt -46.42 -41.72 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.174 -0.954 . . . . 0.0 109.769 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.509 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 44.1 t -49.14 -57.45 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.464 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 8' ' ' VAL . . . -44.76 -37.03 3.5 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.366 -0.834 . . . . 0.0 109.443 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.448 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -75.5 -41.06 56.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.386 -0.822 . . . . 0.0 109.864 179.562 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 13.2 t -48.73 -72.31 0.05 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.0 109.919 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 8' ' ' VAL . 2.2 p30 -48.74 -42.96 37.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.358 -0.839 . . . . 0.0 109.955 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 1.057 ' CE1' HG21 ' A' ' 2' ' ' THR . 53.4 t80 -51.79 -47.93 64.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.244 -0.91 . . . . 0.0 110.182 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 10' ' ' ARG . 11.2 m120 -60.81 -27.21 67.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.139 -0.976 . . . . 0.0 109.433 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.575 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -78.93 -49.58 19.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-O 121.587 0.708 . . . . 0.0 109.453 179.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.575 ' N ' HG12 ' A' ' 15' ' ' VAL . 14.2 t -55.33 -16.41 3.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.564 -0.71 . . . . 0.0 110.741 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.521 ' HD2' ' HG3' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -88.42 -3.13 58.89 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.191 -0.943 . . . . 0.0 110.721 -179.671 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.607 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.5 tt -76.4 -41.62 3.04 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.131 -0.981 . . . . 0.0 111.031 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 47.1 Cg_endo -76.16 -156.19 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.371 0 O-C-N 123.35 1.184 . . . . 0.0 110.042 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.56 27.2 19.82 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.449 ' CG2' ' SG ' ' A' ' 26' ' ' CYS . 29.8 m -90.41 133.19 33.49 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.057 -1.261 . . . . 0.0 109.928 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.493 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 44.2 Cg_endo -72.22 141.8 36.52 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.948 1.499 . . . . 0.0 110.594 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.521 ' HG3' ' HD2' ' A' ' 17' ' ' ARG . 7.2 mt-10 -43.31 -52.13 5.94 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.317 -0.864 . . . . 0.0 110.548 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 23' ' ' GLU . . . -41.98 -62.03 1.01 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 0.0 110.541 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.493 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -53.73 -36.91 62.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.286 -0.884 . . . . 0.0 110.562 -179.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.449 ' SG ' ' CG2' ' A' ' 21' ' ' THR . 91.2 m -76.68 -34.86 58.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.166 -0.959 . . . . 0.0 110.235 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -65.85 -16.6 63.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.173 -0.954 . . . . 0.0 110.326 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 45.6 m -91.01 -47.9 7.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.191 -0.943 . . . . 0.0 110.362 -179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -63.89 -23.22 67.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.198 -0.939 . . . . 0.0 110.226 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 37.0 p -101.19 -48.35 4.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.214 -0.929 . . . . 0.0 110.205 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.84 69.59 0.62 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 48.8 t -140.46 163.87 31.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.214 -1.168 . . . . 0.0 110.128 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.479 ' CG1' ' O ' ' A' ' 3' ' ' CYS . 5.8 pt -112.4 147.13 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.083 -1.011 . . . . 0.0 110.334 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 77.0 mt -119.12 145.73 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.328 -0.857 . . . . 0.0 109.968 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.492 HG12 ' O ' ' A' ' 1' ' ' THR . 15.5 pt -127.15 153.61 76.75 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 0.0 110.463 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.91 -7.91 20.58 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.02 1.537 . . . . 0.0 110.014 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.64 -145.9 16.43 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.1 18.98 1.76 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.189 -1.183 . . . . 0.0 110.478 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.422 ' O ' ' CD1' ' A' ' 35' ' ' ILE . 6.5 t -141.57 145.91 35.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.133 -0.98 . . . . 0.0 110.556 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 70.9 m -103.49 156.7 35.15 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.337 -0.852 . . . . 0.0 109.925 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.05 139.3 32.54 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.952 1.501 . . . . 0.0 110.28 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -55.17 -18.01 12.1 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -93.71 7.97 42.77 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.142 -1.21 . . . . 0.0 110.357 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.401 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 0.3 OUTLIER -166.85 52.81 0.08 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.211 -0.931 . . . . 0.0 110.2 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -124.75 87.72 2.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.334 -0.854 . . . . 0.0 110.107 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.974 -1.012 . . . . 0.0 110.055 -179.98 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.838 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.734 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.7 m -121.65 142.89 49.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 110.329 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.495 ' O ' HG12 ' A' ' 33' ' ' ILE . 19.7 m -134.06 121.07 21.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.267 -0.896 . . . . 0.0 110.252 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.484 ' HB2' ' OXT' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -116.75 165.43 15.28 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.327 -0.858 . . . . 0.0 110.083 179.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' A' ' 9' ' ' ALA . 49.3 Cg_endo -75.36 -94.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.116 1.588 . . . . 0.0 111.265 -179.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.4 t -92.62 168.5 11.19 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.699 0.761 . . . . 0.0 111.28 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.558 HG13 ' ND2' ' A' ' 46' ' ' ASN . 3.0 mt -51.67 -51.17 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.487 -0.758 . . . . 0.0 110.302 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.422 ' C ' ' O ' ' A' ' 7' ' ' ILE . 51.6 t -40.88 -53.26 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.383 -0.823 . . . . 0.0 110.139 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.451 ' O ' ' OD1' ' A' ' 12' ' ' ASN . . . -50.3 -40.8 49.65 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.292 -0.88 . . . . 0.0 109.557 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 46' ' ' ASN . 6.0 ttm180 -66.17 -37.61 86.05 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.268 -0.895 . . . . 0.0 110.276 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.4 t -60.67 -78.13 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.243 -0.911 . . . . 0.0 110.343 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 13' ' ' PHE . 12.1 p30 -45.91 -33.71 3.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.296 -0.878 . . . . 0.0 110.379 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.527 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 24.7 t80 -64.54 -48.15 76.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.394 -0.816 . . . . 0.0 110.4 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -65.13 -55.07 20.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -0.953 . . . . 0.0 110.063 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.624 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -49.77 -53.15 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.367 -0.833 . . . . 0.0 109.658 179.699 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.624 ' N ' HG12 ' A' ' 15' ' ' VAL . 42.2 t -49.51 -31.47 10.27 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -0.848 . . . . 0.0 110.297 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -80.93 -17.59 50.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.148 -0.97 . . . . 0.0 110.058 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.601 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.6 tp -56.21 -49.91 90.56 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.287 -0.883 . . . . 0.0 110.983 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 45.1 Cg_endo -71.51 -155.36 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.551 1.29 . . . . 0.0 110.282 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.08 61.86 1.07 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.0 m -129.84 132.55 24.23 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.279 -1.13 . . . . 0.0 109.893 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -70.8 148.76 59.06 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.993 1.523 . . . . 0.0 110.739 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.478 ' O ' ' CB ' ' A' ' 27' ' ' ALA . 15.9 pt-20 -53.53 -19.91 4.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.366 -0.834 . . . . 0.0 110.342 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -63.56 -48.55 76.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.226 -0.921 . . . . 0.0 110.22 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.09 -26.92 60.64 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.281 -0.887 . . . . 0.0 110.359 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 72.9 m -88.86 -29.26 19.8 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.232 -0.918 . . . . 0.0 110.445 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.478 ' CB ' ' O ' ' A' ' 23' ' ' GLU . . . -74.42 -24.61 59.12 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.271 -0.893 . . . . 0.0 110.209 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.4 m -87.56 -50.34 6.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.252 -0.905 . . . . 0.0 110.258 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -55.06 -23.78 21.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.187 -0.946 . . . . 0.0 110.124 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 67.5 p -98.27 -39.23 8.94 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 110.174 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 110.37 16.19 10.58 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -77.23 175.86 9.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -1.162 . . . . 0.0 110.01 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.495 HG12 ' O ' ' A' ' 3' ' ' CYS . 15.0 pt -136.43 163.51 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.174 -0.954 . . . . 0.0 110.294 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 58.0 mt -132.6 141.61 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.884 . . . . 0.0 110.253 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.65 HD12 ' O ' ' A' ' 37' ' ' GLY . 8.9 pt -145.41 127.18 7.79 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 110.265 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.13 57.47 3.33 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.834 1.439 . . . . 0.0 110.089 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.65 ' O ' HD12 ' A' ' 35' ' ' ILE . . . 119.27 -151.9 17.41 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.58 ' HB3' ' O ' ' A' ' 37' ' ' GLY . . . 61.1 103.03 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.156 -1.203 . . . . 0.0 109.904 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.433 ' C ' ' O ' ' A' ' 38' ' ' ALA . 0.1 OUTLIER -40.98 149.26 0.09 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.415 -0.803 . . . . 0.0 110.418 -179.864 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.462 ' SG ' ' HD2' ' A' ' 41' ' ' PRO . 7.7 t -88.18 140.19 30.58 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.338 -0.851 . . . . 0.0 110.266 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.462 ' HD2' ' SG ' ' A' ' 40' ' ' CYS . 44.7 Cg_endo -70.92 151.21 62.25 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.967 1.509 . . . . 0.0 110.467 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -70.05 -8.79 62.15 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.439 ' OD2' ' HB2' ' A' ' 41' ' ' PRO . 56.8 p30 -89.88 -1.51 58.0 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -1.173 . . . . 0.0 110.044 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -151.93 48.45 0.79 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.361 -0.837 . . . . 0.0 110.088 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.477 ' O ' ' OD1' ' A' ' 46' ' ' ASN . . . -114.57 87.78 2.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.268 -0.895 . . . . 0.0 110.099 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.558 ' ND2' HG13 ' A' ' 7' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.996 -1.002 . . . . 0.0 110.103 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.851 ' N ' ' CB ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.777 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.692 HG21 ' CE2' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -111.7 163.38 14.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.181 -0.95 . . . . 0.0 110.295 . . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 1.3 m -154.56 128.27 8.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.856 . . . . 0.0 109.937 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.42 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 61.1 m -115.29 163.28 20.69 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.23 -0.919 . . . . 0.0 110.328 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 49.4 Cg_endo -75.75 -94.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 124.021 1.537 . . . . 0.0 110.764 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.17 148.61 51.58 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.56 -0.713 . . . . 0.0 110.586 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 29.7 mt -60.0 -45.95 94.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.331 -0.856 . . . . 0.0 110.095 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.8 t -49.36 -43.73 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.185 -0.947 . . . . 0.0 109.786 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -60.02 -37.99 81.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 110.006 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.476 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 5.6 ttm180 -61.24 -55.66 29.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.23 -0.919 . . . . 0.0 110.106 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -45.52 -60.06 2.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.293 -0.88 . . . . 0.0 110.001 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -52.21 -22.93 4.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.334 -0.854 . . . . 0.0 110.114 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.692 ' CE2' HG21 ' A' ' 2' ' ' THR . 17.9 t80 -75.83 -29.97 58.83 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 110.37 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -74.24 -31.17 62.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 109.363 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.429 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.9 OUTLIER -69.3 -41.15 80.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.593 -0.692 . . . . 0.0 109.501 179.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.464 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 49.5 t -68.64 -32.14 71.78 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.555 -0.716 . . . . 0.0 110.998 -179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -84.77 -0.31 53.32 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.053 -1.029 . . . . 0.0 110.722 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.579 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -70.85 -48.9 14.57 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.086 -1.009 . . . . 0.0 110.208 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 48.2 Cg_endo -74.15 -155.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.584 1.308 . . . . 0.0 110.09 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -94.11 53.48 2.19 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.4 m -113.35 135.11 21.82 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.194 -1.18 . . . . 0.0 110.248 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.476 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 45.7 Cg_endo -73.64 158.56 47.15 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.876 1.461 . . . . 0.0 110.509 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.8 -35.86 77.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.303 -0.873 . . . . 0.0 110.327 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.34 -43.55 88.36 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.35 -0.844 . . . . 0.0 110.619 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.476 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -66.69 -34.42 77.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.109 -0.994 . . . . 0.0 110.285 -179.745 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 65.6 m -81.48 -47.93 12.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.193 -0.942 . . . . 0.0 110.066 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.93 -28.22 6.41 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.197 -0.939 . . . . 0.0 110.111 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.1 m -85.77 -37.8 18.9 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.234 -0.916 . . . . 0.0 110.251 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.84 -19.86 60.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.193 -0.942 . . . . 0.0 110.209 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.0 p -112.35 -58.94 2.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.238 -0.914 . . . . 0.0 110.266 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 129.91 34.98 0.46 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 64.0 m -101.3 162.93 12.54 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.315 -1.109 . . . . 0.0 110.09 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.408 ' O ' HG13 ' A' ' 33' ' ' ILE . 1.1 pp -122.99 149.55 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.218 -0.926 . . . . 0.0 110.176 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 4.9 mt -115.14 134.68 57.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.153 -0.967 . . . . 0.0 110.225 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 37' ' ' GLY . 41.4 pt -119.39 151.68 51.67 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.295 -0.878 . . . . 0.0 110.175 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -73.07 -16.83 25.31 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.009 1.531 . . . . 0.0 110.487 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.442 ' O ' HG13 ' A' ' 35' ' ' ILE . . . -98.52 173.92 27.71 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -99.7 -22.07 15.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.233 -1.157 . . . . 0.0 110.405 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.6 t -79.62 151.88 30.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.173 -0.955 . . . . 0.0 110.44 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -138.45 145.85 48.55 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.334 -0.854 . . . . 0.0 110.016 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.89 131.85 18.99 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.997 1.525 . . . . 0.0 110.61 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -48.31 -35.37 14.66 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.61 -47.12 58.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.206 -1.173 . . . . 0.0 110.049 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.92 62.48 0.68 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.333 -0.854 . . . . 0.0 110.054 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.432 ' O ' ' CG ' ' A' ' 46' ' ' ASN . . . -130.19 88.01 2.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.282 -0.886 . . . . 0.0 110.253 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.432 ' CG ' ' O ' ' A' ' 45' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 118.005 -0.998 . . . . 0.0 110.146 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.852 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.729 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.64 150.75 45.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.151 -0.968 . . . . 0.0 110.253 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.7 m -147.78 107.19 3.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.357 -0.84 . . . . 0.0 110.198 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.518 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 24.9 m -99.96 166.25 13.09 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.253 -0.904 . . . . 0.0 110.412 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.542 ' HG2' ' CB ' ' A' ' 9' ' ' ALA . 40.0 Cg_endo -71.41 -153.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 124.034 1.544 . . . . 0.0 110.353 179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.492 ' C ' ' O ' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -31.0 150.24 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.51 0.671 . . . . 0.0 111.548 -179.286 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.439 ' O ' ' C ' ' A' ' 8' ' ' VAL . 2.3 mt -48.44 -54.54 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.426 -0.796 . . . . 0.0 110.639 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.439 ' C ' ' O ' ' A' ' 7' ' ' ILE . 77.0 t -40.87 -55.29 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.437 -0.79 . . . . 0.0 110.322 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.542 ' CB ' ' HG2' ' A' ' 5' ' ' PRO . . . -53.22 -41.52 65.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.261 -0.899 . . . . 0.0 109.961 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.485 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -67.39 -49.75 62.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.272 -0.892 . . . . 0.0 109.951 179.689 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 p -47.66 -38.0 13.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -0.934 . . . . 0.0 109.969 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 13' ' ' PHE . 10.9 m-80 -70.72 -42.61 70.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.922 . . . . 0.0 110.007 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.485 ' HB3' ' O ' ' A' ' 10' ' ' ARG . 9.6 t80 -44.14 -46.43 8.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 0.0 109.764 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -69.55 -50.03 48.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.321 -0.862 . . . . 0.0 109.225 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.489 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.7 OUTLIER -51.64 -45.35 36.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.512 -0.742 . . . . 0.0 109.094 179.2 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.489 ' N ' HG12 ' A' ' 15' ' ' VAL . 40.0 t -66.4 -23.47 66.32 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.453 -0.779 . . . . 0.0 109.853 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.492 ' NH2' ' OE2' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -85.21 1.65 47.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 110.241 -179.819 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.568 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -60.87 -50.26 85.74 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.047 -1.033 . . . . 0.0 110.223 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 49.8 Cg_endo -73.65 -154.85 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.458 0 O-C-N 123.495 1.261 . . . . 0.0 109.621 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.9 64.01 0.88 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.556 HG23 HD22 ' A' ' 25' ' ' LEU . 18.6 m -115.12 140.28 25.45 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.242 -1.152 . . . . 0.0 110.453 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.61 ' HG2' HD13 ' A' ' 25' ' ' LEU . 47.8 Cg_endo -76.09 157.86 38.08 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.1 1.579 . . . . 0.0 110.279 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.492 ' OE2' ' NH2' ' A' ' 17' ' ' ARG . 1.2 mt-10 -58.3 -54.59 45.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.197 -0.94 . . . . 0.0 110.27 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.416 ' C ' ' O ' ' A' ' 23' ' ' GLU . . . -42.06 -32.34 0.45 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.284 -0.885 . . . . 0.0 110.644 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.61 HD13 ' HG2' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -76.94 -52.14 9.93 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.195 -0.941 . . . . 0.0 110.735 -179.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 73.0 m -76.82 -28.5 55.58 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.112 -0.992 . . . . 0.0 110.156 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.73 -48.2 80.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -0.891 . . . . 0.0 109.879 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 93.8 m -66.55 -43.09 86.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.312 -0.867 . . . . 0.0 109.657 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -54.92 -26.64 37.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.361 -0.837 . . . . 0.0 109.909 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.3 p -105.27 -11.98 16.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.33 -0.856 . . . . 0.0 110.082 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 88.88 14.47 60.89 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.591 -1.403 . . . . 0.0 109.591 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 7.5 t -78.57 167.94 20.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.155 -1.203 . . . . 0.0 110.167 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.2 pt -136.24 159.16 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.234 -0.916 . . . . 0.0 110.234 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.2 mt -124.51 122.95 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.33 -0.857 . . . . 0.0 110.498 -179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 35' ' ' ILE . 23.1 pt -126.08 142.99 44.13 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.297 -0.877 . . . . 0.0 109.948 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.14 -7.39 20.91 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.98 1.516 . . . . 0.0 110.309 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.449 ' O ' ' OG1' ' A' ' 1' ' ' THR . . . -81.87 170.96 52.05 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -116.18 13.93 15.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.284 -1.127 . . . . 0.0 109.986 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.606 HG23 ' O ' ' A' ' 39' ' ' THR . 10.8 t -120.92 123.22 41.95 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 110.303 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -119.77 151.91 52.87 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.17 -0.956 . . . . 0.0 110.177 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.429 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 46.3 Cg_endo -72.94 -174.2 1.47 Allowed 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 124.018 1.536 . . . . 0.0 110.413 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -106.88 10.87 41.19 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 43' ' ' ASP . 32.4 p-10 -104.86 -18.61 14.16 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.183 -1.187 . . . . 0.0 110.148 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.403 ' N ' ' OD1' ' A' ' 43' ' ' ASP . 0.1 OUTLIER -131.71 13.02 4.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -0.924 . . . . 0.0 110.117 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -93.83 88.65 5.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.246 -0.909 . . . . 0.0 110.17 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.015 -0.993 . . . . 0.0 110.181 179.958 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.83 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.808 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 1.134 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 17.4 m -83.94 140.63 31.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.371 -0.831 . . . . 0.0 110.228 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.3 m -146.81 158.48 43.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.294 -0.879 . . . . 0.0 110.237 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.518 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -150.66 162.45 27.21 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.3 -0.875 . . . . 0.0 110.023 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.518 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 49.7 Cg_endo -81.34 -92.9 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.892 1.47 . . . . 0.0 110.645 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -50.99 133.08 27.51 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.566 -0.708 . . . . 0.0 110.805 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.469 ' O ' ' HB3' ' A' ' 10' ' ' ARG . 11.7 mm -52.45 -38.46 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.393 -0.817 . . . . 0.0 110.046 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 54.1 t -58.21 -53.12 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -0.911 . . . . 0.0 110.103 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -46.6 -37.1 7.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.167 -0.958 . . . . 0.0 110.019 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.469 ' HB3' ' O ' ' A' ' 7' ' ' ILE . 2.1 tpp180 -65.02 -48.39 74.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.356 -0.84 . . . . 0.0 110.323 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.419 ' O ' ' C ' ' A' ' 12' ' ' ASN . 0.5 OUTLIER -52.76 -64.6 0.76 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.152 -0.967 . . . . 0.0 110.176 -179.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.419 ' C ' ' O ' ' A' ' 11' ' ' SER . 71.8 m-20 -43.18 -41.7 3.87 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.908 . . . . 0.0 110.22 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 1.134 ' CZ ' HG21 ' A' ' 2' ' ' THR . 33.0 t80 -62.03 -38.13 87.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.178 -0.951 . . . . 0.0 110.063 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -67.22 -32.6 73.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.206 -0.933 . . . . 0.0 109.717 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.609 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -71.8 -52.33 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.518 -0.739 . . . . 0.0 109.688 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.609 ' N ' HG12 ' A' ' 15' ' ' VAL . 41.0 t -54.54 -28.59 46.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.408 -0.808 . . . . 0.0 110.432 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.437 ' HD2' ' HG3' ' A' ' 23' ' ' GLU . 2.3 ttp85 -83.96 -12.42 55.35 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.203 -0.936 . . . . 0.0 110.132 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.581 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -59.34 -48.97 94.93 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.374 -0.829 . . . . 0.0 110.485 179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 47.6 Cg_endo -74.94 -155.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.575 0 O-C-N 123.731 1.385 . . . . 0.0 110.117 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.86 69.14 0.72 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.643 HG22 ' HD2' ' A' ' 22' ' ' PRO . 0.7 OUTLIER -130.38 145.28 56.76 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.207 -1.172 . . . . 0.0 110.134 179.686 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.643 ' HD2' HG22 ' A' ' 21' ' ' THR . 46.0 Cg_endo -73.4 135.13 21.85 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.917 1.483 . . . . 0.0 110.561 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.437 ' HG3' ' HD2' ' A' ' 17' ' ' ARG . 39.4 mt-10 -43.15 -46.57 5.96 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.348 -0.845 . . . . 0.0 110.053 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.409 ' HA ' HD11 ' A' ' 34' ' ' ILE . . . -42.8 -64.86 0.55 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.236 -0.915 . . . . 0.0 110.401 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.421 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -50.31 -33.12 19.0 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 110.461 -179.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 85.7 m -80.49 -53.68 6.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.179 -0.951 . . . . 0.0 110.197 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.485 ' HA ' ' OG1' ' A' ' 30' ' ' THR . . . -57.85 -16.24 11.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.0 109.725 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 51.6 m -79.19 -60.31 2.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.391 -0.818 . . . . 0.0 110.215 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -66.83 -16.24 64.15 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.296 -0.877 . . . . 0.0 110.51 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.485 ' OG1' ' HA ' ' A' ' 27' ' ' ALA . 24.1 p -92.67 -38.98 11.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.272 -0.892 . . . . 0.0 110.097 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.37 18.56 10.93 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 83.9 m -89.74 167.57 12.78 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.137 -1.213 . . . . 0.0 110.109 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.2 pt -115.37 152.08 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.888 . . . . 0.0 110.174 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.409 HD11 ' HA ' ' A' ' 24' ' ' ALA . 85.7 mt -118.74 121.99 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.283 -0.886 . . . . 0.0 110.291 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.747 HD12 ' O ' ' A' ' 37' ' ' GLY . 4.3 pt -117.84 157.02 49.27 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.188 -0.945 . . . . 0.0 110.416 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -77.2 -13.51 17.01 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 124.091 1.574 . . . . 0.0 110.546 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.747 ' O ' HD12 ' A' ' 35' ' ' ILE . . . 165.18 -146.11 10.88 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 37' ' ' GLY . . . 63.14 42.95 6.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.329 -1.101 . . . . 0.0 110.293 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.607 HG22 ' C ' ' A' ' 38' ' ' ALA . 7.0 t 36.74 -153.14 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.658 -0.651 . . . . 0.0 110.698 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 15.3 t -120.26 136.45 25.15 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.148 -0.97 . . . . 0.0 110.343 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.04 133.34 19.57 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.971 1.511 . . . . 0.0 110.417 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -51.34 -43.01 51.16 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -49.86 -22.89 1.63 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.254 -1.145 . . . . 0.0 110.155 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.45 ' CE2' ' HD3' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -145.68 59.29 1.26 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -0.884 . . . . 0.0 109.932 179.77 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -122.12 87.65 2.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.247 -0.908 . . . . 0.0 110.238 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.492 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 118.074 -0.965 . . . . 0.0 110.334 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.827 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.771 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.513 ' N ' ' OG1' ' A' ' 1' ' ' THR . 0.6 OUTLIER -74.9 145.09 42.98 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.277 -0.889 . . . . 0.0 110.298 . . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 44' ' ' TYR . 1.8 m -148.75 99.95 3.04 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.203 -0.936 . . . . 0.0 110.397 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.457 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 0.6 OUTLIER -105.8 142.33 24.57 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.271 -0.893 . . . . 0.0 110.139 179.853 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.457 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 45.8 Cg_endo -73.47 -93.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.004 1.528 . . . . 0.0 110.561 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -42.92 121.22 2.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.484 -0.76 . . . . 0.0 110.432 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.415 HD13 ' HB3' ' A' ' 46' ' ' ASN . 38.8 mm -55.13 -44.98 76.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.92 . . . . 0.0 110.108 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.9 t -53.54 -42.42 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -0.928 . . . . 0.0 109.839 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.48 -50.7 64.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.195 -0.941 . . . . 0.0 109.942 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 0.6 OUTLIER -47.86 -46.25 31.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.247 -0.908 . . . . 0.0 109.857 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.79 -36.45 83.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.882 . . . . 0.0 109.912 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.6 m-20 -71.1 -19.04 62.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.203 -0.935 . . . . 0.0 109.878 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.407 ' CZ ' ' HB3' ' A' ' 23' ' ' GLU . 12.3 t80 -75.11 -44.41 47.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.325 -0.859 . . . . 0.0 109.848 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 17' ' ' ARG . 76.7 m-20 -68.14 -43.85 77.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -0.907 . . . . 0.0 109.421 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.535 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -53.02 -48.19 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.447 -0.783 . . . . 0.0 109.344 179.35 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.535 ' N ' HG12 ' A' ' 15' ' ' VAL . 13.7 t -68.38 -15.27 63.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.494 -0.754 . . . . 0.0 110.049 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.474 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -87.07 -12.26 47.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.242 -0.911 . . . . 0.0 109.969 179.606 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.672 ' C ' HD13 ' A' ' 18' ' ' LEU . 3.2 tm? -67.37 -41.67 34.02 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.291 -0.88 . . . . 0.0 111.507 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 48.0 Cg_endo -74.66 -155.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.264 1.139 . . . . 0.0 110.325 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.94 52.86 2.92 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.099 -1.2 . . . . 0.0 110.099 -179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.4 m -129.69 137.49 31.03 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.146 -1.208 . . . . 0.0 110.145 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.467 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 43.6 Cg_endo -71.43 167.78 25.37 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 124.053 1.554 . . . . 0.0 110.549 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.448 ' HG3' ' HD3' ' A' ' 17' ' ' ARG . 32.5 mp0 -68.42 -52.79 28.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.285 -0.884 . . . . 0.0 110.336 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 23' ' ' GLU . . . -41.04 -41.48 1.7 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.378 -0.826 . . . . 0.0 110.474 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.467 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -68.81 -45.41 71.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.351 -0.843 . . . . 0.0 110.177 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 59.9 m -74.85 -51.69 13.3 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.344 -0.847 . . . . 0.0 110.27 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.77 -48.31 50.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.0 110.423 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 40.7 m -63.26 -35.03 79.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.227 -0.921 . . . . 0.0 110.334 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -78.56 -0.98 31.83 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.304 -0.873 . . . . 0.0 110.486 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.3 p -120.88 -25.61 5.37 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.196 -0.94 . . . . 0.0 110.226 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 112.92 6.4 22.81 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 22.5 m -84.35 139.71 32.08 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.149 -1.207 . . . . 0.0 110.266 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.525 HG12 ' CE1' ' A' ' 44' ' ' TYR . 1.1 pp -111.8 149.56 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.209 -0.932 . . . . 0.0 110.037 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.4 mt -120.74 117.39 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.209 -0.932 . . . . 0.0 110.349 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.649 HD12 ' O ' ' A' ' 37' ' ' GLY . 12.7 pt -122.19 140.38 32.31 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.387 -0.82 . . . . 0.0 110.081 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -75.11 -14.72 20.82 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.086 1.572 . . . . 0.0 110.619 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.649 ' O ' HD12 ' A' ' 35' ' ' ILE . . . -165.08 -145.58 4.46 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 37' ' ' GLY . . . 56.6 92.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -1.139 . . . . 0.0 110.084 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.434 ' C ' ' O ' ' A' ' 38' ' ' ALA . 1.2 t -41.63 145.73 0.28 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.257 -0.902 . . . . 0.0 110.379 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -81.89 159.4 65.99 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.155 -0.965 . . . . 0.0 110.045 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.504 ' O ' ' N ' ' A' ' 43' ' ' ASP . 47.7 Cg_endo -82.53 26.41 0.64 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.89 1.468 . . . . 0.0 111.378 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.45 -66.26 0.1 Allowed Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.972 -1.251 . . . . 0.0 109.972 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 41' ' ' PRO . 22.5 p-10 -48.33 -32.22 7.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.186 -1.185 . . . . 0.0 110.496 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.525 ' CE1' HG12 ' A' ' 33' ' ' ILE . 0.1 OUTLIER -81.38 -31.3 33.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.27 -0.894 . . . . 0.0 110.283 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.44 88.03 0.89 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.322 -0.861 . . . . 0.0 110.047 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 4' ' ' CYS . 5.8 m120 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.296 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.835 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.216 -0.662 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.667 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -83.81 133.27 34.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.231 -0.918 . . . . 0.0 110.176 . . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 17.1 m -135.49 141.83 45.37 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.339 -0.851 . . . . 0.0 109.832 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -126.82 154.89 76.02 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.131 -0.981 . . . . 0.0 110.557 -179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -75.76 -94.0 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.195 1.629 . . . . 0.0 110.435 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.76 136.07 34.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.481 -0.762 . . . . 0.0 110.695 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.436 ' O ' ' HB3' ' A' ' 10' ' ' ARG . 13.8 mm -55.36 -53.27 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.342 -0.849 . . . . 0.0 110.077 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.414 ' C ' ' O ' ' A' ' 7' ' ' ILE . 53.0 t -44.15 -51.43 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.259 -0.901 . . . . 0.0 110.023 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -45.65 -52.15 11.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.102 -0.999 . . . . 0.0 109.786 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.486 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -50.48 -47.07 57.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.405 -0.809 . . . . 0.0 109.867 179.63 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.483 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 4.6 t -59.85 -40.99 90.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.303 -0.873 . . . . 0.0 110.073 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -76.19 -8.32 56.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.33 -0.856 . . . . 0.0 110.254 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.667 ' CZ ' HG21 ' A' ' 2' ' ' THR . 53.9 t80 -77.05 -62.24 1.72 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.242 -0.912 . . . . 0.0 110.154 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -60.83 -34.35 74.42 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.149 -0.969 . . . . 0.0 108.899 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.533 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -60.98 -46.77 95.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.533 ' N ' HG12 ' A' ' 15' ' ' VAL . 7.0 t -55.92 -25.23 42.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.424 -0.798 . . . . 0.0 109.92 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 6.2 mmm180 -85.62 -13.19 49.46 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.304 -0.872 . . . . 0.0 110.554 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.616 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 4.0 tp -57.66 -43.58 98.9 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.198 -0.939 . . . . 0.0 111.416 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 45.0 Cg_endo -72.98 -30.42 10.95 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.309 1.163 . . . . 0.0 110.5 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 129.44 6.28 4.31 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.571 HG22 ' HD2' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -67.07 143.28 97.74 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.094 -1.239 . . . . 0.0 110.093 179.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.571 ' HD2' HG22 ' A' ' 21' ' ' THR . 43.9 Cg_endo -71.96 158.46 52.58 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.889 1.468 . . . . 0.0 110.814 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.413 ' HG3' ' CZ ' ' A' ' 13' ' ' PHE . 0.0 OUTLIER -55.45 -47.16 76.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.434 -0.791 . . . . 0.0 110.524 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.54 -45.25 26.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.232 -0.918 . . . . 0.0 110.627 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.462 HD13 ' CG2' ' A' ' 21' ' ' THR . 0.3 OUTLIER -67.14 -42.65 84.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.156 -0.965 . . . . 0.0 110.365 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 39.7 m -70.75 -52.85 18.15 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.208 -0.933 . . . . 0.0 110.179 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.449 ' HA ' ' HB2' ' A' ' 32' ' ' CYS . . . -53.12 -22.37 6.19 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 110.37 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 21.9 m -86.99 -34.44 19.26 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.211 -0.931 . . . . 0.0 110.324 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -79.08 -20.34 49.01 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.197 -0.939 . . . . 0.0 110.197 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.0 p -110.28 -24.49 10.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.156 -0.965 . . . . 0.0 110.202 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.34 61.0 1.34 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.449 ' HB2' ' HA ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -117.32 174.94 5.85 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.278 -1.131 . . . . 0.0 110.418 -179.85 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 2' ' ' THR . 1.0 OUTLIER -135.92 147.43 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.369 -0.832 . . . . 0.0 110.29 179.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.1 mt -116.17 108.88 26.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 110.156 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.998 HD12 ' O ' ' A' ' 37' ' ' GLY . 18.1 pt -88.78 145.05 34.09 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.268 -0.895 . . . . 0.0 110.342 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -74.99 -5.38 16.72 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.997 1.525 . . . . 0.0 110.345 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.998 ' O ' HD12 ' A' ' 35' ' ' ILE . . . 168.15 -160.0 33.4 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.701 ' O ' HG22 ' A' ' 39' ' ' THR . . . 66.85 15.66 10.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.251 -1.147 . . . . 0.0 110.19 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.701 HG22 ' O ' ' A' ' 38' ' ' ALA . 6.7 t 39.65 -163.87 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.52 -0.738 . . . . 0.0 110.751 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.469 ' SG ' ' HD2' ' A' ' 41' ' ' PRO . 4.4 t -122.74 140.44 33.12 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.95 . . . . 0.0 110.38 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.469 ' HD2' ' SG ' ' A' ' 40' ' ' CYS . 43.6 Cg_endo -71.08 -160.91 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.927 1.488 . . . . 0.0 110.311 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -113.52 4.75 24.77 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -96.78 -29.95 13.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.101 -1.235 . . . . 0.0 110.241 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.482 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 5.9 t80 -119.26 7.98 11.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.268 -0.895 . . . . 0.0 110.435 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.81 87.47 5.02 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.116 -0.99 . . . . 0.0 110.138 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.227 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.832 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.747 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.588 HG21 ' CE1' ' A' ' 13' ' ' PHE . 2.1 m -95.94 132.39 41.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.247 -0.908 . . . . 0.0 110.143 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.46 ' HB3' ' HA ' ' A' ' 45' ' ' ALA . 57.7 m -146.19 156.34 43.34 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.139 -0.976 . . . . 0.0 110.716 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.46 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -134.34 174.26 4.85 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.386 -0.821 . . . . 0.0 109.95 179.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.46 ' HD2' ' SG ' ' A' ' 4' ' ' CYS . 46.2 Cg_endo -72.99 -93.57 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.993 1.523 . . . . 0.0 109.913 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 7' ' ' ILE . 5.8 t -75.33 143.65 42.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.528 -0.732 . . . . 0.0 109.789 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.417 ' C ' ' O ' ' A' ' 6' ' ' SER . 71.2 mt -42.79 -47.9 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.223 -0.923 . . . . 0.0 110.125 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.426 ' O ' ' ND2' ' A' ' 12' ' ' ASN . 33.4 t -50.36 -51.19 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.222 -0.924 . . . . 0.0 110.047 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.85 -34.95 13.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.169 -0.957 . . . . 0.0 110.214 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 11' ' ' SER . 0.1 OUTLIER -65.64 -58.74 5.0 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 110.2 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.424 ' C ' ' O ' ' A' ' 10' ' ' ARG . 4.9 p -42.38 -45.07 4.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.231 -0.918 . . . . 0.0 110.323 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 8' ' ' VAL . 61.1 m-80 -57.49 -51.47 69.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.199 -0.938 . . . . 0.0 110.322 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.588 ' CE1' HG21 ' A' ' 2' ' ' THR . 6.1 t80 -54.44 -39.04 67.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.21 -0.931 . . . . 0.0 110.19 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -67.93 -23.01 65.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -0.895 . . . . 0.0 109.129 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.533 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -85.34 -46.9 17.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.302 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.533 ' N ' HG12 ' A' ' 15' ' ' VAL . 9.6 t -60.2 -14.33 16.98 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.594 -0.691 . . . . 0.0 110.312 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.504 ' NH2' ' HB3' ' A' ' 17' ' ' ARG . 7.5 mmm180 -86.98 -7.74 57.86 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.156 -0.965 . . . . 0.0 109.957 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.614 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 2.4 tp -81.18 -43.68 1.17 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.367 -0.833 . . . . 0.0 111.248 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 46.3 Cg_endo -73.34 -155.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.228 1.12 . . . . 0.0 110.214 -179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -97.99 6.36 62.03 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.615 HG22 ' HB3' ' A' ' 25' ' ' LEU . 0.6 OUTLIER -71.37 129.85 88.4 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.186 -1.185 . . . . 0.0 110.047 179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.0 157.76 53.88 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.921 1.485 . . . . 0.0 110.513 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.422 ' HG2' ' HD3' ' A' ' 17' ' ' ARG . 88.0 mt-10 -52.91 -33.84 52.27 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.363 -0.836 . . . . 0.0 110.433 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.56 -65.08 0.69 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.954 . . . . 0.0 110.328 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.615 ' HB3' HG22 ' A' ' 21' ' ' THR . 0.6 OUTLIER -52.97 -27.33 18.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.322 -0.861 . . . . 0.0 110.436 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 82.0 m -81.1 -56.52 4.04 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.16 -0.963 . . . . 0.0 110.392 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.402 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -47.99 -22.92 0.67 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.332 -0.855 . . . . 0.0 110.509 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 30.9 m -82.09 -58.57 2.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.133 -0.979 . . . . 0.0 110.535 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.7 -21.4 40.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.291 -0.881 . . . . 0.0 110.315 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.6 p -109.42 -29.13 8.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.265 -0.897 . . . . 0.0 110.209 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 85.98 20.53 55.33 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.99 173.19 8.73 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.214 -1.168 . . . . 0.0 110.393 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.423 ' C ' HG13 ' A' ' 34' ' ' ILE . 4.5 pt -130.64 152.86 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.359 -0.838 . . . . 0.0 109.774 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.423 HG13 ' C ' ' A' ' 33' ' ' ILE . 34.3 mt -131.96 118.19 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.034 -1.041 . . . . 0.0 110.749 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 1' ' ' THR . 9.2 pt -105.14 159.91 27.78 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.313 -0.867 . . . . 0.0 109.952 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -76.46 -35.65 2.07 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.925 1.487 . . . . 0.0 110.817 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -76.94 -175.6 42.2 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -111.0 19.7 18.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.246 -1.15 . . . . 0.0 110.149 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.464 ' O ' ' CD1' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -121.26 134.92 55.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.228 -0.92 . . . . 0.0 110.167 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.83 135.8 21.19 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.256 -0.903 . . . . 0.0 110.468 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 47.7 Cg_endo -73.92 149.48 42.22 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.029 1.541 . . . . 0.0 110.286 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.78 -19.01 66.95 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -59.47 -34.9 73.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -1.188 . . . . 0.0 110.293 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.414 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 0.3 OUTLIER -147.35 55.57 1.09 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.933 . . . . 0.0 110.239 -179.924 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -129.32 87.61 2.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.874 . . . . 0.0 110.181 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 117.948 -1.025 . . . . 0.0 110.251 179.988 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.842 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.738 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.706 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 2.0 m -104.72 134.32 48.07 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.261 -0.899 . . . . 0.0 110.43 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.456 ' HB2' HD11 ' A' ' 33' ' ' ILE . 83.8 m -133.55 116.21 15.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.257 -0.902 . . . . 0.0 110.172 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 0.7 OUTLIER -108.86 149.86 40.11 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.308 -0.87 . . . . 0.0 110.646 -179.748 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.525 ' O ' ' HB3' ' A' ' 46' ' ' ASN . 48.9 Cg_endo -79.07 -91.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.299 1.684 . . . . 0.0 110.479 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.542 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 6.2 t -50.18 133.24 23.72 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 110.303 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 51.5 mt -52.81 -54.3 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.174 -0.954 . . . . 0.0 109.898 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 9' ' ' ALA . 2.5 t -46.86 -47.49 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -0.935 . . . . 0.0 109.36 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 6' ' ' SER . . . -43.96 -48.5 8.64 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.276 -0.89 . . . . 0.0 109.445 179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -58.34 -41.55 84.88 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.285 -0.884 . . . . 0.0 109.666 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 8' ' ' VAL . 0.3 OUTLIER -60.14 -59.38 5.51 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.345 -0.847 . . . . 0.0 109.621 179.553 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -59.23 -25.6 64.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.207 -0.933 . . . . 0.0 109.558 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.706 ' CZ ' HG21 ' A' ' 2' ' ' THR . 24.1 t80 -71.4 -25.35 62.31 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.43 -0.794 . . . . 0.0 109.809 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.17 -46.41 34.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.314 -0.866 . . . . 0.0 109.053 179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.525 ' O ' ' CD ' ' A' ' 19' ' ' PRO . 1.1 t -56.61 -38.77 58.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.1 t -69.13 -27.65 65.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.485 -0.759 . . . . 0.0 110.455 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.518 ' CZ ' ' HB3' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -86.0 -11.84 51.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.102 -0.999 . . . . 0.0 110.616 -179.719 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.587 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -69.41 -50.03 20.92 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.206 -0.934 . . . . 0.0 110.824 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 45.4 Cg_endo -73.04 -155.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.526 0 O-C-N 123.553 1.291 . . . . 0.0 110.351 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.21 75.36 0.29 Allowed Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 m -135.93 138.71 28.45 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.247 -1.149 . . . . 0.0 109.887 179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.478 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 43.8 Cg_endo -72.19 150.76 54.07 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.982 1.517 . . . . 0.0 110.372 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.1 -49.23 66.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.325 -0.859 . . . . 0.0 110.462 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -44.19 -54.26 5.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.378 -0.826 . . . . 0.0 110.695 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.478 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.6 OUTLIER -56.7 -37.87 71.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.182 -0.949 . . . . 0.0 110.646 -179.626 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 83.7 m -78.88 -44.28 23.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.167 -0.958 . . . . 0.0 110.261 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -51.94 -24.98 7.21 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 110.408 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.1 m -89.5 -48.54 7.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.214 -0.929 . . . . 0.0 110.064 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -63.66 -22.2 66.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.352 -0.842 . . . . 0.0 110.38 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 80.6 p -110.79 -47.02 3.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.201 -0.937 . . . . 0.0 110.378 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.75 56.89 0.34 Allowed Glycine 0 N--CA 1.492 2.426 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.487 ' CB ' ' CE1' ' A' ' 13' ' ' PHE . 0.1 OUTLIER -120.36 176.37 5.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.259 -1.142 . . . . 0.0 110.063 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.456 HD11 ' HB2' ' A' ' 3' ' ' CYS . 1.0 OUTLIER -136.85 148.51 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.181 -0.949 . . . . 0.0 110.316 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 23.9 mt -104.68 132.67 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 110.132 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.867 HD12 ' O ' ' A' ' 37' ' ' GLY . 2.5 pt -103.83 155.39 37.08 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.132 -0.98 . . . . 0.0 110.392 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -79.82 44.94 1.82 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.061 1.558 . . . . 0.0 110.809 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.867 ' O ' HD12 ' A' ' 35' ' ' ILE . . . 94.55 -169.1 28.49 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.914 -1.275 . . . . 0.0 109.914 179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.695 ' HB3' ' O ' ' A' ' 37' ' ' GLY . . . 69.69 32.72 3.19 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.372 -1.075 . . . . 0.0 110.442 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.74 ' O ' HD13 ' A' ' 35' ' ' ILE . 6.2 t 37.61 -156.32 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.524 -0.735 . . . . 0.0 110.486 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.482 ' N ' HG23 ' A' ' 39' ' ' THR . 4.2 t -114.77 137.17 22.64 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.071 -1.018 . . . . 0.0 110.581 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.49 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 47.2 Cg_endo -72.27 -163.51 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.941 1.495 . . . . 0.0 110.322 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -101.44 -14.62 29.68 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.01 -32.63 67.36 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.312 -1.111 . . . . 0.0 110.33 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.461 ' O ' ' SG ' ' A' ' 40' ' ' CYS . 0.2 OUTLIER -135.5 68.32 1.46 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.313 -0.867 . . . . 0.0 110.096 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -130.45 88.93 2.7 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.111 -0.993 . . . . 0.0 110.793 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.525 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 1.2 m120 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.039 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.85 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.721 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.866 HG21 ' CE2' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -96.48 124.0 40.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.15 -0.969 . . . . 0.0 110.447 . . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 26.7 m -129.48 97.08 4.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 0.0 109.922 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.422 ' N ' ' SG ' ' A' ' 32' ' ' CYS . 22.0 m -99.2 158.02 33.01 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.295 -0.878 . . . . 0.0 110.391 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -77.08 -95.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 124.075 1.566 . . . . 0.0 110.469 -179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.7 t -54.68 134.34 47.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.462 -0.773 . . . . 0.0 110.255 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.4 mt -57.93 -44.25 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.231 -0.918 . . . . 0.0 109.852 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.3 t -50.45 -49.17 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.364 -0.835 . . . . 0.0 109.835 179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.93 -43.52 63.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.262 -0.899 . . . . 0.0 109.749 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.464 ' HG3' ' OXT' ' A' ' 46' ' ' ASN . 0.0 OUTLIER -53.81 -58.27 7.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.202 -0.936 . . . . 0.0 109.842 179.652 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -45.97 -51.11 13.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.193 -0.942 . . . . 0.0 109.477 179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -55.17 -36.73 66.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.329 -0.857 . . . . 0.0 109.137 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.866 ' CE2' HG21 ' A' ' 2' ' ' THR . 38.4 t80 -74.6 -28.58 60.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.444 -0.785 . . . . 0.0 109.435 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -68.14 -27.39 66.4 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.454 -0.779 . . . . 0.0 109.147 179.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.559 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -82.46 -49.3 17.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.184 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.559 ' N ' HG12 ' A' ' 15' ' ' VAL . 42.7 t -58.92 -20.84 55.56 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.383 -0.823 . . . . 0.0 109.973 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.534 ' CD ' ' HG3' ' A' ' 23' ' ' GLU . 2.7 tpt85 -89.61 -20.11 24.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.217 -0.927 . . . . 0.0 110.179 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.606 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 15.4 tp -56.75 -41.71 92.66 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.288 -0.882 . . . . 0.0 110.841 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 47.9 Cg_endo -76.11 -156.17 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.381 0 O-C-N 123.324 1.171 . . . . 0.0 110.293 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.84 14.35 65.33 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 -179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 m -75.5 137.65 71.01 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.11 -1.229 . . . . 0.0 110.008 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.433 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 47.9 Cg_endo -73.44 158.56 47.88 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.968 1.509 . . . . 0.0 110.587 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.534 ' HG3' ' CD ' ' A' ' 17' ' ' ARG . 1.0 OUTLIER -60.45 -49.06 79.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.34 -0.85 . . . . 0.0 110.354 -179.901 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 23' ' ' GLU . . . -43.37 -49.02 7.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 110.306 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.433 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -59.84 -47.28 86.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.278 -0.889 . . . . 0.0 110.398 -179.798 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.43 ' HB2' ' CE1' ' A' ' 13' ' ' PHE . 25.9 m -72.38 -43.86 63.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.175 -0.953 . . . . 0.0 110.21 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.6 -38.94 70.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.158 -0.963 . . . . 0.0 110.103 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.4 m -80.32 -21.83 42.14 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 0.0 110.157 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -85.32 -11.07 55.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.202 -0.936 . . . . 0.0 110.131 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 55.4 p -123.87 -31.77 3.37 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.321 -0.862 . . . . 0.0 110.126 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.58 60.05 0.52 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.422 ' SG ' ' N ' ' A' ' 4' ' ' CYS . 8.4 t -131.76 173.42 11.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.285 -1.127 . . . . 0.0 110.185 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.0 pt -135.02 157.81 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.289 -0.882 . . . . 0.0 110.33 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 1' ' ' THR . 26.2 mt -114.29 144.72 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.349 -0.845 . . . . 0.0 110.059 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.436 ' O ' HG13 ' A' ' 35' ' ' ILE . 3.8 pt -120.11 150.42 51.18 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.24 -0.913 . . . . 0.0 110.259 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.16 56.62 3.18 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.103 1.581 . . . . 0.0 110.434 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 166.52 -168.43 40.06 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -120.56 31.21 6.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.17 -1.194 . . . . 0.0 110.336 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.769 HG23 ' O ' ' A' ' 39' ' ' THR . 12.0 t -130.21 104.16 7.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.259 -0.9 . . . . 0.0 110.108 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -111.37 152.74 44.09 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.241 -0.912 . . . . 0.0 110.271 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 42' ' ' GLY . 46.8 Cg_endo -74.7 127.1 10.63 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.967 1.509 . . . . 0.0 110.402 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 45' ' ' ALA . . . -44.68 -28.49 1.64 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -51.82 -35.88 46.03 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.304 -1.116 . . . . 0.0 110.367 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.458 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 1.1 t80 -134.0 31.76 3.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 0.0 110.332 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.463 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . . . -110.07 98.03 7.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.189 -0.944 . . . . 0.0 110.276 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.464 ' OXT' ' HG3' ' A' ' 10' ' ' ARG . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 117.998 -1.001 . . . . 0.0 110.261 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.845 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.78 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.491 ' CG2' ' HB3' ' A' ' 32' ' ' CYS . 99.5 m -131.18 145.2 51.86 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.285 -0.885 . . . . 0.0 110.451 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.734 ' SG ' HD11 ' A' ' 35' ' ' ILE . 61.5 m -120.28 112.25 18.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.375 -0.828 . . . . 0.0 109.93 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.472 ' SG ' ' HD2' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -122.34 146.56 47.43 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.167 -0.958 . . . . 0.0 110.193 -179.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.547 ' HG3' ' CE2' ' A' ' 44' ' ' TYR . 48.0 Cg_endo -72.95 -93.77 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.983 1.517 . . . . 0.0 110.42 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.442 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 1.6 t -42.21 109.51 0.13 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.527 -0.733 . . . . 0.0 110.334 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.2 mt -44.23 -50.83 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.167 -0.958 . . . . 0.0 110.178 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 69.7 t -47.13 -41.79 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -0.953 . . . . 0.0 109.885 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 6' ' ' SER . . . -56.09 -47.71 77.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.92 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.47 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 0.9 OUTLIER -60.93 -42.01 97.31 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.317 -0.864 . . . . 0.0 110.295 179.891 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -54.73 -48.43 72.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.179 -0.951 . . . . 0.0 110.223 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -65.71 -22.44 66.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.153 -0.967 . . . . 0.0 110.016 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.586 ' HA ' HG21 ' A' ' 30' ' ' THR . 49.6 t80 -74.83 -35.07 62.42 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.318 -0.864 . . . . 0.0 109.945 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -64.18 -51.3 64.47 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 0.0 109.477 179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.593 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -55.57 -51.06 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.408 -0.807 . . . . 0.0 109.33 179.422 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.593 ' N ' HG12 ' A' ' 15' ' ' VAL . 53.4 t -48.39 -28.55 3.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.371 -0.831 . . . . 0.0 109.944 179.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.453 ' C ' ' HD2' ' A' ' 19' ' ' PRO . 11.1 tpt180 -83.99 -20.99 31.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.344 -0.847 . . . . 0.0 110.07 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.75 ' C ' HD13 ' A' ' 18' ' ' LEU . 3.4 tm? -49.61 -45.37 78.53 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.286 -0.884 . . . . 0.0 110.934 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 47.3 Cg_endo -73.02 -155.54 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.254 1.134 . . . . 0.0 110.033 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -98.46 50.74 1.26 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.2 m -115.5 140.06 25.45 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.21 -1.17 . . . . 0.0 110.099 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.485 ' HG2' ' HB2' ' A' ' 25' ' ' LEU . 43.8 Cg_endo -71.63 165.92 31.02 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.846 1.445 . . . . 0.0 110.315 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -69.4 -46.36 67.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -0.906 . . . . 0.0 110.424 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -46.76 -45.34 19.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.201 -0.937 . . . . 0.0 110.372 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.485 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -62.6 -48.29 80.07 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.157 -0.964 . . . . 0.0 110.281 -179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.414 ' HB2' ' CE1' ' A' ' 13' ' ' PHE . 73.0 m -68.44 -44.81 74.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.136 -0.978 . . . . 0.0 110.047 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.58 -37.13 26.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.181 -0.949 . . . . 0.0 109.867 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 74.1 m -72.73 -40.63 65.93 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.322 -0.861 . . . . 0.0 109.967 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -78.37 -9.75 59.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.331 -0.855 . . . . 0.0 110.045 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.586 HG21 ' HA ' ' A' ' 13' ' ' PHE . 17.3 p -110.54 -19.57 12.87 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.297 -0.877 . . . . 0.0 110.169 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.23 23.42 48.35 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.491 ' HB3' ' CG2' ' A' ' 2' ' ' THR . 33.4 m -101.02 171.1 7.84 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.192 -1.181 . . . . 0.0 110.231 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 3' ' ' CYS . 23.8 pt -123.47 156.04 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.917 . . . . 0.0 109.985 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.607 ' O ' HG23 ' A' ' 35' ' ' ILE . 20.9 mm -106.09 152.37 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 110.404 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.792 HD12 ' O ' ' A' ' 37' ' ' GLY . 4.6 pt -156.18 150.73 20.23 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.336 -0.852 . . . . 0.0 110.331 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.89 5.26 4.54 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.15 1.605 . . . . 0.0 110.957 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.792 ' O ' HD12 ' A' ' 35' ' ' ILE . . . -141.7 155.88 25.57 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.07 40.23 0.9 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.375 -1.073 . . . . 0.0 109.947 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.777 HG23 ' O ' ' A' ' 39' ' ' THR . 11.2 t -120.85 95.64 4.79 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.901 . . . . 0.0 110.332 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.548 ' HB2' ' HB2' ' A' ' 45' ' ' ALA . 8.2 m -81.88 166.21 38.79 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.228 -0.92 . . . . 0.0 109.699 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.525 ' O ' ' N ' ' A' ' 43' ' ' ASP . 52.8 Cg_endo -79.78 32.77 0.49 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.843 1.444 . . . . 0.0 111.593 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 65.06 -68.21 0.08 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.525 ' N ' ' O ' ' A' ' 41' ' ' PRO . 0.3 OUTLIER -48.67 -41.44 31.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.111 -1.229 . . . . 0.0 109.774 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.547 ' CE2' ' HG3' ' A' ' 5' ' ' PRO . 0.5 OUTLIER -106.34 32.78 4.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.361 -0.837 . . . . 0.0 109.887 179.629 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.548 ' HB2' ' HB2' ' A' ' 40' ' ' CYS . . . -105.31 96.33 6.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.324 -0.86 . . . . 0.0 110.243 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 45' ' ' ALA . 1.3 m-20 . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 118.02 -0.99 . . . . 0.0 110.111 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.834 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.762 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.45 ' O ' ' SG ' ' A' ' 3' ' ' CYS . 91.9 m -117.97 152.99 34.38 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.247 -0.908 . . . . 0.0 110.363 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.451 ' O ' ' SG ' ' A' ' 32' ' ' CYS . 49.1 m -153.63 154.7 34.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.344 -0.847 . . . . 0.0 110.321 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -130.13 171.31 9.15 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 109.983 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.1 -95.32 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.99 1.521 . . . . 0.0 110.707 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.4 t -76.11 157.77 32.49 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.496 -0.753 . . . . 0.0 110.423 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.409 ' O ' ' C ' ' A' ' 8' ' ' VAL . 2.4 mp -58.33 -50.07 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.882 . . . . 0.0 109.874 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.409 ' C ' ' O ' ' A' ' 7' ' ' ILE . 91.1 t -44.69 -47.97 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.312 -0.868 . . . . 0.0 109.901 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.91 -45.17 71.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.242 -0.911 . . . . 0.0 109.915 179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.425 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 9.5 ttm-85 -63.45 -48.6 77.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.388 -0.82 . . . . 0.0 110.271 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -50.11 -59.26 4.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.141 -0.975 . . . . 0.0 110.132 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -55.2 -40.45 70.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.912 . . . . 0.0 110.016 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.486 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 51.0 t80 -56.88 -43.8 81.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 0.0 110.097 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -58.4 -42.08 86.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.241 -0.912 . . . . 0.0 109.263 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.595 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -61.89 -50.65 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.599 -0.688 . . . . 0.0 109.282 179.25 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.595 ' N ' HG12 ' A' ' 15' ' ' VAL . 13.9 t -48.25 -25.61 1.61 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.443 -0.786 . . . . 0.0 110.099 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.549 ' NH2' ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -91.16 10.53 26.6 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.428 -0.795 . . . . 0.0 109.585 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.646 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 2.3 tt -84.04 -36.87 0.64 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.517 -0.739 . . . . 0.0 112.349 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 43.8 Cg_endo -72.54 -37.61 4.01 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 O-C-N 122.994 0.997 . . . . 0.0 111.356 -178.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 135.38 1.22 3.19 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.526 -1.321 . . . . 0.0 110.429 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.966 HG22 ' HD2' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -66.4 157.04 83.81 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 120.97 -1.312 . . . . 0.0 109.486 179.733 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.966 ' HD2' HG22 ' A' ' 21' ' ' THR . 47.7 Cg_endo -74.98 149.5 36.86 Favored 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.795 1.418 . . . . 0.0 110.71 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.484 ' HA ' ' CZ ' ' A' ' 17' ' ' ARG . 1.6 pt-20 -54.84 -25.4 28.35 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.349 -0.844 . . . . 0.0 110.14 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.17 -44.22 84.65 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.311 -0.868 . . . . 0.0 110.44 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.484 HD13 ' CG2' ' A' ' 21' ' ' THR . 0.5 OUTLIER -68.55 -33.69 74.54 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 110.444 -179.782 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.449 ' O ' ' OG1' ' A' ' 30' ' ' THR . 69.6 m -87.45 -32.83 19.29 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.052 -1.03 . . . . 0.0 110.581 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.58 -30.35 70.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.098 -1.001 . . . . 0.0 110.035 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.86 -28.1 17.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.239 -0.913 . . . . 0.0 110.15 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.462 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -68.84 -28.9 67.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.216 -0.928 . . . . 0.0 110.324 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 26' ' ' CYS . 0.6 OUTLIER -101.68 -30.52 11.29 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.214 -0.929 . . . . 0.0 110.092 179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.52 19.05 9.04 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -76.43 -177.55 4.19 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -1.135 . . . . 0.0 110.003 179.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 1.6 pp -145.81 159.53 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.154 -0.966 . . . . 0.0 110.485 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 53.4 mt -125.58 121.37 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.354 -0.842 . . . . 0.0 110.061 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.463 ' HB ' ' HD2' ' A' ' 36' ' ' PRO . 12.1 pt -93.46 163.79 23.38 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.205 -0.935 . . . . 0.0 110.361 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.463 ' HD2' ' HB ' ' A' ' 35' ' ' ILE . 48.7 Cg_endo -73.48 -40.09 1.71 Allowed 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.008 1.531 . . . . 0.0 110.584 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 1' ' ' THR . . . -82.77 -159.8 27.32 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -125.74 -0.08 7.4 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.279 -1.13 . . . . 0.0 110.258 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.668 HG23 ' O ' ' A' ' 39' ' ' THR . 14.3 t -105.42 118.29 36.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.309 -0.869 . . . . 0.0 109.995 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.21 146.21 31.48 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.251 -0.906 . . . . 0.0 110.314 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.699 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 46.4 Cg_endo -72.98 -166.56 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.152 1.606 . . . . 0.0 110.866 -179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -105.47 -5.62 39.48 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.517 ' OD2' ' N ' ' A' ' 44' ' ' TYR . 4.3 p30 -82.35 -24.42 34.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.262 -1.14 . . . . 0.0 110.038 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.517 ' N ' ' OD2' ' A' ' 43' ' ' ASP . 0.2 OUTLIER -144.64 47.15 1.37 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.252 -0.905 . . . . 0.0 110.311 -179.817 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -118.61 89.42 3.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 110.065 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.1 m120 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.022 -0.989 . . . . 0.0 110.258 -179.94 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.847 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.216 -0.71 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.573 HG22 ' O ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -127.85 172.66 10.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.908 . . . . 0.0 110.256 . . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.586 ' HB3' HD11 ' A' ' 33' ' ' ILE . 1.8 t -142.49 121.68 13.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.323 -0.861 . . . . 0.0 110.107 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.443 ' O ' ' OXT' ' A' ' 46' ' ' ASN . 57.8 m -120.71 150.11 51.9 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.246 -0.909 . . . . 0.0 110.214 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.518 ' HD3' ' CE2' ' A' ' 44' ' ' TYR . 52.6 Cg_endo -77.79 -94.29 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 124.125 1.592 . . . . 0.0 110.614 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.1 t -50.29 129.54 21.65 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.476 -0.765 . . . . 0.0 110.593 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.418 HD13 ' HA ' ' A' ' 7' ' ' ILE . 14.3 mm -50.71 -41.05 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.212 -0.93 . . . . 0.0 109.369 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 56.1 t -53.32 -47.3 57.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.436 -0.79 . . . . 0.0 109.715 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -49.47 -52.72 27.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.344 -0.847 . . . . 0.0 109.91 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.9 ttm-85 -55.64 -43.85 76.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.266 -0.896 . . . . 0.0 109.941 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.55 -56.97 6.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.0 109.933 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -60.08 -33.1 71.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.332 -0.855 . . . . 0.0 109.903 179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.464 ' CZ ' ' HD3' ' A' ' 17' ' ' ARG . 16.1 t80 -70.96 -35.91 72.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.0 109.804 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -73.51 -44.57 57.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.346 -0.846 . . . . 0.0 109.447 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.519 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -54.91 -47.3 76.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.459 -0.775 . . . . 0.0 109.197 179.372 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.519 ' N ' HG12 ' A' ' 15' ' ' VAL . 29.7 t -68.78 -25.53 64.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.464 -0.772 . . . . 0.0 109.93 179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.464 ' HD3' ' CZ ' ' A' ' 13' ' ' PHE . 0.2 OUTLIER -88.74 -8.44 54.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.384 -0.822 . . . . 0.0 109.879 179.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.577 ' N ' ' CD ' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -61.94 -45.62 91.95 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.462 -0.774 . . . . 0.0 110.654 179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 18' ' ' LEU . 47.4 Cg_endo -78.29 -157.41 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.759 1.4 . . . . 0.0 110.075 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -91.6 61.77 2.75 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.577 HG23 HD13 ' A' ' 25' ' ' LEU . 99.1 m -119.47 140.67 29.55 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.237 -1.155 . . . . 0.0 110.306 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.47 ' HD2' HG23 ' A' ' 21' ' ' THR . 46.9 Cg_endo -72.31 170.37 19.36 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 124.006 1.53 . . . . 0.0 110.841 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.463 ' O ' ' N ' ' A' ' 25' ' ' LEU . 1.4 mt-10 -72.44 -55.27 7.29 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.358 -0.839 . . . . 0.0 110.477 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.451 ' C ' ' O ' ' A' ' 23' ' ' GLU . . . -39.8 -28.48 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.355 -0.84 . . . . 0.0 110.603 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.577 HD13 HG23 ' A' ' 21' ' ' THR . 0.7 OUTLIER -81.3 -50.13 9.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.169 -0.957 . . . . 0.0 110.599 -179.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.2 m -83.5 -27.6 29.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.141 -0.975 . . . . 0.0 110.666 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -74.14 -49.31 24.3 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.168 -0.957 . . . . 0.0 110.561 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.2 m -76.17 -23.41 54.72 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.224 -0.922 . . . . 0.0 110.503 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.428 ' CB ' ' O ' ' A' ' 25' ' ' LEU . 48.1 t80 -81.44 -6.41 58.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.21 -0.931 . . . . 0.0 110.413 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 31.3 p -119.19 -21.71 7.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.308 -0.87 . . . . 0.0 110.189 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.85 38.93 3.26 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 57.0 m -108.86 -179.34 3.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.18 -1.188 . . . . 0.0 110.23 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.586 HD11 ' HB3' ' A' ' 3' ' ' CYS . 9.1 pt -126.17 149.26 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.271 -0.893 . . . . 0.0 110.398 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.7 mt -109.0 124.65 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.265 -0.897 . . . . 0.0 109.957 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.419 ' CD1' ' O ' ' A' ' 39' ' ' THR . 23.5 pt -123.44 135.34 25.96 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.161 -0.962 . . . . 0.0 110.51 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -77.79 53.98 4.62 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.958 1.504 . . . . 0.0 110.489 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -164.08 -155.97 8.59 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -134.31 29.25 3.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.261 -1.141 . . . . 0.0 110.218 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.419 ' O ' ' CD1' ' A' ' 35' ' ' ILE . 13.1 t -130.02 161.93 29.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.0 110.085 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.6 m -138.93 166.62 23.65 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.247 -0.908 . . . . 0.0 110.197 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.43 ' HG2' ' OD1' ' A' ' 43' ' ' ASP . 50.0 Cg_endo -79.27 15.51 1.54 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.937 1.493 . . . . 0.0 111.189 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.32 -64.16 3.53 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.433 ' CG ' ' N ' ' A' ' 44' ' ' TYR . 4.6 p-10 -52.77 -44.14 66.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.272 -1.134 . . . . 0.0 110.971 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.518 ' CE2' ' HD3' ' A' ' 5' ' ' PRO . 1.8 m-85 -89.87 -2.13 58.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.066 -1.021 . . . . 0.0 110.5 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.501 ' O ' ' ND2' ' A' ' 46' ' ' ASN . . . -75.31 87.93 2.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.214 -0.929 . . . . 0.0 110.407 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.502 ' HB3' ' O ' ' A' ' 5' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.136 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.851 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.214 -0.776 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.1 m -138.23 145.73 41.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.259 -0.901 . . . . 0.0 109.991 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.511 ' HB2' HD11 ' A' ' 33' ' ' ILE . 29.9 m -139.21 128.58 24.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.201 -0.937 . . . . 0.0 110.345 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -123.25 165.24 23.34 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.294 -0.879 . . . . 0.0 110.214 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.456 ' O ' ' CB ' ' A' ' 46' ' ' ASN . 47.8 Cg_endo -73.87 -93.97 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.924 1.486 . . . . 0.0 110.524 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.9 t -62.38 154.99 26.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.583 -0.698 . . . . 0.0 110.339 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.549 HD13 ' O ' ' A' ' 46' ' ' ASN . 48.7 mm -66.28 -30.01 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.333 -0.854 . . . . 0.0 109.776 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 57.7 t -69.44 -44.1 80.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.329 -0.857 . . . . 0.0 109.794 179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.76 -42.1 67.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.394 -0.816 . . . . 0.0 110.067 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.459 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 5.2 ttp180 -67.22 -50.96 58.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.271 -0.893 . . . . 0.0 110.154 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.1 t -50.84 -46.26 60.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.256 -0.902 . . . . 0.0 110.334 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -61.71 -30.49 70.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.296 -0.877 . . . . 0.0 110.329 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.459 ' HB3' ' O ' ' A' ' 10' ' ' ARG . 48.5 t80 -67.9 -40.47 83.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.918 . . . . 0.0 110.232 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 25.1 m-20 -58.05 -47.46 83.05 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -0.941 . . . . 0.0 109.381 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.604 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -54.31 -51.57 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.494 -0.754 . . . . 0.0 109.278 179.319 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.604 ' N ' HG12 ' A' ' 15' ' ' VAL . 35.4 t -48.66 -28.23 3.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.573 -0.704 . . . . 0.0 110.217 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.492 ' NE ' ' O ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -88.6 -14.06 38.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.243 -0.911 . . . . 0.0 110.35 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.797 HD13 ' O ' ' A' ' 18' ' ' LEU . 1.8 tm? -54.89 -43.56 98.88 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.241 -0.912 . . . . 0.0 111.182 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 47.7 Cg_endo -75.86 -90.11 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.395 0 O-C-N 123.382 1.201 . . . . 0.0 110.495 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -175.12 55.7 0.12 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.671 HG22 ' HD2' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -106.76 146.18 32.57 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.293 -1.122 . . . . 0.0 110.059 179.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.671 ' HD2' HG22 ' A' ' 21' ' ' THR . 44.0 Cg_endo -72.04 136.0 26.35 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.903 1.475 . . . . 0.0 110.404 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 22' ' ' PRO . 3.9 mt-10 -39.7 -46.13 1.81 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.461 -0.774 . . . . 0.0 110.779 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -51.11 -38.51 52.27 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.324 -0.86 . . . . 0.0 111.038 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.472 ' HB2' ' HG2' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -72.51 -42.71 64.53 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.112 -0.993 . . . . 0.0 110.81 -179.248 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.429 ' SG ' ' HB ' ' A' ' 21' ' ' THR . 73.8 m -74.49 -39.95 62.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.156 -0.965 . . . . 0.0 110.319 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.8 -41.81 92.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.139 -0.975 . . . . 0.0 110.238 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 38.7 m -75.09 -21.02 59.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.24 -0.913 . . . . 0.0 110.281 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -85.04 -20.9 29.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.283 -0.885 . . . . 0.0 110.24 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.7 p -120.01 -16.16 8.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.888 . . . . 0.0 110.342 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 80.96 53.58 3.9 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.53 -175.17 2.66 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.207 -1.172 . . . . 0.0 110.168 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' A' ' 3' ' ' CYS . 1.2 pt -142.04 147.42 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 110.41 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.543 ' O ' HG23 ' A' ' 35' ' ' ILE . 2.2 mp -115.11 139.69 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.445 -0.785 . . . . 0.0 110.129 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.543 HG23 ' O ' ' A' ' 34' ' ' ILE . 0.9 OUTLIER -154.68 121.15 2.74 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.199 -0.938 . . . . 0.0 110.367 -179.848 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.32 55.52 3.04 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.896 1.472 . . . . 0.0 110.686 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -118.83 -175.69 16.33 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.26 -85.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.182 -1.187 . . . . 0.0 110.298 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.3 t -116.04 175.0 5.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 110.286 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -110.94 160.7 27.89 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.239 -0.913 . . . . 0.0 110.258 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.403 ' O ' ' N ' ' A' ' 45' ' ' ALA . 44.9 Cg_endo -72.27 135.04 23.99 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.94 1.495 . . . . 0.0 110.424 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.475 ' HA2' ' HB3' ' A' ' 45' ' ' ALA . . . -46.25 -38.73 9.02 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -48.15 -27.1 2.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.164 -1.198 . . . . 0.0 110.314 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.58 6.41 2.5 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.27 -0.894 . . . . 0.0 110.392 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.475 ' HB3' ' HA2' ' A' ' 42' ' ' GLY . . . -90.94 89.45 7.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.111 -0.993 . . . . 0.0 110.147 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.549 ' O ' HD13 ' A' ' 7' ' ' ILE . 43.0 m-20 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.131 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.845 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.725 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 99.3 m -135.44 148.59 49.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.287 -0.883 . . . . 0.0 110.225 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.503 ' SG ' HD11 ' A' ' 35' ' ' ILE . 19.0 m -128.94 131.23 47.5 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.269 -0.894 . . . . 0.0 110.174 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.472 ' CB ' ' OXT' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -122.02 153.48 60.93 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.225 -0.922 . . . . 0.0 110.324 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.551 ' HD3' ' CE1' ' A' ' 44' ' ' TYR . 50.9 Cg_endo -78.1 -93.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.08 1.568 . . . . 0.0 110.719 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.81 138.05 58.31 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.547 -0.721 . . . . 0.0 110.914 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.416 ' O ' ' HB3' ' A' ' 10' ' ' ARG . 89.0 mt -47.92 -38.9 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.265 -0.897 . . . . 0.0 109.808 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.458 ' O ' ' OG ' ' A' ' 11' ' ' SER . 94.4 t -51.71 -61.49 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.381 -0.824 . . . . 0.0 110.285 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.442 ' O ' ' OD1' ' A' ' 12' ' ' ASN . . . -45.91 -32.3 2.61 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.159 -0.963 . . . . 0.0 110.251 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 46' ' ' ASN . 0.3 OUTLIER -74.87 -46.96 32.72 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.306 -0.871 . . . . 0.0 110.748 -179.734 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 8' ' ' VAL . 10.6 p -54.88 -69.05 0.14 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.091 -1.006 . . . . 0.0 110.534 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 13' ' ' PHE . 9.4 p30 -51.15 -37.6 47.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.167 -0.958 . . . . 0.0 110.656 -179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.516 ' N ' ' OD1' ' A' ' 12' ' ' ASN . 37.0 t80 -50.82 -50.04 57.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.146 -0.971 . . . . 0.0 110.538 -179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.509 ' OD1' ' NH2' ' A' ' 17' ' ' ARG . 18.9 m-80 -63.91 -41.84 97.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.191 -0.943 . . . . 0.0 109.604 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.561 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -59.61 -48.84 85.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.52 -0.737 . . . . 0.0 109.424 179.369 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.561 ' N ' HG12 ' A' ' 15' ' ' VAL . 44.8 t -57.16 -22.8 42.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.588 -0.695 . . . . 0.0 110.342 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.509 ' NH2' ' OD1' ' A' ' 14' ' ' ASN . 9.7 mtm180 -83.78 -3.98 58.28 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.1 -1.0 . . . . 0.0 110.244 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.611 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 16.6 tp -71.68 -47.75 12.2 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 0.0 110.749 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 46.1 Cg_endo -71.33 -155.81 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.352 1.185 . . . . 0.0 110.39 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.98 2.55 87.12 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 -179.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.511 HG22 ' HB3' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -72.83 125.49 91.13 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.092 -1.24 . . . . 0.0 109.982 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.29 146.95 46.52 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.883 1.465 . . . . 0.0 110.521 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.496 ' HG3' ' N ' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -50.21 -22.56 1.78 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.274 -0.891 . . . . 0.0 110.176 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.496 ' N ' ' HG3' ' A' ' 23' ' ' GLU . . . -67.27 -48.78 66.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.932 . . . . 0.0 110.013 179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.511 ' HB3' HG22 ' A' ' 21' ' ' THR . 1.0 OUTLIER -69.25 -30.52 68.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.873 . . . . 0.0 109.843 179.707 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 78.7 m -75.97 -49.67 17.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.283 -0.885 . . . . 0.0 109.967 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.39 -25.62 50.37 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.155 -0.965 . . . . 0.0 109.819 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.6 m -89.91 -18.85 25.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.307 -0.871 . . . . 0.0 110.025 179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.427 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 1.6 t80 -89.01 -20.36 24.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.395 -0.816 . . . . 0.0 110.402 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.6 p -108.42 -39.86 5.3 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.153 -0.967 . . . . 0.0 110.394 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.22 32.51 1.05 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.89 174.58 6.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -1.13 . . . . 0.0 110.14 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.408 HG12 ' CD1' ' A' ' 44' ' ' TYR . 2.6 pt -138.62 147.54 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 110.362 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.9 mp -109.17 138.36 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.329 -0.857 . . . . 0.0 110.259 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.503 HD11 ' SG ' ' A' ' 3' ' ' CYS . 21.8 pt -134.24 143.94 49.17 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.317 -0.864 . . . . 0.0 110.203 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.72 -10.84 23.73 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.014 1.534 . . . . 0.0 110.435 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -71.75 -169.49 11.28 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -113.54 -25.48 8.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.238 -1.154 . . . . 0.0 110.248 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.0 t -117.27 159.85 22.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 110.266 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.479 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 87.6 m -98.9 165.83 14.22 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.279 -0.888 . . . . 0.0 109.976 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 40' ' ' CYS . 43.1 Cg_endo -70.98 -166.23 0.22 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.88 1.463 . . . . 0.0 110.272 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -104.72 -1.94 43.03 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -108.64 -6.5 15.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.229 -1.159 . . . . 0.0 110.218 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.551 ' CE1' ' HD3' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -143.59 36.46 1.32 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.217 -0.927 . . . . 0.0 110.155 179.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -99.51 88.23 3.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.288 -0.882 . . . . 0.0 110.297 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 10' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.25 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.85 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.216 -0.685 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.491 HG21 ' CZ ' ' A' ' 13' ' ' PHE . 0.3 OUTLIER -114.31 151.36 33.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 110.378 . . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.412 ' C ' ' SG ' ' A' ' 32' ' ' CYS . 77.4 m -144.85 113.42 6.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.39 -0.819 . . . . 0.0 109.644 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.514 ' O ' ' CB ' ' A' ' 46' ' ' ASN . 65.6 m -99.41 151.21 37.35 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.929 . . . . 0.0 110.513 -179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 44' ' ' TYR . 50.8 Cg_endo -76.72 -93.39 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.998 1.525 . . . . 0.0 110.503 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.67 137.5 58.28 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.595 -0.69 . . . . 0.0 110.598 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.471 ' O ' ' HB3' ' A' ' 10' ' ' ARG . 10.0 mt -54.39 -33.64 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.18 -0.95 . . . . 0.0 109.789 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.6 t -48.98 -53.08 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.13 -0.981 . . . . 0.0 109.581 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.11 -40.43 73.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.268 -0.895 . . . . 0.0 109.48 179.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.491 ' CZ ' ' OXT' ' A' ' 46' ' ' ASN . 0.6 OUTLIER -52.9 -57.02 11.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.41 -0.806 . . . . 0.0 109.932 179.581 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 14' ' ' ASN . 9.6 m -51.42 -40.86 60.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.255 -0.903 . . . . 0.0 109.921 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -64.25 -43.98 93.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.331 -0.856 . . . . 0.0 109.867 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.491 ' CZ ' HG21 ' A' ' 2' ' ' THR . 10.9 t80 -53.72 -26.79 24.7 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -0.855 . . . . 0.0 109.828 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 11' ' ' SER . 48.5 m-80 -74.83 -43.7 53.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.377 -0.827 . . . . 0.0 109.598 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.557 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -63.9 -49.17 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.406 -0.809 . . . . 0.0 109.41 179.594 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.557 ' N ' HG12 ' A' ' 15' ' ' VAL . 42.3 t -52.4 -41.81 63.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.362 -0.836 . . . . 0.0 110.222 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -80.93 -2.0 45.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.284 -0.885 . . . . 0.0 110.531 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.586 ' HB3' ' HD3' ' A' ' 19' ' ' PRO . 3.9 tp -51.75 -54.17 42.9 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.085 -1.009 . . . . 0.0 110.259 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.586 ' HD3' ' HB3' ' A' ' 18' ' ' LEU . 43.9 Cg_endo -69.6 -52.72 0.32 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.38 1.2 . . . . 0.0 110.396 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 146.19 39.43 0.05 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.65 HG21 HD22 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -87.37 152.0 51.79 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.19 -1.182 . . . . 0.0 109.768 179.769 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.62 ' HD2' HG22 ' A' ' 21' ' ' THR . 43.5 Cg_endo -70.93 155.21 62.5 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.823 1.433 . . . . 0.0 110.57 -179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 24' ' ' ALA . 1.5 mp0 -53.64 -49.67 67.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.316 -0.865 . . . . 0.0 110.511 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.456 ' O ' ' OG1' ' A' ' 28' ' ' THR . . . -42.33 -49.74 5.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.225 -0.922 . . . . 0.0 110.341 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.65 HD22 HG21 ' A' ' 21' ' ' THR . 0.2 OUTLIER -59.82 -42.6 93.87 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 110.506 -179.841 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.546 ' O ' HG23 ' A' ' 30' ' ' THR . 27.5 m -77.93 -50.12 12.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.163 -0.961 . . . . 0.0 110.472 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.51 -20.23 64.41 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.239 -0.913 . . . . 0.0 110.366 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 24' ' ' ALA . 46.3 m -88.04 -26.27 22.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.894 . . . . 0.0 110.378 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -101.77 -10.49 19.89 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.152 -0.968 . . . . 0.0 110.399 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.546 HG23 ' O ' ' A' ' 26' ' ' CYS . 76.4 p -103.66 -27.16 12.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.0 110.274 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 103.48 28.97 5.82 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.412 ' SG ' ' C ' ' A' ' 3' ' ' CYS . 1.6 t -99.73 -178.17 3.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.349 -1.089 . . . . 0.0 110.306 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 7.7 pt -139.43 148.79 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.293 -0.879 . . . . 0.0 110.23 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 19.4 mt -112.25 133.97 56.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 109.976 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.654 HD11 ' O ' ' A' ' 39' ' ' THR . 17.3 pt -119.38 154.14 53.96 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 110.119 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.63 -16.79 30.17 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.145 1.603 . . . . 0.0 110.645 -179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -72.16 -160.17 4.67 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.13 10.25 5.36 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.167 -1.196 . . . . 0.0 110.222 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.654 ' O ' HD11 ' A' ' 35' ' ' ILE . 11.7 t -140.38 169.92 16.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.199 -0.938 . . . . 0.0 110.308 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 2' ' ' THR . 23.4 m -104.23 166.58 11.37 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.235 -0.916 . . . . 0.0 109.971 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.979 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 43.1 Cg_endo -70.35 -178.25 2.47 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.984 1.518 . . . . 0.0 110.552 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -96.21 -8.56 57.64 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -114.97 -29.17 6.78 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -1.156 . . . . 0.0 110.04 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 5' ' ' PRO . 0.5 OUTLIER -107.47 9.36 29.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 110.151 179.889 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.979 ' HB2' ' O ' ' A' ' 41' ' ' PRO . . . -72.75 90.9 1.44 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.352 -0.842 . . . . 0.0 110.271 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.514 ' CB ' ' O ' ' A' ' 4' ' ' CYS . 1.6 m-20 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.156 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.838 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.726 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.436 HG22 ' SG ' ' A' ' 32' ' ' CYS . 1.1 m -85.88 145.19 27.29 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.182 -0.949 . . . . 0.0 109.986 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.412 ' C ' ' SG ' ' A' ' 32' ' ' CYS . 0.5 OUTLIER -139.69 91.99 2.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.21 -0.931 . . . . 0.0 110.297 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.478 ' N ' ' SG ' ' A' ' 32' ' ' CYS . 25.7 m -96.5 165.64 15.72 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.28 -0.887 . . . . 0.0 110.09 179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.553 ' O ' ' CB ' ' A' ' 46' ' ' ASN . 49.3 Cg_endo -78.59 -92.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 124.31 1.689 . . . . 0.0 110.442 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 7' ' ' ILE . 1.4 t -75.55 143.29 42.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.499 -0.75 . . . . 0.0 109.932 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.401 ' C ' ' O ' ' A' ' 6' ' ' SER . 11.8 mt -42.76 -52.91 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.188 -0.945 . . . . 0.0 110.198 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 31.7 t -43.09 -54.03 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 109.985 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.64 -40.4 19.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.306 -0.871 . . . . 0.0 109.962 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.0 ttm180 -63.78 -49.87 71.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.327 -0.858 . . . . 0.0 110.077 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.61 -50.53 65.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.875 . . . . 0.0 110.021 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.444 ' O ' HG12 ' A' ' 15' ' ' VAL . 38.5 m-80 -51.3 -40.02 58.1 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -0.883 . . . . 0.0 110.07 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.58 ' CZ ' ' HB2' ' A' ' 23' ' ' GLU . 71.7 t80 -60.15 -54.04 50.64 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.227 -0.921 . . . . 0.0 110.043 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.4 m-80 -62.91 -24.89 68.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.295 -0.878 . . . . 0.0 109.19 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.601 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -78.59 -50.72 18.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.404 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.601 ' N ' HG12 ' A' ' 15' ' ' VAL . 46.3 t -51.64 -20.97 2.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.412 -0.805 . . . . 0.0 110.118 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.407 ' HD2' ' HB3' ' A' ' 23' ' ' GLU . 0.0 OUTLIER -89.45 10.12 23.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.211 -0.931 . . . . 0.0 110.167 179.829 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.62 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 2.3 tp -83.44 -42.0 0.81 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.199 -0.938 . . . . 0.0 111.575 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 46.1 Cg_endo -73.9 -94.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.331 1.174 . . . . 0.0 111.0 -179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -160.82 33.46 0.4 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.495 HG22 ' HD2' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -107.13 141.58 23.22 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.229 -1.159 . . . . 0.0 110.087 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.495 ' HD2' HG22 ' A' ' 21' ' ' THR . 44.9 Cg_endo -70.96 136.25 29.38 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.984 1.518 . . . . 0.0 110.313 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.58 ' HB2' ' CZ ' ' A' ' 13' ' ' PHE . 5.7 pt-20 -42.35 -32.23 0.49 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.24 -0.913 . . . . 0.0 110.205 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -47.43 -59.54 3.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.171 -0.956 . . . . 0.0 109.945 179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.502 HD23 ' O ' ' A' ' 25' ' ' LEU . 1.0 OUTLIER -61.96 -28.52 69.61 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.183 -0.948 . . . . 0.0 109.938 179.806 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.471 ' O ' HG23 ' A' ' 30' ' ' THR . 58.6 m -73.62 -50.88 18.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 110.381 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.63 -43.12 79.95 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.188 -0.945 . . . . 0.0 110.348 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.8 m -64.69 -28.67 69.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.221 -0.924 . . . . 0.0 110.511 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -97.91 -34.0 11.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.105 -0.997 . . . . 0.0 110.565 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.471 HG23 ' O ' ' A' ' 26' ' ' CYS . 63.9 p -77.62 -8.13 57.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.198 -0.939 . . . . 0.0 110.161 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.464 ' O ' ' HD3' ' A' ' 5' ' ' PRO . . . 70.95 42.71 59.36 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.478 ' SG ' ' N ' ' A' ' 4' ' ' CYS . 14.3 t -127.26 170.15 12.75 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.103 -1.233 . . . . 0.0 110.081 179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.575 HD12 HG23 ' A' ' 35' ' ' ILE . 1.1 pt -140.32 156.98 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.099 -1.0 . . . . 0.0 110.439 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.46 ' HA ' ' O ' ' A' ' 1' ' ' THR . 8.3 mt -110.84 127.31 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.342 -0.849 . . . . 0.0 110.092 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.575 HG23 HD12 ' A' ' 33' ' ' ILE . 2.0 pt -119.25 140.9 29.63 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.155 -0.966 . . . . 0.0 110.586 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -78.2 57.29 6.12 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 124.109 1.584 . . . . 0.0 110.516 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.553 ' O ' HD12 ' A' ' 35' ' ' ILE . . . 171.32 166.93 30.87 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.49 10.86 18.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.339 -1.095 . . . . 0.0 110.248 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.514 ' O ' HD13 ' A' ' 35' ' ' ILE . 7.7 t -98.62 136.19 39.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.183 -0.948 . . . . 0.0 110.082 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.47 ' SG ' ' HD2' ' A' ' 41' ' ' PRO . 0.5 OUTLIER -152.2 145.05 17.19 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.298 -0.876 . . . . 0.0 110.279 -179.769 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.47 ' HD2' ' SG ' ' A' ' 40' ' ' CYS . 47.7 Cg_endo -74.08 166.68 29.01 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.979 1.515 . . . . 0.0 110.276 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -68.98 -22.75 75.98 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -61.67 -34.18 75.27 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.235 -1.156 . . . . 0.0 110.208 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -136.38 66.13 1.5 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 110.173 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.477 ' O ' ' CB ' ' A' ' 46' ' ' ASN . . . -121.87 86.71 2.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.097 -1.002 . . . . 0.0 110.648 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.553 ' CB ' ' O ' ' A' ' 5' ' ' PRO . 1.5 m-20 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.084 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.844 ' CB ' ' N ' ' A' ' 1' ' ' THR . . . . . . . . 0 C--O 1.215 -0.728 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.435 HG22 ' SG ' ' A' ' 32' ' ' CYS . 1.3 m -94.26 134.04 37.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.215 -0.928 . . . . 0.0 110.231 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 44' ' ' TYR . 59.4 m -128.31 113.78 16.06 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.885 . . . . 0.0 110.182 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -105.88 169.01 7.44 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 0.0 110.28 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.537 ' HD2' ' HB1' ' A' ' 9' ' ' ALA . 48.4 Cg_endo -72.77 -94.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.973 1.512 . . . . 0.0 110.986 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.6 ' O ' ' HB3' ' A' ' 9' ' ' ALA . 30.6 t -78.89 156.7 28.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.463 -0.773 . . . . 0.0 110.699 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 34.9 mt -49.29 -54.48 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -0.874 . . . . 0.0 109.836 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.5 t -46.7 -42.87 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.893 . . . . 0.0 109.492 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.6 ' HB3' ' O ' ' A' ' 6' ' ' SER . . . -50.44 -40.62 51.01 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.312 -0.868 . . . . 0.0 109.413 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.471 ' O ' ' HB3' ' A' ' 13' ' ' PHE . 0.8 OUTLIER -70.69 -43.99 67.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.436 -0.79 . . . . 0.0 109.67 179.518 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 43.9 t -48.99 -63.15 1.18 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.258 -0.901 . . . . 0.0 109.735 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.5 m-80 -47.1 -47.01 23.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.783 179.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.471 ' HB3' ' O ' ' A' ' 10' ' ' ARG . 11.2 t80 -54.41 -38.29 66.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.387 -0.821 . . . . 0.0 109.769 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -70.66 -30.09 66.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 108.999 179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -65.22 -44.3 95.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.523 0.678 . . . . 0.0 109.24 179.242 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.482 ' N ' HG12 ' A' ' 15' ' ' VAL . 37.9 t -65.45 -26.16 67.83 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.465 -0.772 . . . . 0.0 110.435 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 3.9 mmm180 -75.61 -33.17 60.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.223 -0.923 . . . . 0.0 110.468 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.55 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -50.51 -52.51 54.81 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.16 -0.963 . . . . 0.0 110.541 -179.775 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 18' ' ' LEU . 47.6 Cg_endo -71.65 -156.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.413 1.217 . . . . 0.0 110.299 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.93 59.22 0.42 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.494 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 6.7 m -113.24 144.26 30.85 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.354 -1.086 . . . . 0.0 110.08 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.494 ' HD2' ' CG2' ' A' ' 21' ' ' THR . 45.6 Cg_endo -71.98 151.4 56.19 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 124.038 1.547 . . . . 0.0 110.382 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -53.69 -32.88 53.52 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.301 -0.874 . . . . 0.0 110.154 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.456 ' O ' ' HB ' ' A' ' 28' ' ' THR . . . -57.93 -50.65 72.64 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.323 -0.861 . . . . 0.0 110.542 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.474 ' HB3' ' CG2' ' A' ' 21' ' ' THR . 0.1 OUTLIER -65.69 -26.88 67.97 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.074 -1.016 . . . . 0.0 110.358 -179.65 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 19.0 m -81.64 -49.13 10.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.235 -0.916 . . . . 0.0 110.412 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.446 ' O ' ' N ' ' A' ' 31' ' ' GLY . . . -72.2 -50.14 29.91 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.148 -0.97 . . . . 0.0 110.622 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.456 ' HB ' ' O ' ' A' ' 24' ' ' ALA . 80.4 m -59.62 -44.97 93.25 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.23 -0.919 . . . . 0.0 110.85 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -67.37 -15.62 63.79 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.104 -0.997 . . . . 0.0 110.637 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.3 p -110.98 -22.16 11.64 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.114 -0.991 . . . . 0.0 110.512 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 27' ' ' ALA . . . 98.89 23.21 11.96 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.435 ' SG ' HG22 ' A' ' 2' ' ' THR . 0.1 OUTLIER -84.44 175.01 9.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.329 -1.101 . . . . 0.0 109.922 179.837 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.502 ' CD1' HG23 ' A' ' 35' ' ' ILE . 2.3 pp -138.93 152.7 24.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.134 -0.979 . . . . 0.0 110.484 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.3 mt -115.19 124.46 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.39 -0.819 . . . . 0.0 110.363 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.502 HG23 ' CD1' ' A' ' 33' ' ' ILE . 11.8 pt -110.89 148.01 37.71 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.18 -0.95 . . . . 0.0 110.207 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -76.09 51.62 3.2 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.951 1.501 . . . . 0.0 110.627 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -176.42 -173.38 42.0 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -116.75 31.6 6.65 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.266 -1.138 . . . . 0.0 110.169 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.0 113.1 7.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.179 -0.951 . . . . 0.0 110.255 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.455 ' HB3' ' HB2' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -106.94 163.1 17.67 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.894 . . . . 0.0 110.131 179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.454 ' O ' ' HB2' ' A' ' 45' ' ' ALA . 45.2 Cg_endo -72.42 162.99 39.94 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.918 1.483 . . . . 0.0 110.462 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -84.29 11.61 57.61 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -99.79 -21.69 15.66 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -1.148 . . . . 0.0 110.185 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.479 ' O ' ' HB3' ' A' ' 3' ' ' CYS . 1.7 t80 -150.08 48.08 0.92 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.24 -0.912 . . . . 0.0 110.092 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.455 ' HB2' ' HB3' ' A' ' 40' ' ' CYS . . . -121.83 101.45 7.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.324 -0.86 . . . . 0.0 110.275 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.035 -0.983 . . . . 0.0 110.068 179.891 . . . . . . . . 0 0 . 1 stop_ save_